table 2: protective action criteria (pac) rev 22b based on ... · limit values (tlvs), recommended...

Table 4: Protective Action Criteria (PAC) Rev 24B in mass per unit volume (mg/m3), based on applicable AEGLs, ERPGs, or TEELs (Chemicals listed in alphabetical order) PAC Rev 24B – June 2009

Table 4 presents an alphabetical listing of the chemicals in the PAC data set and provides Chemical Abstract Service Registry Numbers (CASRNs), PAC data, and technical information on the source of the PAC values. Table 4 provides PAC values for TEEL-0, PAC-1, PAC-2, and PAC-3 in units of mass per unit volume, with the ppm to mg/m3 conversion (carried out at 25 ºC and 760 mm Hg) performed before rounding.

The columns presented in Table 4 provide the following information:

Heading Definition

No. The ordered numbering of the chemicals as they appear in this alphabetical listing.

Chemical Name The common name of the chemical.

CASRN The Chemical Abstract Service Registry Number for this chemical.

TEEL-0 This is the threshold concentration below which most people will experience no appreciable risk of health effects. This PAC is always based on TEEL-0 because AEGL-0 or ERPG-0 values do not exist.

PAC-1 Based on the applicable AEGL-1, ERPG-1, or TEEL-1 value.



Source of PACs: TEEL-0, PAC-1, PAC-2, PAC-3

Technical comments by the developers of the PAC data set that indicate the source of the data used to derive PAC values. The term “SAR,” often in red font, stands for “Structure Activity Relationships.” Other abbreviations are defined below or in the introductory material found at: http://www.hss.energy.gov/HealthSafety/WSHP/chem_safety/teel.html/. This column will be enhanced in the near future to improve the clarity and completeness of its information.

Chemicals for which AEGLs are available have their chemical name, CASRN, and actual values displayed in a bolded and larger font. Chemicals for which ERPGs are available, but no AEGLs, have their chemical name and CASRN displayed in a bolded font. Chemicals for which TEELs are available, but no AEGLs or ERPGs, have their chemical name and CASRN displayed using a regular font.

The following information is pertinent to the derivation of hierarchy-based TEEL values:

Values are restricted by the hierarchy-based TEEL for the next higher category so that: TEEL-0 ≤ PAC-1 ≤ PAC-2 ≤ PAC-3.

The most recent available references for Permissible Exposure Limits (PELs), Threshold Limit Values (TLVs), Recommended Exposure Limits (RELs), Workplace Environmental Exposure Levels (WEELs), and German limits (MAKs) are used. The most convenient

Introduction to PAC Table 4 – PAC Rev 24B – 06/19/2009 1

http://www.hss.energy.gov/HealthSafety/WSHP/chem_safety/teel.html/

source for these values is the Guide to Occupational Exposure Values – 2008, compiled by the American Conference of Governmental Industrial Hygienists.

For particulate materials, limits used (in mg/m3) are for total dust, even though limits are sometimes also given for the respirable fraction.

PNOS = Particulates Not Otherwise Specified. This TLV-TWA value is for total dust, and the respirable fraction is assumed to be 30% of total concentration.

For substances that are in particulate form, all TEEL values have been reduced to a maximum value of 500 mg/m3. This concentration constitutes an upper bound for a stable cloud of respirable dust. The reason for this is that the coagulation rate of particles is a function of the square of the concentration number. Higher concentrations are unstable.

For a few chemicals whose ERPG-1 value was odor-based rather than toxicity-based, the PAC-1 value was adjusted to the PEL-STEL, TLV-STEL, or 3 x TLV-TWA value. This is noted in the Source of PACs Column when this substitution is made.

In the absence of other concentration limits or appropriate toxicity data for a chemical, a few values are based on British, Finnish, Russian, or other guidelines.

The usual order of use of toxicity data for TEEL-2 and/or TEEL-3 is subordinate to human toxicity data for a particular chemical. A few values depart from the usual guidelines and are estimates based on existing concentration limits (at other TEEL values) and/or a comparison with similar chemicals and/or a review of available toxicity data. For example, the TEEL-3 value for 1-Bromo-3-chloro-5,5-dimethylhydantoin is estimated from the toxicity-based TEEL-3 for 3-Bromo-1-chloro-5,5-dimethylhydantoin.

The PAC values presented in these tables are toxicity-based. In order to alert users as to the potential for other explosion and flammability hazards, Table 2 uses special formatting to indicate the relationship of these values to the Lower Explosive Limit (LEL) of a chemical substance.

Table 4, other PAC Tables, introductory/explanatory material (including a glossary of acronyms and abbreviations), definitions of PAC values, and alternative methods of displaying PAC information are available electronically at: http://www.hss.energy.gov/HealthSafety/WSHP/chem_safety/teel.html.

Additional information on the chemicals presented here is provided in PAC Tables 1, 2, and 3. Definitions for AEGLs, ERPGs, and TEELs are provided in the Introduction to PAC Tables 2 and 3.

Additional information on PAC values and TEELs and links to other sources of information is provided on the Subcommittee for Consequence Assessment and Protective Action (SCAPA) webpages at: http://orise.orau.gov/emi/scapa/teels.htm.

Introduction to PAC Table 4 – PAC Rev 24B – 06/19/2009 2

http://www.hss.energy.gov/HealthSafety/WSHP/chem_safety/teel.html

http://orise.orau.gov/emi/scapa/teels.htm

6/19/2009

Table 4: Protective Action Criteria (PAC) Rev 24B (mg/m3)

Based on applicable 60-min. AEGLs, ERPGs, or TEELs (Chemicals listed in alphabetical order)

PAC Rev 24B

1 Acacia; (Gum Arabic) 9000-01-5 200 500 500 500TEEL-2/21, TEEL-2/7, rat oral TDlo. Rat oral LD50

min.

2 Acenaphthene 83-32-9 0.4 1.25 7.5 250 Rat ip LD50, rat TClo

3 Acenaphthylene 208-96-8 0.06 0.2 1.5 500 Rat ip LD50, rat TClo

4 Acetaldehyde 75-07-0 40 81 486 1,510 TLV-C, AEGL-1, AEGL-2, AEGL-3

5 Acetamide 60-35-5 25 75 500 500 PAC-2/21, PAC-2/7, rabbit oral TDlo, rat oral LD50

6 Acetanilide 103-84-4 0.4 1 7.5 50 Human oral TDlo, human oral LD lo

7 Acetic acid 64-19-7 12 12 86 610 ERPG-1, ERPG-1, ERPG-2, ERPG-3

8Acetic acid ethenyl ester, polymer with 1,1-

bis(ethenyloxy) butane and ethenol27360-07-2 10 30 50 250 Used PNOS default.

9 Acetic acid, 2-propenyl ester 591-87-7 2 6 40 200 Rat LC50

10 Acetic acid, lithium salt 546-89-4 12.5 35 250 500 Mouse oral LD lo.

11 Acetic acid, manganese(2+) salt, tetrahydrate 6156-78-1 0.892 2.68 22.3 500 Mn concentration limits.

12 Acetic acid, manganese(II) salt (2:1) 638-38-0 0.63 9.45 15.7 500 Mn compound concentration limits.

13 Acetic Anhydride 108-24-7 2.09 2.09 62.6 417 PAC-1, ERPG-1, ERPG-2, ERPG-3.

14 Acetone 67-64-1 475 475 7,600 13,500 AEGL-1, AEGL-1, AEGL-2, AEGL-3

15 Acetone thiosemicarbazide 1752-30-3 20 60 100 100 LOC, LC50

PACs based on 60-min. AEGLs, ERPGs or

TEELs (mg/m3) Source of PACs

TEEL-0, PAC-1, PAC-2, PAC-3No. Chemical Name CASRN

TEEL-0 PAC-1 PAC-2 PAC-3

Chemicals with AEGLs: large, bolded font. ERPGs (but no AEGLs): bolded font. The "Source of PACs" column is under construction. 1

6/19/2009



PAC Rev 24B





16 Acetone-d6 666-52-4 500 500 7,500 15,000 Acetone (67-64-1) limits used.

17 Acetonitrile 75-05-8 21.8 21.8 537 1,120 AEGL-1, AEGL-1, AEGL-2, AEGL-3

18 Acetonitrile-d3 2206-26-0 75 100 100 750 Used Acetonitrile TEELs.

19 Acetophenone 98-86-2 10 30 50 350 Concentration limits, rat oral LD50

20 Acetoxytriphenylstannane 900-95-8 0.345 0.689 20 50 Concentration limits, rat oral LD50

21 Acetyl bromide 506-96-7 1 3 20 100 Mouse ip LD50

22Acetyl carbinol; (Acetol (1); 1-Hydroxy-2-

propanone)116-09-6 7.5 25 200 500 Rat oral LD50.

23 Acetyl chloride 75-36-5 0.0075 0.02 0.15 400 Human TClo, rat oral LD50

24 Acetyl triethyl citrate 77-89-4 6 20 125 500 Mouse ip TDlo, rat oral LD50.

25 Acetylaminofluorene, 2- 53-96-3 0.25 0.75 6 30 Pregnant mouse ip TDlo

26 Acetylaminofluorenone, 2- 3096-50-2 0.75 2.5 15 75 Rat oral 32 week TDlo

27 Acetylene 74-86-2 2,500 2,500 2,500 6,000 REL-C, human LClo

28 Acrolein 107-02-8 0.0687 0.0687 0.229 3.21 AEGL-1, AEGL-1, AEGL-2, AEGL-3

29 Acrylamide 79-06-1 0.3 7.5 60 60 Concentration limits

30Acrylamide, N,N'-methylenebisacrylamide

copolymer25034-58-6 10 30 50 250 Used PNOS default


6/19/2009



PAC Rev 24B





31 Acrylic acid 79-10-7 4.42 4.42 135 530 AEGL-1, AEGL-1, AEGL-2, AEGL-3

32 Acrylic acid polymers; (Acrylic polymer or resin) 9003-01-4 10 30 200 500 Rat oral LD50

33 Acrylonitrile 107-13-1 4 22 76 163 PEL-TWA,ERPG-1, ERPG-2, ERPG-3

34 Acrylyl chloride; (Acryloyl chloride) 814-68-6 0.15 0.4 0.75 35 LOC, mouse LC50

35 Adamsite; (Phenarsine chloride) 578-94-9 0.016 0.016 2.6 6.40 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

36 Adipic acid 124-04-9 5 5 5 125 TLV-TWA, rat oral TDlo, rat ip LD50

37 Adipic acid-TDI 68609-57-4 10 30 50 250 Used PNOS default.

38 Adiponitrile 111-69-3 7.5 15 15 750 TLV-TWA, LOC, rat 240 min LC50

39

Aerosol, A-102; (Poly(oxy-1,2-ethanediyl), alpha-

(3-carboxy-1-oxo-3-sulfopropyl)-omega-

(dodecyloxy)-, -disodium salt)

39354-45-5 125 400 500 500 Rat oral LD50.

40 Agar 9002-18-0 500 500 500 500 Rat oral LD50, rat 4 week oral TDlo

41 Agarose, type VII (low gelling temperature) 9012-36-6 10 30 50 250 PNOS TLV-TWA

42 Alamine 336 68814-95-9 20 60 500 500 Rat LD50.

43 Albumin (bovine) 9048-46-8 150 500 500 500 Rat iv 90 day TDlo, rat iv LDlo

44 Alcohol oxidase 9073-63-6 10 30 50 250 PNOS default.


6/19/2009



PAC Rev 24B





45 Alcohols, C6-C12 (N.O.S.) 68603-15-6 10 30 50 250 Default TLV-TWA for chemical class

46

Aldrin; (1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-

hexahydro-1,4-endo,exo-5,8-

dimethanonaphthalene)

309-00-2 0.25 0.25 10 25 PEL-TWA, LOC, IDLH.

47 Aldrithiol-2: (2,2'-Dithiodipyridene) 2127-03-9 10 30 50 250 Used PNOS default.

48

Aliquat 336; (Adogen 464; Quaternary

ammonium compounds, tri(C8-10)-alkylmethyl-,

chlorides)

63393-96-4 30 75 500 500 Rat LClo

49Alizarin; (1,2-Dihydroxyanthraquinone; Turkey red

oil)72-48-0 1.25 4 25 125 Wild bird oral LD50.

50Alizarine Red S, Monohydrate; (Sodium alizarin-3-

sulfonate)130-22-3 0.6 1.5 12.5 60 Mouse intravenous LD50.

51 Alkanes, C4-12- 68333-81-3 1,250 1,500 1,500 7,500 Octane concentration limits.

52Alkenyl dimethylethyl ammonium bromide;

(Aliphatic hydrocarbon)z-0108 2 6 40 200 Rat oral LD50

53 Alkyl benzenes (C8-C9) z-0109 10 30 50 250 Default TLV-TWA for chemical class

54Alkyl dimethylbenzyl ammonium chloride;

(Benzalkonium chloride)8001-54-5 7.5 20 100 100 Women oral TDlo, rat oral LD50

55 Alkylamines 63231-48-1 10 30 50 250 Default TLV-TWA for chemical class

56 Alkylbenzene (C10-C16) 68648-87-3 10 30 50 500 PNOS TLV-TWA, rabbit skin LDlo

57 Allene; (1,2-Propadiene) 463-49-0 60 200 1,250 6,000 Default LC50 based on HR

58 Allyl alcohol 107-18-6 4 4.99 9.97 47.5 PEL-TWA, AEGL-1, AEGL-2, AEGL-3


6/19/2009



PAC Rev 24B





59 Allyl Bromide; (3-Bromopropene) 106-95-6 20 60 400 2,000 Rat LC50

60 Allyl chloride 107-05-1 3 8.76 169 438 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

61 Allyl chlorocarbonate 2937-50-0 0.15 0.5 3.45 10.3 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

62 Allyl isothiocyanate; (Mustard oil) 57-06-7 1.25 4 10 50 WEEL-STEL, Rat LD50.

63 Allylamine 107-11-9 0.3 0.98 7.7 42 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

64 Allylmagnesium bromide 1730-25-2 10 30 50 250 PNOS default used.

65 Allyltrichlorosilane 107-37-9 1.5 4.3 52.4 237 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

66Alpha,alpha,4-trimethyl-3-cyclohexene-1-

methanol, (S)-; (alpha-Terpineol)10482-56-1 125 350 500 500 Rat oral TDlo and LD50.

67Alpha-hydroxybenzeneacetic acid, (+-)-; (DL-

mandelic acid)611-72-3 15 50 350 500 Normal Mandelic acid rat oral LD50.

68 Aluminon 569-58-4 0.0004 0.0013 0.0075 500 Human male 60 day repro. TDlo, rat oral LD50

69 Aluminum 7429-90-5 15 15 15 75 TWA concentration limits for Al total dust

70 Aluminum acetate, basic 7360-44-3 4.45 13.3 22.2 100 Aluminum soluble salts TLV-TWA.

71 Aluminum carbide 1299-86-1 1.33 4 6.67 35 TWA concentration limits for Al soluble salts

72 Aluminum chloride 7446-70-0 4.94 7.5 60 500TLV-TWA Al soluble salts, rat 60 day oral TDlo, rat

oral LD50

73 Aluminum chloride hexahydrate 7784-13-6 8.95 25 150 500 TLV-TWA Al soluble salts, rat oral LD50


6/19/2009



PAC Rev 24B





74 Aluminum fluoride 7784-18-1 3.11 3.11 7.5 40TLV-TWA Al soluble salts, rat oral 28 day TDlo, rat

oral LD50

75 Aluminum grey LB; (Acid black 60) 12218-95-0 8.44 25.3 42.2 422 Concentration limits for Cr III compounds.

76 Aluminum hexafluorosilicate 17099-70-6 3.51 10.5 17.6 351 PEL-TWA and IDLH for fluorides

77 Aluminum hydroxide 21645-51-2 1 3 125 125MAK-TWA concentration limits,child 4 day oral

TDlo, rat ip LDlo

78 Aluminum oxide hydrate 1333-84-2 15 15 15 75 Alumina concentration limits.

79 Aluminum oxide; (Alumina) 1344-28-1 1.5 1.5 15 25 PEL-TWA, 60 min EEGL, 30 min EEGL.

80Aluminum phosphate; (Phosphoric acid,

aluminum salt (1:1), solution)7784-30-7 4.52 13.56 500 500 TLV-TWA Al soluble salts, rat oral LDlo

81 Aluminum phosphide 20859-73-8 2 2 4.74 8.53 TLV-TWA, TEEL-0, AEGL-2, AEGL-3.

82 Aluminum potassium sulfate 10043-67-1 9.57 28.7 47.8 100 TLV-TWA Al soluble salts

83 Aluminum potassium sulfate, dodecahydrate 7784-24-9 17.6 52.7 125 500 TLV-TWA Al concentration limits

84 Aluminum sulfate 10043-01-3 6.34 19 31.7 500 TLV-TWA Al soluble salts concentration limits

85Aluminum tris(dihydrogen phosphate);

(Phosphoric acid, aluminum salt (3:1)13530-50-2 11.9 35.7 60 300 Al soluble salts TLV-TWA.

86 Aluminum yellow 4A; (Acid yellow 99) 10343-58-5 4.77 28.6 50 239 Concentration limits for Cr III compounds.

87 Aluminum(III) isopropylate 555-31-7 7.57 22.7 37.9 500 Al soluble salts TLV-TWA, rat oral LD50.

88 Aluminum(III) nitrate (1:3) 13473-90-0 7.89 23.67 350 500 TLV-TWA Al soluble salts, rat oral LD50


6/19/2009



PAC Rev 24B





89 Aluminum(III) nitrate nonahydrate (1:3:9) 7784-27-2 13.9 20 150 500 TLV-TWA Al soluble salts, rat oral LD50

90 Aluminum(III) silicate (2:1); (Kyanite; Oil-dri) 1302-76-7 3 9.01 75 400 TLV-TWA Al concentration limits

91 Amberlite IR-120(PLUS) ion-exchange resin 78922-04-0 10 30 50 200 PNOS TLV-TWA, Amberlite-LA-1 rat ip LD50

92Amberlite IR-120plus ion-exchange resin, sodium

form; (Cation exchange resin)9002-23-7 7.5 25 150 500 HHR =2, rat LD50 = 2000 mg/kg assumed.

93Amberlite IRA-400(CI);

(Amberlite IRA-400, ion-exchange resin)9002-24-8 10 30 50 250 Used PNOS default.

94 Amberlite IRA-400(CL); (Ion exchange resin) 122560-63-8 10 30 50 250 Used PNOS default.

95Amberlite MB-1 ion-exchange resin; (Amberlite

MB-150)100915-96-6 10 30 50 200 PNOS TLV-TWA, Amberlite-LA-1 rat ip LD50

96 Amberlite XAD-16, -7, -4 resin 104219-63-8 10 30 50 200 PNOS TLV-TWA, Amberlite-LA-1 rat ip LD50

97 Amberlite XAD-2 resin, purified 9060-05-3 10 30 50 200 PNOS TLV-TWA, Amberlite-LA-1 rat ip LD50

98 Amberlite XAD-7HP 37380-43-1 10 30 50 200 PNOS TLV-TWA, Amberlite-LA-1 rat ip LD50

99 Amberlyst 15 ion-exchange resin 9037-24-5 10 30 50 250 PNOS TLV-TWA

100 Amino-1,3-naphthalenedisulfonic acid, 7- 86-65-7 3.5 10 75 400 Mouse 8W ip TDlo

101 Amino-1-propanol, 3- 156-87-6 0.015 0.04 0.3 500 Rat oral LD50

102Amino-2-(hydroxymethyl)-1,3-propanediol, 2-,

acetate salt; (Trizma acetate)6850-28-8 25 75 500 500 Rat oral LD50.

103 Amino-2-methyl-2-propanol, 1- 2854-16-2 10 30 200 500 Mouse oral LD50


6/19/2009



PAC Rev 24B





104 Amino-4,6-dinitrotoluene, 2- 35572-78-2 6 15 125 500 Rat oral LD50

105Aminoacetaldehyde diethyl acetal; (2,2-

diethoxyethylamine)645-36-3 7.5 25 150 500 Estimated rat oral LD50.

106Aminoacetaldehyde dimethyl acetal; (2,2-

dimethoxyethylamine)22483-09-6 10 30 50 250 PNOS default used.

107 Aminoanthraquinone, 2- 117-79-3 7.5 25 150 500 Rat 78W ip TDlo, rat ip LD50

108 Aminobenzoic acid, p- 150-13-0 5 15 100 500 WEEL-TWA, Rat 22 day TDlo preg, rat oral LD50.

109 Aminobutyl)diethoxymethylsilane, (4- 3037-72-7 2 6 45 45 LOC, rat sk LD50

110 Aminodiphenyl, p- 92-67-1 0.5 1.5 10 200 Rat 48W oral TDlo, rat oral LD50

111 Aminoethoxy)ethanol, 2(2- 929-06-6 12.5 35 250 500 Rat oral LD50.

112 Aminoethyl)diphenylborinic acid, o-(2- 524-95-8 0.4 1.25 10 50 Mouse iv LD50

113 Aminoethylethanolamine 111-41-1 12.5 35 250 500 Rat oral LD50.

114 Aminoethylpiperazine, N- 140-31-8 2.5 7.5 50 500 Rat male 28D pre TDlo, rat oral LD50

115 Aminoheptane, 3-; (3-Heptylamine) 28292-42-4 0.3 0.75 6 30 Mouse ip LD50

116 Aminoiminomethyl)urea sulfate(2:1), ( 591-01-5 10 30 50 250 Used PNOS default.

117 Aminophenol, 2-; (Aminophenol, o-) 95-55-6 0.5 1.5 10 500 Ham ip TDlo, rat oral LD50

118 Aminophenol, m- 591-27-5 1 3 20 125 Rat 17 week TClo, rat oral LD50.


6/19/2009



PAC Rev 24B





119 Aminopropiophenone, 4- 70-69-9 1 3.5 5.6 75 LOC, rat oral LD50

120 Aminopropylmethyldiethoxysilane, 3- 3179-76-8 15 50 400 500 Rat oral LD50.

121Aminopropyltriehoxysilane; (3-(Triethoxysilyl)-1-

propanamine)919-30-2 6 15 125 500 Rat TClo, rat LD50.

122 Aminopterin; (Aminopteridine) 54-62-6 5 15 25 25 LOC, mouse oral LD50

123 Aminopyrazine 5049-61-6 2 6 10 20 SAR

124 Aminopyridine, 4-; (4-Pyridinamine) 504-24-5 4 12.5 20 20 LOC, human LDlo

125 Amiton oxalate 3734-97-2 0.6 1.5 3 3 LOC, rat oral LD50

126Amiton; (O,O-Diethyl-S-(2-diethylaminoethyl)

thiophosphate)78-53-5 0.6 2 3.3 3.3 LOC, rat oral LD50

127 Amitrole 61-82-5 0.2 0.6 125 500 TLV-TWA, tox ratio, rat oral LD50

128 Ammonia 7664-41-7 15 20.9 111 766 TLV-TWA, AEGL-1, AEGL-2, AEGL-3

129 Ammonia-d3 13550-49-7 7.5 25 150 750 MW-adjusted ammonia ERPGs

130 Ammonium acetate 631-61-8 2.5 7.5 50 250 Rat ip LD50

131Ammonium aluminum fluoride; (Triammonium

hexafluoroaluminate)7784-19-2 4.28 4.28 4.28 15 F PEL-TWA, mouse iv LD50

132 Ammonium benzoate 1863-63-4 3.5 10 75 350 Rat oral LD50

133 Ammonium bicarbonate 1066-33-7 2 6 40 200 Mouse iv LD50


6/19/2009



PAC Rev 24B





134Ammonium bisulfate; (Ammonium hydrogen

sulfate)7803-63-6 0.025 0.075 0.5 2.5 Rabbit 60 min. TClo

135Ammonium bisulfite; (Ammonium hydrogen

sulfite)10192-30-0 10 10 10 10 TLV-TWA PNOS

136 Ammonium bromide 12124-97-9 10 35 200 500 Rat oral LD50.

137Ammonium carbamate; (Carbamic acid,

ammonium salt)1111-78-0 0.3 1 6 35 Rat iv LD50

138 Ammonium carbonate 506-87-6 0.75 2.5 15 75 Mouse iv LD50

139 Ammonium chloride 12125-02-9 10 20 500 500 TLV-TWA & STEL, rat oral LD50

140 Ammonium chromate 7788-98-9 0.0146 0.438 7.5 43.9 Cr(VI) concentration limits

141 Ammonium citrate 7632-50-0 10 10 30 150 PNOS TLV-TWA, rat oral LD50

142 Ammonium citrate tribasic 3458-72-8 10 30 50 250 Used PNOS default.

143 Ammonium citrate, dibasic 3012-65-5 10 10 10 10 Used PNOS default.

144 Ammonium dichromate 7789-09-5 0.0121 0.363 7.5 36.4 Cr(VI) concentration limits

145Ammonium dihydrogen phosphate;

(Monoammonium phosphate)7722-76-1 15 50 350 500

Rat oral LD50, based on other ammonium

phosphates

146 Ammonium ferrous sulfate hexahydrate 7783-85-9 3.19 9.56 15.9 500 Fe concentration limits, rat oral LD50

147 Ammonium fluoborate 13826-83-0 3.45 3.45 6 20 F TLV-TWA, human TClo and LClo, ex HSDB

148 Ammonium fluoride 12125-01-8 4.88 4.88 4.88 12.5 F TLV-TWA, , rat TClo, rat ip LD50


6/19/2009



PAC Rev 24B





149 Ammonium formate 540-69-2 10 30 50 500 PNOS TLV-TWA, mouse oral LD50

150 Ammonium hexachlorohydrate (III) z-0001 10 30 50 250 Used PNOS default.

151Ammonium hexafluorosilicate; (Ammonium

silicofluoride)16919-19-0 3.91 11.7 20 30 F concentration limits, mouse oral LD50

152Ammonium hydrogen fluoride; (Ammonium

bifluoride)1341-49-7 3.75 3.75 3.75 3.75 F concentration limits

153 Ammonium hydrogen oxalate hemihydrate 37541-72-3 7.5 25 150 500 Estimated rat oral LD50.

154 Ammonium hydroxide 1336-21-6 2.5 7.5 60 150 Human TClo and LClo.

155 Ammonium iodide 12027-06-4 4 12.5 75 400 Human oral LDlo ex HSDB

156 Ammonium lactate 515-98-0 10 35 200 500 PAC-2/21, PAC-2/7, cattle oral TDlo, PAC-2*5.

157 Ammonium lignin sulfonate 8061-53-8 10 30 50 250 Used PNOS default.

158 Ammonium molybdate(VI) tetrahydrate 12054-85-2 60.7 60.7 60.7 150Soluble Mo compounds PEL-TWA, rat oral LD50.

IDLH not used.

159Ammonium molybdate; (Diammonium

molybdate)13106-76-8 10.2 30.7 51.1 500 Mo TLV-TWA, IDLH, as Mo.

160 Ammonium molybdophosphate 12026-66-3 8.15 24.4 40.7 200 Mo TLV-TWA; IDLH not used

161 Ammonium nickel sulfate 15699-18-0 4.89 4.89 5 48.9 Nickel concentration limits

162 Ammonium nitrate 6484-52-2 10 10 10 500 PNOS, rat oral TDlo, rat oral LD50

163 Ammonium oxalate monohydrate 5972-73-6 1.5 4 30 150 Rat oral LD50.


6/19/2009



PAC Rev 24B





164Ammonium oxalate; (Diammonium oxalate

monohydrate)6009-70-7 1.5 4 30 150 Rat oral LD50.

165Ammonium oxalate; (Ethanedioic acid,

diammonium salt)1113-38-8 0.15 0.5 4 20 Rat oral TDlo.

166 Ammonium pentaborate 12007-89-5 10 30 50 250 Used PNOS default.

167 Ammonium perchlorate 7790-98-9 5 15 100 500 Rabbit oral TDlo, rat oral LD50.

168 Ammonium permanganate 13446-10-1 0.2 3 5 500 Manganese concentration limits.

169 Ammonium persulfate 7727-54-0 0.1 0.3 20 100 TLV-TWA, rat ip LD50.

170 Ammonium phosphate dibasic 7783-28-0 10 30 50 250 Used PNOS default.

171 Ammonium picrate 131-74-8 10 30 50 250 Used PNOS default.

172 Ammonium polyacrylate 9003-03-6 10 30 50 250 Used PNOS default.

173 Ammonium sulfamate 7773-06-0 10 30 50 500 TLV-IWA, NH3 IDLH.

174 Ammonium sulfate 7783-20-2 40 125 500 500 Human oral TDlo, rat oral LD50.

175 Ammonium sulfide 12135-76-1 7.5 25 40 40 Human 30 min TClo, human 30 min LC lo.

176 Ammonium sulfite 10196-04-0 10 10 10 10 Used PNOS default.

177 Ammonium sulfite monohydrate 7783-11-1 10 30 50 250 PNOS default used, irritation ignored.

178 Ammonium tartrate 14307-43-8 10 10 10 10 Used PNOS default.


6/19/2009



PAC Rev 24B





179 Ammonium tartrate; (Diammonium tartrate) 3164-29-2 1.5 5 40 200 Rat subcutaneous LD50.

180 Ammonium thiocyanate 1762-95-4 12.5 35 200 200 Human oral TDlo, mouse oral LD50.

181 Ammonium thiosulfate; (Ammonium hyposulfite) 7783-18-8 10 30 50 500 PNOS, rat 240 min LG lo.

182 Ammonium tungstate(VI) 11120-25-5 1.38 4.14 6.9 6.9 TLV-TWA, TLV-STEL.

183Ammonium vanadate; (Ammonium vanadium

oxide; Ammonium metavanadate)7803-55-6 0.0322 0.0965 0.322 3.5

As vanadium pentoxide, TLV-TWA and PEL-C, rat

240 min LC50.

184Ammonium, hexadecyltrimethyl-, bromide;

(Hexadecyltrimethylammonium bromide)57-09-0 0.035 0.1 0.75 150 Mousw ip TDlo, rat oral LD50.

185Ammonium, tetraethyl, bromide; (Tetraethyl

ammonium bromide)71-91-0 1.25 4 30 40 PAC-2/21, PAC-2/7, mouse ip TDlo, rat ip LD50.

186Ammonium, tetramethyl, bromide;

(Tetramethylammonium bromide)64-20-0 0.2 0.6 4 20 Rat oral LD50.

187 Amosite 12172-73-5 0.005 0.05 40 200 PEL-TWA, PEL-STEL, rat TClo.

188 Amphetamine; (Benzedrine) 300-62-9 4 12.5 20 20 LOC, human LD lo.

189 Amyl acetate 628-63-7 500 500 500 5,000 PEL-TWA, TLV-STEL, human TClo, IDLH.

190 Amyl alcohol; (1-Pentanol) 71-41-0 350 350 350 350 WEEL-TWA. Human TClo, human oral LD lo.

191 Amyl methyl ether, tert-; (TAME) 994-05-8 75 600 600 600TLV-TWA, rat 360 min TClo preg, rat LD50

minimum.

192 Amylamine, n-; (1-Pentylamine) 110-58-7 0.3 0.75 6 30 Rat ip LD lo.

193Amyltrichlorosilane;

(Pentyltrichlorosilane)107-72-2 1.5 5.04 61.3 277 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





194 Anhydrone; (Magnesium perchlorate) 10034-81-8 6 15 125 500 Rat oral LD50.

195 Aniline 62-53-3 20 30.5 45.7 76.1 PEL-TWA, AEGL-1, AEGL-2, AEGL-3

196 Anisidine, o- 90-04-0 0.5 1.5 2.5 50 PEL-TWA, IDLH.

197 Anisidine, p- 104-94-9 0.5 1.5 2.5 50 PEL-TWA, IDLH.

198 Anisole; (Anisole anhydrous; Methoxybenzene) 100-66-3 4 12.5 75 400 Mouse 120 min LC50.

199 Anthracene 120-12-7 1.5 4 30 150 Rat oral TDlo, mouse ip LD50.

200

Anthracenedisulfonic acid, 4,8-diamino-9,10-

dihydro-1,5-dihydroxy-9,10-dioxo, disodium salt,

2,6-; (Acid Blue 45; Alizarine Blue)

2861-02-1 12.5 35 250 500 Mouse oral LD50.

201 Anthranilic acid 118-92-3 4 12.5 100 500 Mouse preg sc TDlo, rat oral LD50

202 Anthraquinone 84-65-1 10 30 50 500 PNOS, rat 240 min LC50

203 Antimony 7440-36-0 0.5 1.5 20 50 PEL-TWA, TEEL-0*3. human TClo, IDLH

204 Antimony oxide 1309-64-4 0.599 1.8 4 59.9 As Sb, PEL-TWA, IDLH

205 Antimony pentachloride 7647-18-9 1.23 3.68 6.14 123 As Sb, PEL-TWA, IDLH

206 Antimony pentafluoride 7783-70-2 0.89 0.89 2.7 89 As Sb, PEL-TWA, LOC, IDLH

207 Antimony pentasulfide 1315-04-4 0.829 2.49 4.15 82.9 As Sb, PEL-TWA, IDLH

208 Antimony potassium tartrate trihydrate 28300-74-5 1.31 3.92 6.53 131 As Sb, PEL-TWA, IDLH


6/19/2009



PAC Rev 24B





209 Antimony trichloride 10025-91-9 0.937 0.937 0.937 93.7 As Sb, PEL-TWA, IDLH

210 Antimony trifluoride 7783-56-4 0.734 0.734 4 73.4 As Sb, PEL-TWA, IDLH

211 Antimycin A 1397-94-0 0.35 1 1.8 12.5 LOC, rat oral LD50

212 Antioxidant G-16 (most toxic antiox) 61373-87-3 10 30 50 125 PNOS, mouse ip LD50.

213 Aqua regia (75% hydrochloric + 25% nitric acid) 8007-56-5 3.5 6 75 400 HCl and HNO3 concentration limits

214 Arginine, L- 74-79-3 10 30 50 250 Used PNOS default.

215 Argon 7440-37-1a 100,000 100,000 350,000 600,000 Simple asphyxiant

216 Argon, cryogenic 7440-37-1b 100,000 100,000 350,000 600,000 Simple asphyxiant

217

Aromatic hydrocarbon solvents; (High flash

naphtha distillates; Solvent naphtha (petroleum),

light aromatic)

64742-95-6 2,000 3,500 3,500 3,500 Mouse TClo, rat oral LD50.

218 Aromatic isocyanate mixture "SWD 305A" z-0111 1.25 4 20 125 Calculated from mixture ingredients.

219 Arsenic 7440-38-2 0.01 0.35 2 350 PEL-TWA, PAC-2/7, child oral TDlo, rat oral LD50.

220 Arsenic acid 1327-52-2 0.0189 0.0568 3 55 PEL-TWA, IDLH, as As.

221 Arsenic acid; (o-arsenic acid) 7778-39-4 0.0189 0.4 3 9.5 PEL-TWA, IDLH, as As.

222 Arsenic pentoxide 1303-28-2 0.0153 1 7.7 7.7 PEL-TWA, IDLH, as As, LOC.

223 Arsenic trioxide 1327-53-3 0.0132 0.4 3.0 9.1 PEL-TWA, AEGL-2/7, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





224 Arsenious acid 13464-58-9 0.0168 0.2 1.4 8.41 PEL-TWA, IDLH, as As, LOC.

225 Arsenous trichloride 7784-34-1 0.15 0.5 10 75 PEL-TWA, IDLH, as As, LOC.

226 Arsine 7784-42-1 0.15 0.15 0.542 1.59 PEL-TWA, PEL-TWA, AEGL-2, AEGL-3

227 Asbestos 1332-21-4 0.005 0.075 0.5 2.5 PEL-TWA, PEL-C

228 Asbestos (Chrysotile) 12001-29-5 0.005 7.5 50 250 PEL-TWA, PEL-C, rat ip LD LO.

229 Ascaridole 512-85-6 0.75 2.5 20 75 Mouse skin TDlo, rat oral LD50.

230 Ascarite; (Asbestos, 1332-21-4) 81133-20-2 0.005 0.5 0.5 2.5 Used asbestos limits

231 Ascorbic acid 50-81-7 60 200 500 500 Human iv TDlo, woman iv LD lo.

232 Asphalt; (Bitumen) 8052-42-4a 0.5 0.75 5 25 TLV-TWA, REL-C

233Auramine; (4.4'-(Imidocarbonyl)bis(N,N-

dimethylamine) monohydrochloride)2465-27-2 2.5 7.5 60 60 Rat oral 87 week TDlo, rat ip LD50

234 Azaserine; (L-Serine, diazoacetate (ester)) 115-02-6 0.0125 0.04 0.25 75 Pregnant rat oral TDlo, rat oral LD50.

235 Azinphos ethyl; (Ethyl guthion) 2642-71-9 0.75 2 3.9 150 LOC, rat 240 min LC50.

236 Azinphos methyl; (GuthionR) 86-50-0 0.2 0.6 0.7 10 PEL-TWA, LOC, rat 60 min LC50.

237Aziridine homopolymer; (Ethylenimine

homopolyer; Poly(ethyleneimine)9002-98-6 5 15 100 500 Rat oral LD50.

238 Azobis(2-methylpropionitrile), 2,2'- 78-67-1 7.5 25 150 300 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





239 Azodicarbamide; (Azodicarbonamide) 123-77-3 40 125 200 200 Rat TClo, rat ip LD50.

240 Bacto peptone 51142-18-8 10 30 50 250 Used PNOS default.

241 Barbituric acid 67-52-7 2 6 40 200 Mouse ip LD50.

242 Barium 7440-39-3 0.5 1.5 50 250 PEL-TWA, rat oral TDlo.

243 Barium acetate; (Barium acetate anhydrous) 543-80-6 0.93 2.79 4.65 93 Ba sol compounds as Ba: PEL-TWA, IDLH.

244 Barium carbonate 513-77-9 0.3 0.75 6 500 Human oral TDlo, human oral LD lo.

245 Barium chloride 10361-37-2 0.5 1.5 15 50 Ba sol compounds as Ba: PEL-TWA, IDLH.

246 Barium chloride dihydrate 10326-27-9 0.889 2.67 4.45 88.9 Ba sol compounds as Ba: PEL-TWA, IDLH.

247 Barium chromate 10294-40-3 0.0246 0.737 1.25 73.7 Chromium(VI) concentration limits.

248 Barium cyanide 542-62-1 0.69 2.07 3.5 69 Ba sol compounds as Ba: PEL-TWA, IDLH.

249 Barium dioxide; (Barium peroxide) 1304-29-6 0.617 0.617 1.5 7.5 Ba conc limits as Ba: PEL-TWA, mouse sc LD50.

250 Barium diphenylamine sulfonate 6211-24-1 2.31 6.92 11.5 231 Ba sol compounds as Ba: PEL-TWA, IDLH.

251 Barium fluoride 7787-32-8 0.638 1.92 15 100 Ba sol compounds as Ba: PEL-TWA.

252Barium hydrogen phosphate; (Barium phosphate

dibasic)10048-98-3 0.849 2.55 4.25 20 Ba sol compounds as Ba: PEL-TWA.

253 Barium hydroxide 17194-00-2 0.624 1.87 3.12 62.4 Ba sol compounds as Ba: PEL-TWA.


6/19/2009



PAC Rev 24B





254 Barium hydroxide octahydrate 12230-71-6 1.15 3 20 115 Ba sol compounds as Ba: PEL-TWA, IDLH.

255 Barium metaborate 13701-59-2 10 30 200 500 Rat oral TDlo.

256 Barium nitrate 10022-31-8 0.952 2.5 20 95.2 Ba sol compounds as Ba: PEL-TWA, IDLH.

257 Barium nitrite 13465-94-6 0.835 2.5 4.17 20 Ba sol compounds as Ba: PEL-TWA.

258 Barium oxide 1304-28-5 0.558 1.67 2.79 55.8 Ba sol compounds as Ba: PEL-TWA, IDLH.

259 Barium permanganate 7787-36-2 1.37 20.5 34.1 34.1Mn cmpnd conc limits as Mn: PEL-TWA, human

oral LD50.

260 Barium phosphate 13466-20-1 0.788 2.36 4 20 Ba sol compounds as Ba: PEL-TWA.

261 Barium stearate 6865-35-6 10 30 200 500 Rat oral LD50

262 Barium sulfate 7727-43-7 15 30 350 500 PEL-TWA, rat implant TDlo.

263 Basic Green 4; (Aizen malachite green) 569-64-2 0.35 1 6 35 Mouse oral LD50.

264 Basic Red 1; (Rhodamine 6G extra base) 989-38-8 0.025 0.075 0.6 2.5 Mouse ip TDlo, mouse ip LD50.

265 Bathophenanthroline 1662-01-7 75 250 500 500 Rat oral LD50 based on assumed HHR = 1.

266 Bentonite; (Clay absorbent) 1302-78-9 10 30 50 50 PNOS, mouse oral TDlo, rat iv LD50.

267Benz(e)acephenanthrylene;

(Benzo(b)fluoroanthene)205-99-2 0.2 0.6 4 20 Rat implant TDlo.

268 Benzal chloride 98-87-3 0.4 1.25 2.3 500 LOC, rat oral LD50.


6/19/2009



PAC Rev 24B





269 Benzaldehyde 100-52-7 7.5 15 15 600 WEEL-TWA, -STEL, human TClo, human LD lo.

270 Benzamide 55-21-0 3 10 60 350 Rat ip LD50.

271 Benzenamine, sulfate (2:1) 542-16-5 10 30 50 250 Used PNOS default.

272 Benzene 71-43-2 3 166 2,550 12,800 PEL-TWA, AEGL-1, AEGL-2, AEGL-3

273Benzene hexachloride; (Hexachlorocyclohexane,

mixed isomers)608-73-1 0.15 0.5 4 300

PAC-2/21, Pac-2/7, human TClo, rat 240 min

LC50.

274Benzene, 1-(chloromethyl)-4-nitro-; (p-Nitrobenzyl

chloride)100-14-1 5 15 28 125 LOC, rat oral LD50.

275 Benzenearsonic acid; (Phenylarsonic acid) 98-05-5 0.27 0.27 0.27 0.27 PEL-TWA as As, LOC, mouse oral LD50.

276 Benzene-d6; (Deuterated benzene) 1076-43-3 3.5 150 500 3,500 Benzene concentration limits used, but not AEGLs

277Benzenesulfonic acid chloride; (Benzenesulfonyl

chloride)98-09-9 0.5 1.5 200 200 PEL-TWA as As, LOC, rat 60 min LC lo.

278 Benzenesulfonic acid, 4-chloro 98-66-8 2 6 40 200 Rat oral LD50 minimum.

279 Benzenesulfonic acid, 5-chloro-2 z-0114 10 30 50 250 Used PNOS default.

280 Benzenetetracarboxylic dianhydride, 1,2,4,5- 89-32-7 1.5 5 15 15 Rat oral 30 day TDlo, rat 240 min LC lo.

281Benzenethiol; (Thiophenol; Phenyl

mercaptan)108-98-5 0.4 0.4 2.39 7.21 TLV-TWA, TLV-TWA, AEGL-2, AEGL-3..

282 Benzidene 92-87-5 0.15 0.5 3.5 125 Human TClo, rat oral LD50.

283 Benzo(a)anthracene 56-55-3 0.1 0.3 2 15 Mouse skin TDlo, mouse iv LD lo.


6/19/2009



PAC Rev 24B





284 Benzo(a)pyrene; (Coal tar pitch volatiles) 50-32-8 0.2 0.6 15 80 PEL-TWA, IDLH, pregnant rat ip TDlo.

285 Benzo(ghi)perylene 191-24-2 10 30 50 250 Used PNOS default.

286 Benzo(k)fluoranthene 207-08-9 0.2 0.6 4 20 Rat implant TDlo.

287Benzo-4,7,13,16,21,24-hexaoxa-1,10-

diazabicyclo(8.8.8)hexacosane, 5,6-31250-18-7 1.5 5 35 150 Estimated HHR and rat oral LD50.

288 Benzoic acid 65-85-0 4 12.5 75 400 Human oral LD lo.

289 Benzoic acid, sodium salt 532-32-1 100 350 500 500 Rat oral TDlo, rat oral LD50.

290 Benzoin oxime 441-38-3 0.6 1.5 12.5 60 Mouse ip LD50

291 Benzonitrile 100-47-0 4 12.5 92.7 236 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

292 Benzophenone 119-61-9 0.5 1.5 350 500 WEEL-TWA, rat oral TDlo, mouse oral LD50.

293 Benzoquinone, p-; (Quinone) 106-51-4 0.4 1.25 2 100 PEL-TWA, IDLH, mouse skin TDlo.

294 Benzothiazole 95-16-9 5 15 100 150 Rat oral TDlo, rat oral LD50.

295 Benzotriazole 95-14-7 0.025 0.075 0.5 250 Rat oral 26 week TDlo, rat oral LD50.

296 Benzotrifluoride 98-08-8 6.41 15 125 500 As fluoride, PEL-TWA, IDLH.

297 Benzoyl chloride 98-88-4 0.5 1.7 28.75 115 ERPG-1/3, ERPG-1, ERPG-2, ERPG-3.

298 Benzoyl peroxide 94-36-0 5 5 12.5 500 PEL-TWA, IDLH, mouse skin TDlo.


6/19/2009



PAC Rev 24B





299 Benzyl acetate 140-11-4 60 60 60 150 TLV-TWA, human TClo, cat 480 min LC50.

300 Benzyl alcohol 100-51-6 40 250 600 600 WEEL-TWA, rat TDlo, rat 480 min LC lo.

301 Benzyl aminopurine, 6-; (6-Benzyladenine) 1214-39-7 5 15 100 500 Rat TDlo, rat LC50, 240 min assumed.

302 Benzyl benzoate 120-51-4 12.5 35 250 500 Rabbit 13 week skin TDlo, rat oral LD50.

303 Benzyl chloride 100-44-7 5.2 5.2 53 260 PEL-TWA, ERPG-1, ERPG-2, ERPG-3.

304Benzyl chloroformate; (Carbobenzoxy

chloride)501-53-1 0.3 1 6.76 20.2 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

305 Benzyl cyanide; (Phenylacetonitrile) 140-29-4 0.2 0.6 4.3 30 LOC, rat 120 min LC50.

306 Benzyl trichloride; (Trichloromethylbenzene) 98-07-7 0.35 1 7 25 LOC, rat 240 min LC50.

307 Benzylamine 100-46-9 2.5 7.5 50 250 Mouse ip LD50

308Benzyldimethylamine; (Dimethylbenzylamine,

N,N-; BDMA)103-83-3 1 3 20 200 Rat TClo, rat 120 min LC50.

309Benzyldimethyloctadecylammonium chloride;

(Dimethyloctadecylbenzylammonium chloride)122-19-0 5 15 100 500 Rat oral LD50.

310 Benzylmagnesium chloride 6921-34-2 1.5 5 35 150 Assumed HHR =3, used default rat oral LD50.

311 Benzyltrimethylammonium hydroxide; (Triton b) 100-85-6 0.1 0.35 2.5 12.5 Mouse subcutaneous LD lo.

312 Beryllium 7440-41-7 0.002 0.01 0.025 0.1 PEL-TWA, TLV-STEL, ERPG-2, ERPG-3.

313 Beryllium chloride 7787-47-5 0.0177 0.0443 0.0443 35.5 PEL-TWA, PEL-C, IDLH, as Be.


6/19/2009



PAC Rev 24B





314 Beryllium fluoride 7787-49-7 0.0104 0.0261 0.0261 20.9 PEL-TWA, PEL-C, IDLH, as Be.

315 Beryllium hydroxide 13327-32-7 0.0096 0.0239 0.239 19.1 PEL-TWA, PEL-C, IDLH, as Be.

316 Beryllium nitrate 13597-99-4 0.0295 0.0738 7.38 59 PEL-TWA, PEL-C, IDLH, as Be.

317 Beryllium oxide 1304-56-9 0.0056 0.0139 1.39 11.1 PEL-TWA, PEL-C, IDLH, as Be.

318 Betaine, anhydrous; (Glycine betaine) 107-43-7 40 125 500 500 Rat ip TDlo, mouse subcutaneous LD50.

319

Bicyclo(2.2.1)heptane-2-carbonitrile, 5-chloro-6-

((((methylamino)carbonyl)oxy)imino)-, (lS-(1-

alpha,2-beta,4-alpha,5-alpha,6E))-

15271-41-7 3.5 10 19 19 LOC, rat oral LD50.

320 Bioxirane, 2,2'-; (1,2:3,4-Diepoxybutane) 1464-53-5 0.15 0.5 3.5 35 LOC, rat 240 min. LC50

321 Biphenylol, 4- 92-69-3 10 35 60 60 Mouse sc TDlo, mouse oral LD50.

322 Biphenylol, sodium salt, 2-; 132-27-4 2.5 7.5 60 300 Pregnant mouse oral TDlo, rat oral LD50.

323 Bis(1,1-dimethylethyl)-4-ethylphenol, 2,6- 4130-42-1 4 12.5 75 400LD50 estimated from CASRN = 128-37-0, 4-

methylphenol

324Bis(1,1-dimethylethyl)-4-methylphenol, 2,6-; (BHT

(food grade); 2,6-Di-tert-butyl-p-cresol)128-37-0 2 6 40 400 TLV-TWA, women oral TDlo, rat oral LD50.

325Bis(1-methylethyl)benzene, 1,4-; (p- or 1,4-

Diisopropylbenzene)100-18-5 12.5 40 300 500 Mouse oral LD50.

326 Bis(1-methylethyl)benzene; (Diisopropylbenzene) 25321-09-9 5 15 100 500 Rat 240 min LClo

327 Bis(2,3-epoxypropoxy) butane, 1,4- 2425-79-8 30 100 500 500 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





328Bis(2-butoxyethyl) ether; (Dibutyl carbitol;

Diethylene glycol dibutyl ether)112-73-2 50 150 1,000 1,500 Mouse oral TDlo, rat oral LD50.

329Bis(2-chlorethylthioethyl) ether; (2,2'-Di(3-

chloroethylthio)diethyl ether)63918-89-8 0.3 0.75 6 30 Human 60 min LC lo.

330Bis(2-Chloroethoxy)ethane, 1,2-; (Triglycol

dichloride)112-26-5 1 3 20 100 Rat oral LD50.

331Bis(2-chloroethyl)sulfide; (HD; Sulfur

mustard)505-60-2 0.02 0.065 0.13 2.08 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

332Bis(2-chloroethylthio)ethane, 1,2-;

(Sesquimustard)3563-36-8 0.06 0.15 1.25 6 Human LC lo

333 Bis(2-chloroethylthio)methane 63869-13-6 0.05 0.15 1 5Human LC lo estimated by comparison with

Sesquimustard, 3563-36-8.

334 Bis(2-chloroethylthio)-n-butane, 1,4- 142868-93-7 0.06 0.2 1.25 6Human LC lo estimated by comparison with


335 Bis(2-chloroethylthio)-n-pentane, 1,5- 142868-94-8 0.075 0.2 1.5 7.5Human LC lo estimated by comparison with


336 Bis(2-chloroethylthio)-n-propane, 1,3- 63905-10-2 0.06 0.15 1.25 6Human LC lo estimated by comparison with


337 Bis(2-chloroethylthiomethyl)ether 63918-90-1 0.06 0.15 1.25 6Human LC lo estimated by comparison with


338 Bis(2-ethoxyethyl) ether; (Diethyl carbitol) 112-36-7 75 250 500 500 Pregnant mouse TDlo, rat oral LD50.

339 Bis(2-ethylhexyl) hydrogen phosphate 298-07-7 0.02 0.06 0.4 2 Rat oral LD50.

340 Bis(2-ethylhexyl) phenyl phosphate 16368-97-1 0.075 0.2 1.5 7.5 Rat 240 min LC lo.

341 Bis(2-hydroxyethyl)dodecanamide, N,N- 120-40-1 0.04 0.125 1 1,000 Rat oral TDlo, rat oral LD50.

342Bis(2-methylstyryl)benzene, 4-; (1,4-Bis(2-(2-

methylphenyl)ethenyl)benzene)13280-61-0 10 30 50 250 Used PNOS default.


6/19/2009



PAC Rev 24B





343 Bis(3-tert-butyl-4-hydroxy-6-methylphenyl) sulfide 96-69-5 15 30 300 500 PEL-TWA, rat oral TDlo, rat oral LD50.

344 Bis(chloromethyl)ketone; (1,3-Dichloroacetone) 534-07-6 0.125 0.4 2 2 LOC, rat 120 min LC50.

345 Bis(chloromethyl)oxetane, 3,3- 78-71-7 0.4 1.25 2 75 LOC, mouse 120 min LC50.

346Bis(Dimethylamino)acridine, 3,6-; (Acridine

orange)494-38-2 0.4 1.25 7.5 40 Mouse sc LD50

347 Bis(trifluoromethyl)benzene, 1,3- 402-31-3 4.7 14.1 23.5 470 Fluoride concentration limits.

348Bis(tris(hydroxymethyl)methylamino)propane, 1,3-

; (Bis-tris propane)64431-96-5 10 30 50 250 Used PNOS default.

349 Bis[(benzo-15-crown-5)-15-ylmethyl] pimelate 69271-98-3 10 30 50 250 Used PNOS default.

350Bisbutenylenetetrahydrofurfural; (2,3,4,5-bis(2-

butylene)tetrahydro-2-furaldehyde)126-15-8 10 30 200 500 Rat oral LD50.

351 Bismuth 7440-69-9 1.5 5 40 200 Human LD lo.

352 Bismuth acetate 22306-37-2 10 30 50 250 Used PNOS default.

353 Bismuth germanate 12233-73-7 1.5 5 40 200 Human LD lo.

354 Bismuth hydroxide 10361-43-0 1 1 3 100 SAR

355 Bismuth hydroxide nitrate oxide; (White paint) 1304-85-4 7.5 20 150 500 Infant oral TDlo, infant oral LD lo.

356 Bismuth iodide 7787-64-6 1.5 5 35 150 Estimated rat oral LD50.

357 Bismuth nitrate 10361-44-1 1.25 4 25 500Rat intratracheal TDlo, mouse intraperitoneal LD

lo.


6/19/2009



PAC Rev 24B





358 Bismuth oxide 1304-76-3 20 60 400 500 Rat oral LD50.

359 Bismuth oxychloride 7787-59-9 75 250 500 500 Rat oral LD50.

360 Bismuth(III) nitrate, pentahydrate 10035-06-0 2 6 40 500 Rat 240 min TClo, rat oral LD50.

361 Bisphenol A 80-05-7 5 15 100 500 Female rat ip nTDlo, rat oral LD50.

362 Bisphenol A diglycidyl ether 1675-54-3 1.25 3.5 6 6 Mouse skin TDlo, rat oral LD50.

363 Bitoscanate; (1,4-Phenylenediisothiocyanic acid) 4044-65-9 4 12.5 20 20 LOC, rat oral LD50.

364BoBCalix; (Calix[4]arene-bis(t-octylbenzo-crown-

b)z-0110 10 30 50 250 PNOS TLV-TWA default used.

365Borane methyl sulfide complex; (Methyl sulfide

complex with borane (1:1))13292-87-0 0.35 1 6 35 Rabbit skin LD lo.

366 Borane-tetrahydrofuran 14044-65-6 5 15 25 125 TWA based on borane compound toxicity range

367 Borate 14213-97-9 60 150 500 500 Minimum human oral LD50.

368 Boric acid 10043-35-3 2 6 100 125 TLV-TWA, human TDlo, human LD lo.

369 Boric acid, tributyl ester; (Tri-n-butyl borate) 688-74-4 7.5 25 150 750 Mouse oral LD50.

370 Boron 7440-42-8 2.5 7.5 50 250 Rat oral LD50.

371 Boron carbide 12069-32-8 10 30 50 250 Used PNOS default.

372 Boron nitride 10043-11-5 400 500 500 500 Rat LD lo minimum.


6/19/2009



PAC Rev 24B





373 Boron oxide 1303-86-2 15 30 300 500 PEL-TWA, rat TClo, IDLH.

374 Boron tribromide 10294-33-4 1 3.38 74.8 410 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

375 Boron trichloride 10294-34-5 0.5 1.5 10 12.5 LOC, rat 420 min LC lo.

376 Boron trifluoride 7637-07-2 0.75 2.5 37 110 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

377 Boron trifluoride etherate 109-63-7 9.34 25 150 500 Fluoride concentration limits.

378 Boron trifluoride-dimethyl ether 353-42-4 0.75 2.5 37 110 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

379 Botulinum toxin-A 93384-43-1 0. 0. 0. 0.PAC-2/5, PAC-2*3/5, human subcutaneous

TDlo,.mouse LD50,

380 Botulinum toxin-B z-0117 0. 0. 0. 0.PAC-2/5, PAC-2*3/5, mouse intramuscular TDlo,

mouse intraperitoneal LD50

381 Botulinum toxin-F z-0118 0. 0. 0. 0.PAC-2/5, PAC-2*3/5, mouse intramuscular TDlo,

mouse intraperitoneal LD50.

382 Botulinum, clostridium z-0119 0. 0. 0. 0.PAC-3/105, PAC-3/35, PAC-3/5, mouse

intravenous LD50.

383Brij-35; (alpha-Dodecyl-omega-hydroxypolyoxy-

ethylene)9002-92-0 0.15 0.5 3.5 400

PAC-2/21, PAC-2/7, rat intratracheal TDlo, rat oral

LD50.

384 Brilliant blue 2650-18-2 0.06 0.06 0.06 0.06 Rat subcutaneous TDlo, human iv LD lo.

385 Bromadiolone 28772-56-7 0.2 0.6 1 1 LOC, rat oral LD50.

386 Bromine 7726-95-6 0.216 0.216 1.57 55.5 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

387 Bromine chloride 13863-41-7 0.75 2.36 11.8 35.8 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





388 Bromine pentafluoride 7789-30-2 0.75 1 7.15 236 TLV-TWA, AEGL-2/7, AEGL-2, AEGL-3.

389 Bromine trifluoride 7787-71-5 0.2 0.671 11.2 118 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

390 Bromo acetic acid, methyl ester 96-32-2 0.25 0.75 5 25 Mouse iv LD lo.

391

Bromo-1-chloro-5,5-dimethylhydantoin, 3-;

(Bromo-1-chloro-5,5-dimethyl-2,4-

imidazolidinedione, 3-)

126-06-7 2.5 7.5 50 250 Rat oral LD50.

392Bromo-2-chloro-1,1,2-trifluoroethane, 1-; (1,1,2-

Trifluoro-1-bromo-2-chloroethane)354-06-3 400 1,250 7,500 40,000 Mouse 120 min LC50.

393

Bromo-3-chloro-5,5-dimethylhydantoin, 1-; (1-

Bromo-3-chloro-5,5-dimethyl-2,4-

imidazolidinedione)

16079-88-2 6 15 125 500 Rat oral LD50.

394 Bromo-3-methylbutane, 1- 107-82-4 25 75 500 2,500 Rat ip LD50.

395 Bromoacetaldehyde diethyl acetul 2032-35-1 7.5 25 150 500 Rat oral LD50 estimated from HHR.

396 Bromoacetic acid 79-08-3 0.04 0.125 0.75 4 Rat 30 min LC lo.

397 Bromoacetone 598-31-2 0.4 1.25 7.5 40 Human LC lo

398 Bromoanisole, 99, 3- 2398-37-0 10 30 50 250 PNOS default used.

399 Bromobenzene; (Phenyl bromide) 108-86-1 6 15 125 2,000 Mouse intraperitoneal TDlo, rat 240 min LC50.

400 Bromochlorobenzene, m- 108-37-2 10 30 50 250 Used PNOS default.

401 Bromochlorobenzene, p- 106-39-8 10 30 50 250 Used PNOS default.


6/19/2009



PAC Rev 24B





402 Bromochloromethane 74-97-5 1,000 3,000 5,000 10,000 PEL-TWA, IDLH.

403 Bromocresol green 76-60-8 10 30 50 250 Used PNOS default.

404 Bromocresol purple 115-40-2 10 30 50 250 Used PNOS default.

405 Bromocyclohexanol, Cis-2- 16536-57-5 0.3 0.75 5 300 SAR

406 Bromodecane, 1- 112-29-8 15 40 300 1,500 Mouse 120 min LC50

407 Bromodichloromethane 75-27-4 1.5 4 30 150 Rat oral TDlo, rat oral LD50.

408 Bromododecane, 1- 143-15-7 7.5 25 150 500 Rat oral LD50 based on HHR.

409 Bromoethane; (Ethyl bromide) 74-96-4 20 4,000 7,500 7,500 TLV-TWA, rat TClo, IDLH.

410 Bromoethanol , 2- (ethylene bromohydrin) 540-51-2 0.075 0.2 1.5 60 Mouse ip TDlo, mouse ip LD lo.

411 Bromoethylmagnesium 925-90-6 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

412Bromofluorobenzene, 4-; (p-

fluorobromobenzene)460-00-4 75 200 500 500 Rat 240 min LC50

413 Bromoform; (Tribromomethane) 75-25-2 5 5 10 7,500 PEL-TWA, IDLH.

414 Bromohexane; (n-Hexyl bromide) 111-25-1 250 750 6,000 30,000 Rat 30 min LC50.

415Bromomesitylene, 2-; (2-Bromo-1,3,5-

trimethylbenzene)576-83-0 10 30 50 250 PNOS default used.

416 Bromomethyl-1,3-dioxolane, 2- 4360-63-8 7.5 25 150 500 Rat oral LD50 estimated from HHR = 2.


6/19/2009



PAC Rev 24B





417 Bromonaphthalene 90-11-9 3.5 10 60 350 Mouse ip LD50.

418 Bromonitromethane 563-70-2 0.75 2.5 15 75 Rat oral LD lo.

419 Bromooctane , 1-; (Octyl bromide) 111-83-1 20 60 400 2,000 Rat oral LD50.

420 Bromophenol blue 115-39-9 10 30 50 250 PNOS default used.

421 Bromophenyl phenyl ether, 4- 101-55-3 2 6 40 200 Rat 240 min LC lo.

422 Bromopropane, 1- 106-94-5 50 150 12,500 12,500 TLV-TWA, rat TClo, rat 30 min LC lo.

423 Bromopropane, 2- 75-26-3 3,000 7,500 60,000 125,000 Rat TClo, mouse 240 min LC50

424 Bromopyrene, 3- 1714-29-0 10 30 50 250 Used PNOS default.

425 Bromosuccinimide, N- 128-08-5 2 6 40 200 Mouse ip LD lo.

426 Bromothymol blue 76-59-5 10 30 50 250 Used PNOS default

427 Bromotoluene, A-; (Benzyl bromide) 100-39-0 0.6 1.5 12.5 60 Rabbit 30 min LC lo

428 Bromotrichloromethane 75-62-7 0.5 1.5 10 50 Rat ip LD50.

429 Bromotrifluoroethylene 598-73-2 40 125 200 750Fluoride concentration limits, rat TClo, rat 240 min

LC lo.

430 Bromotrifluoromethane; (Trifluorobromomethane) 75-63-8 6,000 20,000 150,000 250,000 PEL-TWA, 60 min EEGL, 30 min EEGL.

431 Bromotrimethylsilane; (Trimethylsilyl bromide) 2857-97-8 1.5 5 35 150 Rat oral LD50 based on HHR = 3.


6/19/2009



PAC Rev 24B





432 Brown menhaden fish oil 68440-42-6 10 30 50 250 PNOS default used.

433 Brucine; (2,3-Dimethoxystrychnine) 357-57-3 0.6 1.5 12.5 40 Rat ip TDlo, rat ip LD50

434 Buffer solution, aequeous 7732-18-5 500 500 500 500 Human oral TDlo, mouse ip LD50

435 Butadiene,1,3- 106-99-0 2 1,480 11,700 48,600 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

436Butanaminium,N,N,N-tributyl bromide, 1-;

(Tetrabutylammonium bromide)1643-19-2 10 30 50 250 Used PNOS default

437 Butane 106-97-8 2,500 13,100 40,400 126,000 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

438Butanedioic acid, diethyl ester; (Succinic acid,

diethyl ester)123-25-1 35 100 750 3,500 Rat oral LD50.

439Butanedioic acid, dimethyl ester; (Succinic acid,

dimethyl ester)106-65-0 20 60 400 2,000 Rat oral LD50 minimum.

440 Butanediol dinitrate, 1,4- 3457-91-8 0.35 0.75 3 20 SAR

441 Butanediol, 1,3- 107-88-0 25 75 500 500 Mammal oral TDlo, rat oral LD50

442 Butanediol, 1,4-; (1,4-Tetramethylene glycol) 110-63-4 1.25 3.5 25 250 WOMEN LD LO, RAT ORAL TDlo.

443 Butanedione, 2,3- 431-03-8 20 60 400 400 Rat oral TDlo, rat oral LD50.

444 Butanenitrile; (Butyronitrile) 109-74-0 20 60 100 125 REL-TWA, mouse 60 min LC50.

445 Butanephosphonic acid 3321-64-0 0.02 0.06 0.4 2 SAR

446 Butanethiol; (n-Butyl mercaptan) 109-79-5 1.5 20 150 1,500 PEL-TWA, REL-C, IDLH.


6/19/2009



PAC Rev 24B





447 Butanoic acid, butyl ester; (n-Butyl n-butanoate) 109-21-7 10 30 200 1,000 RAT IP LD50.

448 Butanol, aluminum salt, 2- 2269-22-9 18.3 54.8 91.3 400 Al alkyls TLV-TWA.

449 Butanol-d10, n- 34193-38-9 1.5 5 35 150 Estimated rat 240 min LC50.

450 Butanone oxime; (Ethyl methyl ketoxime) 96-29-7 35 150 400 400 WEEL-TWA, Rat TClo, rat oral LD50.

451Butanone, 2-; (Methyl ethyl ketone;

MEK)78-93-3 590 590 7,960 11,800 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

452 Butene, 1-; (Butylene) 106-98-9 600 1,500 30,000 150,000TLV-TWA, TEEL-0 x 3, inferred mouse TClo and

LD lo.

453 Butene, 2- 107-01-7 600 1,500 3,000 150,000TLV-TWA, TEEL-0 x 3, TEEL-0 x 5, rat 240 min

LC50.

454 Butene, cis-2-; (cis-1,2-Dimethylethylene) 590-18-1 600 150,000 500,000 750,000TLV-TWA, simple asphyxiant for PAC-1, PAC-2,

PAC-3.

455 Butene, trans-2-; (Trans-1,2-dimethylethylene) 624-64-6 600 1,500 30,000 150,000TLV-TWA, TEEL-0 x 3, inferred mouse TClo and

LD lo.

456Butoxyethanol acetate, 2-; (Ethylene glycol

monobutyl ether acetate)112-07-2 125 400 600 1,000 TLV-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

457 Butoxyethanol phosphate, 2- 78-51-3 7.5 20 150 500 Rat oral TDlo, rat oral LD50.

458 Butoxyethanol, 2-; (Glycol ether EB) 111-76-2 250 250 500 3,500 PEL-TWA, human TClo, IDLH.

459Butoxyethoxy)ethanol, 2-(2-; (Diethylene glycol

monobutyl ether)112-34-5 100 100 500 500 MAK-TWA, rat oral TDlo, rat oral LD50.

460 Butoxyethoxy)ethyl thiocyanate, 2-(2- 112-56-1 0.35 1 7.5 40 Rat oral LD50.

461 Butoxypolypropylene glycol 9003-13-8 35 100 500 500 Rat oral LD50


6/19/2009



PAC Rev 24B





462 Butyl acetate, n- 123-86-4 24 24 950 14,250 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

463 Butyl acetate, sec- 105-46-4 750 750 1,500 7,500 PEL-TWA, PAC-3/35, PAC-3/5, IDLH.

464 Butyl acetate, tert- 540-88-5 750 2,500 4,000 6,000 PEL-TWA, IDLH.

465 Butyl acetoacetate, tert- 1694-31-1 20 60 400 500 Rat oral LD50 minimum.

466 Butyl acrylate, n- 141-32-2 10 43.5 681 2,510 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

467 Butyl alcohol, n- 71-36-3 150 150 150 4,000 PEL-TWA, REL-C, IDLH.

468 Butyl alcohol, sec-; (2-Butanol) 78-92-2 300 400 6,000 6,000 TLV-TWA, rat TClo, IDLH.

469 Butyl bis(2-ethylhexyl)phosphate z-0002 3 7.5 10 10 SAR

470 Butyl bromide, n-; (1-Bromobutane) 109-65-9 100 300 2,000 10,000 Rat 120 min LC50

471 Butyl chloroformate, n- 592-34-7 1 1.5 12.3 37.4 MAK-TWA, AEGL-2/7, AEGL-2, AEGL-3.

472 Butyl chloroformate, sec- 17462-58-7 0.6 1.5 12.3 37.4 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

473 Butyl ether, n-; (Dibutyl ether) 142-96-1 5 15 100 2,000 Human TClo, rat 240 min LC lo.

474 Butyl glycidyl ether, n- 2426-08-6 15 15 30 1,250 TLV-TWA, REL-C, IDLH.

475 Butyl isocyanate, n- 111-36-4 0.0125 0.04 0.2 4 ERPG-1/3, ERPG-1, ERPG-2, ERPG-3.

476 Butyl isocyanate, Tert- 1609-86-5 0.25 0.75 5 25 Rat 240 min LC50.


6/19/2009



PAC Rev 24B





477 Butyl levulinate 2052-15-5 20 60 400 500 Rat oral LD50 minimum.

478 Butyl lithium 109-72-8 0.231 0.231 1.25 6 LiH rat 240 min LClo

479 Butyl methyl-d3 ether, tert- 29366-08-3 150 500 15,000 15,000Tert-butyl methyl ether TLV-TWA, and toxicity

data.

480 Butyl perbenzoate, tert- 614-45-9 7.5 25 150 400 Mouse uk TDlo, rat oral LD50.

481 Butyl propanoate; (Propanoic acid, butyl ester) 590-01-2 500 500 500 500 Rat TClo, rat oral LD50.

482 Butyl-2-methylcyclopropane, T-1- 38851-70-6 10 30 50 250 Used PNOS default.

483 Butyl-3-iodo-2-propynylcarbamate 55406-53-6 10 30 50 250 Used PNOS default.

484 Butylamine, (S)-sec- 513-49-5 1.5 4 30 150 Rat oral LD50.

485 Butylamine, n- 109-73-9 7.5 20 150 750 MAK-TWA, PEL-C and mouse ip TDlo, IDLH.

486 Butylamine, sec- 13952-84-6 15 15 30 60 MAK-TWA, MAK-C, rat oral LD50.

487 Butylamine, tert- 75-64-9 15 15 30 400MAK-TWA, MAK-C, human TClo, rat 240 min

LC50.

488 Butylbenzene, n-; (1-Phenylbutane) 104-51-8 40 125 750 4,000 Rat oral LD lo.

489 Butylbenzene, sec-; (2-Phenylbutane) 135-98-8 7.5 25 200 1,000 Rat oral LD50

490 Butylbenzene, tert- 98-06-6 40 125 750 4,000 Rat oral LD lo.

491 Butylcyclohexane; (1-Cyclohexylbutane) 1678-93-9 10 30 200 1,000 Estimated rat oral LD50.


6/19/2009



PAC Rev 24B





492 Butylcyclohexanone, p-tert- 98-53-3 20 60 400 500 Rat oral LD50.

493Butylene carbonate; (1,2-Butanediol, cyclic

carbonate)4437-85-8 20 60 400 500 Rat oral LD50 minimum.

494 Butylpyrocatechol, 4-tert-; (4-tert-Butylcatechol) 98-29-3 0.1 0.3 2 500 WEEL-C, rat oral LD50/

495 Butyltrichlorosilane 7521-80-4 1.5 4.7 57.2 258 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

496 Butyne-1,4-diol, 2-; (1,4-Butynediol) 110-65-6 0.35 1 20 30 USSR-STEL, rat TClo, rat 120 min LC lo.

497 Butyraldehyde 123-72-8 0.06 0.15 1.25 40 Human TClo, rat 10 min LC50.

498 Butyric acid 107-92-6 50 150 750 750 Hamster oral TDlo, rat oral LD50.

499 Butyric acid, sodium salt 156-54-7 50 150 500 500 Dog iv TDlo.

500 BZ; (3-Quinuclidinyl benzilate) 6581-06-2 0.006 0.02 0.033 0.62 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

501

C.I. pigment red 53:1; (5-Chloro-2-((2-hydroxy-1-

naphthyl)azo)-p-toluene sulfonic acid, barium

salt)

5160-02-1 12.5 35 250 500 Rat oral TDlo.

502

C-18 Unsarturated fatty acid, dimers, reaction

products with polyethylenepolyamines; (Versamid

140 polyamide resin; Versamid 125)

68410-23-1 10 30 50 250 Used PNOS default

503 Cacodylic acid 75-60-5 0.5 1.5 5 5 Organic arsenic compound PEL-TWA, IDLH.

504 Cadmium and compounds, as Cd. 7440-43-9 0.005 0.03 1.25 9 PEL-TWA, woman TClo, IDLH.

505 Cadmium bromide 7789-42-6 0.0121 0.0727 4 21.8 PEL-TWA, LOC, IDLH.


6/19/2009



PAC Rev 24B





506 Cadmium carbonate 513-78-0 0.0077 0.046 4 13.8 PEL-TWA, LOC, IDLH.

507 Cadmium chloride 10108-64-2 0.0082 0.0489 0.5 14.7 PEL-TWA, rat TClo, IDLH.

508Cadmium chloride hemipentahydrate;

(Cadmium chloride, 2.5-hydrate)7790-78-5 0.25 0.75 5 300 Rat ip TDlo, rat oral LD50.

509 Cadmium fluoride 7790-79-6 0.0067 0.0401 4 12 PEL-TWA, LOC, IDLH.

510 Cadmium hydroxide 21041-95-2 0.0065 0.0391 4 11.7 PEL-TWA, LOC, IDLH.

511 Cadmium nitrate 10325-94-7 0.0105 0.0631 4 18.9 PEL-TWA, LOC, IDLH.

512 Cadmium nitrate tetrahydrate 10022-68-1 0.0137 0.6 4 24.7 PEL-TWA, LOC, IDLH.

513 Cadmium nitrite 7790-83-2 0.0091 0.0546 4 16.4 PEL-TWA, LOC, IDLH.

514 Cadmium oxide 1306-19-0 0.0057 0.0343 4 10.3 PEL-TWA, LOC, IDLH.

515Cadmium stearate; (Octadecanoic acid,

cadmium salt)2223-93-0 0.0303 0.182 13 54.6 PEL-TWA, LOC, IDLH.

516 Cadmium sulfate 10124-36-4 0.0093 0.0557 4 16.7 PEL-TWA, LOC, IDLH.

517 Cadmium sulfate, hydrate 7790-84-3 0.0157 0.0941 0.3 28.2 PEL-TWA, hamster iv TDlo, IDLH.

518 Cadmium sulfide 1306-23-6 0.0064 0.0386 11.6 11.6 PEL-TWA, rat subcutaneous TDlo, IDLH.

519 Cadmium tungstate 7790-85-4 0.016 0.0961 4 28.8 PEL-TWA, LOC, IDLH.

520 Cadmium(II) acetate 543-90-8 0.0052 0.031 4 9.3 PEL-TWA, LOC, IDLH.


6/19/2009



PAC Rev 24B





521 Calcium 7440-70-2 10 30 50 250 Used PNOS default.

522 Calcium acetate 62-54-4 0.02 0.06 0.4 30 Pregnant rat TClo, mouse ip LD50.

523 Calcium arsenate 7778-44-1 0.0266 1.5 10 13.3 PEL-TWA, PAC-2/7, LOC, IDLH.

524 Calcium carbide 75-20-7 10 30 50 250 Used PNOS default.

525 Calcium carbonate; (Dolomite, Limestone) 1317-65-3 15 15 60 300 PEL-TWA, PEL-TWA, rat TClo, TEEL-2*5.

526 Calcium chloride 10043-52-4 25 75 400 400 Women intravenous TDlo, rat oral LD50.

527 Calcium chloride dihydrate 10035-04-8 40 125 500 500 Rat oral TDlo, mouse ip LD50.

528 Calcium chloride hexahydrate 7774-34-7 5 15 100 500 Guinea pig iv LD lo.

529 Calcium chloride hydrate 22691-02-7 30 100 450 500Concentration limits based on TEELs for Ca.Cl2

and Ca.Cl2..2(H2.O)

530 Calcium chromate 13765-19-0 0.015 0.0901 1.25 45 Cr VI concentration limits.

531 Calcium cyanamide 156-62-7 0.5 1.5 125 500 TLV-TWA, rat oral TDlo, human oral LD lo.

532 Calcium fluoride 7789-75-5 5.14 15.4 200 500 Fluoride concentration limits, rat oral LD50.

533 Calcium formate 544-17-2 10 30 200 500 Rat oral LD50.

534 Calcium hydride 7789-78-8 1.5 5 35 150 Estimated rat oral LD50.

535 Calcium hydroxide 1305-62-0 15 15 500 500 PEL-TWA, rat oral LD50.


6/19/2009



PAC Rev 24B





536 Calcium hypochlorite; (Calcium oxychloride) 7778-54-3 3.5 10 75 350 Rat oral LD50.

537 Calcium metasilicate 10101-39-0 10 30 50 250 Used PNOS default.

538 Calcium monohydrogen phosphate dihydrate 7789-77-7 10 30 50 250 Used PNOS default.

539 Calcium nitrite 13780-06-8 0.03 0.075 0.6 50 SAR

540 Calcium oxalate 563-72-4 6 15 50 50 SAR

541 Calcium oxalate, hydrate 5794-28-5 10 30 50 250 Used PNOS default.

542 Calcium oxide 1305-78-8 5 5 5 25 PEL-TWA, IDLH.

543 Calcium phosphate tribasic 12167-74-7 10 30 50 250 Used PNOS default.

544 Calcium phosphate; (Tricalcium phosphate) 10103-46-5 7.5 20 35 350 SAR

545 Calcium phosphide 1305-99-3 0.35 1 7.45 13.4 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

546Calcium sulfate anhydrous; (Drierite; Gypsum;

Plaster of Paris)7778-18-9 15 30 50 250

PEL-TWA, TLV-TWA x 3, TLV-TWA X 5, TLV-

TWA X 25..

547 Calcium(II) nitrate 10124-37-5 1.25 3.5 25 125 Rat oral LD50.

548 Calcium(II) nitrate tetrahydrate (1:2:4) 13477-34-4 15 50 350 500 Rat oral LD50.

549 Calcium(II) sulfate dihydrate (1:1:2) 10101-41-4 15 30 50 75 Ca sulfate PEL-TWA, TLV-TWA, rat ip TDlo.

550 Camphor 76-22-2 2 19 19 200 PEL-TWA, TLV-STEL, rabbit TClo, IDLH.


6/19/2009



PAC Rev 24B





551 Camphorsulfonic acid, (1R)-(-)-10- 35963-20-3 4 12.5 75 400 Mouse sc LD50 of CASRN 3144-16-9.

552 Cantharidin 56-25-7 0.75 2.5 4.3 4.3 LOC, human oral LD lo.

553 Caprolactam (dust) 105-60-2 1 3 3 20REL-TWA, REL-STEL, human TClo, rat 120 min

LC50.

554 Caprolactone; (epsilon-Lactone hexanoic acid) 502-44-3 15 50 350 500 Rat oral LD50.

555 Caprylyl chloride; (Octanoyl chloride) 111-64-8 10 30 50 250 Used PNOS default.

556 CAPSO 73463-39-5 10 30 50 250 Used PNOS default.

557 Captan 133-06-2 5 15 30 500TLV-TWA, male mouse oral TDlo, human oral LD

lo.

558 Carbachol Chloride 51-83-2 3 7.5 15 15 LOC, rat oral LD50.

559Carbamic acid, methyl-, O-(((2,4-dimethyl-1,3-

dithiolan-2-yl)methylene)amino)-26419-73-8 0.2 0.6 1 1 LOC, rat oral LD50.

560

Carbanolate; (Aldicarb; Methyl-2-

(methylthio)propionaldehyde-o-

(methylcarbamoyl)oxime, 2-)

116-06-3 0.07 0.21 0.3 100 WEEL-TWA, LOC, rat 300 min LC50.

561 Carbaryl 63-25-2 5 5 15 100 PEL-TWA, TEEL-0, human oral TDlo, IDLH.

562 Carbazole 86-74-8 0.75 2.5 15 75 Mouse ip LD50.

563 Carbazole violet 6358-30-1 75 250 500 500 Rat oral LD50 based on HHR.

564 Carbethoxyethylidine(triphenylphosphorane) 5717-37-3 10 30 50 250 Used PNOS default.

565 Carbofuran 1563-66-2 0.1 0.3 0.43 0.5 TLV-TWA, LOC, women oral LD50.


6/19/2009



PAC Rev 24B





566 Carbon black 1333-86-4 3.5 10.5 17.5 500 PEL-TWA, IDLH.

567 Carbon dioxide 124-38-9 7,500 50,000 50,000 75,000 PEL-TWA, TLV-STEL, rat TClo, IDLH.

568 Carbon disulfide 75-15-0 40.4 40.4 498 1,490 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

569 Carbon monoxide 630-08-0 60 95 95 378 PEL-TWA, AEGL-2, AEGL-2, AEGL-3.

570 Carbon tetrachloride 56-23-5 60 277 1,190 3,270 TLV-TWA, AEGL-1, -2, -3.

571 Carbon tetrafluoride; (Tetrafluoromethane) 75-73-0 750 2,500 15,000 75,000 Rat 15 min LC lo.

572 Carbon trifluoride; (Trifluoromethane, Fluoroform) 75-46-7 2,500 7,500 60,000 300,000 Estimated human TClo.

573 Carbon; (Graphite, synthetic) 7440-44-0 2 6 10 500 TLV-TWA, rat sc TDlo, IDLH.

574 Carbonic acid, calcium salt 471-34-1 15 45 500 500 PEL-TWA, rat oral LD50.

575 Carbonyl fluoride 353-50-4 0.755 0.755 0.755 2.24 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

576 Carbonyl sulfide 463-58-1 25 75 135 368 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

577 Carbonyldiphthalic anhydride, 4,4'- 2421-28-5 10 30 50 250 Used PNOS default.

578 Carbophenothion; (Trithion) 786-19-6 1.25 4 6.8 6.8 LOC, rat oral LD50.

579 Carboxymethyl cellulose 9000-11-7 40 125 500 500 Rat oral LDlo minimum.

580 Carboxymethyl sepharose; (CM sepharose) 68894-07-5 7.5 25 150 500 Rat oral LD50 based on HHR = 2.


6/19/2009



PAC Rev 24B





581 Casamino acids z-0008 10 30 50 250 Used PNOS default.

582Casein; (Casamino acids; Casein hydrolysate

type 1)9000-71-9 10 30 50 250 PNOS default

583 Castor oil 8001-79-4 40 125 500 500 Rat im TDlo, human oral LD lo minimum.

584 Catechol 120-80-9 20 20 40 100 TLV-TWA, PAC-2/7, rat oral TDlo, rat oral LD50.

585Cation exchange resin 200-400 mesh Hyd.

Dowex 50W-X811119-67-8 10 30 50 250 Used PNOS default

586 Cation exchange resin 50W-X12, 200 - 400 mesh 9056-03-5 10 30 50 250 Used PNOS default

587 Cellulose 9004-34-6 15 30 500 500PEL-TWA, TLV-TWA, rat oral TDlo, rat 240 min

LC 50.

588 Cellulose acetate butanoate 9004-36-8 10 30 50 250 Used PNOS default

589 Cellulose, 2-(diethylamino)ethyl ether 9013-34-7 10 30 50 250 Used PNOS default

590 Ceric ammonium nitrate 16774-21-3 39.1 117 200 500 Used PNOS default

591 Ceric ammonium sulfate 7637-03-8 42.9 129 214 500 Used PNOS default

592 Ceric ammonium sulfate, dihydrate 10378-47-9 10 30 50 250 Used PNOS default

593 Ceric oxide 1306-38-3 6 20 150 500 Rat 240 min TClo, rat oral LD50 minimum.

594 Cerium 7440-45-1 10 30 50 250 Used PNOS default

595 Cerium (iv) nitrate, 1.5 13093-17-9 10 30 50 250 PNOS TLV-TWA default used.


6/19/2009



PAC Rev 24B





596 Cerium acetate 537-00-8 0.1 0.35 2 10 Human iv TDlo.

597 Cerium chloride 7790-86-5 7.5 25 150 500 Rat oral LD50

598 Cerium fluoride 7758-88-5 8.65 25.9 43.2 500 Rat oral LD50 minimum.

599 Cerium hydroxide 15785-09-8 0.75 0.75 2 75 SAR

600 Cerium nitrate hexahydrate 10294-41-4 15 50 350 500 Rat oral LD50

601 Cerium oxalate 15750-47-7 22.6 67.7 113 500 Used PNOS default.

602 Cerium sulfate 13590-82-4 1 3.5 20 100 Male rat intratracheal TDlo.

603 Cerium trioxide 1345-13-7 2 6 40 200 Mouse ip LD50.

604 Cerium(III) sulfate 13454-94-9 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

605 Cerium(IV) hydroxide 12014-56-1 14.9 44.6 75 350 Used PNOS default.

606 Cerous nitrate; (Cerium(III) nitrate) 10108-73-3 1 3 20 500 Male rat intratracheal TDlo, rat oral LD50.

607 Cerous nitrite z-0004 0.04 0.1 0.75 75 SAR

608 Cesium 7440-46-2 6 20 150 500 Mouse ip LD50.

609 Cesium carbonate 534-17-8 10 30 200 500 Rat oral LD50.

610 Cesium chloride 7647-17-8 0.4 1.25 10 500 Female rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





611 Cesium fluoride 13400-13-0 20 60 100 500 Fluoride concentration limits.

612 Cesium hydroxide 21351-79-1 2 2 7.5 250 TLV-TWA, rat TClo, rat oral LD50.

613 Cesium iodide 7789-17-5 10 30 200 500 Rat oral LD50.

614 Cesium nitrate 7789-18-6 10 30 200 500 Rat oral LD50.

615 Cesium nitrite 13454-83-6 0.075 0.2 1.5 60 SAR

616 Cesium oxide 20281-00-9 2.24 6.72 11.2 500 Cs hydroxide TLV-TWA and rat oral LD lo (HSDB).

617 Charcoal, activated 64365-11-3 10 30 50 250 Used PNOS default

618 Chloramben; (3-Amino-2,5-dichlorobenzoic acid) 133-90-4 35 100 500 500 Mouse oral TDlo, rat oral LD50.

619 Chloramphenicol 56-75-7 0.5 1.5 7.5 350 WEEL-TWA, human TDlo, women orak LD lo.

620 Chlordane 57-74-9 0.5 1.5 50 100 PEL-TWA, LOC, IDLH.

621 Chlorfenvinfos 470-90-6 2 6 10 10 LOC, rat oral LD50.

622 Chloric acid, sodium salt; (Sodium chlorate) 7775-09-9 0.15 0.4 3 75 Human oral TDlo, child uk LD50.

623 Chloride 16887-00-6 0.75 1.5 1.5 15 TLV-TWA, TLV-STEL, PEL-C, IDLH.

624 Chlorinated polyolefins 68410-99-1 10 30 50 250 Used PNOS default.

625 Chlorine 7782-50-5 1.45 1.45 5.8 58 TLV-TWA, AEGL-1, AEGL-2, AEGL-3


6/19/2009



PAC Rev 24B





626 Chlorine dioxide 10049-04-4 0.25 0.414 3.03 6.62 PEL-TWA, AEGL-1, AEGL-2, AEGL-3

627 Chlorine Hi dry granular (as Cl) z-0006 0.75 1.5 4 30 Chlorine TLV-TWA, ERPG-1, ERPG-2, ERPG-3.

628 Chlorine pentafluoride 13637-63-3 0.5 1.6 5.33 42.7 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

629 Chlorine trifluoride 7790-91-2 0.15 0.453 7.56 79.3 MAK-TWA, AEGL-1, AEGL-2, AEGL-3

630 Chlormephos 24934-91-6 1.25 4 7 35 LOC, rat 240 min LC50.

631 Chlormequat Chloride; (Choline dichloride) 999-81-5 0.35 1 7 7.5 LOC, human LD lo.

632 Chloro-1,1,1,2-tetrafluoroethane, 2- 2837-89-0 5,580 5,580 27,900 55,800 PAC-1, ERPG-1, ERPG-2, ERPG-3.

633 Chloro-1,1-difluoroethane, 1-; (HCFC-142b) 75-68-3 4,000 41,000 61,500 102,500 WEEL-TWA, ERPG-1, ERPG-2, ERPG-3.

634 Chloro-1,2-propanediol, 3-; (Chlorohydrin) 96-24-2 0.1 0.3 2 60 Rat oral TDlo, rat 240 min LC lo.

635 Chloro-1-butanol, 4- 928-51-8 1.5 5 40 400 Mouse ip TDlo, mouse oral LD50.

636 Chloro-2,4-dinitrobenzene, 1- 97-00-7 3 10 60 350 Rat oral TDlo, rat oral LD50.

637 Chloro-2-methyl-1-propene, 3- 563-47-3 3 7.5 60 300 Rat oral TDlo.

638 Chloro-2-methylpropane, 2-; (Tert-butyl chloride) 507-20-0 1.5 4 30 7,500 Mouse ip TDlo, HHR-based rat oral LD50.

639 Chloro-2-nitrophenol, 4- 89-64-5 0.4 1.25 7.5 40 MSDS rat oral LD50.

640 Chloro-4-nitrophenol, 2- 619-08-9 3.5 10 75 400 Rat oral LD50.


6/19/2009



PAC Rev 24B





641 Chloroacetaldehyde 107-20-0 1.25 4.17 7.06 31.8 PEL-C, AEGL-1, AEGL-2, AEGL-3.

642 Chloroacetaldehyde dimethyl acetal 97-97-2 7.5 25 150 500 Estimated HHR and rat oral LD50.

643 Chloroacetic acid, sodium salt 3926-62-3 2.38 7.14 40 40 WEEL-TWA, rat oral TDlo, rat oral LD50.

644Chloroacetic acid; (Monochloroacetic

acid)79-11-8 2 6 25.5 75 TLV-TWA, TLV*3, AEGL-2, rat 240 min LC50.

645 Chloroacetone 78-95-5 0.75 2 16.6 49.2 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

646 Chloroacetonitrile 107-14-2 4 12.5 98.7 207 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

647 Chloroacetyl chloride 79-04-9 0.185 0.185 7.39 240 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

648Chloroallyl)-3,5,7-triaza-1-azoniaadamantane

chloride, 1-(3-4080-31-3 1 3 20 200 Rat oral TDlo, rat oral LD50.

649 Chloroaniline, p- 106-47-8 0.5 1.5 10 300 Rat oral TDlo, mouse 360 min LC lo.

650 Chlorobenzene; (Benzene chloride) 108-90-7 46 46 690 1,840 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

651 Chlorobenzotrifluoride, 2- 88-16-4 6 20 125 500 Rat oral LD50.

652Chlorobenzylate; (4,4'-Dichlorobenzilic acid ethyl

ester)510-15-6 0.3 0.75 6 300 Rat oral TDlo, rat oral LD50.

653 Chlorobenzylidene malononitrile, o- 2698-41-1 0.005 0.005 0.1 25 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

654 Chlorobutane, 1-; (Butyl chloride) 109-69-3 30 75 600 3,000 Rat oral TDlo, rat 240 min Lclo.

655 Chlorobutane, 2-; (Sec-butyl chloride) 78-86-4 1.5 5 35 12,500 Mouse ip TDlo, rat 240 min LC lo.


6/19/2009



PAC Rev 24B





656 Chlorobutyryl chloride, 4- 4635-59-0 2.5 7.5 50 250 Rat 240 min LC50

657 Chlorocyclohexanol, trans-2- 6628-80-4 3.5 10 75 400 Rat oral LD50.

658 Chlorocyclohexene; (4-Chlorocyclohexene) 930-65-4 100 300 2,500 12,500 SAR

659 Chlorodecane, 1- 1002-69-3 350 1,000 1,500 7,500 Alkane REL-TWA, REL-C

660Chlorodiethylaluminum; (Diethylaluminum

chloride)96-10-6 8.94 26.82 200 500 TLV-TWA, rat 15 min LC50

661 Chlorodifluoromethane 75-45-6 3,500 4,000 30,000 30,000 TLV-TWA, rat 15 min LC50, rat TClo.

662 Chloroethanesulfonyl chloride, 2- 1622-32-8 1.25 3.5 25 150 LOC, rat 240 min LC50.

663 Chloroethyl chloroformate 627-11-2 4 12.5 20 20 LOC, mouse 10 min LC lo..

664Chloroethyl vinyl ether, 2-; (Ethene, 2-

chloroethoxy-)110-75-8 1 3.5 20 100 Rat 240 min LC lo.

665 Chloroethylchloromethylsulfide, 2- 2625-76-5 0.02 0.06 0.1 1.5 Sulfur mustard (505-60-2) AEGLs

666 Chloroform 67-66-3 10 10 312 15,600 REL-STEL, REL-STEL, AEGL-2, AEGL-3

667 Chloroform-D; (Deuterated chloroform) 865-49-6 10 10 250 2,500 Chloroform TLV-TWA, REL-STEL, PEL-C, IDLH.

668 Chloro-m-cresol, 4- 59-50-7 7.5 20 150 500 Rat oral LD50.

669 Chloromethyl methyl ether 107-30-2 0.3 0.75 1.55 6.58 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

670 Chloromethyl(trichloro)silane 1558-25-4 1.5 4.51 54.9 248 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





671 Chloro-methyl-isothiazolin-3-one, 5- 26172-55-4 0.2 0.6 1 1 MAK-TWA, mouse skin TDlo.

672Chloronaphthalene, 1-; (alpha-

Chloronaphthalene)90-13-1 6 20 125 500 Rat oral LD50.

673 Chloronaphthalene, 2-; (beta-Chloronaphthalene) 91-58-7 0.2 0.6 1 500 Rat oral LD50.

674 Chloronitrobenzene, p- ; (p-Nitrochlorobenzene) 100-00-5 1 1.92 100 100 PEL-TWA, TLV-TWA, mouse oral TDlo, IDLH.

675 Chloroperoxybenzoic acid, 3- 937-14-4 0.3 1 6 35 Mouse skin TDlo.

676 Chlorophacinone 3691-35-8 0.2 0.6 1 1 LOC, rat oral LD50.

677 Chlorophenol, 4-; (p-Chlorophenol) 106-48-9 250 400 400 400 Human 480 min TClo, mouse 120 min LClo

678 Chlorophenol, m- 108-43-0 0.3 0.75 6 250 Mouse skin TDlo, rat oral LD50.

679 Chlorophenol, o- 95-57-8 2 6 40 300 Rat oral TDlo, rat oral LD50.

680 Chlorophenyl phenyl ether, 4- 7005-72-3 0.0025 0.0075 0.05 0.25 Human TClo.

681 Chlorophenyl thiourea, 2- 5344-82-1 0.75 2.5 4.6 4.6 LOC, rat oral LD50.

682 Chloropicrin/Methyl bromide mixture 8004-09-9 2 3 12.5 60 Ratios of concentration limits of components.

683 Chloropicrin/Methyl chloride mixture z-0007 2 2 6 30 Ratios of concentration limits of components.

684 Chloropicrin; (Trichloronitromethane) 76-06-2 0.336 0.336 1.01 9.41 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

685 Chloroprene; (Neoprene) 126-99-8 3.5 3.5 3.5 1,000 REL-C, IDLH.


6/19/2009



PAC Rev 24B





686 Chloropropanol, 3-; (1-Propanol, 3-chloro) 627-30-5 10 30 200 500 Rat oral LD50.

687 Chloropropionitrile, 3- 542-76-7 1.5 4 7.5 40 LOC, rat oral LD50.

688Chloropropyl)trimethoxysilane, 3-(; (3-

(Trimethoxysilyl)propyl chloride)2530-87-2 75 250 1,500 3,000 Rat TClo, rat oral LD50.

689 Chloropropylene, 2- 557-98-2 3,000 10,000 60,000 100,000 Rat TClo, mouse 120 min LC50.

690 Chloropropyl-n-octylsulfoxide, 3- 3569-57-1 1.5 5 8 500 LOC, rat oral LD50.

691Chloro-p-toluenesulfonamide, sodium salt, n-;

(Chloramine T)127-65-1 0.075 0.25 2 250 PAC-2/5, PAC-2*3/5, dog iv TDlo, mouse uk LD lo.

692Chlorosarin; (o-Isopropyl

methylphosphonochloridate)1445-76-7 0.001 0.003 0.04 0.125 Used Sarin PACs

693Chlorosoman; (o-Pinacolyl

methylphosphonochloridate)7040-57-5 0.25 0.75 5 25 Rat sc LD50

694Chlorosulfonic acid; (Chlorosulfuric

acid)7790-94-5 0.1 0.10 4.4 25 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

695 Chlorothalonil; (Tetrachloroisophthalonitrile) 1897-45-6 3 7.5 30 30 Rat oral TDlo, rat 60 min LC50.

696 Chlorotoluene, 2-; (o-Chlorotoluene) 95-49-8 250 400 2,500 2,500 TLV-TWA, REL-STEL, rat 240 min LC lo.

697 Chlorotoluene, 4-; (p-Tolyl chloride) 106-43-4 125 400 2,500 12,500 Mouse 120 min LC50.

698 Chlorotrifluoroethene, homopolymer 9002-83-9 0.015 0.04 0.3 500 Rat oral TDlo, rat 240 min LC lo.

699 Chlorotrifluoroethylene 79-38-9 25 76.2 409 2,000 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3.

700 Chlorotrifluoromethane; (CFC-13) 75-72-9 4,000 12,500 20,000 100,000 MAK-TWA.


6/19/2009



PAC Rev 24B





701Chlorovinylarsine dichloride;

(Lewisite 1)541-25-3 0.12 0.12 0.12 0.74 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

702 Chloroxuron 1982-47-4 2 6 10 500 LOC, rat 360 min LC50.

703 Chlorpyrifos; (Dursban) 2921-88-2 0.1 0.6 15 20TLV-TWA, REL-STEL, mouse oral TDlo, rat 240

min LC50.

704 Chlorsulfuran 64902-72-3 0.125 0.35 2.5 500 Rat oral TDlo, rat 240 min LC50 minimum.

705 Chlorthiophos 21923-23-9 0.35 1 7.8 7.8 LOC, RTECS rat oral LD50

706 Chromates 13907-45-4 0.0096 0.2886 6 28.8 Cr VI concentration limits. TEELs are minima.

707 Chromic acetate; (Chromium(III) acetate) 1066-30-4 2.2 6.61 11 110 Cr III concentration limits.

708 Chromic acid ester 11115-74-5 0.0113 0.339 6 34 Cr IV concentration limits.

709 Chromic chloride; (Chromium(III) chloride) 10025-73-7 1.52 4.57 7.61 76.1 Cr III concentration limits.

710Chromic oxide; (Chromium(III) oxide, chromium

sesquioxide)1308-38-9 0.731 15 36.5 36.5 Cr III concentration limits.

711 Chromic sulfate; (Chromium(III) sulfate (2:3)) 10101-53-8 1.89 2.5 15 94.3 Cr III concentration limits.

712Chromic trihydroxide; (Chromic(III) acid;

Chromium hydroxide)1308-14-1 0.991 1.25 10 49.5 Cr III concentration limits.

713 Chromic trioxide; (Chromium(VI) oxide (1:3)) 1333-82-0 0.0096 0.0096 0.06 28.8 Cr VI concentration limits.

714 Chromic(VI) acid 7738-94-5 0.0113 0.339 6 34 Cr VI concentration limits.

715 Chromite; (Chromite (mineral)) 1308-31-2 1.08 3.23 5.38 500 Cr II concentration limits.


6/19/2009



PAC Rev 24B





716 Chromium 7440-47-3 1 1.5 2.5 250 Concentration limits

717 Chromium nitrate 10103-47-6 4.74 14.2 23.7 237 Cr(III) inorganic concentration limits.

718 Chromium nitrate nonahydrate 7789-02-8 3.85 11.5 20 192 Cr(III) concentration limits

719 Chromium perchlorate, hydrated 13537-21-8 3.37 10.1 16.8 168 Cr(III) inorganic concentration limits.

720 Chromium(III) acetate hydroxide 39430-51-8 2.4 7.21 12.5 120 Cr(III) concentration limits

721 Chromium(III) chloride, hexahydrate 10060-12-5 2.56 100 128 128 Cr(III) PEL-TWA, IDLH, rat oral TDlo.

722 Chromium(III) fluoride 7788-97-8 1.05 3.14 5.24 52.4 Cr(III) concentration limits.

723 Chromium(III) nitrate 13548-38-4 2.29 6.87 11.4 114 Cr(III) concentration limits

724Chromium(III) oxide hydroxide; (Chromium

oxyhydroxide)20770-05-2 0.817 1 7.5 40.9 Cr(III) concentration limits

725Chromium(III) potassium sulfate (1:1:2),

dodecahydrate7788-99-0 4.8 14.4 40 240 Cr(III) concentration limits.

726 Chromium(VI) hydroxide 12626-43-6 0.005 0.03 0.05 15 Cr(VI) concentration limits

727 Chromous chloride; (Chromium(II) chloride (1:2)) 10049-05-5 1.18 3.55 6 500 Cr(II) concentration limits

728 Chrysene (coal tar volatile) 218-01-9 0.2 0.6 1 80 PEL-TWA, mouse skin TDlo, IDLH.

729 Cinnamaldehyde 104-55-2 1.25 4 30 500 Mouse sk TDlo, rat oral LD50.

730Cinnamaldehyde, (E);

(trans-Cinnamaldehyde)14371-10-9 0.5 1.5 10 1,500 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





731 Citric acid 77-92-9 12.5 35 250 500 Rat oral LD50.

732 Citric acid monohydrate 5949-29-1 1.5 4 30 150 Rat ip LD50.

733 Citric acid, trisodium salt, dihydrate 6132-04-3 6 20 125 500 Rat ip LD50

734Coal tar pitch volatiles; (Particulate polycyclic

aromatic hydrocarbons)65996-93-2 0.2 0.6 12.5 80 PEL-TWA, rat it TDlo, IDLH.

735 Coal tar, aerosol 8007-45-2a 0.1 1.25 7.5 40 REL-TWA, rat TClo.

736 Coal tar; (Coal tar volatiles) 8007-45-2b 0.2 80 80 80 PEL-TWA, mouse TClo, IDLH.

737 Cobalt 7440-48-4 0.1 3 20 20 PEL-TWA, LOC, IDLH.

738Cobalt acetate tetrahydrate; (Cobaltous acetate

tetrahydrate)6147-53-1 3 7.5 60 300 Rat oral LD50

739 Cobalt carbonyl 10210-68-1 0.27 0.27 27 60 As Co, PEL-TWA, LOC, rat 240 min LC50

740 Cobalt chloride 7646-79-9 0.0441 0.132 25 500 As Co, PEL-TWA, child oral TDlo, infant oral LD lo

741 Cobalt hydrocarbonyl 16842-03-8 0.3 0.3 0.914 2.95 TLV-TWA, PAC-2/7, ERPG-2, ERPG-3.

742 Cobalt hydroxide 21041-93-0 0.0315 0.0946 0.158 0.75 As Co, PEL-TWA.

743Cobalt nitrate hexahydrate; (Cobaltous nitrate

hexahydrate)10026-22-9 0.0988 0.296 0.5 98.8 As Co, TLV-TWA, IDLH.

744 Cobalt nitrate; (Cobalt(II) nitrate) 10141-05-6 0.0621 0.186 12.5 150 As Co, TLV-TWA, rat oral LD50

745 Cobalt nitrite 32486-57-0 0.0512 0.154 0.256 1.25 As Co, TLV-TWA.


6/19/2009



PAC Rev 24B





746 Cobalt oxide 1308-06-1 0.136 0.136 0.136 500 As Co, TLV-TWA, rat oral LD50

747 Cobalt sulfate 10124-43-3 0.0526 0.158 0.263 150 As Co, TLV-TWA, rat oral LD50

748Cobalt sulfate heptahydrate; (Cobalt(II)

sulfate(1:1), heptahydrate)10026-24-1 0.0954 0.286 250 250 As Co, TLV-TWA, rat TClo, rat oral LD50.

749 Cobalt tetraphenylporphine 14172-90-8 10 30 50 250 Used PNOS default

750 Cobalt(II) chloride hexahydrate 7791-13-1 0.0808 0.242 20 80.8 As Co, TLV-TWA, rat sc TDlo, IDLH.

751 Cobalt(II) oxide 1307-96-6 0.127 0.127 20 75 As Co, TLV-TWA, rat oral LD50

752 Cobalt(II) perchlorate, hexahydrate 13478-33-6 0.124 0.373 0.621 60Co inorganic compound TLV-TWA, mouse ip

LD50.

753 Cobalt(II) sulfate hydrate 60459-08-7 0.0587 0.176 0.3 58.7 As Co, TLV-TWA, IDLH.

754

Cobalt, ((2,2’-(1,2-

ethanediylbis(nitrilomethylidyne))bis(6-

fluorophenolato))(2-)-N,N’,O,O’)-

62207-76-5 0.15 0.4 3 15 LOC, rat 360 min LC50

755 Cobaltous bromide; (Cobalt(II) bromide) 7789-43-7 0.0742 0.223 0.371 150 As Co, TLV-TWA, rat oral LD50

756 Cobaltous carbonate 513-79-1 0.0404 0.121 0.202 250 As Co, TLV-TWA, rat oral LD50

757 Colchicine 64-86-8 0.04 0.125 0.9 0.9 LOC, human oral LD lo.

758 Copper 7440-50-8 1 1 1 100 As Cu, PEL-TWA, IDLH.

759 Copper cyanide 544-92-3 1.41 4.23 7.05 25 As Cu, TLV-TWA, CN IDLH.

760 Copper hydroxide 20427-59-2 1.54 4.61 7.68 400 As Cu, PEL-TWA, rat oral LD50.


6/19/2009



PAC Rev 24B





761 Copper nitrate; (Cupric nitrate) 3251-23-8 0.148 0.444 60 295 As Cu, TLV-TWA, IDLH.

762 Copper oxide 1317-39-1 0.113 3.38 15 113 As Cu, PEL-TWA, IDLH.

763 Copper sulfate 7758-98-7 2.51 2.51 6 40As Cu, TLV-TWA, human oral TDlo, human uk LD

lo.

764 Copper(I) chloride; (Cuprous chloride) 7758-89-6 0.0779 0.234 0.4 60 As Cu, TLV-TWA, rat oral LD50.

765 Copper(I) sulfide 22205-45-4 1.25 3.76 6.26 30 As Cu, TLV-TWA.

766 Copper(II) acetate monohydrate 6046-93-1 0.314 7.5 60 300 As Cu, MAK-TWA, rat oral LD50.

767 Copper(II) carbonate hydroxide (2:1:2) 12069-69-1 0.174 0.522 0.87 174 As Cu, MAK-TWA, IDLH.

768 Copper(II) chloride (1:2); (Cupric chloride) 7447-39-4 0.106 0.317 0.529 3 As Cu, TLV-TWA, mouse ip TDlo, mouse ip LD50.

769 Copper(II) chloride dihydrate; (Cupric chloride) 10125-13-0 0.134 0.402 0.671 268 As Cu, TLV-TWA, rat sc TDlo, IDLH.

770 Copper(II) oxalate 814-91-5 2.42 7.25 12.5 242 As Cu, TLV-TWA, IDLH.

771 Copper(II) perchlorate, dihydrate 17031-32-2 4.7 14.1 23.5 23.5 As Cu, TLV-TWA, rat ip LD50.

772 Copper(II) sulfate pentahydrate 7758-99-8 0.393 1.18 150 200As Cu, MAK-TWA, human oral TDlo, human oral

LD lo.

773 Copper(II) sulfide 1317-40-4 1.5 4.51 7.52 150 As Cu, MAK-TWA, IDLH.

774 Corn oil 8001-30-7 200 500 500 500Pregnant rat oral TDlo, rat oral LD50 minimum.

Four day rat oral TDlo ignored.

775 Coumaphos 56-72-4 0.05 0.15 30 125 TLV-TWA, TEEL-0*3, LOC, rat LC50.


6/19/2009



PAC Rev 24B





776 Coumarin 91-64-5 0.025 0.075 0.6 125 Woman oral TDlo, rat oral LD50.

777 Coumatetralyl; (Endrocide) 5836-29-3 3 10 16.5 16.5 LOC, rat oral LD50.

778 Creosote (coal tar) 8001-58-9 0.2 0.6 80 80 PEL-TWA, rat oral TDlo, IDLH.

779 Cresols 1319-77-3 20 60 100 1,000 PEL-TWA, LOC, IDLH.

780 Cresyl violet acetate 10510-54-0 10 30 50 250 Used PNOS default.

781 Crimidine; (Castrix) 535-89-7 0.25 0.75 1.2 1.2 LOC, rat oral LD50.

782 Cristobalite 14464-46-1 0.025 0.075 25 25 TLV-TWA, TEEL-0*3, human TClo, IDLH.

783 Crocidolite 12001-28-4 0.005 0.015 5 250 PEL-TWA, REL-C, rat ip LD lo.

784 Crotonaldehyde, cis- 4170-30-3 0.544 0.544 12.6 40.1 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

785 Crotonaldehyde, trans- 123-73-9 0.15 0.544 12.6 40.1 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

786 Crotonic Acid 3724-65-0 4 12.5 75 400 Rat oral LD50.

787 Crystal violet; (Aniline violet) 548-62-9 0.075 0.25 1.5 150 Rat ip TDlo, rat oral LD50.

788Cs7SB; (1-(2,2,3,3-tetrafluoropropoxy),3-(4-sec-

butylphenoxy)-2-propanol)308362-88-1 11.1 30 200 500 Fluoride concentration limits.

789Cumene hydroperoxide; (Isopropylbenzene

hydroperoxide)80-15-9 6 30 150 150 WEEL-TWA, rat TClo, rat LC50.

790 Cumene; (Isopropyl benzene) 98-82-8 246 246 1,470 3,590 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





791Cumenol methylcarbamate, m-; (3-(1-

methylethyl)phenol methylcarbamate)64-00-6 3 10 16 16 LOC, rat oral LD50.

792Cupferron; (Ammonium-n-

nitrosophenylhydroxylamine)135-20-6 7.5 25 75 75 Rat oral TDlo, rat oral LD50.

793 Cupric acetate, anhydrous; (Copper acetate) 142-71-2 0.143 0.429 3.5 200 As Cu, TLV-TWA, rat sc TDlo, rat oral LD50.

794 Cupric nitrate hemipentahydrate 19004-19-4 3.8 11.4 19 380 As Cu, TLV-TWA, IDLH.

795 Cupric nitrite 14984-71-5 0.122 0.184 0.6 60 SAR

796 Cupric oxide 1317-38-0 0.125 0.376 0.626 125 As Cu, PEL-TWA, IDLH.

797 Cyanamide 420-04-2 2 6 30 35 TLV-TWA, rat oral TDlo, rat 240 min LC lo.

798 Cyanic acid; (Hydrogen cyanate) 420-05-3 0.06 0.2 1.25 6 Human LC50 based on estimated HHR = 3+

799 Cyanide 57-12-5 5 5 5 25 PEL-TWA, IDLH.

800 Cyanoacetamide 107-91-5 6 20 150 500 Mouse oral LD50.

801 Cyanogen 460-19-5 20 20 20 40 TLV-TWA, human TClo, rat 60 min LC50.

802 Cyanogen bromide 506-68-3 20.4 44 44 44 PEL-TWA, LOC, IDLH.

803 Cyanogen chloride 506-77-4 0.05 0.15 1 10 PAC-2/21, PAC-2/7, ERPG-2, ERPG-3.

804 Cyanogen iodide 506-78-5 35 100 180 180 LOC, rat sc LD lo.

805 Cyanoguanidene 461-58-5 0.5 1.5 10 200 Rat TClo, rat oral LD50.


6/19/2009



PAC Rev 24B





806 Cyanophos 2636-26-2 1.25 3.5 25 25 LOC, rat oral LD50

807 Cyanuric acid; (1,3,5-Triazine-2,4,6-triol) 108-80-5 10 10 25 500 WEEL-TWA, rat oral TDlo, rat oral LD50.

808 Cyanuric fluoride; (2,4,6-Trifluoro-s-triazine) 675-14-9 0.17 0.17 0.17 74.8 PEL-TWA and IDLH as CN, LOC.

809 Cyclohexane 110-82-7 1,000 1,000 1,500 4,000 PEL-TWA, IDLH.

810Cyclohexane-1,2-dinitrilotetraacetic acid, trans-;

(CyDTA)13291-61-7 10 30 50 250 Used PNOS default.

811 Cyclohexanediamine, 1,2- 694-83-7 3 10 60 350 PAC-3/105, PAC-3/35, PAC-3/5, rat 240 min LC lo.

812 Cyclohexanedimethanol, cis and trans, 1,4- 105-08-8 12.5 40 250 500 Rat oral LD50.

813 Cyclohexanol 108-93-0 200 200 200 1,500 PEL-TWA, human TClo, IDLH

814 Cyclohexanone; (Ketohexamethylene) 108-94-1 200 200 200 2,500 PEL-TWA, PAC-2/7, human TClo, IDLH

815 Cyclohexene 110-83-8 1,000 1,000 1,500 6,000 PEL-TWA, rat TClo, IDLH

816 Cycloheximide 66-81-9 0.1 0.3 2 2 LOC, rat oral LD50.

817 Cyclohexyl isocyanate 3173-53-3 0.02 0.06 0.1 0.512 PAC-2/5, PAC-2*3/5, AEGL-3/5, AEGL-3.

818 Cyclohexyl methyl phosphonic acid 1932-60-1 10 30 50 250 Used PNOS default.

819 Cyclohexylamine 108-91-8 7.3 7.3 34.9 122 AEGL-1, AEGL-1, AEGL-2, AEGL-3

820Cyclohexylamino)-1-propanesulfonic acid, 3-(;

(CAPS)1135-40-6 1.25 4 25 125 Quail oral LD50 minimum.


6/19/2009



PAC Rev 24B





821 Cyclohexylethanol, 2- 4442-79-9 4 10 75 400 Rat oral LD50.

822 Cyclooctadiene, 1,5- 111-78-4 400 1,250 7,500 40,000 Rat TClo.

823 Cyclooctane 292-64-8 20 60 500 2,500 Estimated LC50.

824 Cyclooctatetraene, 1,3,5,7- 629-20-9 250,000 250,000 1,000,000 1,500,000 Simple asphyxiant

825 Cyclooctene, cis- 931-87-3 3.5 10 60 350 Estimated LD50 based on HHR.

826 Cyclopentane 287-92-3 1,500 5,000 10,000 40,000 TLV-TWA, LOC, rat LC50

827 Cyclopentanone 120-92-3 75 75 400 2,000 Danish OEL, rat LC50.

828 Cyclopropane 75-19-4 300 1,000 6,000 100,000 Human TClo, mouse 120 min LC lo.

829 Cyclotetramethylene tetranitramine; (HMX) 2691-41-0 0.04 0.125 0.75 500 Rat oral TDlo, rat oral LD50.

830 Cyclotol; (RDX-TNT mixture) 8065-53-0 0.2 3 250 250 TLV-TWA, REL-STEL, rat oral TDlo, rat oral LD50.

831 Cyclotrimethylenetrinitramine; (RDX or Cyclonite) 121-82-4 0.5 3 40 40TLV-TWA, REL-STEL, child oral TDlo, rat oral

LD50.

832Cytidine monophosphate; (Cytidine 5-

monophosphate free acid)63-37-6 7.5 25 150 500 Mouse ip LD lo minimum.

833Dawsonite; (Crystalline dehydroxy sodium

aluminum, carbonate)12011-76-6 3.5 10 150 500 SAR

834DDD; (1,1-bis(4-Chlorophenyl)-2,2-

dichloroethane)72-54-8 12.5 35 250 500 Rat oral TDlo, human oral LD lo.

835DDE; (2,2-bis(p-Chlorophenyl)-1,1-

dichloroethylene)72-55-9 4 12.5 75 400 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





836 DDT; (Dichlorodiphenyltrichloroethane) 50-29-3 1 1 2 500 PEL AND TLV-TWA, human oral TDlo, IDLH.

837 DEAE Sepharose CL-6B 57407-08-6 10 30 50 250 Used PNOS default

838 Decaborane 17702-41-9 0.3 0.75 10 15 PEL-TWA, TLV-STEL, LOC, IDLH

839 Decafluoropentane, 1,1,1,2,3,4,4,5,5,5- 138495-42-8 2,000 2,000 4,000 12,500 DuPont OEL-TWA OEL-C, rat 240 min LC50.

840 Decahydronaphthalene 91-17-8 2.5 7.5 50 400 Human TClo, rat 240 min LC50.

841 Decahydronaphthalene, cis-; (cis-Decalin) 493-01-6 2.5 7.5 50 400 Human TClo, rat 240 min LC50.

842 Decahydronaphthalene, trans-; (trans-Decalin) 493-02-7 2.5 7.5 50 400 Human TClo, rat 240 min LC50.

843 Decamethylcyclopentasiloxane 541-02-6 15 50 350 500Pregnant rat subcutaneous TDlo, rat 240 min

LC50

844 Decanal 112-31-2 15 40 300 1,500 Rat oral LD50.

845 Decane 124-18-5 0.4 1 7.5 25,000 Mouse skin TDlo, mouse 120 min LC50.

846 Decene, 1-, homopolymer, hydrogenated 68037-01-4 10 30 50 250 Used PNOS default.

847 Decyl alcohol; (1-Decanol) 112-30-1 4 12.5 75 500 Rabbit TClo, rat oral LD50.

848 Demeton 8065-48-3 0.1 0.15 2 10 PEL- and TLV-TWA, LOC, IDLH.

849 Demeton-s-methyl 919-86-8 0.05 0.15 5 200 TLV-TWA, LOC, rat 240 min LC50.

850 Deoxyribonucleac acid; (DNA) 9007-49-2 12.5 35 250 500 Mouse ip LD lo minimum.


6/19/2009



PAC Rev 24B





851 Deuterium 7782-39-0 10,000 10,000 35,000 60,000 Simple asphyxiant

852 Deuterium oxide; (Heavy water) 7789-20-0 1,500 5,000 35,000 150,000 Mouse oral TDlo.

853 Deuterochloric acid; (Deuterium chloride) 7698-05-7 3 3 7.5 75 H.Cl MAK-TWA, PEL-C, IDLH.

854 Dextran 9004-54-0 0.35 1 6 500 Women iv TDlo, mouse sc LD50.

855 Dextran sulfate sodium 9011-18-1 15 40 300 500 Rat oral TDlo, rat oral LD50.

856 Di(ethylene glycol) diacrylate 4074-88-8 1 3 20 100 Rat oral LD50

857 Di-2-ethylhexyl adipate 103-23-1 50 150 500 500 Rat ip TDlo, rat oral LD50.

858 Diacetoxydibutyl stannane 1067-33-0 0.296 0.592 7.5 73.9Sn organic PEL-TWA, TLV-STEL, rat oral TDlo

preg, IDLH.

859 Diacetyl peroxide; (Acetyl peroxide) 110-22-5 7.5 20 150 500 Mouse uk TDlo.

860 Dialifor 10311-84-9 1 3 5 5 LOC, rat oral LD50.

861 Diallyl phthalate 131-17-9 1 1 300 300Other TWA, MAK-STEL, rat oral TDlo, rat oral

LD50.

862 Diallyldimethylammonium chloride 7398-69-8 25 75 500 500 Mammal oral TDlo, mouse oral LD50.

863 Diallyldimethylammonium chloride polymer 26062-79-3 12.5 35 250 500 Rat oral TDlo, rat oral LD50.

864 Diaminodiphenyl ether, 4,4'-; (4,4'-Oxydianiline) 101-80-4 0.5 1.5 10 300 Rat oral TDlo, rat oral LD50.

865 Diaminodiphenylsulfone; (4,4'-Sulfonyldianiline) 80-08-0 1 3 20 400 Human oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





866Diaminodipropylamine, 3,3-;

(Aminobis(propylamine))56-18-8 3 7.5 60 300 Rat oral LD50.

867 Diaminopyridine, 2,6- 141-86-6 0.4 1.25 7.5 40 Mouse ip LD50.

868 Diammonium molybdate 27546-07-2 8.81 8.81 8.81 500 Mo soluble compound concentration limits.

869 Diamond 7782-40-3 7.5 20 150 500 Mouse ip TDlo and ip LD50.

870Dianisidine dihydrochloride, o-; (3,3'-

Dimethoxybenzidine dihydrochloride)20325-40-0 0.1 0.35 2.5 7.5 Rat oral TDlo, rat oral LD lo.

871Diatomaceous earth (flux calcinated; Filter agent,

celite)68855-54-9 0.3 0.9 1.5 500 MAK-TWA, MAK-TWA*3, MAK-TWA*5, IDLH.

872Diatomaceous earth; (Silica-amorphous

diatomaceous earth (uncalcined))61790-53-2 6 18 30 500 REL-TWA, IDLH

873 Diatomaceous silica, calcined 91053-39-3 0.3 0.9 1.5 500 MAK-TWA, IDLH.

874 Diazabicyclo(2,2,2)octane, 1,4- 280-57-9 1 3 20 500 Rat oral TDlo, rat oral LD50.

875 Diazabicyclo(5.4.0)undec-7-ene, 1,8- 6674-22-2 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

876 Diazoacetic acid; (Ethyl diazoacetate) 623-73-4 0.2 0.6 4 150 Rat oral TDlo, rat oral LD50.

877 Diazomethane 334-88-3 0.35 1 3.5 3.5 PEL-TWA, rat TClo, IDLH.

878 Dibenza(a,h)anthracene 53-70-3 0.0008 0.0025 0.015 15 Rat sc TDlo, mouse iv LD lo.

879Dibenzo(a,e)pyrene; (Naphtho(1,2,3,4-

def)chrysene)192-65-4 0.005 0.015 0.1 0.5 Mouse skin TDlo.

880 Dibenzofuran 132-64-9 10 30 50 250 PNOS default used.


6/19/2009



PAC Rev 24B





881 Dibenzo-p-dioxin 262-12-4 1.5 4 30 500 Mouse skin TDlo, rat oral LD50.

882 Diborane 19287-45-7 0.1 0.15 1.1 4.19 PEL-TWA, AEGL-2/7, AEGL-2, AEGL-3

883 Dibromo-3-chloropropane, 1,2-; (DBCP) 96-12-8 0.01 0.75 5 150 PEL-TWA, rat TClo, rat 480 min LC50.

884 Dibromo-4-nitrophenol, 2,6- 99-28-5 0.4 1.25 10 50 Mouse iv LD50.

885Dibromochloromethane;

(Chlorodibromomethane)124-48-1 2 6 40 150 Mouse oral TDlo, rat oral LD50.

886 Dibromohexane, 1,6- 629-03-8 1 3.5 20 100 Mouse ip LD50.

887 Dibromomethane; (Methylene dibromide) 74-95-3 60 200 1,500 7,500 PAC-2/21, PAC-2/7, rat TClo, rat 120 min LC50.

888 Dibromophenol, 2,6- 608-33-3 0.5 0.5 2.5 2.5 SAR

889 Dibromopropane, 1,3- 109-64-8 2 6 40 200 Mouse ip LD50.

890 Dibromotetrafluoroethane; (Halon 2402) 124-73-2 1,500 5,000 35,000 150,000 Rat 120 min LC50.

891 Dibutyl (2-ethylhexyl)phosphate z-0011 2.5 7.5 7.5 7.5 SAR

892 Dibutyl butylphosphonate 78-46-6 0.4 1.25 10 50 Mouse iv LD50.

893 Dibutyl peroxide, tert- 110-05-4 7.5 20 150 2,500 Rat TClo, rat 240 min LC50.

894 Dibutyl phosphate 107-66-4 7.5 15 40 250 ILV-TWA, TLV-STEL, IDLH.

895 Dibutyl phosphite 1809-19-4 12.5 40 250 500 Rat oral LD50.


6/19/2009



PAC Rev 24B





896 Dibutyl phthalate 84-74-2 5 15 500 500 PEL-TWA, rat ip TDlo, IDLH.

897Dibutylboron triflate; (Dibutylboryl

trifluoromethanesulfonate)60669-69-4 12 36.1 60.1 500 Fluoride concentration limis.

898 Dibutylhexamethylenediamine, N,N'- 4835-11-4 1 3 22 75 LOC, rat 240 min LC50.

899 Dichloran; (2,6-Dichloro-4-nitroaniline; Resisan) 99-30-9 0.004 0.0125 0.075 500 Mouse oral TDlo, rat oral LD50.

900

Dichloro(4,4-dimethylzinc -

5((((methylamino)carbonyl) oxy)-

imino)pentanenitrile), (trans-4)-; (Ethienocarb)

58270-08-9 1.5 5 9 9 LOC, rat oral LD50.

901Dichloro-1,1,1-trifluoroethane, 2,2-; (HCFC-

123)306-83-2 300 750 6,250 62,500 WEEL-TWA, WEEL-TWA*3, ERPG-2, ERPG-3.

902Dichloro-1-fluoroethane, 1,1-; (HCFC-

141b; Freon 141)1717-00-6 2,500 4,780 8,130 14,300 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3

903 Dichloro-2-butene 1,4- 764-41-0 0.025 0.075 12.5 750 TLV-TWA, rat TClo, mouse 240 min LC50.

904 Dichloro-2-propanol, 1,3- 96-23-1 30 100 250 250 Mouse TClo, rat 240 min LC lo.

905Dichloro-2-trifluoromethylbenzimidazole, 4,5-;

(Chloroflurazole)3615-21-2 2.5 7.5 13 13 LOC, rat oral LD50.

906 Dichloroacetic acid 79-43-6 2.5 50 400 1,250 TLV-TWA, rat oral TDlo, rat oral LD50.

907 Dichloroacetyl chloride 79-36-7 0.075 0.241 9.64 313 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

908 Dichloroacetylene 7572-29-4 2 6 15 15 TLV-C, mouse 360 min LC50.

909 Dichloroamine; (Chlorimide) 3400-09-7 1 3 20 100 Rat oral TDlo.

910 Dichlorobenzene, m- 541-73-1 4 12.5 75 400 Mouse ip LD50.


6/19/2009



PAC Rev 24B





911 Dichlorobenzene, o- 95-50-1 150 300 300 1,250 TLV-TWA, TLV-STEL, PEL-C, IDLH.

912 Dichlorobenzene, p- 106-46-7 60 60 150 750 PEL-TWA, PAC-2/7, human oral TDlo, IDLH.

913 Dichlorobenzidene 3,3'- 91-94-1 2 6 40 2,000 Rat oral TDlo, rat oral LD50.

914 Dichlorocyclohexane, 1,1- 2108-92-1 1.5 4 35 150 SAR

915 Dichlorocyclohexane, trans-1,2- 822-86-6 75 250 500 500 Estimated rat TClo, mouse 120 min LC50.

916 Dichlorodifluoromethane; (Freon 12, CFC 12) 75-71-8 5,000 15,000 50,000 75,000 PEL-TWA, EEGL-60 min. IDLH.

917 Dichloroethanol acetate, 1,2- 10140-87-1 2 6 10 40 LOC, rat 240 min LC lo.

918 Dichloroethyl ether; (1,1'-Oxybis(2-chloro)ethane) 111-44-4 30 60 150 600 TLV-TWA, TLV-STEL, LOC, IDLH.

919 Dichloroethylaluminum 563-43-9 9.41 9.41 9.41 9.41 TLV-TWA as Al, soluble salts.

920 Dichloroethylbenzene; (Ethyldichlorobenzene) 1331-29-9 20 60 500 500 Rat oral LD50.

921 Dichloroethylene, 1,2- 540-59-0 750 2,500 4,000 4,000 PEL-TWA, IDLH

922 Dichloroethylene, cis-1,2- 156-59-2 555 555 1,980 3,370 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

923 Dichloroethylene, cis-and trans-1,2- 156-60-5 750 1,110 3,960 6,740 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

924 Dichlorofluoromethane; (Freon 21, CFC 21) 75-43-4 40 125 400 20,000 TLV-TWA, EEGL60 min, IDLH.

925 Dichlorohexane, 1,2- 2162-92-7 1.5 5 40 200 SAR


6/19/2009



PAC Rev 24B





926 Dichloroisopropyl ether 108-60-1 25 75 500 2,500 Rat 300 min LC lo.

927 Dichloromethane-d2 1665-00-5 75 600 2,500 12,500 Used mehylene chloride values, D2 replacing H2.

928Dichloromethoxy ethane; (bis(2-

Chloroethoxy)methane)111-91-1 5 15 40 40 Rat oral TDlo, rat 240 min LC lo.

929Dichloromethyl ether;

(bis(Chloromethyl)ether)542-88-1 0.004 0.03 0.207 0.846 TLV-TWA, AEGL-2/7, AEGL-2, AEGL-3.

930 Dichloromethylphenylsilane 149-74-6 1 3 20 20 LOC, mouse 120 min LC lo.

931Dichloromethylphosphine; (Methylphosphonous

dichloride)676-83-5 0.5 1.5 10 50 Rat 240 min LC50, based on SAX hazard rating

932 Dichlorophene 97-23-4 6 15 125 500 Rat oral LD50.

933 Dichlorophenol, 2,4- 120-83-2 1.34 1.34 13.4 134 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

934 Dichlorophenol, 2,6- 87-65-0 1.5 5 35 150 Rat ip LD50.

935 Dichlorophenoxyacetic acid, 2,4-; (2,4-D) 94-75-7 10 10 40 100 PEL-TWA, rat oral TDlo, rat oral LD50.

936 Dichloropropane 26638-19-7 40 1,250 1,500 1,500 Propylene dichloride limits used.

937 Dichloropropane, 1,1- 78-99-9 15 50 400 2,000 Rat 240 min LC lo.

938 Dichloropropane, 1,2-; (Propylene dichloride) 78-87-5 40 1,250 1,500 1,500 TL V-TWA, mouse TClo, IDLH.

939 Dichloropropane, 1,3- 142-28-9 25 75 500 1,500 Rat oral TDlo, mouse uk LD50..

940 Dichloropropane, 2,2- 594-20-7 20 60 400 2,000 Rat 360 min LC lo minimum.


6/19/2009



PAC Rev 24B





941 Dichloropropene, 1,1- 563-58-6 4 12.5 20 750 OEL-TWA, rat oral LD50.

942 Dichloropropene, 1,2- 563-54-2 7.5 25 150 750 Rat oral LD50

943 Dichloropropene, 1,3- 542-75-6 4 60 250 250 TLV-TWA, mouse TClo, rat 240 min LC50.

944 Dichloropropene, 2,3- 78-88-6 2 6 50 250 Rat 240 min LC lo.

945Dichloropropene, cis-1,2-; (1,2-dichloro-1-

propene, (Z)-)6923-20-2 7.5 25 150 750 Rat oral LD50.

946 Dichloropropene, cis-1,3- 10061-01-5 4 60 250 250 TLV-TWA, mouse TClo, rat LC50.

947 Dichloropropene, trans-1,3- 10061-02-6 4 6 50 250 TLV-TWA, mouse TClo, rat LC50.

948 Dichlorosilane 4109-96-0 1.25 3.72 45.4 206 AEGL--1/3, AEGL-1, AEGL-2, AEGL-3.

949 Dichlorotetrafluoroethane 1320-37-2 6,000 20,000 100,000 100,000 PEL-TWA, IDLH.

950Dichlorotetrafluoroethane, 1,2-; (Freon 114, CFC

114)76-14-2 6,000 20,000 100,000 100,000 PEL-TWA, IDLH.

951 Dichlorovos; (Dichlorvos) 62-73-7 7.5 7.5 20 750 PEL-TWA, LOC, IDLH.

952 Dicrotophos 141-66-2 0.05 0.15 0.9 40 TLV-TWA, LOC, rat 240 min. LC50.

953 Dicyclohexano-18-crown-6 16069-36-6 0.2 0.6 4 75 Rat oral TDlo, rat oral LD50.

954 Dicyclohexyl; (Cyclohexylcyclohexane) 92-51-3 7.5 25 150 500 Rat oral LD50 based on assumed HHR.

955 Dicyclohexylcarbodiimide 538-75-0 0.0035 0.01 0.06 100 Mouse skin TDlo, rat 360 min LC50.


6/19/2009



PAC Rev 24B





956 Dicyclopentadiene 77-73-6 0.11 0.11 27 406 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

957 Didecyldimethylammonium chloride 7173-51-5 1.5 5 35 35 Rat oral TDlo, rat oral LD50.

958 Dieldrin 60-57-1 0.25 0.75 2.5 50 PEL-TWA, rat oral TDlo, IDLH.

959 Diesel fuel marine; (Diesel fuel No. 4) z-0012 100 350 500 500 TLV-TWA, mu sk TDlo, rat oral LD50

960 Diesel fuel marine; (Fuel oil No.2) 68476-30-2 100 100 100 500 TLV-TWA, mu sk TDlo, rat oral LD50

961 Diesel fuels 68334-30-5 100 100 500 500 TLV-TWA, rat oral LD50.

962 Diethanolamine 111-42-2 2 150 300 300 TLV-TWA, rat oral TDlo, rat oral LD50.

963

Diethenylbenzene, polymer with ethenylbenzene

and ethenylethylbenzene, sulfonated; (Dowex 50-

X8 resin)

69011-20-7 10 30 50 250 Used PNOS default.

964 Diethoxydimethylsilane 78-62-6 30 75 600 3,000 Rat 480 min LC50.

965 Diethyl (methylthiomethyl) phosphonate 28460-01-7 0.4 1.25 7.5 40 Rat oral LD50 based on Methyl demeton methyl,

966 Diethyl benzene isomers; (Dowtherm J) 25340-17-4 25 55 550 2,750 WEEL-TWA, ERPG-1, ERPG-2, ERPG-3.

967 Diethyl carbonate 105-58-8 12.5 40 300 1,500 Mouse oral TDlo, rat subcutaneous LD50.

968 Diethyl chlorophosphate 814-49-3 0.4 1 8 8 LOC, rat oral LD50.

969 Diethyl ethylphosphonate 78-38-6 2 6 40 500 Rat oral TDlo, rat orsl LD50.

970 Diethyl malonate; (Ethyl malonate) 105-53-3 60 150 1,250 6,000 Rat oral LD50.


6/19/2009



PAC Rev 24B





971 Diethyl mercury 627-44-1 0.0129 0.0387 0.0516 2.58 As Hg, PEL-TWA, TLV-STEL, PEL-C, IDLH.

972 Diethyl methylphosphonate; (DEMP) 683-08-9 7.5 25 200 500 Mouse ip LD50.

973 Diethyl oxalate 95-92-1 1.5 5 35 150 Rat oral LD50.

974 Diethyl phosphite 762-04-9 15 50 350 500 Rat oral LD50

975 Diethyl phthalate; (Ethyl phthalate) 84-66-2 5 15 100 500 TLV-TWA, human TClo, rat oral LD50.

976 Diethyl pyrocarbonate 1609-47-8 10 30 200 500 Rat 60 min LC lo.

977 Diethyl sulfate 64-67-5 0.4 1.25 10 150 Female rat iv TDlo, rat 240 min LC lo.

978 Diethyl tartrate 87-91-2 10 30 50 250 PNOS default used.

979 Diethyl telluride 627-54-3 0.1 0.3 6 10 OEL-TWA; rat TClo, rat LC50

980 Diethylamine 109-89-7 40 40 200 600 PEL-TWA, TLV-STEL, rat TClo, IDLH.

981 Diethylaminoacetone 1620-14-0 2.5 7.5 50 250 SAR

982 Diethylaminopropylamine 104-78-9 2 6 50 250 Rat oral LD50.

983 Diethylaniline, N,N- 91-66-7 3 10 60 350 Rat oral LD50.

984 Diethylbenzene, m- 141-93-5 40 125 500 500 Rat oral LD lo.

985 Diethylbenzene, o- 135-01-3 1.5 5 35 500 Rat oral TDlo, rat oral LD lo.


6/19/2009



PAC Rev 24B





986 Diethyldichlorosilane 1719-53-5 2 5.78 70.6 321 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

987 Diethylene glycol 111-46-6 10 200 750 750 WEEL-TWA, child oral TDlo, human oral LD lo.

988Diethylene glycol di(3-aminopropyl) ether;

(Polyglycol diamine)4246-51-9 15 50 350 500 Rat oral LD50.

989Diethylene glycol diacetate; (2,2’-oxybisethanol

diacetate) 628-68-2 100 300 500 500 Rat oral LD lo.

990Diethylene glycol dimethyl ether; (Bis(2-methoxy

ethyl)ether)111-96-6 25 75 125 2,000 MAK-TWA, rat oral TDlo, rat oral LD50.

991 Diethylene glycol hexyl ether; (n-Hexyl carbitol) 112-59-4 7.5 25 150 500 Rabbit skin TDlo, rat oral LD50

992 Diethylenetriamine 111-40-0 4 4 6 400 TLV-TWA, rabbit oral TDlo, rat oral LD50.

993 Diethylenetriaminepentaacetic acid 67-43-6 2 6 50 250 Mouse ip LD50.

994 Diethylethanolamine, N,N-; (Diethylaminoethanol) 100-37-8 50 50 100 500 PEL-TWA, PAC-2/7, human TClo, IDLH.

995 Diethylphosphatoethyltriethoxy silane 757-44-8 75 200 500 500 Rat oral LD50.

996Diethylstilbestrol; ((E)-4,4'-(1,2-diethyl-1,2-

ethenediyl)bisphenol)56-53-1 0.025 0.075 0.6 15 Women oral TDlo, rat ip LD 50.

997 Diethylthiourea, N,N'- 105-55-5 0.6 1.5 12.5 125 Rat oral TDlo, rat oral LD50.

998 Diethylurea, 1,3- 623-76-7 25 75 500 2,500 Mouse ip LD lo.

999 Diethylzinc 557-20-0 10 20 20 50 Estimated TLV-TWA, TLV-STEL, and rat LC50

1000Difluoroethane; (1,1-Difluoroethane; HFC

152a)75-37-6 2,500 27,035 40,552 67,587 WEEL-TWA, ERPG-1, ERPG-2, ERPG-3.


6/19/2009



PAC Rev 24B





1001 Digitoxin 71-63-6 0.0075 0.025 0.18 0.25 LOC, human oral LD lo.

1002 Diglycidyl Ether 2238-07-5 0.05 50 50 50 TLV-TWA, LOC, mouse 240 min LC50.

1003Diglycol monoethyl ether acetate; (Carbitol

acetate)112-15-2 40 125 500 500 Rat oral LD50.

1004 Digoxin 20830-75-5 0.04 0.125 0.2 0.35 LOC, infant iv LD lo.

1005

Dihexyl((diethylcarbamoyl)methyl)phosphonate;

(Dihexyl-N,N-diethylcarbamoylmethyl

phosphonate)

7369-66-6 4 12.5 75 400 Rat oral LD50.

1006 Dihydro-2(3H)-furanone; (4-Butanolide) 96-48-0 2 6 40 500 Rat oral TDlo, rat oral LD50.

1007 Dihydro-2H-pyran, 3,4- 110-87-2 1.25 4 30 150 Estimated rat 240 min LC50 based on HR.

1008 Dihydro-3-(Nonenyl)-2,5-furandione 28928-97-4 10 30 50 250 Used PNOS default.

1009 Dihydro-4-methyl furan, 2,3- 34314-83-5 1.5 5 35 150 Rat 240 min LC50 based on methyl furan.

1010Dihydrogen hexachloroplatinate; (Chloroplatinic

acid)16941-12-1 0.0042 0.0126 1.5 8.4 As Pt, PEL-TWA, IDLH.

1011Dihydroxy-1,3-indandione, 2,2-;

(Ninhydrin monohydrate)485-47-2 0.3 1 6 35 Mouse ip LD50

1012 Dihydroxy-2-butene, 1,4-; (2-Butene-1,4-diol) 110-64-5 5 15 100 500 Rat oral LD50.

1013 Dihydroxyanthraquinone, 1,8- 117-10-2 25 75 200 200 Rat oral TDlo, mouse ip LD50.

1014 Dihydroxybenzoic acid, 2,4- 89-86-1 1 3 20 350 Preg rat sc TDlo, mouse ip LD50 minimum.

1015Dihydroxynaphthalene-2,7-disulfonic acid,

disodium salt dihydrate, 4,5-5808-22-0 10 30 50 250 Used PNOS default.


6/19/2009



PAC Rev 24B





1016 Diiodomethane; (Methylene iodide) 75-11-6 75 200 500 500 Child oral LD lo.

1017 Diisoamylamine 544-00-3 30 100 150 750TLV-TWA by analogy with related butyl

compounds

1018 Diisobutyl ketone 108-83-8 300 300 300 3,000 PEL-TWA, human TClo. IDLH.

1019Diisobutylaluminum hydride;

(Diisobutylhydroaluminum)1191-15-7 60 150 300 5,000 Guinea pig 60 min LC lo.

1020 Diisobutylamine 110-96-3 1 3 20 100 Rat oral LD50.

1021 Diisooctyl acid phosphate 27215-10-7 7.5 25 150 500 Estimated rat oral LD50.

1022 Diisopropyl methylphosphonate 1445-75-6 3.5 10 75 350 Rat oral LD50.

1023 Diisopropyl peroxydicarbonate 105-64-6 7.5 25 150 500 Rat oral LD50.

1024 Diisopropylamine 108-18-9 20 20 150 750 PEL-TWA, IDLH.

1025 Diisopropylamino)ethyl chloride hydrochloride, 2-(- 4261-68-1 0.0125 0.035 0.25 1.25 Rat 240 min LD50.

1026Diisopropylaminoethanol, 2-; (N,N-Diisopropyl

ethanolamine)96-80-0 2.5 7.5 50 250 Rat 360 min LC50.

1027 Diisopropylaniline, 2,6- 24544-04-5 35 100 500 500 Rat oral TDlo, rat oral LD50.

1028 Diisopropylbenzene, 1,3- 99-62-7 150 500 500 500 Rat TClo, rat 120 min LC lo.

1029 Diisopropylethylamine, N,N- 7087-68-5 10 30 200 1,000 Rat 240 min LC50 assumed from HHR = 2.

1030Diisopropylfluorophosphate; (Phosphorofluoridic

acid, bis(1-methylethyl) ester)55-91-4 0.75 2 3.6 3.6 LOC, human oral LD lo.


6/19/2009



PAC Rev 24B





1031Diisopropylnaphthalene;

(Bis(isopropyl)naphthalene)38640-62-9 12.5 40 300 500 Mouse oral LD50.

1032 Diketene; (Ketene dimer) 674-82-8 1 3.44 20.6 61.9 ERPG-1/3, ERPG-1, AEGL-2, AEGL-3

1033 Dilauroyl peroxide 105-74-8 0.003 0.01 0.06 0.35 Mouse skin TDlo.

1034 Dimefox; (bis(Dimethylamido)fluorophosphate)) 115-26-4 0.2 0.6 1 1 LOC, rat 10 min LC50

1035 Dimethoate 60-51-5 6 15 30 30 LOC, human oral LD50.

1036 Dimethoxybenzene, 1,3- 151-10-0 3.5 10 75 400 Mouse ip LD50

1037 Dimethoxybenzene, o- 91-16-7 3.5 10 75 400 Rat oral LD50.

1038 Dimethoxybenzidene 3,3'-; (o-Dianisidine) 119-90-4 1.25 4 25 500 Rat oral TDlo, rat oral LD50.

1039 Dimethoxybutane, 1,3- 10143-66-5 40 100 750 4,000 Rat 240 min LC lo.

1040 Dimethoxybutane, 2,2- 3453-99-4 35 100 750 4,000 Estimted rat 240 min LC lo.

1041 Dimethoxydiphenylsilane 6843-66-9 0.15 0.5 3.5 15 Rat 240 min LC minimum.

1042 Dimethoxyethane, 1,2- 110-71-4 12.5 40 300 4,000 Mouse oral TDlo, rat 360 min LC lo.

1043 Dimethoxypropane, 2,2- 77-76-9 1.5 5 35 150 Rat 240 min LC50 based on HHR = 3.

1044 Dimethyglyoxime; (Diacetyldioxime) 95-45-4 2 6 40 200 Rat oral LD lo.

1045 Dimethyl butane, 2,2- 75-83-2 1,500 1,500 1,500 7,500 TLV-TWA, TLV-STEL, REL-C


6/19/2009



PAC Rev 24B





1046 Dimethyl carbamoyl chloride 79-44-7 0.02 0.06 10 500 TLV-TWA, rat TClo, rat 360 min LC50.

1047 Dimethyl carbonate 616-38-6 50 150 1,000 5,000 Rat oral LD50

1048 Dimethyl cyclopentanol, 1,3- 19550-46-0 10 30 50 250 Used PNOS default.

1049 Dimethyl disulfide 624-92-0 0.04 0.04 193 963 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

1050 Dimethyl hydrogen phosphite 868-85-9 20 60 400 500 Rat oral TDlo, rat oral LD50.

1051 Dimethyl mercury 593-74-8 0.0115 0.0345 0.046 2.3 PEL-TWA, TLV-STEL, PEL-C, IDLH.

1052 Dimethyl methylphosphonate; (DMMP) 756-79-6 100 350 500 500 Mouse oral TDlo, rat oral LD50.

1053 Dimethyl phosphorochloridothioate 2524-03-0 1.5 4 32 150 LOC, rat oral LD50.

1054Dimethyl siloxane; (Dimethylpolysiloxane;

Syltherm XLT; Syltherm 800; Silicone 360)63148-62-9 15 50 350 500 Pregnant rat TDlo, rat oral LD50 minimum.

1055 Dimethyl sulfate 77-78-1 0.124 0.124 0.619 8.25 AEGL-1, AEGL-1, AEGL-3, AEGL-3..

1056 Dimethyl sulfide; (2-Thiopropane) 75-18-3 25 350 2,540 12,700 TLV-TWA, ERPG-2/7, ERPG-2, -3.

1057 Dimethyl sulfone 67-71-0 20 60 400 500 Rat oral LD50 minimum.

1058 Dimethyl sulfoxide; (DMSO) 67-68-5 750 750 750 6,000 WEEL-TWA, human iv TDlo, rat oral LD50.

1059 Dimethyl(1-phenylethyl)benzene 40766-31-2 4 12.5 75 500 Rat oral TDlo, rat oral LD50.

1060

Dimethyl(polysiloxane); (Polydimethylsiloxane,

silanol terminated; Dimethylsiloxane, poly,

hydroxy end-blocked)

70131-67-8 250 500 500 500 Rat oral LD50 minimum.


6/19/2009



PAC Rev 24B





1061 Dimethyl-1,3-dioxolane-4-methanol, 2,2- 100-79-8 30 75 600 3,000 Rat oral LD50

1062Dimethyl-1,3-propanediamine, N,N-; (1-Amino-3-

dimethylaminopropane)109-55-7 10 30 200 750 Rat oral TDlo, rat oral LD50

1063 Dimethyl-1-butanamine, N,N- 927-62-8 200 500 500 500 Rat 240 min LC lo.

1064 Dimethyl-2-pentene, (E)-3,4- 4914-92-5 1.5 5 35 150 Rat oral 240 min LC50 based on HHR.

1065 Dimethyl-3-nitrobenzene, 1,2- 83-41-0 10 30 50 250 Used PNOS default.

1066 Dimethyl-3-pentanone, 2,4- 565-80-0 25 75 500 4,000 Human 180 min TClo, rat 240 min LC50.

1067Dimethyl-5-phenylphenazinium chloride, 3,7-

diamino-2,8-; (Safranine; Gossypimine)477-73-6 0.25 0.75 5 25 Rat iv LD50.

1068 Dimethylacetamide, N,N- 127-19-5 35 250 1,000 1,000 PEL-TWA, rat TClo, IDLH

1069 Dimethylacrylamide, N,N- 2680-03-7 0.6 1.5 12.5 200 Rat skin TDlo, mouse oral LD50.

1070 Dimethylamine 124-40-3 18.4 18.4 122 461 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1071 Dimethylamino)benzaldehyde, p-( 100-10-7 7.5 25 150 250 Rat ipTDlo, rat ip LD50.

1072Dimethylamino)phenyl)azo)benzenesulfonic acid,

sodium salt, P-((P-(; (Methyl orange,sodium salt)547-58-0 0.25 0.75 5 25 Rat oral LD50

1073 Dimethylaminoazobenzene, 4- 60-11-7 15 50 75 75 Mouse ip TDlo, rat oral LD50.

1074 Dimethylaminoethanol, 2- 108-01-0 40 125 600 600 Rat TClo, rat 240 min LC50.

1075 Dimethylaminoethyl chloride hydrochloride, 2- 4584-46-7 0.6 2 15 100 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





1076 Dimethylammonium N,N-dimethylcarbamate 4137-10-4 1.5 5 35 150 Rat oral LD50 based on assumed HHR - 3.

1077 Dimethylaniline, N,N- 121-69-7 25 50 50 500 PEL-TWA, TLV-STEL, rat TClo, IDLH.

1078 Dimethylbenzidene 3,3'-; (o-Tolidine) 119-93-7 0.1 0.3 2 100 REL-C, rat ip LD50.

1079 Dimethylbutyric acid, 2,2- 595-37-9 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

1080Dimethylchlorosilane;

(Chlorodimethylsilane)1066-35-9 2 6.96 85.1 387 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1081 Dimethylcyclohexane, cis-1,4- 624-29-3 3.5 10 60 350 Estimated rat oral LD50.

1082 Dimethyldecane, 2,2- 17302-37-3 350 350 1,500 7,500 NIOSH limits for Alkanes used

1083 Dimethyldichlorosilane 75-78-5 1.5 4.75 68.6 280 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1084 Dimethyldicyclopentadiene 26472-00-4 7.5 25 200 500 Rat TClo, rat oral LD50.

1085 Dimethyldimethoxysilane 1112-39-6 20 60 400 500 Rat 240 LC lo minimum.

1086Dimethylethyl hydroperoxide, 1,1-; (tert-

Butylhydroperoxide)75-91-2 3 10 60 200 Guinea pig TClo, rat oral LD50.

1087 Dimethylformamide, N,N- 68-12-2 6 6 272 1,580 ERPG-1, ERPG-1, AEGL-2, AEGL-3.

1088 Dimethylheptane, 2,2- 1071-26-7 350 350 1,500 7,500 NIOSH limits for Alkanes used.

1089 Dimethylhexane, 3,3- 563-16-6 350 350 1,500 7,500 NIOSH limits for Alkanes used.

1090 Dimethylhydrazine, 1,1- 57-14-7 1.25 1.25 7.37 27 PEL-TWA, PEL-TWA, AEGL-2, AEGL-3


6/19/2009



PAC Rev 24B





1091 Dimethylhydrazine, 1,2- 540-73-8 1.5 4 7.37 27 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3

1092 Dimethylimidizole, 1,2- 1739-84-0 4 12.5 75 400 Mouse ip LD50.

1093 Dimethylisopropylamin, n,n- 996-35-0 1 3 5 25 MAK-TWA concentration limit.

1094 Dimethylnonane, 4,5. 17302-23-7 750 1,500 1,500 1,500Estimated TWA and STEL based on nonane-

butane ratio.

1095 Dimethyloctane, 3,5- 15869-93-9 600 1,000 3,000 15,000Estimated TWA and STEL based on octane-

butane ratio.

1096 Dimethylphenol, 2,4-; (2,4-Xylenol) 105-67-9 0.3 1 6 500 Mouse skin TDlo, rat oral LD50.

1097 Dimethylphenol, 2,6-; (2,6-Xylenol) 576-26-1 0.75 2 15 125 Rat TClo, rat oral LD50.

1098 Dimethylphthalate 131-11-3 5 15 75 500 PEL-TWA, pregnant rat TDlo, IDLH

1099 Dimethylpolysilane; (Poly(dimethylsilane)) 28883-63-8 0.75 2.5 10 25Concentration limits based on Trimethoxysilane

ERPGs (times 5)

1100 Dimethyl-p-phenylenediamine, N,N- 99-98-9 0.025 0.075 0.13 1 LOC, rabbit 240 min LC lo.

1101 Dimethylpropane, 2,2-; (Neopentane) 463-82-1 1,500 1,500 1,500 150,000 PEL-TWA, REL-C, mouse 120 min LC lo.

1102 Dimethylpyridine, 2,4-; (2,4-Lutidine) 108-47-4 0.75 2.5 15 75 Rat oral LD50.

1103 Dimethyltetramethoxydisiloxane, 1,3- 18186-97-5 10 30 50 250 Used PNOS default.

1104 Dimetilan 644-64-4 5 15 25 25 LOC, rat oral LD50.

1105 Di-N-amylamine 2050-92-2 0.4 1.25 7.5 40 Rat 240 min LC lo.


6/19/2009



PAC Rev 24B





1106 Di-n-butylamine 111-92-2 1.25 3.5 25 250 WEEL-C, rat 240 min LC lo.

1107 Dinitraniline orange; (Hansa orange RN) 3468-63-1 10 30 50 250 Used PNOS default.

1108 Dinitroaniline, 2,4- 97-02-9 0.035 0.1 0.75 12.5 Pregnant rat TClo, rat oral LD50.

1109 Dinitrobenzene, m- 99-65-0 1 3 5 50 PEL-TWA, rat oral TDlo, IDLH.

1110 Dinitrobenzene, o- 528-29-0 1 3 5 50 PEL-TWA, IDLH.

1111 Dinitrobenzene, p- 100-25-4 1 3 5 50 PEL-TWA, IDLH.

1112 Dinitro-o-cresol, 4,6- 534-52-1 0.2 0.2 0.5 5 PEL-TWA, LOC, IDLH.

1113 Dinitrophenol 25550-58-7 0.25 0.75 5 25 Rat oral LD lo.

1114 Dinitrophenol, 2,3- 66-56-8 0.75 2 15 75 Rat ip LD50.

1115 Dinitrophenol, 2,4- 51-28-5 1.5 5 30 30 Rat oral TDlo, human oral LD lo.

1116 Dinitrophenol, 2,6- 573-56-8 0.15 0.4 3 15 Rat ip LD50.

1117Dinitro-p-toluidine, 2,6-; (4-Amino-3,5-

dinitrotoluene)6393-42-6 2.5 7.5 50 250 Mouse iv LD50

1118 Dinitrosopiperazine; (Piperazine, 1,4-dinitroso-) 140-79-4 0.5 1.5 10 60 Mouse oral TDlo, rat oral LD 50.

1119 Dinitrotoluene 25321-14-6 0.2 0.6 12.5 50 TLV-TWA, IDLH.

1120 Dinitrotoluene, 2,4- 121-14-2 0.2 0.6 30 50 TLV-TWA, IDLH.


6/19/2009



PAC Rev 24B







1123 Dinoseb; (2-sec-Butyl-4,6-dinitrophenol) 88-85-7 0.75 2.5 4.5 10 LOC, cat 180 min LC lo.

1124Dinoterb; (2-(1,1-Dimethylethyl)-4,6-

dinitrophenol)1420-07-1 5 15 25 25 LOC, rat oral LD50.

1125 Dioctyl phthalate, n- 117-84-0 15 50 400 500 Rat ip TDlo, rat oral LD50.

1126 Dioctyl sebacate; (Bis(2-ethylhexyl) sebacate) 122-62-3 7.5 20 150 500 Rat iv LD50.

1127Dioctyl sodium sulfosuccinate; (Di-(2-ethylhexyl)

sodium sulfosuccinate)577-11-7 7.5 20 150 500 Rat oral TDlo, rat oral LD50.

1128 Dioxane, 1,4- 123-91-1 61.2 61.2 1,150 2,740 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1129 Dioxathion 78-34-2 0.1 0.3 3.4 150 TLV-TWA, LOC, rat 60 min LC50.

1130Dioxin; (TCDD; 2,3,7,8-tetrachlorodibenzo-p-

dioxin)1746-01-6 0.0006 0.0015 0.0075 0.0075 Human skin TDlo, rat oral LD50.

1131 Dioxolane, 1,3- 646-06-0 60 60 200 15,000 TLV-TWA, LOC, mouse 120 min LC50.

1132 Dipentaerythritol; (Dipentek) 126-58-9 10 30 50 250 Used PNOS default.

1133 Dipentyl pentylphosphonate 6418-56-0 25 75 500 500 Rat oral LD lo minimum.

1134 Diphacinone; (Diphenadione) 82-66-6 0.15 0.5 0.9 500 LOC, rat 240 min LC50.

1135 Diphenyl mercury 587-85-9 0.177 0.177 0.177 17.7 TLV-TWA, TLV-TWA, PEL-C, IDLH.


6/19/2009



PAC Rev 24B





1136Diphenyl o-cresol phosphate; (Diphenyl cresol

phosphate)26444-49-5 2.5 7.5 50 500 Guinea pig skin TDlo, rat oral LD50.

1137 Diphenyl; (Biphenyl) 92-52-4 1.25 7.5 60.5 100 PEL-TWA, AEGL-2/7, AEGL-2, IDLH.

1138 Diphenylamine 122-39-4 10 30 125 125 TLV-TWA, rat oral TDlo. Guinea pig oral LD50.

1139Diphenylchloroarsine;

(Chlorodiphenylarsine)712-48-1 0.39 0.39 0.39 1.2 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1140 Diphenyldichlorosilane 80-10-4 3 9.31 114 517 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1141 Diphenylguanidine, 1,3- 102-06-7 0.2 0.6 4 125 Mouse oral TDlo, rat oral LD50.

1142 Diphenylhydrazine, 1,2- 122-66-7 0.2 0.6 4 125 Rat oral TDlo, rat oral LD50.

1143 Diphenylmethane 101-81-5 7.5 25 200 500 Rat oral LD50

1144 Diphenylnitrosamine 86-30-6 7.5 25 150 500 Rat oral TDlo, rat oral LD50.

1145 Diphenyloxazole, 2,5- 92-71-7 3 7.5 60 300 Mouse ip LD50.

1146 Dipicolinic acid; (2,6-Pyridinedicarboxylic acid) 499-83-2 10 30 50 250 Used PNOS default.

1147 Dipotassium cadmium oxide z-0013 0.0099 0.0594 0.1 17.8 PEL-TWA, TLV-TWA, IDLH.

1148 Dipotassium dihydrogen silicate z-0014 10 30 50 250 Used PNOS default.

1149 Dipotassium metasilicate 10006-28-7 6 15 125 500 SAR

1150 Dipropyl ketone; (4-Heptanone) 123-19-3 200 200 300 1,500 TLV-TWA, rat 360 min LC50.


6/19/2009



PAC Rev 24B





1151 Dipropylamine 142-84-7 15 50 350 500 Rat 240 min LC50.

1152 Dipropylene glycol methyl ether 34590-94-8 600 750 1,500 3,500 PEL-TWA, TLV-STEL, rat oral LD50.

1153 Direct Black 38; (Apomine black GX) 1937-37-7 25 75 500 500 Mouse oral TDlo, rat 60 min LC lo.

1154 Di-sec-octylphthalate 117-81-7 5 10 75 500 TLV-TWA, REL-STEL, mouse oral TDlo, IDLH.

1155 Disodium (2-ethylhexyl)phosphate 15505-13-2 0.02 0.06 0.4 2 SAR

1156 Disodium 3,6-endoxohexahydrophthalate 129-67-9 1 3 20 20 Rat oral TDlo, rat oral LD50.

1157 Disodium butylphosphate 64114-42-7 0.02 0.06 0.4 2 SAR

1158 Disodium cadmium oxide z-0016 0.0085 0.0508 0.0847 15.2 PEL-TWA, TLV-TWA, IDLH.

1159 Disodium dihydrogen silicate z-0017 10 30 50 250 Used PNOS default.

1160Disodium ethylenediaminediacetate (S and U

isomers)38011-25-5 4 12.5 75 400 SAR

1161 Disodium hexafluorosilicate (2-) 16893-85-9 4.12 4.12 5 5 Fluoride PEL-TWA, human oral LD lo.

1162 Disodium iminodiacetate 928-72-3 35 100 600 3,500 Rat oral LD50

1163 Disulfiram 97-77-8 2 2 3 125 TLV-TWA, women oral TDlo, human oral LD lo.

1164 Disulfoton 298-04-4 0.05 0.15 2 75 TLV-TWA, LOC, rat 240 min LC50.

1165 Di-tert-butyl dicarbonate 24424-99-5 0.4 1.25 7.5 40 Rat 240 min LC50


6/19/2009



PAC Rev 24B





1166 Di-tert-butylhydroquinone, 2,5- 88-58-4 12.5 40 250 400 Rat oral TDlo, mouse oral LD50.

1167Dithiazanine iodide; (3,3'-

Diethylpentamethinethiacyanine iodide)514-73-8 4 12.5 20 20 LOC, mouse oral LD50.

1168 Dithiobiuret 541-53-7 1 3 5 5 LOC, rat oral LD50.

1169 Dithiodiethanol, 2,2-; (Dithiodiglycol) 1892-29-1 0.75 2 15 75 Rat oral LD50.

1170 Dithioerythritol, 1,4- 6892-68-8 1.25 4 25 125 Mouse intramuscular LD50.

1171 Diurethane dimethacrylate 72869-86-4 75 250 500 500 Rat oral toxicity based on HHR.

1172 Divinylbenzene, m-; (m-Vinylstyrene) 108-57-6 50 50 400 2,000 REL-TWA, mean rat oral LD50.

1173 Divinylbenzene, mixed isomers; (Vinylstyrene) 1321-74-0 50 60 400 2,000 TLV-TWA, rat oral LD50.

1174 Dodecamethylcyclohexasiloxane 540-97-6 10 30 50 500 SAR

1175 Dodecane 112-40-3 0.125 0.35 2.5 150 Rabbit skin TDlo, rat 480 min LC50 minimum.

1176Dodecanethiol, 1-; (Dodecyl mercaptan; Lauryl

mercaptan)112-55-0 0.75 2.5 4 20 TLV-TWA, REL-C

1177 Dodecen-1-yl)succinic anhydride, (2-; (DDSA) 19780-11-1 10 30 50 250 PNOS default used.

1178 Dodecenylsuccinic anhydride 25377-73-5 5 15 100 500 Rat 240 min LC lo.

1179 Dodecyl alcohol 112-53-8 0.4 1 7.5 500 Mouse skin TDlo, rat oral LD50.

1180 Dodecyl methacrylate 142-90-5 50 150 1,000 5,000 Rat ip LD50.


6/19/2009



PAC Rev 24B





1181Dodecylbenzene sulfonic acid;

(Laurylbenzenesulfonic acid)27176-87-0 2.5 7.5 50 250 Rat oral LD50.

1182 Dodecylphenol, 4- (mixture of isomers) 27193-86-8 7.5 25 150 500 Rat oral TDlo, rat oral LD50.

1183Dodecylsarcosine sodium salt, N-; (N-laurel

sarcosine sodium salt)7631-98-3 1.5 4 30 150 Mouse iv LD50.

1184 Dodecyltrichlorosilane 4484-72-4 2.5 7.45 90.6 410 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1185Dodenyl succine anhydride;

(Tetrapropenylsuccinic anhydride)26544-38-7 10 30 200 500 Rat oral LD50

1186 Dowex 50WX4 (50-400 ion exchange resin) 11113-61-4 10 30 50 250 Used PNOS default.

1187Dv methyl ester; (Methyl 3-(2,2-dichlorovinyl)-2,2-

dimethylcyclopropanecarboxylate)61898-95-1 10 30 50 250 PNOS TLV-TWA default used.

1188 Dysprosium 7429-91-6 10 30 50 250 PNOS default used.

1189 Dysprosium nickelide 12175-27-8 10 30 50 250 Used PNOS default.

1190 Dysprosium nitrate 10143-38-1 10 30 200 500 Rat oral LD50.

1191 Dysprosium oxide; (Dysprosium(III) oxide) 1308-87-8 20 60 400 500 Rat oral LD50 minimum.

1192 Ecolite z-0018 20 60 400 500 Rat oral LD50.

1193 Emetine dihydrochloride, l- 316-42-7 0.05 0.15 0.25 0.25 LOC, women sc LD lo.

1194 Endosulfan 115-29-7 0.1 0.3 0.8 35 TLV-TWA, LOC, rat 240 min LC50.

1195 Endothion 2778-04-3 3.5 10 17 17 LOC, rat oral LD50.


6/19/2009



PAC Rev 24B





1196 Endrin 72-20-8 0.1 0.3 2 2 PEL-TWA, LOC, IDLH.

1197 Epibatadine (nicotine-like) z-0019 0.0015 0.004 0.025 0.025 Rat ip TDlo, rat ip LD50.

1198 Epibromohydrin 3132-64-7 1.25 3.5 25 125 Mouse ip LD50.

1199 Epichlorohydrin 106-89-8 1.5 21.6 90.8 272 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

1200Epinephrine; (Vasotonin; (R)-4-(1-Hydroxy-2-

(methylamino)ethyl)-1,2-benzenediol)51-43-4 0.25 0.25 0.25 0.25 Human oral TDlo, human subcutaneous LD lo.

1201EPN; (O-Ethyl-O-(4-nitrophenyl)

phenylthiophosphonate)2104-64-5 0.5 0.5 5 5 PEL-TWA, LOC, IDLH.

1202 Epoxy resin (EPON 1001) 25068-38-6a 125 350 500 500 Rat oral LD50.

1203 Epoxy resin (EPON 1007) 25068-38-6b 125 350 500 500 Rat oral LD50.

1204 Epoxy resin (EPON 820) 25068-38-6c 50 150 500 500 Rat oral LD50.

1205 Epoxy resin ERL-2795 25068-38-6d 4 12.5 100 500 Rat oral LD50.

1206

Epoxy resin, cured; (4,4'-(1-

Methylethylidene)biscyclohexanol, polymer with

(chloromethyl)oxirane)


1207Epoxy resin; (Bisphenol A-Bisphenol A diglycidyl

ether polymer))25036-25-3 7.5 25 150 500 Rat oral LD50 estimated from HHR = 2.

1208Epoxy resin; (Epichlorhydrin, polymer with

diethylene glycol)25928-94-3 0.06 0.2 1.25 6 Rat 240 min LC lo.

1209 Epoxybutane, 1,2- ; (1,2-Butylene oxide) 106-88-7 6 200 600 600 WEEL-TWA, rat TClo, rat 240 min LC50.

1210Epoxyethyl)-7-oxabicyclo(4.1.0)heptane, 3-( ;

(Vinyl cyclohexene dioxide)106-87-6 0.6 2 12.5 500 TLV-TWA, rat skin TDlo, rat 240 min LC50.


6/19/2009



PAC Rev 24B





1211 Erbium nitrate pentahydrate 10031-51-3 10 30 50 250 Used PNOS default.

1212 Erbium(III) nitrate 10168-80-6 0.2 0.6 5 25 Rat iv LD50.

1213 Erbium(III) nitrate hexahydrate 13476-05-6 1 3 20 100 Rat oral LD50.

1214 Erbium(III) oxide 12061-16-4 20 60 400 500 Rat oral LD50 minimum.

1215 Ergocalciferol; (Vitamin D2) 50-14-6 7.5 25 40 40 LOC, rat oral LD50.

1216 Ergotamine tartrate 379-79-3 2 6 10 60 LOC, rat iv LD50.

1217 Estane; (Polyurethane resin; Urethane rubber) 61789-63-7 10 30 50 250 Used PNOS default.

1218 Ethane 74-84-0 1,250 3,500 6,000 30,000 TLV-TWA

1219 Ethanedioic acid, dimethyl ester 553-90-2 4 12.5 75 400 Rat oral LD minimum.

1220 Ethanedithiol, 1,2- 540-63-6 1.25 4 30 150 Mouse oral LD50.

1221 Ethanediyl)bisbenzene, 1,1'-(1,2-; (Bibenzyl) 103-29-7 15 50 400 500 Rat oral LD50.

1222Ethanediylbis(N-(carboxymethyl)glycine), N,N'-

1,2-, dipotassium salt2001-94-7 1.5 5 40 200 Mouse ip LD50.

1223 Ethanediylbis(oxy))bisbenzene, 1,1'-(1,2- 104-66-5 10 30 50 250 Used PNOS default.

1224 Ethanethiol; (Ethyl mercaptan) 75-08-1 1.25 2.54 305 914 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

1225 Ethanol, titanium(4+) salt 3087-36-3 10 30 50 250 Used PNOS default.


6/19/2009



PAC Rev 24B





1226 Ethanolamine 141-43-5 7.5 15 75 75 PEL-TWA, TLV-STEL, rat oral TDlo, IDLH.

1227 Ethenylsilanetriol triacetate 4130-08-9 10 30 50 250 Used PNOS default.

1228Ethidium bromide; (2,7-Diamino-10-ethyl-9-

phenylphenanthridinium bromide)1239-45-8 0.15 0.5 4 20 Mouse sc LD50.

1229 Ethion 563-12-2 0.05 0.15 13 350 TLV-TWA, LOC, rat 240 min LC50.

1230 Ethoxyethanol, 2- 110-80-5 15 50 750 1,500 TLV-TWA, rat TClo, IDLH.

1231Ethoxyethoxy)ethanol, 2-(2-; (Carbitol cellosolve;

Diethylene glycol monoethyl ether)111-90-0 125 150 1,000 2,000 WEEL-TWA, human TDlo, rat oral LD50

1232 Ethoxyethyl methacrylate, 2- 2370-63-0 4 12.5 75 400 Estimated rat oral LD50.

1233 Ethoxyethylacetate, 2- 111-15-9 25 400 2,500 2,500 TLV-TWA, rat TClo, IDLH.

1234

Ethoxyimino)butyl)-5-(2-ethylthiopropyl)-3-

hydroxycyclohex-2-en-1-one, 2-(1-( ;

(Checkmate)

74051-80-2 12.5 40 250 500 Rat oral LD50.

1235Ethoxylated alcohols, C16-18; (Nonionic

surfactant)68439-49-6 5 15 100 500 Rat oral LD50.

1236 Ethoxylated alcohols, C7-C21 68991-48-0 10 10 10 10 Used PNOS default.

1237Ethoxylated nonylphenol; (Nonyl phenyl

polyethylene glycol ether)9016-45-9 5 15 100 500 Rat oral LD50.

1238 Ethyhexyloxy)ethanol, 2-(2- 1559-35-9 100 350 500 500 Rat oral TDlo, rat oral LD50

1239 Ethyl (or dimethyl) pyrrolidine z-0020 5 15 100 500 SAR

1240 Ethyl acetate 141-78-6 1,500 1,500 1,500 7,500 PEL-TWA, human TClo, IDLH.


6/19/2009



PAC Rev 24B





1241 Ethyl acetoacetate 141-97-9 15 50 350 500 Rat oral LD50

1242 Ethyl acrylate 140-88-5 20 34 147 982 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

1243 Ethyl alcohol; (ethanol) 64-17-5 1,500 5,000 6,000 6,000 PEL-TWA, woman oral TDlo, IDLH.

1244 Ethyl alcohol-d; (Ethanol-d) 925-93-9 2,000 6,000 6,000 6,000 Used ethanol (64-17-5) PEL-TWA, IDLH.

1245Ethyl amyl ketone; (5-Methyl-3-heptanone; 3-

Octanone)106-68-3 125 125 125 500 PEL-TWA, IDLH.

1246 Ethyl benzene 100-41-4 400 500 500 3,500 PEL-TWA, TLV-STEL, human TClo, IDLH.

1247 Ethyl benzoate 93-89-0 7.5 25 150 500 Rat oral LD50

1248 Ethyl bromoacetate 105-36-2 0.006 0.02 0.125 0.6 Mouse skin TDlo.

1249 Ethyl butyl ketone; (3-Heptanone) 106-35-4 200 350 750 4,000 PEL-TWA, TLV-STEL, IDLH.

1250 Ethyl cellulose 9004-57-3 20 60 400 500 Rat oral LD50 minimum.

1251 Ethyl chloride 75-00-3 250 5,000 10,000 10,000 PEL-TWA, rat TClo, IDLH.

1252 Ethyl chloroacetate 105-39-5 0.75 2 15 75 Rat oral LD50.

1253 Ethyl chloroformate 541-41-3 4 4 7.1 21.3 UK OEL-TWA, OEL-TWA, AEGL-2, AEGL-3.

1254Ethyl dimethylamido-

cyanophosphate; (Tabun; GA)77-81-6 0.0008 0.0028 0.0351 0.258 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

1255 Ethyl ether 60-29-7 1,250 1,500 1,500 6,000 PEL-TWA, TLV-STEL, human TClo, IDLH.


6/19/2009



PAC Rev 24B





1256 Ethyl formate 109-94-4 300 750 1,500 4,000 PEL-TWA, IDLH concentration limits.

1257 Ethyl hexanoic acid, 2-; (Butyl ethyl acetic acid) 149-57-5 5 15 125 500TLV-TWA, PAC-2/7, regnant rat TDlo, rat oral

LD50.

1258 Ethyl lactate; (Ethyl (s)-(-)-lactate) 687-47-8 15 40 300 500 Mouse oral LD50.

1259 Ethyl mercury chloride; (Chloroethyl mercury) 107-27-7 0.0132 0.0396 0.0529 2.64 PEL-TWA, TLV-STEL, PEL-C, IDLH.

1260Ethyl methacrylate; (2-Methyl-2-propenoic acid,

ethyl ester)97-63-2 200 600 4,000 4,000 Pregnant rat TClo, rat 240 min LC50.

1261 Ethyl nitrite 109-95-5 2 6 40 200 Rat 240 min LC50.

1262

Ethyl O-2-

diisopropylaminoethylmethylphosphonite, O-;

(QL)


1263 Ethyl propionate 105-37-3 35 100 750 4,000 Rat oral LD50.

1264Ethyl S,S-dipropylphosphorodithioate, O-; (Mocap

PC-84; Ethoprophos)13194-48-4 0.25 0.75 5 15 Chicken oral TDlo, rat oral LD50.

1265 Ethyl silicate polymer; (Silicic acid, ethyl ester) 11099-06-2 10 30 50 250 PNOS TLV-TWA default used.

1266 Ethyl-1,3-hexanediol, 2-; (Ethyl hexylene glycol) 94-96-2 75 250 1,500 4,000 Rat oral TDlo, rat 480 min LC lo minimum.

1267 Ethyl-1-hexanol, 2- 104-76-7 0.53 0.53 639 1,209 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

1268 Ethyl-2-methylheptane, 3- 14676-29-0 75 250 2,000 10,000 Estimated rat LD50

1269 Ethyl-2-methyloctane, 6- 62016-19-7 2 6 40 200PAC-3/105, PAC-3/35, PAC-3/5, undecane rat oral

LD50.

1270 Ethyl-2-oxazoline, 2- 10431-98-8 0.4 1.25 7.5 40PAC-3/105, PAC-3/35/ PAC-3/5, rat 240-min LC50

(based on estimated HHR = 3).


6/19/2009



PAC Rev 24B





1271Ethyl-4-hydroxybenzoate; (p-Hydroxybenzoic acid

ethyl ester)120-47-8 250 500 500 500 Rat oral TDlo, mouse oral LD50.

1272 Ethyl-5-methylheptane, 3- 52896-90-9 0.4 1 7.5 25,000 Mouse skin TDlo, mouse 120 min LC50.

1273

Ethyl-6-methyl-4-phenyl-3-cyclohexene-1-

carboxylic acid sodium salt, 5-; (Mebane sodium

salt)

16550-39-3 0.001 0.003 0.02 0.1 Rat oral TDlo.

1274Ethylamine; (Monoethylamine;

Ethylamine anhydrous)75-04-7 13.8 13.8 90.3 498 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1275 Ethylbenzaldehyde, 2- 22927-13-5 50 150 1,000 6,000 Estimated rat LC50

1276

Ethylbis(2-chloroethyl)amine; (Bis(2-

chloroethyl)ethylamine; Nitrogen

mustard-1)

538-07-8 0.004 0.0125 0.022 0.37 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

1277 Ethylchlorothioformate 2941-64-2 0.25 0.75 1.41 4.28 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

1278Ethyldichloroarsine;

(Dichloroethylarsine)598-14-1 0.029 0.029 0.029 0.086 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1279 Ethylene 74-85-1 200 600 10,000 10,000 TLV-TWA, mouse TClo, mouse 5 min LC lo.

1280Ethylene chlorohydrin; (2-

Chloroethanol)107-07-3 3 3 13.2 39.5 MAK-TWA, TEEL-0, AEGL-2, AEGL-3.

1281 Ethylene dibromide; (Dibromoethane) 106-93-4 131 131 184 353 AEGL-1. AEGL-1, AEGL-2, AEGL-3.

1282 Ethylene dichloride; (1,2-Dichloroethane) 107-06-2 202 202 810 1,210 PEL-TWA, ERPGs-1, ERPG-2, ERPG-3.

1283 Ethylene fluorohydrin; (2-Fluoroethanol) 371-62-0 0.0125 0.035 0.06 3.5 LOC, rat 10 min LC50.


6/19/2009



PAC Rev 24B





1284 Ethylene glycol 107-21-1 25 25 100 150 MAK-TWA, EEGL-60 min, EEGL-30 min

1285 Ethylene glycol diacetate 111-55-7 25 75 500 500 Rat TClo, rat oral LD50.

1286 Ethylene glycol dimethacrylate 97-90-5 12.5 40 300 500 Rat oral LD50.

1287Ethylene glycol monomethyl ether acetate;

(EGMEA; 2-Methoxyethyl acetate)110-49-6 0.5 1.5 25 1,000 TLV-TWA, human TClo, IDLH.

1288Ethylene glycol monomethyl ether; (2-

Methoxyethanol; EGME; Methyl Cellosolve(R))109-86-4 0.3 1 7.5 600 TLV-TWA, human TClo, IDLH.

1289Ethylene glycol monopropyl ether; (Propyl

cellosolve; Ektasolve EP)2807-30-9 15 50 350 4,000 Rat TClo, rat 240 min LC50.

1290 Ethylene glycol mono-sec-butyl ether 7795-91-7 3 10 60 350 Rat oral LD50.

1291 Ethylene oxide; (Oxirane) 75-21-8 1.5 7.5 81 360 PEL-TWA, PEL-STEL, AEGL-2, AEGL-3.

1292 Ethylene/vinyl acetate copolmer 24937-78-8 10 30 50 250 Used PNOS default.

1293 Ethylenediamine dihydrochloride 333-18-6 0.1 0.3 2 60 Rat oral TDlo, rat im LD50.

1294 Ethylenediamine, 1,2- 107-15-3 23.8 23.8 23.8 49.1 AEGL-2, AEGL-2, AEGL-2, AEGL-3

1295 Ethylenediaminetetraacetic acid, disodium salt 139-33-3 60 150 500 500 Pregnant rat oral TDlo, rat oral LD50.

1296Ethylenediaminetetraacetic acid, disodium salt,

dihydrate6381-92-6 10 30 50 250 Used PNOS default.

1297Ethylenediaminetetraacetic acid, ferric

ammonium salt21265-50-9 2.5 7.5 50 250 Mouse intraperotoneal LD50.

1298Ethylenediaminetetraacetic acid, tetrasodium

salt, dihydrate10378-23-1 7.5 25 150 500 Estimated rat oral LD50 from HHR.


6/19/2009



PAC Rev 24B





1299Ethylenediaminetetraacetic acid, tetrasodiumn

salt; (Tetrasodium EDTA)64-02-8 40 125 500 500 Rat oral LD50.

1300 Ethylenediaminetetraacetic acid; (EDTA) 60-00-4 40 125 150 150 Pregnant rat oral TDlo, rat ip LD50.

1301 Ethylenedinitrilo)tetra-2-propanol, 1,1',1'',1'''-( 102-60-3 15 50 350 500 Mammalian LD50.

1302 Ethyleneimine 151-56-4 0.75 1 8.1 17.4 TLV-TWA, AEGL-2/7. AEGL-2, AEGL-3.

1303 Ethylenethiourea; (2-Imidazolidinethione) 96-45-7 0.75 2.5 15 500 Pregnant rat TClo, rat oral LD50.

1304 Ethylheptane, 4- 2216-32-2 15 50 350 1,500 Estimated rat oral LD 50 based on HHR.

1305Ethylhexyl acrolate, 2-; (Acrylic acid, 2-ethylhexyl

ester)103-11-7 4 12.5 75 75 Rat TClo, Mouse LC lo.

1306 Ethylhexyl bromide, 2- 18908-66-2 10 30 50 250 Used PNOS default.

1307 Ethylhexylchloroformate, 2- 24468-13-1 0.35 1 7.64 22.8 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

1308 Ethylidene chloride, 1,1-; (1,1-Dichloroethane) 75-34-3 400 1,250 12,500 12,500 PEL-TWA, rat TClo, IDLH.

1309 Ethylidene norbornene 16219-75-3 0.3 0.982 491 2,460 ERPG-1/3, ERPG-1, ERPG-2, ERPG-3.

1310Ethylmagnesium chloride; (Chloroethyl

magnesium)2386-64-3 10 30 50 250 PNOS default used.

1311

Ethyl-S-dimethylaminoethyl

methylphosphonothiolate; (VX nerve

agent)

50782-69-9 0.0001 0.0002 0.003 0.01 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

1312 Ethylthiocyanate 542-90-5 20 60 100 100 LOC, mouse ip LD50.


6/19/2009



PAC Rev 24B





1313 Ethyltoluene, o- 611-14-3 500 500 500 500 Rat TClo, mouse 240 min LC50.

1314 Ethyltoluene, p- 622-96-8 500 500 500 500 Rat TClo, mouse 240 min LC50.

1315 Europium 7440-53-1 10 30 50 250 Used PNOS default.

1316 Europium nitrate; (Europium trinitrate) 10138-01-9 15 50 350 500 Rat oral LD50.

1317 Europium oxide 1308-96-9 20 60 400 500PAC-3/105, PAC-3/35, PAC-3/5, rat oral LD50

minimum.

1318 Europium(II) iodide 22015-35-6 10 30 50 250 PNOS default used.

1319 Farnesol 4602-84-0 25 75 500 500 Rat oral LD50

1320Fatty acids, tall-oil, polymers with glycerol,

pentaerythritol and phthalic anhydride66070-62-0 10 30 50 250 PNOS TLV-TWA

1321 Fenamiphos 22224-92-6 0.05 0.15 0.9 40 TLV-TWA, LOC, rat 240 min LC50.

1322 Fensulfothion 115-90-2 0.01 0.03 2 12.5

1323 Fenthion 55-38-9 0.05 0.15 40 40TLV-TWA, TEEL=0*3, women oral TDlo, human

LD lo.

1324 Ferric ammonium citrate 1185-57-5 1 3 500 500TLV-TWA as Fe, 3*TEEL-0, rat oral TDlo, rat oral

LF50 minimum.

1325 Ferric ammonium sulfate dodecahydrate 7783-83-7 8.64 25.9 43.2 200 Fe soluble salts TLV-TWA.

1326Ferric ammonium sulfate; (Sulfuric acid,

ammonium iron(3e+) salt (2:1:1))10138-04-2 4.82 14.5 25 125

1327 Ferric chloride 7705-08-0 2.9 3.5 25 125 Fe concentration limits, rat repro TDlo, oral LD50


6/19/2009



PAC Rev 24B





1328 Ferric chloride hexahydrate 10025-77-1 4.84 75 100 100Fe concentration limits, rat 14W TDlo mouse ip

LD50

1329 Ferric fluoride 7783-50-8 14.8 40 300 500

1330 Ferric hydroxide; (Iron(III) hydroxide) 1309-33-7 3.5 10 75 400 PAC-3/105, PAC-3/35, PAC-3/5, rabbit oral LD.

1331 Ferric nitrate 10421-48-4 4.33 13 21.7 100 TLV-TWA, TEEL-0*3, TEEL-0*5, PAC-2*5

1332Ferric nitrate nonahydrate; (Iron(III) nitrate

nonahydrate (1:3:9))7782-61-8 7.24 21.72 250 500 TLV-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

1333 Ferric phosphate 10045-86-0 2.75 8.26 13.8 60 TLV-TWA, TEEL-0*3, TEEL-0*5, PAC-2*5

1334 Ferric sulfate; (Iron(III) sulfate) 10028-22-5 3.58 10.7 17.9 75 TLV-TWA, TEEL-0*3, TEEL-0*5, mouse ip LD lo.

1335 Ferrous ammonium sulfate 10045-89-3 5.09 15.3 25.4 125

1336 Ferrous carbonate 563-71-3 15 40 300 500 PAC-3/105, PAC-3/35, PAC-3/5, mouse oral LD50.

1337 Ferrous chloride 7758-94-3 2.27 6.81 11.3 200

1338 Ferrous disulfide; (Iron disulfide) 12068-85-8 2.15 6.44 10.7 50 Iron concentration limits.

1339 Ferrous hydroxide; (Iron(III) hydroxide) 18624-44-7 1.61 4.83 8.05 400 TLV-TWA, 3*TEEL-0, 5*TEEL-0, rabbit oral LD.

1340 Ferrous sulfamate 14017-39-1 1 3 5 25

1341 Ferrous sulfate 7720-78-7 2.72 8.16 13.6 350 Fe TLV-TWA, child oral LD lo.

1342 Ferrous sulfate heptahydrate 7782-63-0 4.98 14.9 25 500


6/19/2009



PAC Rev 24B





1343Fibrous glass; (Fiber glass; Glass frit; Synthetic

vitreous fibers)65997-17-3 5 15 60 500

1344 Fluenetil 4301-50-2 1.25 3.5 6 6 PAC-2/5, PAC-2*3/5, LOC, rat oral LD50.

1345 Fluoboric acid; (Tetrafluoroboric acid) 16872-11-0 2.89 2.89 7.5 40

1346 Fluoranthene 206-44-0 0.004 0.01 0.075 500

1347 Fluorene, 9H- 86-73-7 7.5 25 150 500

1348 Fluorides (as F) 16984-48-8 2.5 2.5 2.5 250

1349 Fluorine 7782-41-4 0.15 2.64 7.75 20.2 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1350 Fluoro-2-nitrobenzene, 1-; (o-Fluoronitrobenzene) 1493-27-2 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

1351 Fluoro-4-nitrophenol, 2- 403-19-0 0.75 2.5 15 75 SAR

1352 Fluoro-6-nitrophenol, 2- 1526-17-6 0.75 2.5 15 75 SAR

1353 Fluoroacetamide 640-19-7 1 3.5 5.8 5.8 PAC-2/5, PAC-2*3/5, LOC, human oral LDlo.

1354Fluoroacetic acid, sodium salt; (Sodium

fluoroacetate)62-74-8 0.05 0.15 0.5 2.5

1355 Fluoroacetic acid; (Fluoroethanoic acid) 144-49-0 0.075 0.25 0.47 2

1356 Fluoroacetyl chloride 359-06-8 2 6 10 10

1357 Fluoroaniline, p- 371-40-4 1.5 5 35 150 Rat oral LD50.


6/19/2009



PAC Rev 24B





1358 Fluorobenzene 462-06-6 125 350 500 500

1359 Fluorosulfonic acid; (Fluorosulfuric acid) 7789-21-1 2 2 10 30 PAC-1, ERPG-1, ERPG-2, ERPG-3.

1360 Fluorotrimethylsilane 420-56-4 10 30 200 1,000

1361 Fluorouracil 51-21-8 0.75 2.5 19 100

1362 Fonofos 944-22-9 0.01 0.03 1.3 200 TLV-TWA, LOC, rat 60 min LC50.

1363 Food Red 15; (FD&C Red No. 19) 81-88-9 0.4 1.25 7.5 50

1364 Forane 26675-46-7 15,000 35,000 35,000 35,000 TClo and LC50 r inhalation data

1365 Formaldehyde 50-00-0 0.35 1.1 17.2 68.7 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1366Formaldehyde cyanohydrin; (Hydroxyacetonitrile;

Glycolonitrile)107-16-4 0.3 0.75 6 10

1367 Formamide 75-12-7 15 35 250 2,500

1368 Formetanate hydrochloride 23422-53-9 3.5 10 18 18

1369 Formic acid 64-18-6 7.5 15 15 50 PEL-TWA, TLV-STEL, human TClo, IDLH.

1370 Formic acid, 2-propenyl ester; (Allyl formate) 1838-59-1 4 12.5 75 400

1371 Formic acid, butyl ester; (n-Butyl formate) 592-84-7 200 600 4,000 4,000

1372 Formothion 2540-82-1 0.05 0.15 0.27 10


6/19/2009



PAC Rev 24B





1373 Formparanate 17702-57-7 1.5 4 7.2 7.2

1374 Formylpiperidine, 1- 2591-86-8 15 50 400 400 Rat oral TDlo preg, rat oral LD50.

1375 Fosthietan 21548-32-3 0.75 2.5 4.7 4.7

1376 Fuberidazole 3878-19-1 0.6 2 3.3 125

1377 Fuel oil, residual 68476-33-5 35 100 500 500

1378 Fuller's earth 8031-18-3 5 6 500 500

1379 Fulminic acid; (Carbyloxime) 506-85-4 1 3 20 100 Human LC50 based on HHR = 3

1380 Fumaric acid 110-17-8 40 100 500 500

1381 Furan 110-00-9 3.5 10 18.9 52.9 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

1382 Furancarboxaldehyde, 2-; (Furfural) 98-01-1 8 8 39 393 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

1383Furancarboxylic acid, ethyl ester, 2-; (Ethyl

furoate)614-99-3 1.5 4 30 150

1384 Furfuryl alcohol 98-00-0 60 60 60 300

1385 Fusariotoxin T2; (T2-Trichothecene) 21259-20-1 0.0015 0.004 0.03 0.4

1386 Gadolinium 7440-54-2 500 500 500 500

1387 Gadolinium chloride hexahydrate 13450-84-5 40 75 75 75 Rat oral TDlo, mouse iv LD50.


6/19/2009



PAC Rev 24B





1388 Gadolinium hydroxide 16469-18-4 0.75 0.75 2.5 75 SAR

1389 Gadolinium nitrate, solid 10168-81-7 10 30 50 500

1390 Gadolinium nitrite z-0022 0.04 0.125 0.75 75 SAR

1391 Gadolinium(III) oxide 12064-62-9 2 6 50 500

1392 Gallic acid monohydrate 5995-86-8 15 50 350 500 Rat oral LD50.

1393 Gallium 7440-55-3 10 30 50 250

1394 Gallium oxide 12024-21-4 10 30 50 500

1395 Gallium trichloride 13450-90-3 6 20 32 100

1396 Gallium trifluoride 7783-51-9 5.56 16.7 27.8 125

1397 Gasoline 8006-61-9 750 1,500 1,500 4,000 TLV-TWA, -STEL, human TClo, rat LC50

1398 Gelatin; (Pharmagel A) 9000-70-8 2.5 7.5 60 300

1399 Germane; (Germanium tetrahydride) 7782-65-2 0.6 1.5 3 500

1400 Germanium 7440-56-4 0.0125 0.035 0.25 500 Human oral TDlo, rat oral LD50.

1401 Germanium oxide 1310-53-8 0.75 2 15 500

1402 Germanium tetrafluoride 7783-58-6 4.89 12.5 100 489 PEL-TWA and IDLH concentration limits for F


6/19/2009



PAC Rev 24B





1403 Germanous acid z-0023 2 6 40 200

1404 Giemsa's stain; (… blood stain) 51811-82-6 10 30 50 250

1405 Gluconic acid, D- 526-95-4 10 30 50 250 PNOS default used.

1406 Glucose monohydrate, D(+)-; (Dextrose) 14431-43-7 10 30 50 250 Used PNOS default.

1407 Glucose, alpha-D-; (alpha-Dextrose) 492-62-6 0.4 1.25 7.5 500 Women iv TDlo, rat oral LD50.

1408 Glucose, D-; (Dextrose, anhydrous) 50-99-7 0.4 1.25 7.5 500 Women iv TDlo, rat oral LD50.

1409 Glutamic acid, L-; ((S)-(+)-Glutamic acid) 56-86-0 2 6 40 200

1410 Gluteraldehyde 111-30-8 0.2 0.82 4.1 20.5 MAK-TWA, ERPG-1, ERPG-2, ERPG-3.

1411 Glycerine (mist); (Glycerol, glycerin) 56-81-5 15 125 500 500

1412Glycerine carbonate; (4-Hydroxymethyl]-1,3-

dioxolan-2-one)931-40-8 10 30 50 250 PNOS default used.

1413Glyceryl monostearate; (Octadecanoic acid,

monoester with 1,2,3-propanetriol)31566-31-1 10 30 50 75

1414 Glycidaldehyde 765-34-4 0.06 0.2 1.5 75

1415 Glycidol; (Oxiranemethanol) 556-52-5 6 12.5 75 400 TLV-TWA, rat TClo, rat LC50.

1416Glycidoxypropyltrimethoxysilane; (3-(2,3-

Epoxypropoxy) propyltrimetyh-oxysilane)2530-83-8 150 400 500 500 Rat TClo, rat LC lo.

1417 Glycidyl acrylate; (2,3-Epoxypropyl acrylate) 106-90-1 0.6 2 12.5 60 Rat 240 min LC lo.


6/19/2009



PAC Rev 24B





1418 Glycine; (Aminoacetic acid) 56-40-6 25 75 500 500

1419 Glycol carbonate; (Ethylene carbonate) 96-49-1 40 125 500 500

1420 Glycolic acid 79-14-1 0.75 0.75 0.75 0.75

1421 Glycols, polyethylene, dimethyl ether 24991-55-7 75 200 500 500 Rat oral TDlo, rat oral LD lo.

1422Glycols, polyethylene, mono(p-nonylphenyl)

ether; (Nonoxynol-9)26027-38-3 0.025 0.075 0.6 60

1423 Glycoluril; (Acetyleneurea) 496-46-8 10 30 50 250

1424 Glyoxal 107-22-2 0.1 35 75 75

1425 Goethite; (Iron hydroxide oxide) 1310-14-1 5 7.5 12.5 250 SAR

1426 Gold 7440-57-5 7.5 25 100 100

1427 Graphite; (Mineral carbon) 7782-42-5 2 6 10 500

1428 Grease; (Animal grease, inedible) 68153-81-1 10 30 50 250

1429 Guanidine, N-methyl-N'-nitro-N-nitroso- 70-25-7 0.125 0.35 2.5 40

1430 Guanidinehydrochloride 50-01-1 2 6 40 200 Rat oral LD50.

1431 Hafnium 7440-58-6 0.5 1.5 2.5 50

1432 Hafnium oxide 12055-23-1 0.59 1.77 3 59


6/19/2009



PAC Rev 24B





1433 Halon 1211; (Bromochlorodifluoromethane) 353-59-3 75 250 1,500 35,000

1434 Hansa yellow 13515-40-7 10 30 50 250

1435 Helium 7440-59-7 10,000 10,000 35,000 60,000 Simple asphyxiant

1436 Hematoxylin 517-28-2 10 30 50 50

1437 Heptachlor 76-44-8 0.5 0.5 0.5 35

1438 Heptachlor epoxide; (Epoxyheptachlor) 1024-57-3 0.05 0.15 6 6 TLV-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

1439Heptachlorodibenzofuran, 1,2,3,4,6,7,8-;

(HeptaCDF, 1,2,3,4,6,7,8-)67562-39-4 0.06 0.15 1.25 6

1440Heptachlorodibenzofuran, 1,2,3,4,7,8,9- ;

(HeptaCDF, 1,2,3,4,7,8,9-)55673-89-7 0.075 0.25 1.5 7.5

1441Heptachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-;

(HeptaCDD, 1,2,3,4,6,7,8-)35822-46-9 0.15 0.5 2.5 2.5

1442 Heptadecane 629-78-7 150 500 3,500 15,000

1443 Heptafluorobutyric acid 375-22-4 0.6 2 12.5 60 Mouse ip LD50.

1444

Heptafluorotetrahydro-5-(nonafluorobutyl)furan,

2,2,3,3,4,4,5-; (Perfluoro-2-butyltetrahydrofuran;

Fluorinert FC-75)

335-36-4 3.42 10.3 17.1 75

1445 Heptane 142-82-5 1,500 1,500 1,500 3,000

1446 Heptanoic acid 111-14-8 30 75 600 3,000 Rat oral LD50.

1447 Heptanol, 1-; (Heptyl alcohol) 111-70-6 3.5 10 500 500


6/19/2009



PAC Rev 24B





1448 Heptene, 1- 592-76-7 7,500 20,000 150,000 750,000 Mouse TClo

1449Hexacarbonylchromium; (Chromium

hexacarbonyl)13007-92-6 0.05 1.25 1.25 1.25

1450 Hexachloroacetone 116-16-5 0.4 1.25 7.5 200 Rat oral TDlo, rat 180 min LC50.

1451 Hexachlorobenzene 118-74-1 0.002 0.006 2 200

1452 Hexachlorobutadiene 87-68-3 0.2 10.7 32.1 106.9 TLV-TWA, ERPG-1, ERPG-2, ERPG-3.

1453Hexachlorocyclohexane, alpha-; (Benzene

hexachloride-alpha-isomer)319-84-6 0.5 1.5 2.5 500

MAK-TWA, TEEL-0*3, TEEL-0*5, human oral LD

lo.

1454Hexachlorocyclohexane, beta-1,2,3,4,5,6-;

(Benzene hexachloride, trans-alpha-)319-85-7 0.5 1.5 2.5 500 MAK-TWA, TEEL-0*3, rat oral TDlo, rat oral LD50.

1455 Hexachlorocylopentadiene 77-47-4 0.1 0.2 0.2 0.2

1456Hexachlorodibenzodioxin, 1,2,3,4,7,8-;

(HexaCDD, 1,2,3,4,7,8-)39227-28-6 0.0004 0.0013 0.0075 0.4

1457 Hexachlorodibenzofuran, 1,2,3,4,7,8- 70648-26-9 0.0025 0.0075 0.06 0.3


1459Hexachlorodibenzofuran, 1,2,3,7,8,9-;

(HexaCDF, 1,2,3,7,8,9-)72918-21-9 0.04 0.125 0.75 4


1461 Hexachlorodibenzo-p-dioxin, 1,2,3,6,7,8- 57653-85-7 0.005 0.015 0.1 0.5

1462Hexachlorodibenzo-p-dioxin, 1,2,3,7,8,9-;

(HexaCDD, 1,2,3,7,8,9-)19408-74-3 0.005 0.015 0.1 0.5


6/19/2009



PAC Rev 24B





1463 Hexachloroethane 67-72-1 10 30 50 3,000

1464 Hexachloronaphthalene 1335-87-1 0.2 0.2 0.2 2

1465 Hexachlorophene 70-30-4 10 10 20 200 Infant oral TDlo, child oral LD lo.

1466 Hexachloropropene 1888-71-7 1.5 4 30 150

1467 Hexadecanamine, 1- 143-27-1 0.125 0.35 2.5 75 Mouse oral TDlo preg, mouse ip LD50.

1468 Hexadecane 544-76-3 3 7.5 60 500 Guinea pig skin TDlo, mouse intravenous LD lo.

1469 Hexadecanoic acid; (Palmitic acid) 57-10-3 25 50 50 50

1470 Hexadecanol, 1- 36653-82-4 2.5 7.5 60 300

1471 Hexadecene, 1- 629-73-2 4 12.5 75 400 Rat 60 min LC lo minimum.

1472Hexadecylpyridinium chloride, 1-; (Cepacol

chloride)123-03-5 0.075 0.25 2 10 Rat 240 min LC50.

1473 Hexadecyltrimethylammonium chloride 112-02-7 2.5 7.5 50 250 Mouse oral LD lo.

1474 Hexafluoro-2-propanol, 1,1,1,3,3,3- 920-66-1 50 150 1,000 6,000 Rat 240 min LC50

1475 Hexafluoroacetone 684-16-2 0.6 0.6 1.36 543 TLV-TWA, TLV-TWA, AEGL-2, AEGL-3.

1476 Hexafluorobenzene 392-56-3 1,250 3,500 12,500 12,500 Dog TClo, rat 30 min LC50.

1477Hexafluorobutyne-2; (1,1,1,4,4,4-Hexafluoro-2-

butyne)692-50-2 2 6 40 200 Rat 240 min LC50.


6/19/2009



PAC Rev 24B





1478 Hexafluoroethane; (Freon 116; Perfluoroethane) 76-16-4 250,000 250,000 250,000 250,000 Rat TClo

1479Hexafluoropropylene;

(Hexafluoropropene)116-15-4 0.6 245 558 2,940 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

1480Hexafluoropropylene-vinylidene fluoride polymer;

(Viton)9011-17-0 10 30 50 250 PNOS default.

1481 Hexamethylcyclotrisiloxane 541-05-9 10 30 200 500 Estimated rat oral LD50.

1482 Hexamethyldisilazane 999-97-3 12.5 40 250 350

1483 Hexamethyldisiloxane 107-46-0 250 750 2,000 2,000

1484 Hexamethylene diisocyanate polymer 28182-81-2 7.5 25 200 500 Rat 60-min LC50

1485Hexamethylene diisocyanate; (1,6-

Diisocyanatohexane)822-06-0 0.035 0.1 1.25 20

1486 Hexamethyleneimine 111-49-9 15 40 300 500 Mouse 120 min LC50.

1487 Hexamethylenetetraamine hydrochloride 58713-21-6 10 30 50 250

1488 Hexamethylenetetraamine; (Methenamine) 100-97-0 10 30 500 500

1489 Hexamethylphosphoramide 680-31-9 0.3 0.75 6 1,000

1490Hexamethyltetracosane, 2,6,10,15,19,23-;

(Squalane)111-01-3 75 250 1,500 7,500 Estimated rat 240 min LC50 based on HR.

1491 Hexanal 66-25-1 50 150 750 750

1492 Hexane 110-54-3 150 1,500 11,600 30,300 TLV-TWA, AEGL-2/7, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





1493 Hexanediol diacrylate, 1,6- 13048-33-4 1 3.5 25 500 WEEL-TWA, rabbit dermal TDlo, rat oral LD50.

1494 Hexanediol, 1,6-; (Hexamethylene glycol) 629-11-8 50 150 500 500 Rat ip TDlo, rat oral LD50.

1495 Hexanehexol, 1,2,3,4,5,6-; (Mannitol) 69-65-8 500 500 500 500

1496 Hexanenitrile 628-73-9 2 6 40 200

1497 Hexanethiol, 1-; (N-Hexylmercaptan) 111-31-9 0.125 0.35 2.5 500 REL-C, rat 240 min LC50.

1498 Hexanitrostilbene 20062-22-0 0.25 0.75 6 30 Rat oral TDlo for 4-Nitrostilbene.

1499 Hexanoic acid 142-62-1 5 15 100 500

1500 Hexanol, 2-; (2-Hydroxyhexane) 626-93-7 5 15 100 500 Human TClo.

1501 Hexanol, n-; (n-Hexyl alcohol) 111-27-3 3 7.5 60 300

1502 Hexanone, 2-; (Methyl n-butyl ketone) 591-78-6 20 40 6,000 6,000

1503 Hexanone, 3-; (Ethyl propyl ketone) 589-38-8 15 50 350 1,500

1504 Hexanoyl chloride 142-61-0 1.5 5 35 150 Rat oral LD50 from estimated HHR = 3.

1505 Hexaphenylcyclotrisiloxane 512-63-0 7.5 25 150 500 Estimated rat oral LD50 based on HHR.

1506 Hexene, 1- 592-41-6 150 250 1,720 17,200 TLV-TWA,PAC-2/7, ERPG-2, ERPG-3.

1507 Hexylene glycol 107-41-5 50 50 125 1,500


6/19/2009



PAC Rev 24B





1508 Hexyltrichlorosilane 928-65-4 1.5 5.39 65.5 296 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1509 Holmium 7440-60-0 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

1510 Holmium trioxide 12055-62-8 10 30 50 250

1511 Humic acid, sodium salt 68131-04-4 2 6 40 200 Rat ip TDlo preg., rat ip LD50.

1512 Hydrazine 302-01-2 0.131 0.131 17 45.9 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1513 Hydrazine hydrate, aequeous solutions 10217-52-4 0.03 0.0625 0.0625 0.0625

1514 Hydrazine hydrate; (Hydrazine monohydrate) 7803-57-8 0.003 0.0075 0.0625 50

1515Hydrazine hydrochloride; (Hydrazine

monochloride)2644-70-4 0.0075 0.025 0.04 50

1516 Hydrazine nitrate; (Hydrazinium nitrate) 13464-97-6 1 3 5 25

1517 Hydrazine sulfate 10034-93-2 0.6 2 15 250

1518 Hydrazine, dihydrochloride 5341-61-7 25 75 500 500 Rat oral TDlo.

1519 Hydriodic acid; (Hydrogen iodide) 10034-85-2 1.5 5.23 115 627 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1520Hydrobromic acid; (Hydrogen

bromide)10035-10-6 3.31 3.31 72.8 397 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1521 Hydrogen 1333-74-0 5,000 5,000 15,000 30,000 Simple asphyxiant

1522Hydrogen chloride; (Hydrochloric

acid) 7647-01-0 0.75 2.68 32.8 149 CEGL, AEGL-1, AEGL-2, AEGL-3


6/19/2009



PAC Rev 24B





1523 Hydrogen cyanide; (Hydrocyanic acid) 74-90-8 2 2.21 7.84 16.6 MAK-TWA, AEGL-1, AEGL-2, AEGL-3

1524 Hydrogen fluoride; (Hydrofluoric acid) 7664-39-3 0.818 0.818 19.6 36 AEGL-1, AEGL-1, AEGL-2, AEGL-3

1525 Hydrogen peroxide 7722-84-1 1.25 14 71 142 PEL-TWA, ERPG-1, ERPG-2, ERPG-3.

1526 Hydrogen peroxide - 30% 7722-84-1a 12.5 40 200 400 Concentration-adjusted ERPGs

1527

Hydrogen potassium phthalate; (Phthalic acid,

monopotassium salt; Potassium acid phthalate;

Potassium biphthalate)

877-24-7 12.5 40 250 500 Rat oral LD50 minimum.

1528 Hydrogen selenide 7783-07-5 0.15 0.35 2.42 7.28 PEL-TWA, AEGL-2/7, AEGL-2, AEGL-3.

1529 Hydrogen sulfide 7783-06-4 0.71 0.71 37.6 69.6 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1530 Hydrogenated terphenyl 61788-32-7 0.5 1.5 2.5 500 TLV-TWA, RAT oral LD50.

1531 Hydroquinone 123-31-9 2 3 20 50 PEL-TWA, TLV-TWA*3, LOC, IDLH.

1532Hydrotreated (mild & severe) heavy paraffinic

distillates64742-54-7 60 150 500 500

1533Hydrotreated middle distillate (Petroleum base

oil)64742-46-7 3 7.5 60 300

1534Hydroxy-2-methylpropanoic acid, 2-; (2-

Methyllactic acid)594-61-6 10 30 50 250

1535Hydroxy-4'-hydroxyethoxy-2-

methylpropiophenone, 2-106797-53-9 15 50 350 500 Rat oral LD50

1536Hydroxy-4-methyl-2-pentanone, 4-; (Diacetone

alcohol)123-42-2 200 200 200 7,500


6/19/2009



PAC Rev 24B





1537 Hydroxyapatite; (Calcium hydroxyapatite) 1306-06-5 12.5 35 60 500 SAR

1538Hydroxybenezenesulfonic acid, 4-; (4-

Hydroxyphenylsulfonic acid)98-67-9 25 75 500 500 Mouse oral LD50

1539 Hydroxybenzoic acid, 4-; (p-Salicylic acvid) 99-96-7 20 60 400 500 Rat oral TDlo, mouse oral LD50.

1540Hydroxybenzotriazole, 1-; (1-

Hydroxybenzotriazole hydrate)2592-95-2 40 125 500 500 Rat oral LD lo.

1541Hydroxyethyl acrylate, 2-; (Acrylic acid, 2-

hydroxyethyl ester)818-61-1 1.5 5 35 250 Rat TClo, rat 240 min LC lo.

1542 Hydroxyethyl methacrylate, 2- 868-77-9 0.1 0.3 2 500 Rat oral TDlo, rat oral LD50.

1543Hydroxyethyl)-1-piperazineethanesulfonic acid, 4-

(2-7365-45-9 1.25 4 25 125 Quail LD50 maximum.

1544 Hydroxyethylenediaminetriacetic acid, N- 150-39-0 1.25 4 30 150

1545Hydroxyethylidene-1,1-diphosphonic acid, 1-;

(Hydroxyethylidine bisphosphonic acid, 1-)2809-21-4 10 30 50 500

1546 Hydroxylamine 7803-49-8 0.25 0.75 5 25

1547Hydroxylamine chloride; (Hydroxylamine

hydrochloride)5470-11-1 10 35 60 60

1548 Hydroxylamine nitrate 13465-08-2 7.62 15.2 26 150 PEL-TWA, TLV-STEL and IDLH as HNO3, LOC.

1549 Hydroxylamine sulfate; (Oxammonium sulfate) 10039-54-0 4 10 75 400

1550Hydroxymethanesulfinic acid, monosodium salt;

(Formaldehyde hydrosulfite)149-44-0 15 50 350 500 Mouse oral LD50.

1551Hydroxy-N-phenylbenzamide, N-;

(Phenylbenzohydroxamic acid, N-)304-88-1 10 30 50 250 PNOS default.


6/19/2009



PAC Rev 24B





1552 Hydroxyphenyl)benzothiazole, 2(2- 3411-95-8 35 100 500 500 Mouse ip LD lo minimum.

1553 Hydroxyphenylacetic acid, alpha- 90-64-2 15 50 350 500 Rat ip LD50.

1554 Hydroxypropyl cellulose 9004-64-2 40 125 500 500 Rat oral LD50.

1555 Hydroxyquinoline sulfate, 8- 134-31-6 5 15 100 500 Rat oral LD50.

1556Hypophosphorous acid-d3; (Hydrophosphorus

acid-d3 solution, 50 wt.% in D2O)57583-56-9 2 6 50 750

Rat oral TDlo, rat oral LD50 for non-deuterated

compound.

1557 Hypophosphorus acid; (Phosphinic acid) 6303-21-5 10 30 50 250

1558 Imidazole 288-32-4 4 12.5 75 100

1559 Imidazole hydrochloride 1467-16-9 7.5 25 150 500 Rat oral LD50 based on HHR.

1560

Imidazole, substituted; (1,3,5-Triazine-2,4-

diamine, 6-[2-(2-metyhyl-1H-imidazol-1-yl)ethyl];

Curezol 2MEA-PW)

38668-46-1 10 30 50 250 PNOS default used.

1561 Iminodiacetic acid 142-73-4 1 3 20 100

1562 Iminodiacetic acid, disodium salt hydrate 17593-73-6 35 100 500 500 MSDS rat oral LD50.

1563 Indan 496-11-7 40 125 500 500

1564 Indene 95-13-6 20 40 300 1,500 TLV-TWA, TEEL-0, PAC-3/5, rat 240 min LC50.

1565 Indeno(1,2,3-cd)pyrene 193-39-5 0.15 0.5 3.5 15

1566 Indigo carmine; (FD&C blue No 2) 860-22-0 20 60 75 75


6/19/2009



PAC Rev 24B





1567 Indium 7440-74-6 0.1 0.1 0.6 3.5 Indium concentration limits, mouse sc LD lo.

1568 Indium oxide (vapor) 1312-43-2b 0.107 0.321 0.535 2.5 Indium concentration limits.

1569 Indium sulfate 13464-82-9 0.225 0.676 1.13 4 In compound concentration limits, rat sc LD50.

1570 Indium trichloride 10025-82-8 0.193 0.578 1 1Indium concentration limits, T-2 toxicity adjusted,

rat ip LD50.

1571 Indium(III) oxide 1312-43-2a 0.121 0.363 100 500Indium concentration limits, rat TClo, mouse oral

LD lo.

1572 Indole-3-carboxaldehyde, 1H-; (3-Formylindole) 487-89-8 5 15 100 500

1573 Iodic acid 7782-68-5 0.0139 0.02 0.139 2.77

1574Iodide, Ammonium, tetraethyl-;

(Tetraethylammoniumiodide)68-05-3 0.0203 0.0608 0.101 15 Mouse ip LD50.

1575 Iodine 7553-56-2 0.1 1 5.2 52 MAK-TWA, ERPG-1, ERPG-2, ERPG-3.

1576 Iodine 125 17144-19-3 0.1 1 5 50 Iodine (7753-56-2) PACs.

1577 Iodobenzene 591-50-4 0.0161 0.0482 500 500 Rat TDlo, rat LC50.

1578 Iodoethane; (Ethyl iodide) 75-03-6 0.075 0.2 0.4 3,500 Rat 30 min LC50

1579Iodoheptafluoropropane, 1-; (Heptafluoropropyl

iodide)754-34-7 0.25 0.75 1.25 150,000 Mouse 120 min LC50

1580 Iodopentane, 1- 628-17-1 0.0156 0.0468 0.078 400 Rat ip LD50.

1581 Iotalamic acid 2276-90-6 0.0161 0.0484 1.25 500 Human TDlo, rat ip LD50.


6/19/2009



PAC Rev 24B





1582 Iridium 7439-88-5 6 20 125 500 Rat oral LD50.

1583 Iron 7439-89-6 1.5 4 30 500 Rat oral LD50.

1584 Iron carbide 12011-67-5 5.36 16.1 26.8 125 Iron concentration limits.

1585 Iron hydroxide oxide 20344-49-4 15.9 47.7 79.6 400 Iron concentration limits.

1586 Iron oxide; (Ferric oxide) 1309-37-1 5 15 40 500 Concentration limits.

1587 Iron pentacarbonyl 13463-40-6 0.48 0.48 0.48 1.44 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1588 Iron(II) chloride tetrahydrate 13478-10-9 3.56 3.56 7.5 40 Mouuse ip LD50.

1589 Iron(II) perchlorate hexahydrate 13520-69-9 6.33 19 31.6 150 Used TLV-TWA for soluble iron salts

1590Iron(II,III) oxide; (Ferrosoferric oxide; Iron(III)

oxide)1317-61-9 20.7 31.1 51.8 250 Iron oxide concentration limits.

1591 Iron(III) perchlorate 13537-24-1 6.34 19 31.7 150 Fe soluble salts TLV-TWA.

1592 Iron(III) sulfate heptahydrate 35139-28-7 4.98 14.9 25 500Insol. Fe salts, concentration limits, mouse oral

LD50.

1593 Isoamyl acetate; (Isopentyl acetate) 123-92-2 500 500 1,000 5,000

1594 Isoamyl alcohol (primary); (3-Methyl-1-butanol) 123-51-3 350 400 400 1,500 PEL-TWA, TLV-STEL, human TClo, IDLH.

1595 Isoamyl alcohol (secondary); (3-Pentanol) 584-02-1 350 400 400 1,500 PEL-TWA, TLV-STEL, IDLH.

1596 Isoamyl nitrite; (Isopentyl nitrite) 110-46-3 12.5 40 300 1,500


6/19/2009



PAC Rev 24B





1597 Isobenzan 297-78-9 0.5 1.5 2 2

1598 Isobutanol-2-amine 124-68-5 0.03 0.075 0.6 500

1599 Isobutyl acetate 110-19-0 600 600 1,250 6,000

1600 Isobutyl alcohol 78-83-1 300 3,500 5,000 5,000

1601 Isobutyl chloride; (1-Chloro-2-methylpropane) 513-36-0 1.5 4 30 150 Estimated rat 240 min LC50 based on HR.

1602Isobutyl Chloroformate;

(Chloroformic acid butyl ester)543-27-1 1 3.5 12.3 37.4 MAK-TWA, TEEL-0*3, AEGL-2, AEGL-3.

1603 Isobutyl isobutyrate 97-85-8 150 500 500 500

1604 Isobutylamine 78-81-9 15 15 20 100

1605 Isobutyraldehyde 78-84-2 75 750 5,000 5,000WEEL-TWA, pregnant rat TClo, mouse 120 min

LC50.

1606 Isobutyric acid 79-31-2 1 3.5 25 125

1607Isobutyric anhydride; (2-Methylpropionic

anhydride)97-72-3 0.6 2 12.5 60 Rat LC50 based on HHR.

1608 Isobutyronitrile 78-82-0 20 28.3 50.9 192 REL-TWA, ERPG-1, AEGL-2, AEGL-3.

1609 Isocyanate-bearing waste (as CNs N.O.S.) z-0024 5 5 5 25

1610 Isocyanatoethyl methacrylate, 2- 30674-80-7 0.125 0.35 0.634 6.34 ERPG-2/5, ERPG-2*3/5, ERPG-2, ERPG-3.

1611 Isocyanic acid 75-13-8 0.06 0.2 1.25 6 Human LC50 based on estimated HHR = 3+


6/19/2009



PAC Rev 24B





1612Isocyanic acid, 3,4-dichlorophenyl ester; (3,4-

Dichlorophenyl isocyanate)102-36-3 2.5 7.5 14 500

1613 Isodrin 465-73-6 1.25 4 7 7

1614 Isonate 181 MDI prepolymer z-0113 7.5 25 100 225 Calculated from mixture ingredients

1615 Isooctane; (2,2,4-Trimethylpentane) 540-84-1 1,250 1,500 1,500 4,000 Octane TLV-TWA, REL-C, IDLH.

1616Isopentane; (Ethyldimethylmethane; 2-

Methylbutane)78-78-4 1,500 1,500 1,500 60,000

1617 Isophorone 78-59-1 25 25 25 1,000

1618 Isophorone diisocyanate 4098-71-9 0.04 0.15 1.25 50

1619 Isophthalic acid 121-91-5 10 30 50 500 WEEL-TWA, rat oral LD50

1620 Isoprene 78-79-5 5 13.9 2,780 11,100 WEEL-TWA, ERPG-1, ERPG-2, ERPG-3.

1621 Isopropyl acetate 108-21-4 750 750 750 7,500 TLV-STEL, TLV-STEL, PAC-1, IDLH.

1622 Isopropyl alcohol 67-63-0 1,000 1,000 1,000 5,000 PEL-TWA, TLV-STEL, EEGL, IDLH.

1623 Isopropyl chloride; (2-Chloropropane) 75-29-6 150 500 50,000 50,000 WEEL-TWA, rat TClo, rat LC50.

1624Isopropyl chloroformate; (Isopropyl

chlorocarbonate)108-23-6 0.75 2 16.5 50.1 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

1625 Isopropyl ether; (Diisopropyl ether) 108-20-3 1,250 1,250 1,250 6,000 Concentration limits, human TClo.

1626Isopropyl methanefluoro-

phosphonate; (Sarin; GB)107-44-8 0.0008 0.0028 0.0344 0.126 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3


6/19/2009



PAC Rev 24B





1627 Isopropyl nitrate 1712-64-7 6 20 600 3,000 Russian STEL, rat 240 min LC50

1628 Isopropyl titanate(IV); (Titanium(IV) isopropoxide) 546-68-9 30 75 500 500

1629 Isopropylamine; (2-Propanamine) 75-31-0 12.5 25 300 1,500

1630Isopropylmagnesium chloride; (Chloro(1-

methylethyl)magnesium)1068-55-9 1 3 20 100

1631Isopropylmethylpyrazolyl dimethylcarbamate;

(Isolan)119-38-0 1 3.5 5.6 5.6

1632 Isopropyltoluene, 4-; (p-Cymene) 99-87-6 75 250 500 500 Human TDlo, rat oral LD50.

1633 Jeffamine M-600 77110-54-4 10 30 50 250 Used PNOS default.

1634 Jet fuels (JP-5 and JP-8) 70892-10-3 200 290 1100 1,100 TLV-TWA, AEGL-1, AEGL-2, AEGL-2.

1635 Kaolin; (Aluminum silicate hydroxide) 1332-58-7 5 6 125 500

1636 Kepone; (Chlordecone) 143-50-0 0.001 0.003 0.6 40

1637 Kerosene 8008-20-6 200 290 1100 1,100 REL-TWA, AEGL-1, AEGL-2, AEGL-2

1638 Ketene; (Carbomethene, Ethenone) 463-51-4 0.326 0.326 1.13 3.44 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1639 Krypton 7439-90-9 200,000 200,000 750,000 1,250,000 Simple asphyxiant (see Introduction)

1640 Lactic acid 50-21-5 15 40 300 500

1641Lactic acid, sodium salt, DL-; (Propanoic acid, 2-

hydroxy-, monosodium salt)312-85-6 10 30 50 250 PNOS default used.


6/19/2009



PAC Rev 24B





1642 Lactonitrile 78-97-7 3.5 10 18 150

1643Lactose, beta-D; (beta-D-Glucopyranose, 4-O-

beta-D-galactopyranosyl-)5965-66-2 10 30 50 250 Used PNOS default.

1644 Lanthanum 7439-91-0 10 30 50 250

1645 Lanthanum alizarin z-0026 10 30 50 250

1646 Lanthanum boride 12008-21-8 14.7 44 75 350 Used PNOS default as La

1647 Lanthanum carbonate 6487-39-4 10 30 50 250

1648 Lanthanum chloride 10099-58-8 6 20 150 500 Rat 120 min TClo, rat oral LD50.

1649 Lanthanum fluoride 13709-38-1 8.59 8.59 50 250

1650 Lanthanum hydroxide 14507-19-8 0.2 0.75 2 2.5 SAR

1651 Lanthanum nitrate 10099-59-9 0.4 1.25 7.5 500

1652 Lanthanum oxide 1312-81-8 40 125 500 500

1653 Lanthanum phosphate 14913-14-5 0.3 0.75 3 3 SAR

1654 Lanthanum(III) nitrate hexahydrate 10277-43-7 1.5 5 35 150

1655Laromin C 260; (bis(4-Amino-3-methylcyclohexyl)

methane; Dimethyldicyane)6864-37-5 1.5 5 35 150 Rat 240 min LC50.

1656 Lauryl sulfate; (Dodecyl sulfate) 151-41-7 5 15 100 500 Rat oral LD50.


6/19/2009



PAC Rev 24B





1657 Lead 7439-92-1 0.05 0.15 0.25 100

1658Lead acetate(II), trihydrate;

(Bis(acetato)trihydroxytrilead)6080-56-4 0.0915 0.275 100 183

1659 Lead acetate, basic; (Lead subacetate) 1335-32-6 0.065 0.195 130 130

1660 Lead acetate; (Lead diacetate) 301-04-2 0.0785 0.235 75 157

1661 Lead acid arsenate; (Dibasic lead arsenate) 7784-40-9 0.0838 0.251 168 168

1662 Lead arsenate 3687-31-8 0.012 0.012 0.012 30

1663 Lead bromide 10031-22-8 0.0886 0.266 0.443 177 PEL-TWA, IDLH.

1664 Lead carbonate 598-63-0 0.0645 0.193 4 500

1665 Lead chloride 7758-95-4 0.0671 0.201 7.5 134

1666 Lead chromate 7758-97-6 0.0311 0.186 1 93.2 Cr VI concentration limits.

1667 Lead dioxide 1309-60-0 0.0577 0.1731 20 115

1668 Lead fluoborate 13814-96-5 0.0919 0.276 0.459 184

1669 Lead fluoride 7783-46-2 0.0592 0.178 15 118

1670 Lead hydroxide 19783-14-3 0.0582 0.175 0.3 1.5

1671 Lead iodide 10101-63-0 0.111 0.334 0.556 222


6/19/2009



PAC Rev 24B





1672 Lead nitrate 10099-74-8 0.0799 0.6 4 160

1673 Lead nitrite 13826-65-8 0.0722 0.217 0.361 1.5

1674 Lead oxalate 814-93-7 0.0712 0.214 0.356 1.5

1675 Lead oxide; (Lead monoxide) 1317-36-8 0.0539 0.0539 0.0539 108

1676 Lead phosphate 7446-27-7 0.0653 0.196 30 150

1677 Lead sulfate; (Sulfuric acid, lead(2+) salt (1:1)) 7446-14-2 0.0732 0.2196 30 146 Inorganic Pb concentration limits, as Pb.

1678 Lead sulfide 1314-87-0 0.0577 0.173 350 500

1679 Lead tetroxide 1314-41-6 0.0551 0.165 0.276 110

1680 Lead(II) arsenite 10031-13-7 0.0281 0.0843 0.14 14

1681 Lead(II) perchlorate hydrate 13453-62-8 0.111 0.333 0.555 100 Lead inorganic concentration limits,

1682 Leco set 7007 powder z-0027 10 30 50 250

1683 Leptophos 21609-90-5 6 15 30 30

1684Lewisite 2; (Bis(2-

chlorovinyl)chloroarsine)40334-69-8 0.12 0.12 0.12 0.74 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1685 Lewisite 3; (Tris(2-chlorovinyl)arsine) 40334-70-1 0.12 0.12 0.12 0.74 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1686 Lignosulfonate (aqueous) 8062-15-5 10 30 500 500


6/19/2009



PAC Rev 24B





1687 Limonene, d- 5989-27-5 150 500 750 2,000 WEEL-TWA, rat oral TDlo, rat oral LD50.

1688 Lindane; (gamma-Benzenehexachloride) 58-89-9 0.5 1.5 50 50

1689 Linseed oil 8001-26-1 0.5 1.5 10 60

1690 Liquified petroleum gas; (L.P.G.) 68476-85-7 1,500 3,500 3,500 3,500

1691 Lithium 7439-93-2 10 30 50 400

1692 Lithium acetate dihydrate 6108-17-4 12.5 35 250 500

1693 Lithium aluminate 12003-67-7 12.2 36.6 61.1 300 Aluminum pyro powders, as Al, TLV-TWA.

1694 Lithium aluminum oxide; (Lithium aluminate) 11089-89-7 10 30 50 250

1695 Lithium aluminum silicate; (Petalite) 1302-66-5 2 6 10 50

1696 Lithium azide 19597-69-4 10 10 10 10

1697 Lithium borohydride; (Lithium tetrahydroborate) 16949-15-8 4.03 12.1 20.2 35 Borate TLV-TWA, -STEL, mammal LC50.

1698 Lithium bromide 7550-35-8 1 7 15 500

1699 Lithium carbonate 554-13-2 0.2 0.6 4 200 Human oral TDlo, rat oral LD50

1700 Lithium chloride 7447-41-8 0.5 1.5 10 60

1701 Lithium chromate; (Lithium chromate dihydrate) 14307-35-8 0.016 0.479 0.798 47.9 Cr VI concentration limits.


6/19/2009



PAC Rev 24B





1702 Lithium deuteride 13587-16-1 0.0282 0.0282 0.1 0.5 Used Li.H (7580-67-8) PACs.

1703 Lithium diisopropylamide; (LDA) 4111-54-0 10 30 50 250 PNOS default used.

1704 Lithium fluoride 7789-24-4 3.41 10.2 17.1 341

1705 Lithium hydride 7580-67-8 0.025 0.025 0.100 0.500 PEL-TWA, ERPG-1, ERPG-2, ERPG-3.

1706 Lithium hydroxide 1310-65-2 0.05 0.15 1 100 WEEL-C, rat 240-min LC50

1707 Lithium hydroxide monohydrate 1310-66-3 0.05 0.15 1 100

1708 Lithium iodide 10377-51-2 10 30 50 250 PNOS default.

1709 Lithium metaborate, anhydrous 13453-69-5 2 6 10 50Inorganic borate compounds TLV-TWA and TLV-

STEL

1710 Lithium molybdate 13568-40-6 9.06 27.2 45.3 200

1711 Lithium niobium oxide; (Lithium niobate) 12031-63-9 5 15 25 500

1712 Lithium nitrate 7790-69-4 10 30 50 250

1713 Lithium nitride 26134-62-3 10 10 10 10

1714 Lithium nitrite 13568-33-7 0.025 0.06 0.4 40 SAR

1715 Lithium perchlorate, anhydrous 7791-03-9 0.0005 0.0015 0.01 0.06 IRIS LOEL.

1716 Lithium stearate 4485-12-5 60 150 500 500


6/19/2009



PAC Rev 24B





1717 Lithium sulfate 10377-48-7 0.15 0.5 3.5 500

1718 Lithium tetraborate 12007-60-2 10 30 50 250 PNOS default.

1719 Lithium tetraborate pentahydrate 1303-94-2 1 3 5 25 NIOSH REL-TWA

1720Lithium tetrahydroaluminate(1-); (Lithium

aluminum hydride)16853-85-3 2.81 2.81 7.5 35 Al sol. Salt concentration limits, mouse oral LD50.

1721 Lithium triethylborodeuteride; (Super-deuteride) 74540-86-6 10 30 50 250 PNOS default used.

1722 Lithium triethylborohydride; (Super-hydride) 22560-16-3 1.5 5 35 150 Rat oral LD50 based on HHR.

1723 Lubricating oil, rerefined 68476-77-7 10 30 50 250 PNOS default used.

1724 Lutetium 7439-94-3 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

1725 Lutetium oxide 12032-20-1 10 30 50 250

1726 Lutidine, 2,6-; (2,6-Dimethylpyridine) 108-48-5 350 1,000 6,000 35,000 Rat 60 min LC lo.

1727 Magnesium 7439-95-4 1.25 4 30 150 PAC-2/21, PAC-2/7, rat TClo, PAC-2*5.

1728 Magnesium acetate tetrahydrate 16674-78-5 0.75 2.5 20 100

1729 Magnesium aluminum phosphide z-0116 5.01 5.01 5.01 8.97 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1730 Magnesium carbonate hydroxide 7760-50-1 10 30 50 250 PNOS default.

1731 Magnesium carbonate; (Magnesite) 546-93-0 15 45 200 500PEL-TWA, TEEL-0*3, rat 240 min TClo, rat oral

LD50.


6/19/2009



PAC Rev 24B





1732Magnesium carbonate-magnesium hydroxide,

pentahydrate39409-82-0 48.8 97.7 163 500 Magnesite PEL-TWA.

1733 Magnesium chloride 7786-30-3 10 30 50 500

1734 Magnesium chloride hexahydrate 7791-18-6 75 250 500 500

1735 Magnesium ethoxide 2414-98-4 47.1 141 235 500 Used Mg.O TLV-TWA

1736 Magnesium fluoride 7783-40-6 4.1 12.3 20.5 410

1737 Magnesium formate 557-39-1 10 30 50 250 Used PNOS default.

1738 Magnesium hydroxide 1309-42-8 75 200 500 500

1739 Magnesium iodate tetrahydrate 7790-32-1 10 30 50 250 PNOS default.

1740 Magnesium nitrate hexahydrate 13446-18-9 20 60 500 500

1741 Magnesium nitrate; (Magnesium(II) nitrate (1:2)) 10377-60-3 10 30 50 250

1742 Magnesium oxide 1309-48-4 10 30 150 500

1743 Magnesium phosphide 12057-74-8 1 3 5.51 9.92 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

1744 Magnesium silicate hydrate 1343-90-4 10 30 50 250

1745 Magnesium silicate; (Florisil) 1343-88-0 10 30 50 500

1746 Magnesium sulfate (1:1) 7487-88-9 0.5 1.5 10 125


6/19/2009



PAC Rev 24B





1747 Magnesium sulfate heptahydrate 10034-99-8 5 15 100 500

1748 Magnesium(II) nitrate (1:2), hexahydrate 13446-18-9 20 60 500 500 Rat oral LD50.

1749 Malathion 121-75-5 15 15 15 250 PEL-TWA, TEEL-0, TEEL-0, IDLH.

1750 Maleic acid 110-16-7 3 7.5 60 300 Rat oral LD50.

1751 Maleic acid, disodium salt 371-47-1 25 75 500 500 Rat oral LD50.

1752 Maleic anhydride 108-31-6 0.8 0.8 8 80.2 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

1753Maleic hydrazide; (3,6-Pyridazinedione,1,2-

dihydro-)123-33-1 0.6 2 12.5 500

1754 Malic acid, DL- 617-48-1 6 20 125 500 Mouse oral LD50 minimum,

1755 Malonic acid; (Carboxyacetic acid) 141-82-2 10 15 100 500

1756 Mancozeb; (Dithane M-45) 8018-01-7 1 3 200 500 WEEL-TWA, rat oral TDlo, rat oral LD50

1757 Manganese 7439-96-5 0.2 3 5 500

1758 Manganese carbonate 598-62-9 0.418 6.28 10.5 500

1759 Manganese dioxide 1313-13-9 0.317 4.75 79.1 500

1760 Manganese hydroxide 18933-05-6 0.324 4.86 8.1 500

1761 Manganese nitrite 18488-90-9 0.535 8.02 13.4 500Mn compounds TLV-TWA, REL-STEL, PEL-C,

IDLH.


6/19/2009



PAC Rev 24B





1762 Manganese oxalate 640-67-5 0.52 7.81 13 500

1763 Manganese oxide; (Manganese tetroxide) 1317-35-7 0.278 0.833 69.4 500

1764 Manganese phosphate 10124-54-6 0.43 6.46 10.8 500 TLV-TWA, REL-STEL, PEL-C, IDLH.

1765 Manganese tricarbonyl methylcyclopentadienyl 12108-13-3 0.6 0.6 0.6 7.5

1766Manganese(II) chloride (1:2); (Manganous

chloride)7773-01-5 0.458 6.87 11.5 100

1767 Manganese(II) chloride tetrahydrate 13446-34-9 0.721 10.8 180 500

1768 Manganese(II) nitrate 10377-66-9 0.651 9.77 16.3 500

1769 Manganese(II) nitrate hydrate 15710-66-4 0.717 10.8 17.9 500 Mn inorganic compound concentration limits.

1770 Manganese(II) sulfate monohydrate 10034-96-5 0.615 9.23 15.4 75

1771 Manganese(III) oxide 1317-34-6 0.287 4.31 71.8 500 Mn inorganic concentration limits, rat it LD lo.

1772 Manganese(VII) oxide 12057-92-0 0.404 6.06 10.1 50

1773 Manganous oxide; (Manganese(II) oxide) 1344-43-0 0.258 0.775 6.46 150

1774 Manganous sulfate 7785-87-7 0.55 8.25 13.7 500

1775 Manganous sulfide; (Manganese(II) sulfide) 18820-29-6 0.317 0.95 7.92 500

1776 Mastic (resin) 61789-92-2 4 12.5 100 500


6/19/2009



PAC Rev 24B





1777 Melamine 108-78-1 10 10 10 350 WEEL-TWA, rat TClo, rat LC50.

1778 Mephosfolan 950-10-7 1.5 5 9 9

1779 Mercaptoacetic acid; (Thioglycolic acid) 68-11-1 3.5 3.5 4 20 TLV-TWA, rat LC50.

1780 Mercaptobenzoic acid, o- 147-93-3 0.2 0.6 4 20 Mouse ip LD50.

1781 Mercaptobenzothiazole, 2-; (2-Benzothiazolethiol) 149-30-4 5 15 40 40 WEEL-TWA, pregnant rat TDlo. rat oral LD50.

1782 Mercaptoethanol, 2- 60-24-2 0.6 6 40 600 WEEL-TWA, rat oral TDlo, mouse LC50.

1783 Mercaptopropionic acid, 3- 107-96-0 0.25 0.75 6 40 Mouse subcutaneous TDlo, rat oral LD50.

1784 Mercuric acetate 1600-27-7 0.159 0.159 0.159 15.9 Hg Aryl cmpds. TLV-TWA, PEL-C, PEL-C, IDLH.

1785 Mercuric cyanide 592-04-1 0.0315 1.5 12.6 12.6 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1786 Mercuric iodide; (Mercury(II) iodide) 7774-29-0 0.0566 0.17 0.227 22.7 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1787 Mercuric sulfate; (Mercury(II) sulfate) 7783-35-9 0.037 0.037 0.148 14.8 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1788 Mercuric thiocyanate; (Mercuric sulfocyanate) 592-85-8 0.0395 0.118 0.158 15.8 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1789 Mercuric trifluoroacetate 13257-51-7 0.0213 0.0638 0.0851 4.3 Hg Alkyl cmpds. TLV-TWA, PEL-C, PEL-C, IDLH.

1790 Mercurol; (Mercury nucleate) 12002-19-6 0.025 0.075 0.1 10 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1791 Mercurous chloride; (Mercury monochloride) 7546-30-7 0.0294 0.0883 0.118 11.8 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.


6/19/2009



PAC Rev 24B





1792 Mercurous nitrate monohydrate 7782-86-7 0.0351 0.0351 0.14 14 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1793 Mercurous nitrate; (Mercury(I) nitrate(1:1)) 10415-75-5 0.0327 0.0327 0.131 13.1 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1794 Mercurous oxide; (Mercury(I) oxide) 15829-53-5 0.026 0.026 0.104 10.4 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1795 Mercury hydroxide 12135-13-6 0.0292 0.0292 0.117 11.7 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1796 Mercury nitrate; (Mercury(II) nitrate (1:2)) 10045-94-0 0.0405 0.0405 0.162 16.2 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1797 Mercury nitrite; (Mercury(II) nitrite) 18541-72-5 0.0365 0.0365 0.146 14.6 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1798 Mercury vapor 7439-97-6 0.025 0.3 2.05 4.10 TLV-TWA, PAC-2/7, ERPG-2, ERPG-3.

1799 Mercury(I) chloride; (Dimercury chloride) 10112-91-1 0.0294 0.0883 1.18 11.8 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1800 Mercury(II) chloride; (Mercury bichloride) 7487-94-7 0.0338 2 13.5 13.5 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1801 Mercury(II) nitrate monohydrate 7783-34-8 0.0427 0.128 0.171 17.1 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1802 Mercury(II) oxide; (Mercuric oxide) 21908-53-2 0.027 0.15 1.08 10.8 Hg compounds TLV-TWA, PEL-C, PEL-C, IDLH.

1803 Mesitylene; (1,3,5-Trimethylbenzene) 108-67-8 125 688 1,770 2,500TLV-TWA, AEGL-1, AEGL-2, rat 240 min

LC50.

1804 Metaphosphoric acid 37267-86-0 10 30 50 250 Used PNOS default.

1805Methacrolein diacetate; (Acetic acid, 2-methyl-2-

propene-1,1-diol diester)10476-95-6 7.5 25 44 44

1806 Methacrylaldehyde 78-85-3 0.2 0.573 8.02 13.5 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





1807 Methacrylamide 79-39-0 0.015 0.04 0.3 200 Human TClo, rat LD50.

1808 Methacrylic acid 79-41-4 23.6 23.6 215 774 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1809Methacrylic acid, diester with triethylene glycol;

(Polyester TGM3)109-16-0 10 30 50 500

1810 Methacrylic anhydride 760-93-0 0.75 2.5 4.5 150

1811 Methacrylonitrile; (Methylacrylonitrile) 126-98-7 2.74 2.74 35.7 68.6 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1812 Methacryloyl chloride 920-46-7 0.125 0.35 0.6 25

1813 Methamidophos 10265-92-6 3.5 10 60 60

1814 Methane 74-82-8 600 2,000 3,000 125,000TLV-TWA for aliphatic hydrocarbon gases, mouse

120 min LC50.

1815 Methane-d3 676-80-2 750 2,000 4,000 20,000 TLV-TWA.

1816 Methanesulfonic acid 75-75-2 4 12.5 75 400

1817Methanesulfonic acid, ethyl ester; (Ethyl

methanesulfonate)62-50-0 0.5 1.5 10 150

1818 Methanesulfonyl chloride 124-63-0 0.4 1.25 9.83 29 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

1819 Methanesulfonyl fluoride 558-25-8 12.5 12.5 12.5 12.5

1820Methidathion; (O,O-Dimethyl-S-(5-methoxy-1,3,4-

thiadiazolinyl-3-methyl)dithiophosphate)950-37-8 1 3 20 400

1821 Methiocarb; (Mercaptodimethur) 2032-65-7 3 7.5 15 15


6/19/2009



PAC Rev 24B





1822 Methomyl 16752-77-5 2.5 7.5 10 200

1823 Methoxybenzaldehyde; (p-Anisaldehyde) 123-11-5 0.075 0.2 1.5 500 Rat oral TDlo, rat oral LD50.

1824 Methoxybenzyl alcohol, 4- 105-13-5 7.5 25 200 500 Rat skin TDlo, rat oral LD50.

1825 Methoxychlor 72-43-5 15 30 250 500

1826Methoxyethoxy)ethanol, 2-(2-; (Diethylene glycol

monomethyl ether)111-77-3 1.5 1.5 1.5 1.5

1827 Methoxyethylamine, 2- 109-85-3 1.5 5 35 150

1828 Methoxyethylmercuric acetate 151-38-2 0.0159 0.0477 3.18 3.18

1829 Methoxyphenol, p- 150-76-5 5 15 100 500 Mouse ip TDlo, rat oral LD50.

1830 Methoxypropylamine, 3-; (3-MPA) 5332-73-0 15 50 50 150 WEEL-TWA, WEEL-STEL, MOUSE IV LD50.

1831 Methoxytrimethylsilane 1825-61-2 0.2 2 7.5 20 SAR

1832Methyl 2-cyanoacrylate; (Permabond 910

adhesive)137-05-3 0.75 15 60 60

1833 Methyl 2-pyrrolidinone, 1-; (N-Methylpyrrolidone) 872-50-4 40 40 100 100 WEEL-TWA, rat TClo, rat LC lo.

1834 Methyl acetate 79-20-9 600 750 1,500 7,500 Concentration limits.

1835 Methyl acetylene 74-99-7 1,500 2,500 2,500 2,500

1836 Methyl acetylene-propadiene mixture; (MAPP) 59355-75-8 3,000 4,000 4,000 10,000 PEL-TWA, TLV-STEL, IDLH.


6/19/2009



PAC Rev 24B





1837 Methyl acrylate 96-33-3 6 6 25 500

1838 Methyl alcohol; (Methanol) 67-56-1 250 694 2,750 9,430 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1839 Methyl alcohol-d 1455-13-6 250 350 1,250 7,500 Methanol concentrtation limits.

1840 Methyl alcohol-d4 811-98-3 200 250 500 500 Methanol concentrtation limits.

1841 Methyl benzoate; (Benzoic acid, methyl ester) 93-58-3 12.5 35 250 500 Rat oral TDlo, rat oral LD50.

1842Methyl bis(2-hydroxyethyl) cocoalkyl quaternary

ammonium chlorides70750-47-9 1.5 5 35 150 PAC-3/105, PAC-3/35, PAC-3/5, rat oral LD50.

1843Methyl bis(2-hydroxyethyl) cocoalkyl quaternary

ammonium nitrates71487-00-8 1.5 5 35 150 PAC-3/105, PAC-3/35, PAC-3/5, rat oral LD50.

1844 Methyl bromide; (Bromomethane) 74-83-9 4 100 815 2,870 TLV-TWA, PEL-C, AEGL-2, AEGL-3.

1845 Methyl butylacrylate, 2-; (Butyl methacrylate) 97-88-1 2.5 7.5 50 500

1846 Methyl chloride 74-87-3 200 200 1,880 6,190 PEL-TWA, TLV-STEL, AEGL-2, AEGL-3.

1847Methyl chloroformate; (Methyl

chlorocarbonate)79-22-1 0.75 1.25 8.5 9.27 MAK-TWA, AEGL-2/7, AEGL-2, AEGL-3.

1848Methyl chlorosilane;

(Chloromethylsilane)993-00-0 2 5.93 72.5 329 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

1849Methyl cyclohexylfluorophosphonate;

(GF)329-99-7 0.0005 0.0015 0.0177 0.133 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

1850Methyl demeton methyl; (Phosphorothioic acid,

O,O-dimethyl-S-(2-methylthio)ethyl ester)2587-90-8 4 12.5 20 20


6/19/2009



PAC Rev 24B





1851Methyl dichlorosilane;

(Dichloromethylsilane)75-54-7 1.25 4.23 51.7 221 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1852Methyl difluorophosphite; (Methylphosphonic

difluoride)676-99-3 0.75 2.5 20 100

1853 Methyl ether; (Dimethyl ether) 115-10-6 1,500 5,000 7,500 125,000 WEEL-TWA, human TClo, rat LC50.

1854 Methyl ethyl ketone peroxide 1338-23-4 7.5 20 150 150

1855 Methyl fluoride; (Fluoromethane) 593-53-3 4.48 13.4 22.4 448

1856 Methyl fluoroacetate 453-18-9 0.015 0.05 0.35 5

1857 Methyl fluorosulfate 421-20-5 0.0125 0.035 0.25 1.25

1858 Methyl formate; (Formic acid, methyl ester) 107-31-3 250 350 2,000 10,000

1859 Methyl iodide 74-88-4 30 145 290 725 PEL-TWA, ERPG-1, ERPG-2, ERPG-3.

1860 Methyl isobutyl ketone; (Hexone) 108-10-1 300 300 300 2,000 PAC-1, TLV-STEL, PAC-1, IDLH.

1861 Methyl isocyanate 624-83-9 0.04 0.058 0.156 0.466 PEL-TWA, ERPG-1, AEGL-2, AEGL-3

1862 Methyl isopropyl ketone; (3-Methyl-2-butanone) 563-80-4 600 600 600 2,000

1863 Methyl isothiocyanate; (Isothiocyanatomethane) 556-61-6 1.5 4 33 500

1864 Methyl lithium 917-54-4 1 3 20 100

1865 Methyl mercaptan 74-93-1 1 12.5 92.4 134 TLV-TWA, AEGL-2/7, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





1866 Methyl mercury 22967-92-6 0.0107 0.0322 0.043 2.15 PEL-TWA, TLV-STEL, PEL-C, IDLH.

1867 Methyl methacrylate 80-62-6 69.6 69.6 491 2,330 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

1868 Methyl n-amyl ketone 110-43-0 400 400 600 3,500

1869 Methyl nitrate; (Nitric acid, methyl ester) 598-58-3 15 50 350 1,500 Rat LC50

1870

Methyl nonafluorobutyl ether (40%)

and Methyl nonafluoroisobutyl ether

(60%) (ppm) (HFE-7100)

163702-07-

6 163702-

08-7

7,500 25,600 83,800 153,000 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3

1871 Methyl parathion 298-00-0 0.2 0.34 0.34 15

1872 Methyl phencapton 3735-23-7 2 6 11 100

1873 Methyl phosphonic dichloride 676-97-1 0.06 0.2 1.4 15

1874 Methyl phosphonothioic dichloride 676-98-2 1.5 4 30 150

1875 Methyl pyridine, 3-; (3-Picoline) 108-99-6 7.5 20 500 2,500 WEEL-TWA, WEEL-STEL, rat 120 min LC lo.

1876 Methyl salicylate 119-36-8 0.75 2.5 15 75

1877 Methyl sulfoxide-d6; (Dimethyl-d6-sulfoxide) 2206-27-1 35 100 500 500

1878 Methyl tert-butyl ether; (MTBE) 1634-04-4 180 180 2,050 19,100 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

1879 Methyl thiocyanate 556-64-9 15 40 75 75


6/19/2009



PAC Rev 24B





1880 Methyl vinyl carbinol; (3-Buten-2-ol) 598-32-3 0.6 2 15 75

1881 Methyl vinyl ketone; (3-Buten-2-one) 78-94-4 0.15 0.487 3.44 6.88 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1882 Methyl-1-butene, 2- 563-46-2 150,000 150,000 600,000 1,000,000 Simple asphyxiant

1883 Methyl-1H-benzotriazole 29385-43-1 10 30 50 300

1884 Methyl-1-phenyl-2-pyrazolin-5-one, 3- 89-25-8 15 40 300 500

1885Methyl-1-propanethiol, 1-; (sec-Butyl mercaptan;

2-Butanethiol)513-53-1 7.5 20 150 750 Rat 240 min LC50 based on HHR = 2.

1886 Methyl-1-propen-1-one, 2-; (Dimethylketene) 598-26-5 0.075 0.25 2 10

1887 Methyl-2-(1-methylethyl)phenol, 5-; (Thymol) 89-83-8 0.075 0.25 1.5 400 Rat sc TDlo pre, rat oral LD50.

1888 Methyl-2-butene, 2- 513-35-9 6 15 125 600 Rat LC50 eztimated from HHR = 2.

1889 Methyl-2-chloroacrylate 80-63-7 0.25 0.75 5 35

1890 Methyl-2-heptanone, 6- 928-68-7 10 30 50 250 PNOS default.

1891 Methyl-2-hexanone, 5-; (Methyl isoamyl ketone) 110-12-3 400 600 7,500 7,500

1892 Methyl-3-penten-2-one, 4-; (Mesityl oxide) 141-79-7 100 100 100 5,000

1893 Methyl-4-penten-2-one, 4- 3744-02-3 100 100 100 5,000

1894Methyl-5-nitroaniline, 2-; (5-Nitro-o-toluidine;

Benzenamine, 2-methyl-5-nitro-)99-55-8 1 3 150 250

TLV-TWA, TEEL-0*3, mouse oral TDlo, rat oral

LD50.


6/19/2009



PAC Rev 24B





1895 Methyl-5-vinylpyridine, 2- 140-76-1 0.35 1 1.9 40

1896 Methyl-8-quinolinol, 2- 826-81-3 10 30 50 250 PNOS default.

1897 Methylal; (Dimethoxymethane) 109-87-5 3,000 6,000 6,000 6,000

1898 Methylamine hydrochloride 593-51-1 3.5 10 60 500 Mouse ip TDlo, rat oral LD50.

1899 Methylamino)ethanol, 2-( 109-83-1 10 30 200 1,000 Rat oral LD50.

1900 Methylaniline, N- 100-61-8 7.5 7.5 10 400

1901 Methylaziridine, 1- 1072-44-2 4 4 4 200 SAR

1902 Methylbutanamide, 3-; (Isovaleramide) 541-46-8 6 20 125 500

1903 Methylbutylamine, N- 110-68-9 7.5 20 150 750 Rat 240 min LC lo.

1904 Methylcellulose 9004-67-5 10 30 50 500

1905 Methylchlorodisilane; (Chloromethyldisilane) 68937-17-7 0.4 1.25 10 50

1906 Methylcholanthrene 3- 56-49-5 0.2 0.6 4 75

1907 Methylcyclohexane 108-87-2 2,000 5,000 5,000 5,000 Concentration limits

1908 Methylcyclohexanone 1331-22-2 7.5 25 150 750

1909Methylcyclohexanone, 2-; (o-

Methylcyclohexanone)583-60-8 350 350 500 2,500


6/19/2009



PAC Rev 24B





1910 Methylcyclopentane 96-37-7 15 40 300 12,500 Rat oral TDlo, Mouse LC lo (120 min assumed)

1911 Methyldecane, 4- 2847-72-5 10 30 50 250 PNOS default.

1912Methyldichloroarsine;

(Dichloromethylarsine)593-89-5 0.053 0.053 0.053 0.16 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

1913 Methylene bis(2-chloroaniline), 4,4'-; (MBOCA) 101-14-4 0.1 0.3 5 500

1914 Methylene bis(4-isocyanatocyclohexane), 1,1'- 5124-30-1 0.05 0.05 0.1 2

1915Methylene chloride;

(Dichloromethane)75-09-2 75 694 1,940 24,000 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1916Methylene diphenyl diisocyanate;

(Diphenylmethane diisocyanate; MDI)101-68-8 0.05 0.2 2 25 TLV-TWA, ERPG-1, ERPG-2, ERPG-3.

1917 Methylene fluoride; (Difluoromethane; HFC-32) 75-10-5 2,000 6,000 100,000 750,000 WEEL-TWA, rat TClo, rat 240 min LC50.

1918Methylenebis(isocyanato-benzene), 1,1'-;

(Diphenyl methane diisocyanate)26447-40-5 5 15 25 125 PEL-TWA as CN.

1919 Methylenebisacrylamide, N,N'- 110-26-9 1.5 5 35 150 Mouse oral TDlo, rat oral LD50

1920 Methylenedianiline, 4,4'- 101-77-9 0.075 0.75 4 150

1921Methylethyl hydroperoxide, 1-; (Isopropyl

hydroperoxide)3031-75-2 0.6 2 12.5 60

1922 Methylformamide, N- 123-39-7 40 125 750 1,000 Rat TClo, rat oral LD50.

1923 Methylfuran, 2- 534-22-5 20 60 150 150

1924 Methylheptane, 2- 592-27-8 10 30 200 1,000 Estimated rat 240 min LC50 from HHR.


6/19/2009



PAC Rev 24B





1925 Methylheptane, 4- 589-53-7 40 125 200 1,000

1926Methylhydrosiloxane (3-4%) + dimethylsiloxane

(96-97%) copolymer68037-59-2 10 30 50 250 PNOS TLV-TWA default used.

1927 Methylimidazole, 1- 616-47-7 6 15 125 500 Mouse oral LD50.

1928 Methylimidazole, 4- 822-36-6 20 60 300 300 Rat oral TDlo, rat oral LD50.

1929Methyllactic acid ethyl ester, 2-; (Ethyl 2-

hydroxyisobutyrate)80-55-7 15 50 400 500

1930Methyllactonitrile 2-; (Acetone

cyanohydrin)75-86-5 5 6.96 24.7 52.2 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3.

1931 Methylmagnesium bromide, 3.0 m in diethyl ether 75-16-1 2 6 40 200 Rat 240 min LC50 based on HR =3.

1932 Methylmagnesium chlordie 676-58-4 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

1933 Methylmercuric dicyanamide 502-39-6 0.0149 0.0447 2.98 2.98

1934 Methylmorpholine, 4- 109-02-4 7.5 25 150 750 Rat 240 min LC lo

1935 Methylnaphthalene, 1- 90-12-0 0.5 20 20 500TLV-TWA, Russ STEL, rabbit skin TDlo, rat oral

LD50.

1936 Methylnaphthalene, 2- 91-57-6 0.5 0.5 3.5 500TLV-TWA, PAC-2/7, rabbit skin TDlo, rat oral

LD50.

1937Methylnitrosopiperidine, 3-; (Piperidine, 3-methyl-

1-nitroso-)13603-07-1 0.3 0.75 6 30

1938 Methylnonane, 4- 17301-94-9 12.5 40 250 1,250 Estimated rat LC50.

1939 Methylpentane, 2-; (Isohexane) 107-83-5 1,500 1,500 1,500 7,500 TLV-TWA, REL-C, REL-C, PAC-2*5.


6/19/2009



PAC Rev 24B





1940 Methylpentane, 3- 96-14-0 1,500 1,500 1,500 7,500 Concentration limits (TLV-TWA, STEL, REL-C.

1941 Methylpentanol-1, 2-; (Amyl methyl alcohol) 105-30-6 1 3 20 600 Human TClo, rat oral LD50.

1942 Methylphenol, 2-; (o-Cresol) 95-48-7 20 20 100 1,000

1943 Methylphenol, 3-; (m-Cresol) 108-39-4 20 20 100 1,000

1944 Methylphenol, 4-; (p-Cresol) 106-44-5 20 20 100 1,000

1945 Methylphenylthiourea, 2-; (o-Tolyl thiourea) 614-78-8 10 30 50 50

1946 Methylphosphonate 993-13-5 10 10 10 10 PNOS default.

1947Methylphosphonothioic acid, S-(2-

(dimethylamino)ethyl) O-ethyl ester20820-80-8 0.0006 0.0015 0.0125 0.06 Human LC50.

1948Methylphosphonothioic acid-O-(4-nitrophenyl)-O-

phenyl ester2665-30-7 1.5 5 8 8

1949Methylphosphonothioic acid-O-ethyl O-(4-

(methylthio)phenyl) ester2703-13-1 2 6 10 10 LOC, rat oral LD lo.

1950 Methylpropane, 2-; (Isobutane) 75-28-5 2,500 7,500 12,500 35,000 TLV-TWA, TEEL-0*3, TEEL-0*5, rat LC50.

1951 Methylpropene, 2-; (Isobutene) 115-11-7 600 1,500 3,000 200,000TLV-TWA, TEEL-0 x 3, TEEL-0 x 5, rat 240 min

LC50.

1952Methylpropylnitrosoamine; (N-Methyl-N-nitroso-1-

propanamine)924-46-9 0.04 0.125 0.75 15

1953 Methylpyridine, 2-; (2-Picoline) 109-06-8 7.5 20 20 1,250 WEEL-TWA, WEEL-STEL, rat oral TDlo, rat LC50

1954 Methylpyrrole, N- 96-54-8 75 250 500 500 Rat oral LD50 based on HHR


6/19/2009



PAC Rev 24B





1955 Methylpyrrolidine; (Methylpyrrolidine, 1-) 120-94-5 0.75 2 15 75 Mouse ip LD50

1956 Methylstyrene, alpha- 98-83-9 250 500 500 3,500 Concentration limits.

1957 Methyltetrahydrofuran, 2- 96-47-9 20 60 400 2,000 Rat LC50

1958 Methyltriacetoxysilane 4253-34-3 7.5 25 150 500

1959Methyltrichlorosilane;

(Trichloromethyl silane)75-79-6 1.25 3.67 37.9 171 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1960 Methyltriethoxysilane 2031-67-6 40 125 750 4,000 Rat 480 min LC lo.

1961 Methyl-trifluoromethanesulfonate 333-27-7 7.2 21.6 36 500

1962 Methyltrimethoxysilane 1185-55-3 50 150 500 500 Rat oral LD50

1963 Methyltrioctylammonium chloride 5137-55-3 0.75 2.5 20 100

1964Methylvinyldichlorosilane;

(Dichloromethylvinylsilane)124-70-9 1.5 5.19 63.4 288 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

1965Methylvinylsiloxane-dimethylsiloxane copolymer,

vinyl terminated68083-18-1 10 30 50 250 PNOS default used.

1966 Metolcarb; (Methylcarbamic acid m-tolyl ester) 1129-41-5 1 3 4.8 200

1967 Mevinphos; (Phosdrin) 7786-34-7 0.1 0.3 4 4 PEL-TWA, REL-STEL, LOC, 1DLH.

1968Mexacarbate; (4-(Dimethylamine)-3,5-xylyl N-

methylcarbamate)315-18-4 2.5 7.5 14 14

1969 Mica; (mica silicates) 12001-26-2 3 9 15 75 TLV-TWA, TEEL-0*3, TEEL-0*5, PAC-2*5.


6/19/2009



PAC Rev 24B





1970Michler's ketone; (4,4'-

bis(dimethylamino)benzophenone)90-94-8 1 3.5 25 40

1971 Mineral fibers, fine z-0032 10 30 50 50

1972Mineral oil, heavy or light; (Paraffin oil; Deobase,

deodorized)8020-83-5 0.2 0.6 500 500

1973Mineral oil, petroleum distillates, heavy

naphthenic64741-53-3 0.2 0.6 100 500 Mouse sk TDlo

1974Mineral oil, petroleum distillates, solvent-refined

(mild) heavy paraffinic64741-88-4 0.2 0.6 1 500 Rat oral LD50

1975Mineral oil, petrolleum distillates, solvent refined

light naphthenic64741-97-5 40 125 500 500 Rat oral LD minimum.

1976 Mineral oil, white 8042-47-5 0.2 0.6 500 500 Used PNOS default

1977 Mineral oil; (Oil mist, mineral) 8012-95-1 5 10 10 500 Conc. limits

1978 Mirex; (Perchloropentacyclodecane) 2385-85-5 0.03 0.075 0.6 100

1979 Mitomycin C 50-07-7 4 12.5 23 23 LOC, rat LD50

1980 Molecular sieve 13X 63231-69-6 7.5 25 150 500 Estimated rat oral LD50 from HHR.

1981 Molybdate orange 12656-85-8 5 15 75 500

1982 Molybdenum 7439-98-7 10 30 50 500 TLV-TWA, TLV-TWA*3, TLV-TWA*5, IDLH.

1983 Molybdenum carbide 12011-97-1 11.3 33.8 56.3 500

1984 Molybdenum dioxide 18868-43-4 6.67 6.67 6.67 500 Mo insol cmpd conc. Limits, mouse sc LD50


6/19/2009



PAC Rev 24B





1985 Molybdenum disilicide 12136-78-6 15.9 47.6 79.3 500 Mo insol cmpd conc. Limits

1986 Molybdenum hexacarbonyl 13939-06-5 27.5 82.6 138 500 TLV-TWA for insoluble Mo compounds.

1987 Molybdenum pentachloride 10241-05-1 14.2 14.2 500 500 Mo soluble concentration limits, rat oral TDlo.

1988 Molybdenum trioxide 1313-27-5 7.5 7.5 7.5 500 Mo insol cmpd conc. limits

1989 Molybdenum(IV) sulfide 1317-33-5 16.7 50.1 83.4 500 Rat oral LD50 > 2 g/kg

1990 Molybdic acid 7782-91-4 8.44 8.44 8.44 500 Mo sol cmpds conc. limits

1991Molybdic acid, ammonium salt; (Ammonium

molibdate)11098-84-3 11.7 11.7 500 500 Mo TLV-TWA, IDLH, as Mo.

1992Molybdic acid, disodium salt; (Disodium

molybdate)7631-95-0 10.7 10.7 10.7 500 Mo sol cmpds conc. limits

1993Molybdic acid, hexaammonium salt; (Ammonium

heptamolybdate)12027-67-7 8.67 8.67 8.67 500 Mo sol cmpds conc. limits

1994 Molybdophosphoric acid 12026-57-2 7.93 7.93 7.93 500 Mo soluble concentration limits.

1995Molybdophosphoric acid hydrate;

(Phosphomolybdic acid hydrate)51429-74-4 8.07 8.07 8.07 500 Mo sol cmpds conc. limits

1996 Monobutyl phosphite 16456-56-7 6 20 150 500 Mo sol cmpds conc. limits

1997 Monochloroamine; (Chloramide) 10599-90-3 0.1 0.35 2 10 PAC-2/21, PAC-2/7, rat oral TDlo, PAC-2 x 5.

1998 Monochloropentafluoroethane; (CFC-115) 76-15-3 6,000 15,000 30,000 2,000,000

1999 Monocrotophos 6923-22-4 0.05 0.15 0.63 25


6/19/2009



PAC Rev 24B





2000 Monomethylamine; (Methylamine) 74-89-5 12.5 19 81.3 444 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

2001Monomethylhydrazine; (Methyl

hydrazine)60-34-4 0.015 0.35 1.7 5.09 TLV-TWA, PEL-C, AEGL-2, AEGL-3.

2002 Monosodium titanate 60704-88-3 10 30 50 250

2003 Montmorillonite 1318-93-0 30 30 30 30 Rat intratracheal TDlo, rat iv LD50.

2004 Morpholine 110-91-8 60 100 100 5,000

2005 Morpholinepropanesulfonic acid, 4- 1132-61-2 1.25 4 25 125 Quail oral LD50 maximum.

2006Morpholino)ethanesulfonic acid monohydrate, 2-

(N-4432-31-9 1.25 4 25 125 Quail oral LD50 minimum.

2007 Muscimol; (5-Aminomethyl-3-isoxyzole) 2763-96-4 3.5 10 17 20 Rat oral LD50, human TDlo

2008Mustard gas sulfoxide; (bis(2-

chloroethyl)sulfoxide)5819-08-9 0.4 1.25 7.5 40 Mouse subcutaneous LD lo.

2009 Myoglobins 9008-45-1 10 30 50 250 PNOS default.

2010Myristic acid, butyl ester; (Tetradecanoic acid,

butyl ester)110-36-1 35 100 600 3,500 Rat oral LD50

2011Myristic acid, isopropyl ester; (Tetradecanoic

acid, isopropyl; Isopropyl myristate)110-27-0 200 500 500 500

2012Nabumetone; (Relafen; 4-(6-methoxy-2-naphthyl)-

2-butanone)42924-53-8 10 30 125 500

2013 Nadic methyl anhydride 25134-21-8 0.75 2 15 75

2014Naphtha (coal tar); (Naphtha [petroleum] light

aliphatic; Aliphatic naphtha)8030-30-6 400 1,500 4,000 4,000 PEL-TWA, PAC-2/7, women oral TDlo, IDLH.


6/19/2009



PAC Rev 24B





2015 Naphtha (petroleum), heavy catalytic cracked 64741-54-4 15 40 300 500 PAC-2/21, PAC-2/7, rat oral TDlo, rat LC lo min.

2016 Naphtha (petroleum), light straight-run 64741-46-4 400 1,500 4,000 4,000 Used Naphtha (coal tar) (8030-30-6) PACs.

2017 Naphtha, heavy aliphatic solvent 64742-96-7 15 40 300 500Used Naphtha (petroleum) heavy catalytic cracked

(64741-54-4) PACs

2018 Naphtha, hydrotreated heavy; (Isopar L-rev 2) 64742-48-9 1,250 3,500 6,000 7,500 OEL-TWA, rat oral LD50 from HHR.

2019 Naphthalenamine, 1-; (1-Naphthylamine) 134-32-7 0.6 1.5 12.5 350

2020 Naphthalene 91-20-3 50 75 75 1,250 PEL-TWA, TLV-STEL, PAC-1, IDLH.

2021 Naphthaleneacetamide, 1- 86-86-2 6 20 150 500

2022 Naphthalenetrisulfonic acid sodium salt, 1,3,6- 19437-42-4 10 30 50 250 PNOS default.

2023 Naphthenic acid, lead salt 61790-14-5 0.0544 0.163 30 109

2024 Naphthol, 1- 90-15-3 25 75 500 500 Rabbit TDlo, rat LD50.

2025 Naphthol, 2- 135-19-3 0.0025 0.0075 0.05 500 Human TClo, rat oral LD50.

2026 Naphthol-8-sulfonic acid, sodium salt, 2- 832-85-9 2 6 40 200 PNOS default. Mouse oral LD lo.

2027 Naphthoquinone, 1,4- 130-15-4 0.075 0.25 1.5 75

2028 Naphthylamine, beta- 91-59-8 1.5 5 35 300

2029 Naphthylthiourea, alpha-; (ANTU) 86-88-4 0.3 0.9 10 100


6/19/2009



PAC Rev 24B





2030 Neatsfoot oil; (Fats and glyceridic oils) 8002-64-0 10 30 50 250 PNOS default used.

2031 Neodecanoic acid 26896-20-8 12.5 40 300 500

2032 Neodymium 7440-00-8 0.0008 0.0025 0.02 0.1 Human intracerebral TDlo.

2033 Neodymium bromide 13536-80-6 10 30 50 250

2034 Neodymium fluoride 13709-42-7 8.83 26.5 44.1 500

2035 Neodymium hydroxide 16469-17-3 0.75 0.75 2 75 SAR

2036 Neodymium nitrate 10045-95-1 7.5 25 150 500

2037 Neodymium nitrate, pentahydrate 14517-29-4 10 30 50 250 PNOS default.

2038 Neodymium nitrite z-0033 0.04 0.1 0.75 75 SAR

2039 Neodymium(III) chloride 10024-93-8 0.6 1.5 12.5 60PAC-3/105, PAC-3/35, PAC-3/5, rat intraperitoneal

LD50.

2040 Neodymium(III) oxide 1313-97-9 10 30 50 500 Rat oral LD50

2041 Neon 7440-01-9 50,000 50,000 150,000 300,000 Simple asphyxiant

2042 Nickel 7440-02-0 1 4.5 10 10 Nickel concentration limits.

2043 Nickel acetate tetrahydrate 6018-89-9 4.24 4.24 4.24 42.4 Ni PEL-TWA, IDLH

2044 Nickel aluminide 12003-78-0 1.36 1.36 1.36 13.6 Ni compound concentration limits.


6/19/2009



PAC Rev 24B





2045Nickel carbonate hydroxide; (Basic nickel

carbonate tetrahydrate)39430-27-8 2.14 2.14 4 21.4 Nickel concentration limits.

2046Nickel carbonate hydroxide; (Basic nickel(II)

carbonate)12607-70-4 1.73 1.73 1.73 17.3 Nickel concentration limits.

2047 Nickel carbonyl 13463-39-3 0.006 0.251 0.251 1.12 PEL-TWA, AEGL-2, AEGL-2, AEGL-3.

2048 Nickel chloride; (Nickelous chloride) 7718-54-9 2.21 2.21 2.21 22.1 Nickel concentration limits.

2049 Nickel cyanide 557-19-7 0.377 1.13 9.44 18.9 Nickel concentration limits.

2050 Nickel fluoride 13940-83-5 2.88 2.88 3 28.8 Ni insoluble concentration limits.

2051 Nickel formate 3349-06-2 3.15 3.15 6 31.5 Nickel concentration limits.

2052 Nickel oxalate (liquids) 6018-94-6a 2.5 2.5 2.5 25 Nickel concentration limits.

2053 Nickel oxalate (solids) 6018-94-6b 2.5 2.5 2.5 25 Nickel concentration limits.

2054 Nickel oxide; (Nickel(II) oxide) 1313-99-1 1.27 1.27 12.7 12.7 Nickel concentration limits.

2055 Nickel perchlorate 13637-71-3 6.23 6.23 6.23 62.3 Ni insoluble PEL-TWA, IDLH.

2056 Nickel sulfamate; (Nickel(II) sulfamate) 13770-89-3 4.27 4.27 4.27 200 Nickel concentration limits.

2057Nickel sulfate hexahydrate; (Nickel(II) sulfate

hexahydrate)10101-97-0 4.48 4.48 10 44.8 Nickel concentration limits.

2058 Nickel sulfate; (Nickel(II) sulfate) 7786-81-4 2.64 2.64 2.64 26.4 Nickel concentration limits.

2059 Nickel(2+) stearate 2223-95-2 10.7 32 53.3 107 Ni compound concentration limits.


6/19/2009



PAC Rev 24B





2060 Nickel(II) bromide 13462-88-9 3.72 3.72 3.72 37.2 Nickel concentration limits.

2061 Nickel(II) carbonate (1:1) 3333-67-3 2.02 2.02 2.02 20.2 Ni concentration limits.

2062 Nickel(II) chloride hexahydrate 7791-20-0 4.05 4.05 40.5 40.5 Nickel concentration limits.

2063 Nickel(II) hydroxide; (Nickelous hydroxide) 12054-48-7 1.58 1.58 1.58 15.8 Nickel concentration limits.

2064 Nickel(II) nitrate hexahydrate 13478-00-7 4.96 4.96 49.6 49.6 Nickel concentration limits.

2065 Nickel(II) nitrate; (Nickelous nitrate) 13138-45-9 3.11 3.11 12.5 31.1 Nickel concentration limits.

2066 Nickel(II) nitrite 17861-62-0 1 1 1 10 Nickel concentration limits.

2067 Nickel(II) phosphate 10381-36-9 1 1 1 10 Nickel concentration limits.

2068 Nickel(III) hydroxide; (Nickelic hydroxide) 12125-56-3 1.87 1.87 1.87 18.7 Nickel concentration limits.

2069 Nicotinamide 98-92-0 6 20 150 500 Mouse ip TDlo, rat oral LD50.

2070 Nicotine sulfate 65-30-5 4 9 9 9

2071 Nicotine, dl-beta-; (DL-Nicotine) 22083-74-5 1.29 3.5 3.5 75

2072Nicotine; (Pyridine, (S)-3-(1-methyl-2-pyrrolidinyl)-

)54-11-5 0.5 1.5 3.5 5

2073 Nicotinic acid; (Niacin) 59-67-6 0.75 2.5 15 500 Human oral TDlo, rat oral LD50.

2074 Niobium 7440-03-1 40 125 500 500


6/19/2009



PAC Rev 24B





2075 Niobium chloride 10026-12-7 6 15 125 500

2076 Niobium pentoxide; (Niobium(V) oxide) 1313-96-8 10 30 200 500 Rat it TDlo, mouse oral LD50.

2077 Niobium(IV) carbide 12069-94-2 11.3 33.9 56.5 250 PNOS default used.

2078 Nitrapyrin; (2-Chloro-6-(trichloromethyl)pyridine) 1929-82-4 15 20 20 400PEL-TWA, TLV-STEL, rabbit oral TDlo, rat oral

LD50.

2079 Nitrate(s) 14797-55-8 10 30 50 250

2080 Nitric acid 7697-37-2 1.37 1.37 61.8 237 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2081 Nitric acid, butyl ester; (Butyl nitrate) 928-45-0 10 30 50 250 PNOS default.

2082 Nitric acid, ethyl ester; (Ethyl nitrate) 625-58-1 1.25 3.5 25 125 Cat ip LD50.

2083 Nitric acid, pentyl ester; (Amyl nitrate) 1002-16-0 125 400 2,500 12,500 Mouse 420 min LC lo.

2084 Nitric oxide 10102-43-9 0.613 0.613 14.7 24.5 N.O2 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2085Nitrilotriacetic acid, disodium salt; (Disodium

nitrilotriacetate)15467-20-6 6 15 125 500 Rat oral LD50.

2086 Nitrilotriacetic acid, trisodium salt, monohydrate 18662-53-8 0.06 0.2 1.25 500 Rat oral TDlo, rat oral LD50.

2087 Nitrilotriacetic acid; (Aminotriacetic acid) 139-13-9 35 100 500 500

2088Nitrilotris tri-phosphonic acid; (Amino,

tris[methylene phosphonic acid])6419-19-8 10 10 35 500 WEEL-TWA, rat oral TDlo, rat oral LD50

2089 Nitroaniline, 2-; (o-Nitroaniline) 88-74-4 6 20 125 500 Rat 4 hr LC50


6/19/2009



PAC Rev 24B





2090 Nitroaniline, 3-; (m-Nitroaniline) 99-09-2 0.6 1.5 12.5 200

2091 Nitroaniline, p- 100-01-6 6 9 300 300

2092 Nitrobenzene 98-95-3 5 15 100 1,000

2093 Nitrobenzenesulfonic acid, sodium salt, 3- 127-68-4 40 125 500 500 Rat oral LD50.

2094 Nitrobiphenyl, 4-; (p-Nitrobiphenyl) 92-93-3 0.25 0.75 5 500

2095Nitrochlorobenzene, m-; (1-Chloro-3-

nitrobenzene; m-chloronitrobenzene)121-73-3 0.06 0.2 1.25 150 Rat TClo, rat oral LD50.

2096 Nitrocyclohexane 1122-60-7 0.3 0.75 1.5 60

2097 Nitrocyclohexene, 1-; (1-Nitrocyclohex-1-ene) 2562-37-0 1.5 5 40 200 SAR

2098 Nitrodiphenylamine, 2- 119-75-5 30 100 500 500

2099 Nitroethane 79-24-3 300 300 600 3,000

2100 Nitrogen dioxide 10102-44-0 0.94 0.94 22.6 37.6 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2101 Nitrogen mustard hydrochloride 55-86-7 0.75 2.5 4 4

2102Nitrogen mustard; (Bis(b-

chloroethyl)methylamine)51-75-2 0.001 0.003 0.022 0.37 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

2103 Nitrogen tetroxide 10544-72-6 10 15 15 75

2104 Nitrogen trifluoride 7783-54-2 30 150 1,160 2,320 PEL-TWA, ERPG-2/7, ERPG-2, ERPG-3.


6/19/2009



PAC Rev 24B





2105 Nitrogen trioxide; (Dinitrogen trioxide) 10544-73-7 75 150 300 1,500

2106 Nitroglycerin 55-63-0 0.1 0.1 2 75

2107 Nitromethane 75-52-5 50 150 250 1,500 TLV-TWA, IDLH.

2108 Nitromethane-d3; (Trideuteronitromethane) 13031-32-8 50 150 250 2,000 TLV-TWA, IDLH of Nitromethane, 75-52-5.

2109 Nitro-m-xylene, 2-; (1,3-Dimethyl-2-nitrobenzene) 81-20-9 10 30 200 500 Rat oral LD50.

2110 Nitronium Tetrafluoroborate 13826-86-3 4.37 13.1 21.8 150 Fluoride PEL-TWA, mouse iv LD50.

2111 Nitrophenol (mixed isomers) 25154-55-6 0.75 2.5 15 75 4-Nitrophenol PACs used.

2112 Nitrophenol, 2-; (o-Nitrophenol) 88-75-5 1.25 4 30 150 Rat oral LD50

2113 Nitrophenol, 3-; (m-Nitrophenol) 554-84-7 1.25 4 30 150 Rat oral LD50

2114 Nitrophenol, 4-; (p-Nitrophenol) 100-02-7 0.75 2.5 15 75 Rat oral LD50

2115 Nitropropane, 1- 108-03-2 75 75 75 3,500

2116 Nitropropane, 2- 79-46-9 75 100 150 350

2117 Nitropyrene, 1- 5522-43-0 0.1 0.3 2 10

2118Nitropyridine-N-oxide, 4-; (Pyridine, 4-nitro, 1-

oxide)1124-33-0 15 50 80 80

2119 Nitrosodimethylamine 62-75-9 3.5 10 19 19


6/19/2009



PAC Rev 24B





2120 Nitrosodiphenylamine, p- 156-10-5 0.1 0.3 2 150

2121 Nitrosodipropylamine; (DPNA) 621-64-7 0.06 0.2 1.25 200

2122 Nitrosomorpholine 59-89-2 12.5 30 30 30

2123 Nitroso-N-methylurea, N- 684-93-5 0.015 0.05 0.35 50

2124 Nitrosophenol, p- 104-91-6 2 6 40 200

2125 Nitrosotoluene, 2-: (o-Nitrosotoluene) 611-23-4 7.5 25 150 500 Rat oral TDlo.

2126 Nitrosyl chloride 2696-92-6 0.06 0.2 1.25 6

2127 Nitrosylsulfuric acid 7782-78-7 1.5 5 35 150 Rat LD50 based on HHR = 3.

2128 Nitrotoluene, m- 99-08-1 25 35 50 1,000

2129 Nitrotoluene, o- 88-72-2 25 35 50 1,000 PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH.

2130 Nitrotoluene, p- 99-99-0 25 35 50 1,000

2131 Nitrous acid 7782-77-6 1 3 15 200 Used HNO3 limits

2132 Nitrous oxide 10024-97-2 75 250 15,000 35,000

2133 Nonacosane 630-03-5 10 30 50 250

2134 Nonanal 124-19-6 2 6 40 500


6/19/2009



PAC Rev 24B





2135 Nonane; (Shellsol 140) 111-84-2 1,000 3,000 5,000 7,500

2136 Nonanenitrile; (1-Octyl cyanide) 2243-27-8 150 150 150 750 Used PEL-TWA for cyanides

2137 Nonanoic acid 112-05-0 25 75 500 500 Rat oral LD lo.

2138 Nonanone, 2- 821-55-6 6 15 125 500 Rat LClo > 3980 mg/m3

2139 Nonene, 1- 124-11-8 2.5 7.5 50 250 Estimated rat LC50.

2140 Nonoxynol-4 7311-27-5 10 30 50 250

2141 Nonyl alcohol 143-08-8 25 75 500 500 Rat 240 min TClo, mouse 120 min LC50.

2142 Nonyl phenol (mixed isomers) 25154-52-3 6 20 125 500

2143 Nonyl phenol, 4- (branched) 84852-15-3 5 15 100 500

2144 Nonyl phenol, p- 104-40-5 6 20 125 500

2145 Nonylphenol, 4-, branched, ethoxylated 127087-87-0 10 30 200 500

2146 Nonylphenoxypolyethoxyethanol 68412-54-4 10 30 50 250

2147 Nonyltrichlorosilane 5283-67-0 2 6.42 78.1 353 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2148 Norbormide 991-42-4 0.75 2 3.8 3.8

2149 Norchlorofluoroepibatidine z-0034 0. 0.0001 0.0008 0.0013


6/19/2009



PAC Rev 24B





2150Octachlorodibenzodioxin, 1,2,3,4,6,7,8,9-;

(OCDD, Octachlorodibenzo-p-dioxin)3268-87-9 0.004 0.01 0.075 0.4

2151 Octachlorodibenzofuran, 1,2,3,4,6,7,8,9- 39001-02-0 0.003 0.0075 0.06 10

2152 Octachloronaphthalene 2234-13-1 0.1 0.3 0.5 1 Concentration limits.

2153 Octacosane 630-02-4 350 350 1,500 7,500 NIOSH concentration limits for alkanes.

2154 Octadecane, n- 593-45-3 350 350 1,500 7,500 NIOSH concentration limits for alkanes.

2155 Octadecanoic acid, n-; (Stearic acid) 57-11-4 60 150 500 500 Rat oral TDlo, rat oral LD50.

2156 Octadecanol, 1- 112-92-5 25 75 600 7,500

2157 Octadecenoic acid, 9-; (Oleic acid) 112-80-1 0.015 0.05 0.4 500 Rat oral LD50

2158 Octadecyl methacrylate 32360-05-7 10 30 50 250 PNOS default.

2159 Octadecyltrichlorosilane 112-04-9 3 9.51 116 523 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2160Octafluorocyclobutane; (Cyclooctafluorobutane;

Freon C-318)115-25-3 200,000 600,000 2,500,000 2,500,000 Mouse TClo, mouse 120 min LC lo.

2161 Octamethylcyclotetrasiloxane 556-67-2 150 400 3,000 4,000 Rat 240M LC50, rat TClo

2162Octamethyldiphosphoramide;

(Octamethylpyrophosphoramide) 152-16-9 0.15 0.5 0.8 3.5

2163 Octanal, 1-; (Octanal; Octanaldehyde) 124-13-0 20 60 500 500

2164 Octanamine, 1- 111-86-4 0.4 1.25 7.5 40 Rat oral LD lo


6/19/2009



PAC Rev 24B





2165 Octane, n- 111-65-9 1,250 1,250 1,500 4,000

2166 Octanedione, 2,5- 3214-41-3 20 60 500 500 Estimated LC50.

2167 Octanenitrile 124-12-9 7.5 20 150 750

2168 Octanethiol, 1- 111-88-6 0.15 0.4 3 750 REL-C, rat oral LD50

2169 Octanoic acid; (Caprylic acid) 124-07-2 40 125 500 500 Rat oral LD50

2170 Octanol, 2- 123-96-6 12.5 35 250 350PAC-2/21, PAC-2/7, rat 120 min TClo, human oral

LD lo.

2171 Octanone, 2- 111-13-7 60 200 200 500

2172 Octaphenylcyclotetrasiloxane 546-56-5 20 60 400 500 Rat oral LD50 minimum.

2173 Octene, 1- 111-66-0 183 183 3,670 9,170 ERPG-1, ERPGs-1, ERPG-2, ERPG-3.

2174 Octyl alcohol; (n-octanol) 111-87-5 50 50 50 350 WEEL-TWA, human TClo, human LD lo.

2175Octyl(phenyl)-N,N-

diisobutylcarbamoylmethylphosphine oxide83242-95-9 10 30 50 250

2176 Octyltrichlorosilane 5283-66-9 2 6.05 73.6 333 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2177 Oil gas; (Oil fog) z-0035 200 750 1,500 2,000

2178 Oleum; (fuming sulfuric acid) 8014-95-7 0.2 0.20 8.7 160 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2179 Organorhodium complex z-0036 0.292 8.75 15 500


6/19/2009



PAC Rev 24B





2180Orthoformic acid, trimethyl ester; (Trimethyl

orthoformate)149-73-5 0.4 1.25 7.5 40 Rat LC50 assumed.

2181 Osmium 7440-04-2 0.25 0.75 6 30 Dog intravenous LD lo.

2182 Osmium tetroxide 20816-12-0 0.002 0.006 0.0873 41.6 PEL-TWA, TLV-STEL, AEGL-2, AEGL-3.

2183Otto Fuel (mainly Propylene glycol

dinitrate 6423-43-4)

106602-80-

60.4 1.18 6.95 90.3 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3

2184 Ouabain 630-60-4 1.5 5 8.3 12.5

2185 Oxalic acid dihydrate 6153-56-6 1 2 100 500 PEL-TWA, TLV-STEL, PAC-3/5, IDLH.

2186 Oxalic acid, anhydrous; (Ethanedioic acid) 144-62-7 1 2 40 500 PEL-TWA, TLV-STEL, rat ip TDlo, IDLH.

2187 Oxalyl chlorine 79-37-8 10 30 200 1,000 Rat 60 min LC50.

2188 Oxamide 471-46-5 1.5 5 40 200

2189 Oxamyl 23135-22-0 0.35 1 1.7 15

2190 Oxathiane, 1,4- 15980-15-1 15 50 350 1,500

2191 Oxirane, ethenyl-; (3,4-Epoxy-1-butene) 930-22-3 10 30 75 75

2192 Oxone, monopersulfate compound 37222-66-5 10 30 50 250 PNOS default.

2193Oxybis(n,n-dimethylethanamine), 2,2'-; (Bis(2-

dimethylaminoethyl) ether; DMAEE)3033-62-3 0.3 1 100 100 TLV-TWA, TLV-STEL, rat TClo, rat 360 min LC50.

2194 Oxydiacetic acid; (Oxodiacetic acid) 110-99-6 2 6 40 200


6/19/2009



PAC Rev 24B





2195 Oxydiethylenedicarbonic acid, diallyl ester 142-22-3 3 10 60 125 Rabbit skin 6-18 day preg. TDlo, rat LC50.

2196Oxydiphenoxarsine, 10,10’-; (Phenoxyarsine

oxide)58-36-6 1.68 2 14 14 PEL-TWA, LOC, guinea pig LC lo.

2197 Oxydisulfoton 2497-07-6 0.6 2 3.5 3.5

2198 Oxygen (liquid) 7782-44-7 TEELs withdrawn.

2199Oxygen difluoride; (Fluorine

monoxide)7783-41-7 0.1 0.25 1.83 5.52 PEL-TWA, AEGL-2/7, AEGL-2, AEGL-3.

2200 Ozone 10028-15-6 0.2 0.3 2 10 PEL-TWA, PAC-2/7, EEGL, IDLH.

2201 Palladium 7440-05-3 10 30 50 200

2202 Palladium chloride 7647-10-1 0.15 0.4 3 500

2203 Palladium hydroxide 12135-22-7 0.125 0.3 2.5 75 SAR

2204

Paraffin waxes, petroleum, clay-treated, reaction

products with petroleum white mineral oil, stearic

acid and triethanolamine

71808-29-2 10 30 50 250 Used PNOS default

2205 Paraffin, n- 8002-74-2 2 15 15 500

2206 Paraffins, petroleum, normal C5-C20 64771-72-8 2,000 2,000 2,000 2,000

2207 Paraformaldehyde 30525-89-4 4 12.5 75 100

2208 Paraldehyde 123-63-7 10 30 50 500

2209 Paraquat 4685-14-7 0.15 0.2 1.5 150 LOC, PAC-2/7, rat ip TDlo, human oral LD lo.


6/19/2009



PAC Rev 24B





2210 Paraquat dichloride 1910-42-5 0.5 0.5 0.5 1 PEL-TWA, TEEL-0, TEEL-0, IDLH.

2211Paraquat methosulfate; (Paraquat dimethyl

sulphate)2074-50-2 0.75 2 15 40

2212 Parathion 56-38-2 0.1 0.15 2 10 PEL-TWA, TLV-TWA*3, LOC, IDLH.

2213 Paris Green; (Cupric acetoarsenite) 12002-03-8 1.13 3.38 22 22

2214 Particulate material (PNOS) z-0037 10 30 50 250 Used PNOS default

2215 PBX (mixture of HMX and nitrocellulose) z-0038 0.24 0.6 5 500 Assumed 25% HMX & 75% CTN mixture

2216 Pentaborane 19624-22-7 0.0125 0.04 0.361 1.81 PEL-TWA, TLV-STEL, AEGL-2, AEGL-3.

2217 Pentachlorobenzene 608-93-5 10 30 150 400

2218 Pentachlorodibenzofuran, 1,2,3,7,8- 57117-41-6 0.0025 0.0075 0.06 0.3

2219 Pentachlorodibenzofuran, 2,3,4,7,8- 57117-31-4 0. 0.0001 0.0006 0.4

2220 Pentachlorodibenzo-p-dioxin, 1,2,3,7,8- 40321-76-4 0.0008 0.0025 0.015 0.075

2221 Pentachloroethane 76-01-7 10 30 500 500

2222 Pentachloronitrobenzene 82-68-8 0.5 1.5 300 500

2223 Pentachlorophenol 87-86-5 0.5 2.5 2.5 2.5

2224 Pentadecafluorooctanoic acid 335-67-1 4 12.5 75 75 Rat ip TDlo and LD50.


6/19/2009



PAC Rev 24B





2225 Pentadecane 629-62-9 30 75 600 3,000 Mouse intravenous LD50.

2226 Pentadecanoic acid 1002-84-2 0.4 1.25 7.5 40

2227 Pentadecylamine 2570-26-5 0.1 0.3 2 100

2228 Pentaerythritol 115-77-5 15 30 50 500

2229

Pentaerythritol tetra(3-mercaptopropionate),

reaction products with 2-(hydroxymethyl)-2-((3-

mercapto-1-oxopropoxy)methyl)-1,3-propanediyl

bis(3-mercaptopropanoate) and 1-octene

95823-35-1 10 30 50 250 PNOS default used.

2230 Pentaerythritol tetranitrate 78-11-5 0.015 0.05 0.35 500

2231 Pentafluorobenzoic acid 602-94-8 0.75 2 15 75 Mouse intraperitoneal LD50.

2232 Pentafluoropropane, 1,1,1,3,3- 460-73-1 1,500 5,000 300,000 300,000 WEEL-TWA, rat TClo, mouse 120 min LC lo.

2233 Pentane, n- 109-66-0 1,500 1,500 1,500 4,000

2234 Pentanediol, 1,5- 111-29-5 7.5 25 150 500 Rat oral LD50

2235 Pentanedione, 2,4-; (Acetylacetone) 123-54-6 60 200 400 400

2236 Pentanenitrile 110-59-8 5 15 75 75

2237Pentanol, 2-; (sec-amyl alcohol; Methyl propyl

carbinol; Isoamyl alcohol, secondary)6032-29-7 350 400 400 1,500

Concentration limits for isoamyl alcohol,

secondary.

2238 Pentanone, 2-; (Methyl propyl ketone) 107-87-9 500 500 500 5,000 PEL-TWA, TLV-STEL, human TClo, IDLH.


6/19/2009



PAC Rev 24B





2239 Pentanone, 3-; (Diethyl ketone) 96-22-0 600 1,000 1,000 3,000 TLV-TWA, TWA-STEL, rat LClo

2240 Pentatriacontane 630-07-9 10 30 50 250

2241 Pentene, 1- 109-67-1 750 2,500 15,000 200,000 Human TClo. Rat 240 min LC50.

2242 Pentobarbital sodium; (Nembutal sodium) 57-33-0 0.15 0.5 3.5 50

2243 Pentyl alcohol, tert-; (tert-Amyl alcohol) 75-85-4 200 400 400 400 Human LD lo, rat TClo

2244 Peptone; (Hydrolized protein, Tryptones) 73049-73-7 10 30 50 250

2245 Peracetic acid 79-21-0 0.15 0.52 1.60 15 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2246 Perboric acid, sodium salt 7632-04-4 0.5 1.5 10 500 Rat TClo, mouse LD50.

2247 Perchloric acid 7601-90-3 4 12.5 100 500

2248 Perchloric acid, zinc salt, hexahydrate 10025-64-6 0.6 1.5 12.5 60 Mouse ip LD lo.

2249Perchloroethylene;

(Tetrachloroethylene)127-18-4 150 237 1,560 8,130 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

2250 Perchloromethyl mercaptan 594-42-3 0.0988 0.0988 2.28 6.84 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2251 Perchloryl fluoride; (Chlorine oxyfluoride) 7616-94-6 12.5 25 75 400 PEL-TWA, TLV-STEL, IDLH/5, IDLH.

2252 Percoll 65455-52-9 10 30 50 250 PNOS default

2253Perfluoro compounds, C5-C18; (Fluorinert

electronic liquid perfluoro compounds)86508-42-1 2,500 7,500 60,000 350,000 Rat TClo, rat 360 min LC lo minimum.


6/19/2009



PAC Rev 24B





2254

Perfluoroalkylether polymer; (Capped

homopolymers of hexafluoropropylene epoxide,

Fluorine End-)

60164-51-4 75 250 500 500 Rat oral LD50 based on HHR = 1.

2255Perfluoroisobutylene; (Octafluoro-sec-

butene)382-21-8 0.04 0.1 0.82 2.5 ERPG-2/21, ERPG-2/7, ERPG-2, ERPG-3.

2256

Perfluoropolyether; (1,1,2,3,3,3-hexafluoro-1-

propene, oxidized, polymerized; Vacuum pump

oil)

69991-67-9 10 30 200 500 Estimated LC50.

2257 Periodic acid 10450-60-9 0.18 0.18 0.5 5

2258 Periodic acid, sodium salt 7790-28-5 0.25 0.75 5 25 Mouse ip LD50.

2259 Perlite; (Fused NaKAl silicate, < 1% quartz) 93763-70-3 15 45 75 500PEL-TWA, TEEL-0*3, TEEL-0*5, mouse oral

LD50.

2260 Permafluor E+ z-0039 100 150 500 500

2261 Permafluor-V (85+% toluene) z-0040 150 500 1,000 1,500

2262 Peroxydicarbonic acid, disodium salt 3313-92-6 7.5 25 150 500

2263 Petrolatum 8009-03-8 15 50 350 500 Rabbit skin TDlo, mouse ip LD50 maximum.

2264 Petroleum 50 thinner; (Paint thinner) z-0041 40 125 750 4,000

2265 Petroleum asphalt 8052-42-4b 1.25 4 25 125 Rat 24W im TDlo

2266 Petroleum coke, calcined 64743-05-1 10 30 50 500 PNOS default, IDLH.

2267 Petroleum distillate 8002-05-9a 350 350 500 500 REL-TWA, TEEL-0, REL-C, IDLH.


6/19/2009



PAC Rev 24B





2268 Petroleum distillates, clay-treated light naphthenic 64742-45-6 20 60 400 500

2269 Petroleum distillates, low boiling 68477-31-6 350 350 500 500 REL-TWA, TEEL-0, REL-C, IDLH.

2270Petroleum mineral oil; (Extracts, petroleum,

middle distillate solvent)64742-06-9 10 30 500 500

2271 Petroleum spirits; (Mineral spirits; Soltrol) 64475-85-0 75 250 1,500 7,500

2272 Petroleum spirits; (VM & P Naphtha) 8032-32-4 1,250 1,250 1,500 1,500

2273 Petroleum; (Petroleum crude oil) 8002-05-9b 350 500 500 500 REL-TWA, TEEL-0, REL-C, IDLH.

2274 Phenacetin; (p-acetophenetidide) 62-44-2 10 30 50 60

2275Phenaglycodol; (Ultran; 2-p-chlorophenyl-3-

methyl-2,3-butanediol)79-93-6 10 30 50 350

2276 Phenanthrene 85-01-8 0.4 1 7.5 300

2277 Phenanthroline ferrous sulfate, 1,10- 14634-91-4 10 30 50 250

2278 Phenanthroline, 1,10- 66-71-7 0.1 0.3 2 30 Mouse ip 8D preg TDlo, mouse ip LD50.

2279 Phenol 108-95-2 20 57.7 88.5 769 PEL-TWA, AEGL-1, AEGL-2, ERPG-3.

2280 Phenol red, sodium salt 34487-61-1 7.5 25 150 500 Rat LD50 estimated from HHR = 2.

2281Phenol, polymer with formaldehyde,

oxiranylmethyl ether28064-14-4 15 50 350 500 Rat oral LD50 minimum ex MSDS.

2282 Phenolphthalein 77-09-8 0.75 2.5 15 400


6/19/2009



PAC Rev 24B





2283 Phenoxyethanol, 2-; (Phenyl cellosolve) 122-99-6 100 100 100 500 MAK-TWA, rat TClo, rat LD50.

2284Phenyl Chloroformate;

(Carbonochloridic acid, phenyl ester)1885-14-9 0.06 0.15 1.22 3.65 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

2285Phenyl dichloroarsine;

(Dichlorophenylarsine)696-28-6 0.061 0.061 0.061 0.18 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

2286 Phenyl ether; (Diphenyl ether) 101-84-8 6 12.5 125 600

2287 Phenyl isocyanate. 103-71-9 0.3 0.75 2 2 Rat TClo, rat LC50.

2288 Phenyl sepharose cl-4b 69106-59-8 10 30 50 250 PNOS default used.

2289 Phenyl-1,2-propanedione, 1- 579-07-7 2.5 7.5 50 250

2290 Phenyl-2-oxzaoline, 2- 7127-19-7 6 15 30 150 TLV-TWA based on other phenyl compounds.

2291 Phenyl-2-propanol, 2-; (Dimethylphenylmethanol) 617-94-7 5 15 100 500

2292 Phenylacetylene; (Ethynylbenzene) 536-74-3 40 100 500 500 Rat oral LD50.

2293 Phenylazo)aniline, p-( 60-09-3 0.6 2 12.5 75

2294 Phenylboric acid; (Benzeneboronic acid) 98-80-6 3 7.5 60 300

2295 Phenylcyclohexane; (Cyclohexylbenzene) 827-52-1 40 125 500 500 Rat oral LD lo.

2296 Phenylene diisocyanate, 1,4- 104-49-4 3.5 10 35 35


6/19/2009



PAC Rev 24B





2297 Phenylenediamine dihydrochloride, 1,2- 615-28-1 10 30 125 125

2298 Phenylenediamine dihydrochloride, 1,4- 624-18-0 0.6 1.5 12.5 60

2299 Phenylenediamine, 1,2-; (o-Phenylenediamine) 95-54-5 0.1 0.3 200 500

2300 Phenylenediamine, 1,3-; (m-Phenylenediamine) 108-45-2 0.1 0.3 10 125

2301 Phenylenediamine, p- 106-50-3 0.1 0.6 4 25

2302 Phenylhydrazine 100-63-0 0.4 1.25 2 60 Conc. limits

2303 Phenylhydrazine hydrochloride 59-88-1 50 150 250 250

2304 Phenylmagnesium bromide 100-58-3 1.5 5 35 150 Estimated rat oral LD50 based on HHR.

2305 Phenylmercury acetate; (Acetoxyphenylmercury) 62-38-4 0.168 16.8 16.8 16.8 TLV-TWA, TEEL-0, PEL-C, IDLH.

2306 Phenylphenol, 2- 90-43-7 25 75 500 500

2307 Phenylphosphine 638-21-1 0.04 0.125 0.2 75

2308Phenylpropanolamine hydrochloride; (Propadrine

hydrochloride)154-41-6 0.06 0.15 1.25 500 Human oral TDlo, rat oral LD50.

2309 Phenylsilatrane 2097-19-0 0.2 0.6 1 1

2310 Phenylthiourea; (1-phenyl-2-thiourea) 103-85-5 3 3 3 3

2311 Phenyltriethoxysilane 780-69-8 10 35 250 500 Rat oral LD50


6/19/2009



PAC Rev 24B





2312 Phenyltrimethoxysilane 2996-92-1 1.5 4 30 150 Mouse iv LD50

2313 Phenylxylylethane; (PXE) 6196-95-8 10 30 50 250

2314 Phloroglucinol dihydrate 6099-90-7 4 12.5 75 400 Mouse ip LD lo minimum.

2315 Phorate 298-02-2 0.05 0.1 0.6 0.6

2316 Phosacetim 4104-14-7 0.75 2 3.7 3.7

2317 Phosfolan 947-02-4 1.5 5 9 9

2318 Phosgene 75-44-5 0.4 0.4 1.21 3.03 PEL-TWA, PEL-TWA, AEGL-2, AEGL-3

2319 Phosmet 732-11-6 0.025 0.075 0.54 40

2320 Phosphamidon; (Famfos) 13171-21-6 0.06 0.15 0.3 60

2321 Phosphine 7803-51-2 0.4 1.25 2.78 5 PEL-TWA, TLV-STEL, AEGL-2, AEGL-3.

2322 Phosphomolybdic acid 11104-88-4 16.7 50 83.3 400 Mo TLV-TWA concentration limit.

2323 Phosphonic acid 13598-36-2 2 6 50 500 Rat oral TDlo, rat oral LD50.

2324 Phosphonic acid, dioctadecyl ester 19047-85-9 0.02 0.06 0.4 2 SAR

2325 Phosphonic acid, tridodecyl ester 3076-63-9 12.5 40 250 500 Rat oral LD lo

2326 Phosphoric acid 7664-38-2 1 3 500 500


6/19/2009



PAC Rev 24B





2327Phosphoric acid, dimethyl-p-(methylthio)phenyl

ester3254-63-5 1.25 4 7 7

2328 Phosphorous acid, o-; (Phosphonic acid) 10294-56-1 1 3 200 500Phosphoric acid (7664-38-2) concentraqtion limits

used.

2329 Phosphorous pentafluoride 7647-19-0 3 7.5 60 300

2330 Phosphorous trifluoride 7783-55-3 4 10 75 400

2331 Phosphorus (red) 7723-14-0 0.04 0.125 0.75 4 Rat oral TDlo, human LD lo.

2332 Phosphorus (yellow); (White phosphorus) 12185-10-3 0.1 0.4 3 5 PEL-TWA, LOC, IDLH.

2333 Phosphorus oxychloride 10025-87-3 0.6 3 3 5.33 TLV-TWA, LOC, LOC, AEGL-3.

2334 Phosphorus pentachloride 10026-13-8 1 2 12.5 70

2335 Phosphorus pentasulfide 1314-80-3 1 3 50 250

2336 Phosphorus pentoxide 1314-56-3 1 1 10 50 MAK-TWA, ERPG-1, ERPG-2, ERPG-3.

2337 Phosphorus trichloride 7719-12-2 1.91 1.91 11.2 31.4 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2338 Phosphorus trioxide 1314-24-5 0.4 1.25 7.5 40 Estimated rat 240 min LC50

2339 Phthalic acid 88-99-3 0.02 0.06 0.5 500

2340Phthalic acid, benzyl butyl ester; (Benzyl butyl

phthalate)85-68-7 5 15 500 500 UK OEL-TWA, rat TClo, rat oral LD50.

2341 Phthalic anhydride 85-44-9 12 12 40 60


6/19/2009



PAC Rev 24B





2342 Phthaloyl dichloride; (Phthaloyl chloride) 88-95-9 0.75 2.5 15 75 Rat 240 min LC50 based on HHR = 3

2343 Physostigmine 57-47-6 0.75 2.5 4.5 4.5

2344 Physostigmine salicylate (1:1) 57-64-7 0.5 1.5 2.5 2.5

2345 Picolinic acid; (2-Pyridinecarboxylic acid) 98-98-6 10 35 150 150 Mouse ip TDlo and LD50.

2346 Picric acid 88-89-1 0.1 0.3 15 75

2347 Picrotoxin 124-87-8 3 7.5 15 15

2348 Pigment green 36 14302-13-7 15 50 350 500

2349Pigment yellow 13; (Butanamide, 2,2'-((3,3'-

dichloro(1,1'-biphenyl)-4,4'-diyl)bis(azo)bis(N-(2,4-

dimethylphenyl)-3-oxo-)

5102-83-0 75 250 500 500

2350 Pigment yellow 14 5468-75-7 20 60 400 500 Rat LD 50 minimum.

2351 Pigment yellow 36; (Zinc chromate) 13530-65-9 0.0176 0.106 15 52.9 Cr VI concentration limits.

2352 Pinacolone; (3,3-Dimethyl-2-butanone) 75-97-8 6 20 750 4,000 Mouse 240 min LC50.

2353 Pinacolyl alcohol; ((tert-Butyl methyl carbinol) 464-07-3 1,000 3,000 3,500 3,500

2354 Piperazine 110-85-0 2 6 40 500

2355 Piperidine 110-89-4 3.5 23 115 383 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3.

2356 Pirimifos-ethyl 23505-41-1 5 15 25 60


6/19/2009



PAC Rev 24B





2357 Pivalic anhydride; (Trimethylacetic anhydride) 1538-75-6 10 30 50 250 PNOS default.

2358 Platinum 7440-06-4 1 3 4 4

2359 Platinum cyanide 592-06-3 0.0025 0.0076 0.0127 5.07

2360

Poly alpha olefin; (Synthetic hydrocarbon mixture,

PAO; Hydrogenated trimer and tetramer of

decene)

68649-12-7 5 10 50 250

2361Poly(1-(2-oxo-1-pyrrolidinyl)ethylene)iodine

complex; (Iodine solutions)25655-41-8 12.5 50 400 500

Mixt OEL, PAC-2/7, human skin TDlo, mouse oral

LD50.

2362Poly(1-vinyl-2-pyrrolidinone) homopolymer;

(Polyvinylpyrrolidone; Plasdone)9003-39-8 100 300 500 500 Rat iv TDlo, mouse ip LD50

2363Poly(acrylamide-co-diallyldimethylammonium

chloride)26590-05-6 10 30 50 250 PNOS dwfault used.

2364Poly(dimethylsiloxane), ethoxylated, dihydroxy

terminated; (Silicon oil polymer)68037-63-8 75 250 500 500 Rat LD50 based on HHR.

2365 Poly(dimethylsiloxane), hydride terminated 70900-21-9 10 30 50 250 PNOS default used.

2366Poly(dimethylsiloxane), vinyl dimethylsiloxy

terminated68083-19-2 60 200 500 500 Rat oral LD50 minimum.

2367Poly(divinylbenzene); (Diethylbenzene

homopolymer)9003-69-4 7.5 25 150 500 Rat oral LD50, based on HHR.

2368 Poly(ethylene glycol methyl ether) 9004-74-4 75 250 500 500 Rat oral LD50.

2369 Poly(ethylene glycol)diacrylate 26570-48-9 1.5 5 35 150 Rat oral LD50 estimated from HHR = 3.

2370 Poly(melamine-co-formaldehyde), methylated 68002-20-0 60 150 500 500 Rat oral LD50.


6/19/2009



PAC Rev 24B





2371

Poly(oxy-1,2-ethanediyl), alpha-(4-octylphenyl)-

omega-hydroxy-; (Polyethylene glycol mono(p-

octylphenol)ether)

26636-32-8 3 7.5 60 300 Mouse intravenous LD50.

2372 Poly(oxyethylene)(2) stearyl ether 9005-00-9 7.5 20 150 500 Rat oral LD50

2373Poly(Styrene-co-divinylbenzene); (Dowex

Optipore V-502)69011-14-9 10 30 50 250 PNOS default used.

2374Polyamide 6; (Capron;

Poly(iminocarbonylpentamethylene))25038-54-4 10 30 200 500

2375 Polybutyl acrylate 9003-49-0 10 30 50 250

2376Polychlorinated biphenyl (Aroclor 1016);

(Chlorodiphenyl (41% Cl))12674-11-2 0.2 0.6 1 5

2377Polychlorinated biphenyl (Aroclor 1016/1242):

(Chlorodiphenyl (37% Cl))z-0042 0.2 0.6 1 5






(Chlorodiphenyl (42% Cl))53469-21-9 1 3 5 5




(Chlorodiphenyl (54% Cl))11097-69-1 0.5 1.5 2.5 5


(Chlorodiphenyl (60% Cl))11096-82-5 0.2 0.6 1.5 5

2384Polychlorinated biphenyl (Aroclor 1260/1262):

(Chlorodiphenyl (61% Cl?))z-0043 0.2 0.6 1.5 5


(Chlorodiphenyl (62% Cl))37324-23-5 1 3 5 5


6/19/2009



PAC Rev 24B







2387 Polychlorinated biphenyl; (Aroclor; PCBs) 1336-36-3 1 3 5 5

2388 Polydimethyl siloxane; (Dimethylpolysiloxane) 9016-00-6 7.5 25 150 500 Rat ip LD50 > 2 g/kg

2389 Polyether polyol ester z-0112 15 50 350 500 Rat oral LD lo.

2390 Polyethylbenzene residue; (Dowtherm Q) 68987-42-8 7.5 20 150 750 WEEL-TWA, WEEL-TWA*3, ERPG-2, ERPG-2*5.

2391 Polyethylene 9002-88-4 10 30 50 500

2392 Polyethylene glycol 25322-68-3 10 60 500 500 WEEL-TWA, rat TClo, rat iv LD lo.

2393 Polyethylene glycol 20M 37225-26-6 10 30 500 500

2394 Polyethylene glycol dimethacrylate 25852-47-5 10 30 50 250 PNOS default used.

2395 Polyglycol 15-200: (Calthane NF and ND "B") 9082-00-2 40 125 500 500 Rat oral LD50 > 10 g/kg

2396 Polyisocyanate prepolymer (based on MDI) z-0115 0.6 1.5 12.5 60 Rat TClo

2397Polymaleic acid; (2-Butenediiodic acid

homopolymer)26099-09-2 10 30 50 250 PNOS TLV-TWA default used.

2398 Polymerized linseed oil 67746-08-1 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

2399Polymethylene polyphenyl isocyanate; (Polymeric

diphenylmethane diisocyanate)9016-87-9 2 6 40 200 Rat TClo, rat 240 min LC50.

2400Polymethylhydrosiloxane; (Methyl hydrogen

polysiloxane)63148-57-2 10 30 50 250 PNOS TLV-TWA default used.


6/19/2009



PAC Rev 24B





2401 Polymethylmethacrylate; (Lucite) 9011-14-7 5 15 100 500 Rat implant TDlo.

2402Polyoxyalkyleneamine;

(Poly(oxypropylene)diamine)9046-10-0 10 30 50 100

2403 Polyoxyethylene (20) sorbitan monolaurate 9005-64-5 3 7.5 60 500 Mouse, pregnant, ip TDlo, rat ip LD50.

2404 Polyoxyethylene monooctylphenyl ether 9036-19-5 15 50 350 500

2405Polyoxyethylene sorbitan monopalmitate; (Tween

40)9005-66-7 12.5 40 250 500 Rat iv LD50.

2406 Polyoxypropylene polyamine 39423-51-3 10 30 50 250 Used PNOS default.

2407 Polyphosphoric acid 8017-16-1 1.5 5 40 200

2408 Polypropylene 9003-07-0 12.5 40 250 500

2409Polypropylene glycol,chloromethyl) oxirane

polymer9072-62-2 7.5 25 150 500 Rat oral LD50 minimum.

2410 Polypropylene glycols 25322-69-4 10 30 200 500 WEEL-TWA, rat oral LD50.

2411Polypropylene-polyethylene glycol; (Pluronic L-

81)9003-11-6 10 30 200 500

2412 Polysorbate 85; (Tween 85) 9005-70-3 75 250 500 500 Rat oral LD50 based on HHR = 1,

2413 Polystyrene resin; (Styrene polymer) 9003-53-6 10 30 50 75

2414 Polysulfone resin 25135-51-7 10 30 50 250 PNOS default.

2415 Polytetrafluoroethylene; (Teflon) 9002-84-0 3.5 10 60 350 Rat implant TDlo


6/19/2009



PAC Rev 24B





2416 Polyurethane foam; (Urethane polymers) 9009-54-5 0.2 0.6 5 25

2417Polyurethane prepolymer of MDI + polyether

polyol65636-36-4 10 30 50 250 Used PNOS default.

2418 Polyurethane prepolymer of MDI and PEP 68092-58-0 10 30 50 250 Used PNOS default.

2419 Polyvinyl alcohol 9002-89-5 40 125 500 500

2420 Polyvinyl chloride 9002-86-2 1 3 40 200TLV-TWA, TEEL-0*3, rat intratracheal TDlo, TEEL-

2*5.

2421 Potassium 7440-09-7 0.075 0.2 1.5 300 PAC-2/21, PAC-2/7, rat oral TDlo, mouse ip LD50.

2422 Potassium acetate 127-08-2 12.5 40 250 500

2423 Potassium acid fluoride 7789-29-9 5.14 15.4 25.7 500 Fluoride concentration limits.

2424 Potassium aluminate 12003-63-3 7.27 21.8 36.3 150

2425 Potassium aluminite z-0044 2.5 7.5 12.5 500 SAR

2426 Potassium aluminosilicate 1327-44-2 5 30 50 500 SAR

2427 Potassium antimonate 29638-69-5 2.1 6.31 10.5 210

2428Potassium antimonate; (Potassium

hexahydroxyantimonate)12208-13-8 1.08 3.24 5.4 108

2429 Potassium antimonite z-0045 0.94 2.82 4.7 94 Sb Conc. limits

2430 Potassium argentate z-0046 0.0168 0.0503 0.0839 16.8


6/19/2009



PAC Rev 24B





2431 Potassium arsenate; (Monopotassium arsenate) 7784-41-0 0.024 0.072 2.5 12

2432 Potassium arsenite 10124-50-2 0.0533 6 26.7 26.7

2433Potassium arsenite; (Arsenous acid, potassium

salt)13464-35-2 0.0195 0.0585 6 9.74

2434 Potassium beryllium oxide z-0047 0.016 0.08 6 32

2435 Potassium bicarbonate 298-14-6 12.5 35 60 500

2436 Potassium bi-iodate 13455-24-8 4 12.5 75 400 MSDS K.I.O3 mouse oral LD lo.

2437 Potassium bismuthate 12589-75-2 1.25 4 25 200 SAR

2438 Potassium bisulfate 7646-93-7 10 30 200 500

2439 Potassium bromate 7758-01-2 0.1 0.3 60 60 WEEL-TWA, human oral TDlo, rat oral LD50.

2440 Potassium bromide 7758-02-3 12.5 40 250 500

2441 Potassium cadminate z-0048 0.0115 0.069 0.115 20.7

2442 Potassium carbonate 584-08-7 10 20 150 500

2443 Potassium chlorate 3811-04-9 12.5 40 300 350

2444 Potassium chloride 7447-40-7 1.5 5 15 15

2445 Potassium chromate(VI) 7789-00-6 0.0187 0.75 6 56 Cr VI concentration limits.


6/19/2009



PAC Rev 24B





2446 Potassium citrate 866-84-2 1.25 4 30 150

2447 Potassium citrate, monohydrate 6100-05-6 10 30 50 250 PNOS default.

2448 Potassium columbate; (Potassium niobate) 12030-85-2 12.5 35 250 500

2449 Potassium cyanide 151-50-8 5 5 5 62.6

2450 Potassium dichromate 7778-50-9 0.0141 1.5 10 42.4 Cr VI concentration limits.

2451 Potassium dideuterium phosphate 13761-79-0 0.0015 0.004 0.0075 0.015 MSDS data.

2452 Potassium ferricyanide 13746-66-2 5.9 17.7 30 500

2453Potassium ferrocyanide; (Tetrapotassium

hexacyanoferrate)13943-58-3 11.8 35.4 59 59 Rat TClo, rat oral LD50.

2454 Potassium fluoride 7789-23-3 7.65 22.9 38.2 500

2455 Potassium fluoride dihydrate 13455-21-5 12.4 37.2 61.9 500 Fluoride concentration limits.

2456 Potassium formate 590-29-4 20 60 500 500

2457 Potassium glycolate 1932-50-9 35 75 600 3,500 SAR

2458 Potassium gold cyanide 554-07-4 27.7 83 138 138PEL-TWA, PEL-TWA*3, PEL-TWA*5, IDLH, as

CN.

2459Potassium hexacyanoferrate(II) trihydrate;

(Potassium ferricyanide trihydrate)14459-95-1 13.5 40.6 67.6 67.6

PEL-TWA, PEL-TWA*3, PEL-TWA*5, IDLH, as

CN.

2460Potassium hexafluorosilicate; (Silicate(2-),

hexafluoro-, dipotassium)16871-90-2 0.4 1.25 7.5 60 Rat oral TDlo, rat oral LD50.


6/19/2009



PAC Rev 24B





2461 Potassium hydride 7693-26-7 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

2462 Potassium hydrogen lead oxide z-0049 0.06 0.06 0.06 125 SAR

2463 Potassium hydrogen metasilicate z-0051 10 30 50 250 Used PNOS default.

2464 Potassium hydrogen pyrophosphate z-0050 4 12.5 20 400 SAR

2465 Potassium hydroxide 1310-58-3 0.1 0.3 2 125 PAC2/21, PAC-2/7, TLV-C, ret oral LD50.

2466 Potassium iminodiacetate; (Potassium IDA) z-0052 35 100 750 4,000

2467 Potassium iodate 7758-05-6 20 60 60 60

2468 Potassium iodide 7681-11-0 0.25 0.75 6 300

2469 Potassium lanthanate z-0053 0.4 1.25 2.5 2.5 SAR

2470 Potassium metaborate 13709-94-9 12.5 35 250 500 SAR

2471 Potassium molybdate 13446-49-6 12.4 37.2 62.1 500 Molybdenum concentration limits.

2472Potassium nickel oxide (liquids); (Nickel

potassium oxide)50811-97-7 2.88 2.88 3 28.8 Nickel concentration limits.

2473 Potassium nickelate (liquids) z-0055 3.49 3.49 3.5 34.9 Nickel concentration limits.

2474 Potassium nickelate (solids) z-0056 3.49 3.49 3.5 34.9 Nickel concentration limits.

2475 Potassium nitrate 7757-79-1 1 3.5 25 500


6/19/2009



PAC Rev 24B





2476 Potassium nitrilotriacetate; (Potassium NTA) 2399-85-1 5 15 100 500

2477 Potassium nitrite 7758-09-0 0.04 0.1 0.75 500

2478 Potassium orthovanadate 14293-78-8 0.0638 0.191 0.638 44.6

2479 Potassium oxalate 583-52-8 7.5 25 150 500 Woman oral LD lo.

2480 Potassium oxalate monohydrate 6487-48-5 7.5 25 150 500

2481 Potassium oxide 12136-45-7 0.05 0.15 1 60 Based on potassium hydroxide TEELs.

2482 Potassium perchlorate 7778-74-7 125 400 500 500

2483 Potassium periodate 7790-21-8 1 3 20 100 Estimated rat 240 min LC50 based on HR.

2484 Potassium permanganate 7722-64-7 0.575 8.63 14.4 125

2485 Potassium persulfate; (Dipotassium persulfate) 7727-21-1 0.1 0.3 60 350

2486 Potassium phosphate dibasic trihydrate 16788-57-1 300 500 500 500

2487 Potassium phosphate, dibasic 7758-11-4 10 30 50 250

2488 Potassium phosphate, monobasic 7778-77-0 10 30 50 500

2489 Potassium phosphate, tribasic 7778-53-2 10 30 50 500

2490 Potassium phosphide 20770-41-6 2.5 7.5 12.1 21.8 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





2491Potassium pyrophosphate; (Tetrapotassium

diphosphorate)7320-34-5 10 30 500 500

2492Potassium pyrosulfate; (Disulfuric acid,

dipotassium salt)7790-62-7 10 30 50 250

2493 Potassium pyrosulfite; (Potassium metabisulfite) 16731-55-8 20 60 400 500TEEL-2/35, TEEL-2/7, rat oral pre/post preg TDlo,

TEEL-2*5.

2494 Potassium selenate 7790-59-2 0.56 1.68 2.8 2.8

2495 Potassium selenite 10431-47-7 0.52 0.52 0.52 2.6

2496 Potassium silicate; (Silicic acid, potassium salt) 1312-76-1 10 30 50 250 PNOS default

2497 Potassium silver cyanide 506-61-6 1 3 20 20

2498 Potassium stannate 12142-33-5 2.5 7.5 12.5 125 SAR

2499 Potassium strontium phosphate 53201-92-6 10 30 50 500 SAR

2500 Potassium sulfate (2:1); (Dipotassium sulfate) 7778-80-5 2 6 40 500

2501 Potassium sulfite 10117-38-1 7.5 25 150 500TEEL-3/105, TEEL-3/35, TEEL-3/5, estimated

human LD lo.

2502 Potassium tellurate 15571-91-2 0.211 0.634 1.06 2

2503 Potassium tellurite 7790-58-1 0.199 0.597 3.5 15

2504 Potassium tetrafluoroborate(1-) 14075-53-7 4.14 124 207 414 Fluoride concentration limits.

2505 Potassium tetraphenylborate 3244-41-5 1 3 5 25


6/19/2009



PAC Rev 24B





2506 Potassium thiocyanate 333-20-0 12.5 35 60 60

2507 Potassium trihydrogen silicate z-0058 10 30 50 250

2508 Potassium tungstate (liquids) 7790-60-5a 1.77 5.32 5.32 5.32

2509 Potassium tungstate (solids) 7790-60-5b 1.77 5.32 5.32 5.32

2510 Potassium uranyl carbonate z-0059 0.429 1.03 3.5 17.2

2511Potassium zirconate; (Dipotassium zirconium

oxide)12030-98-7 11.9 23.8 25 119 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

2512Potassium-tert-butoxide; (tert-Butyl alcohol,

potassium derivitave)865-47-4 1.5 5 35 150

2513 Praseodymium 7440-10-0 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

2514 Praseodymium nitrate 10361-80-5 7.5 20 150 500

2515 Praseodymium oxide 12036-32-7 7.5 25 150 500

2516 Praseodymium(III,IV) oxide 12037-29-5 20 60 400 500 Rat oral LD50 minimum.

2517 Promecarb; (m-Cym-5-yl methylcarbamate) 2631-37-0 3 10 16 25

2518 Propanamine, 1-; (Propylamine) 107-10-8 40 125 600 600

2519 Propane 74-98-6 1,500 9,920 30,600 59,500 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

2520 Propane sultone, 1,3- 1120-71-4 0.4 1.25 7.5 20


6/19/2009



PAC Rev 24B





2521 Propanediamine, 1,2- 78-90-0 7.5 25 200 500

2522 Propanediamine, 1,3- 109-76-2 0.6 1.5 12.5 125

2523 Propanedinitrile; (Malononitrile) 109-77-3 7.5 7.5 13.2 27 REL-TWA, REL-TWA, AEGL-2, AEGL-3.

2524 Propanediol, 1,3- 504-63-2 20 60 400 500 Mouse oral LD50

2525 Propanediol, 2,2-dimethyl-, 1,3- 126-30-7 2,500 2,500 2,500 2,500 Rat 360 min TClo, rat oral LD50.

2526 Propanethiol 107-03-9 0.075 0.2 1.5 2,500 REL-C, rat 240 min LC50.

2527 Propanol, zirconium(4+) salt, 1- 23519-77-9 18 53.9 89.8 180 Zr concentration limits.

2528 Propargyl alcohol 107-19-7 2 5.73 36.7 170 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

2529 Propargyl bromide 106-96-7 0.03 0.03 0.03 20 WEEL-TWA, LOC, rat oral LD50.

2530 Propiolactone, b- 57-57-8 1.5 1.5 15 40

2531 Propionaldehyde 123-38-6 40 107 617 1,990 TLV-TWA, AEGL-1, AEGL-2, AEGL-3..

2532 Propionic acid 79-09-4 30 30 40 1,000

2533 Propionic acid, 3-ethoxy-, ethyl ester 763-69-9 20 60 400 500

2534 Propionic acid, sodium salt 137-40-6 15 50 350 500 Mouse oral LD50, rat TDlo.

2535 Propionic anhydride 123-62-6 10 30 200 500


6/19/2009



PAC Rev 24B





2536 Propionitrile; (Propiononitrile) 107-12-0 12.5 12.5 15.8 83.3 REL-TWA, REL-TWA, AEGL-2, AEGL-3.

2537 Propionyl chloride 79-03-8 0.3 0.75 6 30

2538 Propoxur 114-26-1 0.5 1.5 20 20

2539Propoxypropanol, , n-; (Propylene glycol

monpropyl ether)30136-13-1 12.5 35 250 1,250 PAC-3/105, PAC-3/35, PAC-3/5, rat oral LD50

2540 Propyl acetate, n- 109-60-4 750 1,000 4,000 6,000 PEL-TWA, TLV-STEL, human TClo, IDLH.

2541 Propyl alcohol, n-; (n-Propanol) 71-23-8 500 600 600 2,000 PEL-TWA, REL-STEL, rat oral TDlo, IDLH.

2542Propyl chloroformate; (Propyl

chlorocarbonate)109-61-5 3.5 10 18.5 55.1 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

2543 Propyl nitrate 627-13-4 100 150 400 2,000 PEL-TWA, TLV-STEL, PAC-3/5, IDLH.

2544 Propyl-1-butanamine, N- 20193-21-9 15 50 350 500

2545 Propylbenzene, n-; (Isocumene) 103-65-1 150 400 3,000 15,000

2546 Propylene carbonate, 1,2- 108-32-7 0.125 0.35 2.5 12.5

2547 Propylene glycol dinitrate 6423-43-4 0.35 1.15 6.79 88.3 TLV-TWA, AEGL-1, AEGL-2, AEGL-3

2548Propylene glycol monomethyl ether acetate; (1-

Methoxypropyl-2-acetate)108-65-6 250 750 1,250 3,500 WEEL-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

2549Propylene glycol monomethyl ether; (Ucar Triol

HG-170)107-98-2 350 500 1,000 2,500

2550Propylene glycol mono-n-butyl ether; (3-butoxy-1-

propanol)10215-33-5 250 250 1,500 2,500 WEEL-TWA, rat TClo, rat ral LD50.


6/19/2009



PAC Rev 24B





2551 Propylene glycol; (1,2-Propanediol) 57-55-6 10 10 10 500

2552Propylene oxide; (Methyl ethylene

oxide)75-56-9 4 173 689 2,070 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

2553 Propylene; (1-Propene) 115-07-1 750 2,500 4,000 35,000 TLV-TWA, mouse TClo, rat LC minimum.

2554 Propyleneimine, 1,2- 75-55-8 4 4 28 53.7 PEL-TWA, PEL-TWA, AEGL-2, AEGL-3.

2555 Propyltrichlorosilane 141-57-1 1.5 4.35 53 239 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2556Prothoate; (Isopropyl

diethyldithiophosphorylacetamide)2275-18-5 0.35 1 1.7 7.5

2557 Pump oil 64742-65-0 100 300 500 500

2558 Pyrene 129-00-0 2.5 7.5 15 15

2559 Pyridine 110-86-1 15 50 600 3,000

2560 Pyridinecarboxaldehyde, 4-; (Isonicotinaldehyde) 872-85-5 12.5 40 250 500 Mouse oral LD lo.

2561 Pyridine-d5 7291-22-7 15 50 75 400 Pyridine PEL-TWA, rat oral LD50.

2562 Pyriminil; (Pyriminyl) 53558-25-1 1.25 3.5 6.2 20

2563 Pyrogallic acid 87-66-1 0.75 2.5 15 25 Human oral LD lo, rat oral TDlo.

2564 Pyromellitic acid 89-05-4 1.25 3.5 25 125

2565 Pyroxylin; (Cellulose tetranitrate) 9004-70-0 10 30 50 500


6/19/2009



PAC Rev 24B





2566 Pyrrole; (Imidole) 109-97-7 0.1 0.3 2 10 Mouse sc LD50

2567 Pyrrolidine 123-75-1 5 15 100 500

2568 Pyrrolidinone, 2- 616-45-5 3.5 10 60 150

2569 Pyruvate kinase 9001-59-6 2.5 7.5 50 500

2570Quaternary ammonium compounds, benzyl-C12-

C16-alkyldimethyl, chlorides68424-85-1 1.5 5 35 150

2571 Quinhydrone 106-34-3 0.3 0.75 6 30

2572 Quinoline 91-22-5 0.005 3.5 25 150 WEEL-TWA, rat oral TDlo, rat oral LD50.

2573 Quinolinol, 8- 148-24-3 2.5 7.5 50 500

2574 Resorcinol 108-46-3 40 75 75 75

2575

Rexyn I-300; (Ethylene glycol dimethacrylate

polymer with styrene, chloromethylated,

trimethylamine-quanternized, hydroxide)

69011-49-0 10 30 50 250 PNOS default.

2576 Rhenium hexafluoride 10049-17-9 6.58 19.8 32.9 500 Fluoride PEL-TWA and IDLH, as F.

2577 Rhenium oxide; (Rhenium(VII) oxide) 1314-68-7 1.3 3.9 6.5 30

2578 Rhodium 7440-16-6 0.1 3 5 100

2579 Rhodium oxide (liquids); (Rhodium(IV) oxide) 12137-27-8a 0.0013 0.0393 0.5 2.6

2580 Rhodium oxide (solids); (Rhodium((IV) oxide) 12137-27-8b 0.131 3.93 6.56 131


6/19/2009



PAC Rev 24B





2581 Rhodium(III) hydroxide (liquids) 21656-02-0a 0.0015 0.045 0.6 2.99

2582 Rhodium(III) hydroxide (solids) 21656-02-0b 0.15 4.49 7.5 150

2583 Rhodium(III) oxide (solids) 12036-35-0 0.123 3.7 6.17 123

2584 Riboflavine 83-88-5 7.5 25 150 500 Rat sc LD50.

2585 Ribonuclease T1 9026-12-4 10 30 50 250

2586Rosin core solder decomposition products;

(Colophony Gum)8050-09-7 0.1 0.3 40 40 Netherlands MAC, rat LC50.

2587 Rotenone 83-79-4 5 15 25 125 PEL-TWA, TEEL-O, TEEL-0, human oral LD lo.

2588Rubber solvent; (Naphtha (petroleum) light

aliphatic)64742-89-8 400 400 750 4,000 PEL-TWA, PAC-2/7, PAC-3/5, IDLH.

2589 Rubidium 7440-17-7 5 15 100 500

2590 Rubidium bromide 7789-39-1 10 30 50 250

2591 Rubidium chloride 7791-11-9 0.015 0.05 0.35 500

2592 Rubidium hydroxide 1310-82-3 2.5 7.5 50 250

2593 Rubidium nitrate 13126-12-0 10 30 50 500

2594 Ruthenium 7440-18-8 10 30 50 250

2595 Ruthenium trichloride 10049-08-8 1.5 4 30 150


6/19/2009



PAC Rev 24B





2596 Ruthenium(IV) oxide 12036-10-1 4 12.5 15 15

2597 Safrol; (5-(2-Propenyl)-1,3-benzodioxole) 94-59-7 5 15 100 500

2598Salcomine; (bis(Salicylaldehyde)ethylenediimine

cobalt(II))14167-18-1 7.5 20 39 400

2599 Salicylaldehyde 90-02-8 0.6 1.5 12.5 200 Pregnant rat subcutaneous TDlo, rat oral LD50.

2600 Salicylic acid 69-72-7 0.3 0.75 6 400

2601 Salicylic acid, monoammonium salt 528-94-9 1.5 4 30 500 Human oral TDlo, rat parenteral LD lo.

2602 Salicylic acid, phenyl ester 118-55-8 4 12.5 75 500 Rat oral TDlo and LD50.

2603 Samarium 7440-19-9 10 30 50 250 PNOS default used.

2604 Samarium nitrate 10361-83-8 7.5 25 150 500

2605 Samarium(ii) iodide solution 32248-43-4 7.5 25 150 500 Estimated rat oral LD50 based on HHR.

2606 Samarium(III) chloride hexahydrate 13465-55-9 12.5 40 250 500 Rat oral LD50.

2607 Samarium(III) oxide 12060-58-1 20 60 400 500

2608 Saxitoxin 35523-89-8 0. 0.0001 0.0006 0.0035 Human uk LD lo

2609 Scandium 7440-20-2 10 30 50 250 PNOS default.

2610 Scandium oxide 12060-08-1 10 30 50 250


6/19/2009



PAC Rev 24B





2611 Sec-butyllithium 598-30-1 1 3 20 100 Estimated rat 240 min LC50 based on HHR.

2612 Selenious acid 7783-00-8 0.327 0.98 1.6 1.6

2613 Selenium 7782-49-2 0.2 0.6 1 1

2614 Selenium dioxide 7446-08-4 0.281 0.843 1.4 1.4

2615 Selenium hexafluoride 7783-79-1 0.418 0.418 0.686 2.05 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2616 Selenium monosulfide 7446-34-6 0.281 0.844 12.5 15

2617 Selenium oxychloride 7791-23-3 0.42 1.26 4.41 4.41

2618 Selenium sulfide; (Selenium(IV) disulfide (1:2)) 7488-56-4 0.362 1.09 1.81 60

2619 Semicarbazide hydrochloride 563-41-7 20 60 100 100

2620 Sephacryl s-200, superfine 65546-95-4 10 30 50 250 PNOS default used.

2621 Sephacryl s-300 82785-74-8 10 30 50 250 PNOS default used.

2622 Sephadex G-25 9041-35-4 10 30 50 250

2623 Sepharose cl-4b 61970-08-9 10 30 50 250 PNOS default used.

2624 Silane; (Silicon tetrahydride) 7803-62-5 6 131 171 355 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

2625 Silica amorphous hydrated 7631-86-9 6 18 125 500 PEL-TWA, TEEL-0*3, rat TClo, IDLH.


6/19/2009



PAC Rev 24B





2626 Silica gel 63231-67-4 6 18 30 150

2627 Silica gel dessicant 1343-98-2 6 18 30 100 PEL-TWA, TEEL-0*3, TEEL-0*5, PAC-2*5.

2628 Silica gel, amorphous synthetic 112926-00-8 6 18 100 500 REL-TWA, TEEL-0*5, rat TClo, TEEL-2*5.

2629 Silica, amorphous fume 69012-64-2 0.3 0.9 1.5 3.5MAK-TWA, TEEL-O*3, TEEL-0*5, rat oral LD50

minimum.

2630 Silica, amorphous fumed 112945-52-5 6 18 200 500

2631 Silica, crystalline-quartz; (Silicon dioxide) 14808-60-7 0.3 0.3 0.3 50 PEL-TWA, TEEL-0, TEEL-0, IDLH.

2632 Silicic acid 7699-41-4 10 10 75 400

2633 Silicic acid, aluminum calcium sodium salt 1344-01-0 10 30 50 250 Al sol. Salts TLV-TWA.

2634 Silicic acid, sodium salt; (Sodium silicate) 1344-09-8 7.5 25 150 500 Rat oral LD50.

2635 Silicofluoric acid; (Fluorosilicic acid) 16961-83-4 3.16 9.48 15.8 50

2636 Silicon 7440-21-3 15 45 75 500 PEL-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

2637 Silicon carbide 409-21-2 15 30 250 500

2638 Silicon nitride 12033-89-5 10 30 50 250 PNOS default.

2639Silicon tetrafluoride;

(Tetrafluorosilane)7783-61-1 0.213 0.213 14 42.5 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2640 Silicon(II) oxide; (Silicon oxide) 10097-28-6 10 30 50 250


6/19/2009



PAC Rev 24B





2641 Siloprene k 1000 63394-02-5 35 100 500 500 Rat implant TDlo, rat oral LD50 maximum.

2642

Siloxanes and silicones, -di-Me,-reaction

products with silica; (Hydrophobic silicon dioxide,

amorphous)

67762-90-7 6 15 125 500 Rat TClo.

2643Siloxanes and silicones, methyl phenyl; (Silicone

fluid, high temp)63148-58-3 10 10 50 250 Rat 240 min LC50.

2644 Silver 7440-22-4 0.01 0.3 0.5 10 Concentration limits.

2645 Silver carbonate; (Silver(I) carbonate) 534-16-7 0.0128 0.0383 0.0639 12.8 Silver concentration limits.

2646 Silver chloride 7783-90-6 0.0133 0.0399 0.0664 13.3 Silver concentration limits.

2647 Silver cyanide 506-64-9 25.7 25.7 25.7 129 Cyanide concentration limits.

2648 Silver hydroxide 12673-77-7 0.0116 0.0347 0.06 11.6 Silver concentration limits.

2649 Silver nitrate 7761-88-8 0.0157 0.4 3 15.7 PEL-TWA, PAC=2/7, rat intratracheal TDlo, IDLH

2650 Silver nitrite; (Silver(I) nitrite) 7783-99-5 0.0143 0.0428 0.075 14.3 Silver concentration limits.

2651 Silver oxide 20667-12-3 10 30 50 50 PNOS gefault.

2652 Soda lime 8006-28-8 5 5 5 25 Calcium oxide concentration limits.

2653 Sodium 7440-23-5 0.5 0.5 5 50 PAC-1, ERPG-1, ERPG-2, ERPG-3.

2654 Sodium acetate 127-09-3 15 40 300 500

2655Sodium acetate trihydrate; (Acetic acid, sodium

salt trihydrate)6131-90-4 15 40 300 500


6/19/2009



PAC Rev 24B





2656Sodium aluminate anhydrous; (Aluminum sodium

dioxide anhydrous)11138-49-1 8.75 8.75 8.75 8.75 Al soluble salts concentration limits.

2657 Sodium aluminate; (Aluminum sodium dioxide) 1302-42-7 6.08 6.08 6.08 6.08 Al soluble salts concentration limits.

2658 Sodium aluminosilicate 1344-00-9 3.5 10 150 500 SAR

2659 Sodium aluminum hydride 13770-96-2 3 7.5 60 300 Mouse oral LD50.

2660 Sodium aluminum silicate 73987-94-7 3.5 10 15 500 SAR

2661Sodium antimonate; (Antimonic acid, sodium

salt)11112-10-0 1.01 3.04 5.07 101

2662Sodium antimonate; (Sodium

hexahydroxoantimonate)33908-66-6 0.792 2.37 4 79.2

2663 Sodium antimonite z-0061 0.874 2.62 4.37 87.4

2664 Sodium argentate z-0062 0.0153 0.0459 0.0764 15.3

2665 Sodium arsenate 7631-89-2 0.0271 7.5 13.5 13.5

2666 Sodium arsenite 7784-46-5 0.0173 0.075 0.6 8.67

2667 Sodium azide 26628-22-8 0.0125 0.04 0.29 12.5

2668 Sodium beryllium oxide z-0063 0.0124 0.0621 5 24.9

2669 Sodium bicarbonate 144-55-8 10 30 50 500

2670 Sodium bifluoride; (Sodium hydrogen fluoride) 1333-83-1 4.08 4.08 6 35


6/19/2009



PAC Rev 24B





2671 Sodium bis(2-methoxyethoxy) aluminum hydride 22722-98-1 15 45 75 350 Al soluble salts TLV-TWA.

2672 Sodium bismuthate 12232-99-4 1.5 5 35 150

2673 Sodium bisulfate monohydrate 10034-88-5 0.75 2.5 15 75

2674 Sodium bisulfate; (Sodium acid sulfate) 7681-38-1 1.25 3.5 25 125

2675 Sodium bisulfite 7631-90-5 5 15 25 500

2676 Sodium borate decahydrate 1303-96-4 2 6 200 500TLV-TWA, TLV-STEL, rat oral TDlo, human oral

LD lo.

2677Sodium borate; (Disodium tetraborate; Borates,

tetrasodium salts)1330-43-4 2 6 6 500

TLV-TWA, TLV-STEL, rat oral TDlo, rat oral

LD50..

2678 Sodium borohydride 16940-66-2 0.075 0.2 1.5 7.5

2679 Sodium bromate 7789-38-0 0.6 1.5 12.5 60

2680 Sodium bromide 7647-15-6 1.5 5 35 500

2681 Sodium butyl (2-ethylhexyl)phosphate z-0064 0.02 0.06 0.4 2 SAR

2682 Sodium butyl butylphosphonate z-0065 0.02 0.06 0.4 2 SAR

2683 Sodium cacodylate; (Sodium dimethylarsinate) 124-65-2 1.07 3.2 40 500

2684 Sodium cadminate z-0066 0.0101 0.0604 0.101 18.1

2685 Sodium carbonate 497-19-8 10 30 50 500


6/19/2009



PAC Rev 24B





2686 Sodium carbonate monohydrate 5968-11-6 1.5 5 35 150

2687 Sodium carboxymethyl cellulose; (Dowex 11) 9004-32-4 0.4 1.25 7.5 500

2688 Sodium chloride 7647-14-5 15 40 300 500

2689 Sodium chlorite 7758-19-2 0.75 2.5 15 75

2690 Sodium chromate decahydrate 13517-17-4 0.0329 0.987 20 98.7 Cr VI concentration limits.

2691 Sodium chromate tetrahydrate 10034-82-9 0.0291 0.873 15 87.4 Cr VI concentration limits.

2692 Sodium chromate(VI); (Disodium chromate) 7775-11-3 0.0156 0.125 0.75 46.7 Cr VI concentration limits.

2693 Sodium citrate; (Monosodium citrate) 18996-35-5 10 30 50 500

2694 Sodium cobaltinitrite 13600-98-1 0.125 0.4 3 15

2695 Sodium cyanide 143-33-9 5 5 5 47.1

2696Sodium cyclopentadienylide; (Cyclopentadienyl

sodium)4984-82-1 10 30 50 250 PNOS default.

2697 Sodium deuteroxide 14014-06-3 0.15 0.5 5 50 Used NaOH ERPG values.

2698 Sodium dichromate dihydrate 7789-12-0 0.0143 0.43 0.716 43 Cr VI concentration limits.

2699 Sodium dichromate; (Disodium dichromate) 10588-01-9 0.0126 20 37.8 37.8 Cr VI concentration limits.

2700 Sodium diethyldithiocarbamate trihydrate 20624-25-3 6 15 125 500 Rat oral LD50.


6/19/2009



PAC Rev 24B





2701Sodium diethyldithiocarbamate;

(Diethyldithiocarbamic acid, sodium salt)148-18-5 2 6 250 500

2702Sodium dihydrogen phosphate; (Sodium

phosphate monobasic, monohydrate)10049-21-5 100 300 500 500

2703 Sodium dithionate dihydrate 7631-94-9 10 30 50 250

2704Sodium dodecylbenzenesulfonate; (Dodecyl

benzene sodium sulfonate)25155-30-0 4 12.5 75 200

2705 Sodium ethoxide 141-52-6 1.5 5 35 150 Rat pral LD50 based on HHR = 3.

2706 Sodium ferrocyanide 13601-19-9 5.44 16.3 27.2 500

2707 Sodium fluoride 7681-49-4 5.53 5.53 5.53 75

2708 Sodium formate 141-53-7 40 125 500 500

2709 Sodium gluconate 527-07-1 0.6 2 15 75

2710 Sodium glycinate 6000-44-8 4 12.5 100 500

2711 Sodium glycolate; (Sodium hydroxyacetate) 2836-32-0 40 125 750 3,000

2712Sodium hexamethyldisilazane; (Sodium

bis(trimethylsilyl)amide)1070-89-9 10 30 50 250 PNOS default

2713 Sodium hydride 7646-69-7 10 10 10 10

2714 Sodium hydrogen lead oxide z-0067 0.06 0.06 0.06 125 SAR

2715 Sodium hydrogen metasilicate z-0068 4 12.5 75 400 SAR


6/19/2009



PAC Rev 24B





2716 Sodium hydrogen pyrophosphate z-0069 4 12.5 20 400 SAR

2717 Sodium hydrosulfite 7775-14-6 10 30 50 250

2718 Sodium hydroxide 1310-73-2 0.5 0.5 5 50 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

2719 Sodium hypobromite 13824-96-9 10 30 50 250 PNOS default used.

2720 Sodium hypochlorite 7681-52-9 0.6 2 50 500 WEEL-STEL, human iv TDlo, mouse oral LD50.

2721 Sodium hypochlorite pentahydrate 10022-70-5 0.075 0.2 1.5 500

2722 Sodium hypophosphite 7681-53-0 6 20 125 500 Mouse ip LD50.

2723 Sodium hypophosphite hydrate 123333-67-5 6 20 125 500 Mouse intraperitoneal LD50.

2724 Sodium iodate 7681-55-2 2 6 40 200 Mouse oral LD50.

2725 Sodium iodide 7681-82-5 0.75 2.5 15 500

2726Sodium isothiocyanate; (Thiocyanic acid, sodium

salt)540-72-7 0.25 0.75 6 100

2727 Sodium lactate; (Lactic acid, monosodium salt) 72-17-3 15 40 300 500 Rat ip TDlo and LD50.

2728 Sodium lanthanate z-0070 0.4 1.25 2.5 2.5

2729 Sodium lauryl sulfate 151-21-3 0.35 1 6 500

2730 Sodium metabisulfite 7681-57-4 5 15 25 100


6/19/2009



PAC Rev 24B





2731 Sodium metaborate 7775-19-1 6.18 18.5 30.9 500Inorganic borate compound TLV-TWA, TLV-STEL,

rat oral LD50

2732 Sodium metaphosphate 10361-03-2 3.5 10 75 350

2733 Sodium metasilicate nonahydrate 13517-24-3 61.1 183 306 500 Used REL-TWA for silicates, rat oral LD50.

2734 Sodium metavanadate; (Sodium vanadate) 13718-26-8 0.1 0.35 2 30

2735 Sodium methylate 124-41-4 7.5 25 150 500

2736Sodium molybdate dihydrate; (Disodium

molybdate dihydrate)10102-40-6 12.6 12.6 200 200

2737 Sodium monoxide; (Sodium oxide) 12401-86-4 10 10 10 10

2738 Sodium nickel oxide (Liquid) 37367-09-2 2.33 2.33 2.33 23.3 Nickel soluble concentration limits.

2739 Sodium nickelate (Liquids) z-0073 2.94 2.94 3 29.4 Nickel soluble concentration limits.

2740 Sodium nickelate (Solids) z-0074 2.94 2.94 3 29.4 Nickel insoluble concentration limits.

2741 Sodium nitrate 7631-99-4 0.4 1 7.5 100

2742 Sodium nitrite 7632-00-0 0.05 0.15 1 60

2743 Sodium nitroferricyanide 14402-89-2 0.6 2 12.5 20 Woman iv TDlo, human inh 3 hour LD lo.

2744 Sodium o-benzyl-p-chlorophenate 3184-65-4 10 30 50 250

2745 Sodium orthovanadate 13721-39-6 0.182 0.25 1.82 35.4


6/19/2009



PAC Rev 24B





2746 Sodium oxalate 62-76-0 10 30 50 50

2747Sodium oxide; (Disodium oxide; Sodium

monoxide)1313-59-3 0.25 0.25 2.5 25 Based on sodium hydroxide PACs.

2748 Sodium pentachlorophenate 131-52-2 1 3.5 24 75

2749 Sodium perchlorate 7601-89-0 10 30 50 500

2750 Sodium perchlorate monohydrate 7791-07-3 5 15 100 500

2751 Sodium permanganate 10101-50-5 0.517 7.75 12.9 500 TLV-TWA, REL-STEL, PEL-C, IDLH., as Mn.

2752 Sodium peroxide 1313-60-6 10 10 10 10

2753 Sodium perrhenate; (Rhenium(VII) sodium oxide) 13472-33-8 10 30 50 500

2754 Sodium persulfate 7775-27-1 0.1 0.3 20 100

2755 Sodium pertechnetate 13718-28-0 10 30 50 250

2756 Sodium phosphate 7632-05-5 0.75 2.5 15 75

2757 Sodium phosphate, dibasic 7558-79-4 60 200 500 500

2758 Sodium phosphate, dibasic, dodecahydrate 10039-32-4 1.5 5 35 150

2759 Sodium phosphate, dibasic, heptahydrate 7782-85-6 50 150 500 500

2760 Sodium phosphate, monobasic 7558-80-7 35 100 500 500


6/19/2009



PAC Rev 24B





2761 Sodium phosphate, tribasic 7601-54-9 1.5 5 500 500 WEEL-STEL, rabbit intravenous LD lo..

2762 Sodium phosphate, tribasic, dodecahydrate 10101-89-0 10 30 50 500

2763Sodium phosphate, tribasic; (Sodium

hexametaphosphate; Calgon)10124-56-8 25 75 500 500

2764Sodium phosphate, tribasic; (Sodium

trimetaphosphate)7785-84-4 15 40 300 500

2765 Sodium phosphide 12058-85-4 1.5 5 8.17 14.7 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

2766 Sodium polyphosphate 68915-31-1 12.5 40 250 500 Rat oral LD50.

2767 Sodium polytungstate 12141-67-2 6.77 13.5 35 150 Tungsten insoluble TLV-TWA, TLV-STEL.

2768 Sodium potassium tartrate tetrahydrate 6381-59-5 20 60 400 500

2769Sodium potassium tartrate; (Potassium sodium

tartrate)304-59-6 20 60 400 500 Mouse iv TDlo.

2770Sodium p-tert-amylphenate; (4-(1,1-

dimethylpropyl)phenol, sodium salt)31366-95-7 10 30 50 250

2771 Sodium pyrophosphate decahydrate 13472-36-1 10 30 200 500 Estimated mouse LD50.

2772 Sodium pyrophosphate, di- 7758-16-9 10 30 200 500

2773 Sodium pyruvate; (Pyruvic acid, sodium salt) 113-24-6 10 30 50 250 PNOS default used.

2774 Sodium salicylate; (Salicylic acid, sodium salt) 54-21-7 40 100 500 500 Women TDlo, human LD lo.

2775 Sodium selenate; (Disodium selenate) 13410-01-0 0.479 1.44 1.6 1.6


6/19/2009



PAC Rev 24B





2776 Sodium selenite 10102-18-8 0.438 1.31 2.3 3

2777 Sodium silicate; (Sodium metasilicate) 6834-92-0 75 200 500 500 Human oral TDlo, rat oral LD50.

2778 Sodium stannate 12058-66-1 3.58 10.8 17.9 179 Tin inorganic concentration limits.

2779 Sodium stearate 822-16-2 0.15 0.5 3.5 15

2780 Sodium strontium phosphate 19553-80-1 10 30 50 500 SAR

2781 Sodium succinate 150-90-3 35 100 750 4,000

2782 Sodium succinate, hexahydrate 6106-21-4 35 100 500 500 Used sodium succinate mouse iv LD50.

2783 Sodium sulfate, anhydrous 7757-82-6 10 30 500 500

2784 Sodium sulfhydrate; (Sodium hydrosulfide) 16721-80-5 0.06 0.15 1.25 6

2785 Sodium sulfide 1313-82-2 0.75 2.5 15 75

2786 Sodium sulfide nonahydrate 1313-84-4 0.2 0.6 4 20 Mouse intraperitoneal LD50.

2787 Sodium sulfite 7757-83-7 10 30 50 100

2788 Sodium tartrate dihydrate 6106-24-7 5 15 100 500 Rat oral LD50.

2789 Sodium tellurate 10101-83-4 0.186 0.559 0.931 150

2790 Sodium tellurite 10102-20-2 0.174 0.521 7.5 25


6/19/2009



PAC Rev 24B





2791 Sodium tetrafluoroborate(1-) 13755-29-8 3.61 10.8 18.1 100 Fluoride concentration limits, rat sc LD50.

2792 Sodium tetraphenyl borate 143-66-8 1.25 3.5 25 125

2793 Sodium thiosulfate 7772-98-7 10 30 50 500

2794 Sodium thiosulfate pentahydrate 10102-17-7 10 30 50 500

2795 Sodium titanate 12034-34-3 10 30 50 250 PNOS default used.

2796Sodium tolyltriazole; (1H-benzzotriazole, 4(or 5)-

methyl-, sodium salt)64665-57-2 2.5 7.5 50 250 Rat LD50 minimum.

2797 Sodium tridecylbenzene sulfonate 26248-24-8 2 6 40 200 Human minimum LD = 500 mg/kg.

2798 Sodium triethylborohydride 17979-81-6 22.6 67.7 113 150Borate TLV-TWA, -STEL rat oral LD50 based on

HHR.

2799 Sodium trihydrogen silicate z-0076 10 30 50 250

2800 Sodium tripolyphosphate 7758-29-4 10 30 50 500

2801 Sodium tungstate 13472-45-2 1 3 7.5 500

2802 Sodium tungstate dihydrate 10213-10-2 1.79 5.38 15 75 TLV-TWA, TLV-STEL, rat ip LD50.

2803 Sodium uranate; (Disodium uranate hexahydrate) 66018-57-3 0.0779 0.935 3 15.6 Uranium compound concentration limits.

2804 Sodium uranium oxide monohydrate 13721-34-1 0.0685 0.822 2.5 13.7 Uranium compound concentration limits.

2805 Sodium uranyl carbonate z-0078 0.395 0.948 3 15.8 Uranium compound concentration limits.


6/19/2009



PAC Rev 24B





2806 Sodium zirconate; (Disodium zirconium oxide) 12201-48-8 10.9 21.8 21.8 54.6 Zr concentration limits.

2807 Sodium-Potassium 11135-81-2 0.482 0.482 5 50 Sodium hydroxide concentration limits.

2808Solvent naphtha, petroleum, medium aliphatic;

(Mineral spirits, naphtha)64742-88-7 25 75 500 500 PAC-2/21, PAC-2*7, rat TClo, PAC-2*5.

2809 Solvent Yellow 3 97-56-3 2 6 40 500

2810Soman; (3,3-Dimethyl-2-butyl

methylphosphonofluoridate; GD)96-64-0 0.0002 0.0013 0.0164 0.127 MSDS-TWA, AEGL-1, AEGL-2, AEGL-3

2811Sorbitan monolaurate; (D-Glucitol, 1,4-anhydro-,

6-dodecanoate)5959-89-7 10 30 50 250 PNOS default used.

2812Sorbitan monostearate polyoxyethylene;

(Ethoxylated sorbitan monostearate)9005-67-8 0.75 2 15 500 Rat 7 week TDlo, rat iv LD50

2813 Sorbitan trioleate 26266-58-0 15 50 350 500 Rat iv TDlo.

2814 Sorbitan, monolaurate 1338-39-2 350 500 500 500 Rat oral 14 day TDlo, rat oral LD50.

2815 Sorbitan, monooleate 1338-43-8 250 500 500 500 Rat oral TDlo

2816Sorbitan, monooleate polyoxyethylene;

(Polyethylene sorbitan monooleate; Tween 80)9005-65-6 0.75 2.5 15 500 Rat oral TDlo, mouse oral LD50

2817 Sorbitan, monostearate 1338-41-6 400 500 500 500 Rat oral repro TDlo, rat LD50.

2818 Sorbitol, D-; (D-Glucitol) 50-70-4 40 125 500 500

2819Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-

one, 3',6'-dihydroxy-; (Fluorescein) 2321-07-5 0.4 1.25 7.5 250 Human iv TDlo, mouse iv LD50.

2820Squalene; (2,6,10,15,19,23-Hexamethyl-

2,6,10,14,18,22-tetracosahexene, (all-E)-)111-02-4 20 60 400 500 Mouse oral LD50.


6/19/2009



PAC Rev 24B





2821Stannic chloride; (Tin(IV) chloride; Tin(IV)

tetrachloride)7646-78-8 4.39 4.39 5 219

2822 Stannous chloride; (Tin(II) chloride (1:2)) 7772-99-8 3.19 9.58 50 160 PEL-TWA, TLV-TWA*3, rat TClo, IDLH.

2823 Stannous octoate 301-10-0 0.341 1.023 15 85.3 Organic tin compound concentration limits.

2824 Starch dust 9005-25-8 15 30 500 500 PEL-TWA, rat oral TDlo, mouse ip LD50.

2825 Stibine; (Antimony hydride) 7803-52-3 0.5 1 7.65 49 PEL-TWA, AEGL-2/7, AEGL-2, AEGL-3.

2826 Stilbene 588-59-0 5 15 100 500 Mouse ip LD50.

2827Stilbene 3; (Stilbene 420; Tinopal CBS; Disodium

4,4'-bis(2-sulfostyryl)biphenyl)27344-41-8 0.25 0.75 6 500

2828Stoddard solvent; (Mineral spirits, 85% nonane

and 15% trimethyl benzene)8052-41-3 500 500 500 500

2829 Strontium 7440-24-6 10 30 50 250

2830 Strontium carbonate 1633-05-2 20 20 20 20 SAR

2831 Strontium chloride 10476-85-4 7.5 20 150 500 Rat oral TDlo, rat oral LD50.

2832 Strontium hydroxide 18480-07-4 0.75 0.75 20 75 SAR

2833 Strontium nitrate 10042-76-9 10 30 250 500

2834 Strontium nitrite; (Nitrous acid, strontium salt) 13470-06-9 0.04 0.1 0.75 75 SAR

2835 Strontium oxalate 814-95-9 7.5 25 60 75 SAR


6/19/2009



PAC Rev 24B





2836 Strontium phosphate; (Strontium orthophosphate) 14414-90-5 10 30 500 500 SAR

2837 Strontium phosphide 12504-13-1 1 3 4.85 8.72 AEGL-2/5, AEGL-2*3/5, AEGL-2, AEGL-3.

2838 Strontium sulfate 7759-02-6 10 30 50 250

2839 Strychnine 57-24-9 0.15 0.3 0.3 3

2840 Strychnine sulfate (2:1) 60-41-3 1 3 5 30

2841 Styrene 100-42-5 85.1 85.1 553 4,680 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2842 Styrene oxide; (1,2-Epoxyethylbenzene) 96-09-3 20 60 250 250

2843 Styrene-allyl alcohol copolymer 25119-62-4 10 30 50 250 PNOS default,

2844

Styrene-divinylbenzene resin, chloromethylated,

aminated with trimethylamine; (Bio-Rad AG1-X8

anion exchange resin, formate form)


2845 Styrenesulfonate), poly(sodium 4- 25704-18-1 150 500 500 500 Pregnant rai oral TDlo, rat oral LD50 minimum.

2846 Succinic acid 110-15-6 7.5 25 200 500

2847 Succinic anhydride 108-30-5 0.75 2 15 500

2848 Sucrose 57-50-1 15 30 50 500 Concentration limits, rat oral LD50

2849Sucrose, diacetate hexaisobutyrate; (Sucrose

acetate isobutyrate; SAIB)126-13-6 12.5 40 300 500 Dog oral TDlo, rat oral LD lo.


6/19/2009



PAC Rev 24B





2850 Sulfamic acid 5329-14-6 12.5 40 250 500

2851 Sulfanilamide 63-74-1 1 3 20 500

2852 Sulfanilic acid 121-57-3 50 150 500 500 Rat oral LD50.

2853Sulfonic acids, petroleum; (Petrolatum acid

sulfonate)61789-85-3 10 30 50 250

2854 Sulfonylbis-ethanol, 2,2'- 2580-77-0 1.5 5 35 150 Estimated HHR = 3 and rat oral LD50.

2855 Sulfosalicylic acid 97-05-2 10 30 200 500

2856 Sulfosalicylic acid, dihydrate, crystal 5965-83-3 7.5 20 150 500 Rat oral LD50.

2857 Sulfotep; (TEDP) 3689-24-5 0.2 0.5 3.5 10

2858 Sulfur 7704-34-9 0.125 0.4 2.5 12.5

2859 Sulfur dioxide 7446-09-5 0.524 0.524 1.96 78.5 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2860 Sulfur hexafluoride 2551-62-4 6,000 15,000 30,000 30,000 Concentration limits, mam LC lo

2861 Sulfur monochloride 10025-67-9 2.92 2.92 35.3 82.8 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2862 Sulfur pentafluoride 5714-22-7 0.1 0.1 0.1 10

2863 Sulfur tetrafluoride 7783-60-0 0.35 1 7.5 7.5

2864 Sulfur trioxide 7446-11-9 0.06 0.20 8.7 160 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





2865 Sulfuric acid 7664-93-9 0.2 0.20 8.7 160 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

2866 Sulfuric Acid-d2; (Deuterosulfuric acid) 13813-19-9 1 1 3 15Used sulfuric acid concentration limits PEL-TWA,

IDLH.

2867 Sulfurous acid 7782-99-2 0.0125 0.04 0.3 1.5

2868 Sulfuryl chloride 7791-25-5 1 3 20.4 60.7 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

2869 Sulfuryl fluoride 2699-79-8 20 40 87.6 267 PEL-TWA, TLV-STEL, AEGL-2, AEGL-3.

2870 Talc 14807-96-6 2 2 10 500

2871 Tall oil (alkyd resin) 68333-62-0 10 30 50 250

2872 Tantalum 7440-25-7 5 10 500 500

2873 Tantalum carbide 12070-06-3 5.33 10.7 500 500 Tantalum and oxide dust concentration limits used.

2874 Tantalum(V) ethoxide 6074-84-6 10 30 50 250 PNOS default.

2875 Tantalum(V) fluoride 7783-71-3 7.26 21.8 36.3 100

2876 Tantalum(V) oxide 1314-61-0 6.11 12.2 500 500

2877 Tartaric acid 87-69-4 4 12.5 75 400

2878 Tartaric acid, monopotassium salt 868-14-4 150 500 500 500 Rat oral LD50.

2879 Tartaric acid, monosodium salt 526-94-3 15 50 400 500 Mouse oral LD50.


6/19/2009



PAC Rev 24B





2880 Technetium(IV) oxide 12036-16-7 10 30 50 250

2881 Technetium-99 14133-76-7 Radiation dose will dominate. No TEELs.

2882 Tellurium 13494-80-9 0.1 0.3 20 25

2883 Tellurium chloride 10026-07-0 0.211 0.633 15 52.8

2884 Tellurium hexafluoride 7783-80-4 0.35 1 1 15

2885 Tellurium oxide; (Tellurium dioxide) 7446-07-3 0.125 0.375 5 31.3

2886 Tellurous acid 10049-23-7 0.139 0.418 0.696 34.8

2887 Terbium 7440-27-9 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

2888 Terbium oxide 12036-41-8 10 30 50 250

2889 Terbium(III,IV) oxide 12037-01-3 10 30 50 250 PNOS default.

2890 Terbufos 13071-79-9 0.01 0.03 1 1 TLV-TWA, TEEL-0*3, LOC, rat oral LD50.

2891 Terephthalic acid 100-21-0 10 125 500 500

2892 Terephthaloyl chloride 100-20-9 0.75 2.5 20 500

2893 Terphenyl; p- 92-94-4 0.4 1.25 9 500

2894 Terphenyls; (Diphenylbenzene) 26140-60-3 1.5 5 9 500


6/19/2009



PAC Rev 24B





2895 Tert-butyl alcohol; (tert-Butanol) 75-65-0 300 400 5,000 5,000

2896 Tert-butyl benzoic acid, p- 98-73-7 2 6 50 200 Rat 360 min TClo, rat oral LD50.

2897 Tert-butyllithium 594-19-4 1.5 5 35 150 Rat LD50 estimated from HHR = 3.

2898 Tert-butylphenol, p-; (Tert-butylphenol, 4-) 98-54-4 0.5 0.5 0.75 500 MAK-TWA, mouse TClo, rat LC lo.

2899 Tert-butylpyridine, 4- 3978-81-2 10 30 50 250 PNOS default used.

2900 Tetraamminepalladium(II) nitrate 13601-08-6 1.5 5 35 150

2901Tetrabromoethane, 1,1,2,2-; (Acetylene

tetrabromide)79-27-6 1.25 75 100 100 TLV-TWA, mouse TClo, IDLH.

2902 Tetrabutyl ammonium phosphate 5574-97-0 10 30 50 250 Used PNOS default

2903 Tetrabutyl titanate; (Butyl titanate) 5593-70-4 12.5 40 250 1,250

2904Tetrabutylammonium fluoride; (N,N,N-Tributyl-1-

butanaminium, fluoride)429-41-4 34.4 103 172 500 Fluoride concentration limits.

2905 Tetrabutylammonium hydroxide 2052-49-5 0.06 0.15 1.25 6

2906 Tetrabutylammonium nitrate 1941-27-1 0.075 0.25 1.5 7.5

2907 Tetrachloro-1,2-difluoroethane, 1,1,2,2- 76-12-0 4,000 4,000 15,000 15,000 PEL-TWA, TEEL-0, IDLH, IDLH.

2908 Tetrachlorobenzene, 1,2,3,4- 634-66-2 12.5 35 250 500

2909 Tetrachlorobenzene, 1,2,4,5- 95-94-3 10 30 50 500


6/19/2009



PAC Rev 24B





2910 Tetrachlorodibenzofuran, 2,3,7,8- 51207-31-9 0.0006 0.002 0.002 0.002

2911 Tetrachlorodibenzo-p-dioxin, 1,2,3,8- 53555-02-5 0.004 0.0125 0.075 0.4

2912 Tetrachloroethane (mixed isomers) 25322-20-7 10 35 200 3,000

2913 Tetrachloroethane, 1,1,1,2- 630-20-6 20 60 400 1,500

2914 Tetrachloroethane, 1,1,2,2- 79-34-5 35 35 35 600

2915Tetrachlorohexafluorobutane, 2,2,3,3-; (FLON;

CFC316)375-34-8 2.5 7.5 50 250

2916 Tetrachlorosilane; (Silicon chloride) 10026-04-7 1 3.12 38.2 174 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

2917Tetracosafluorotetradecahydro-phenanthrene;

(Perfluorophenanthrene)306-91-2 3.42 10.3 17.1 75 Fluoride concentration limits.

2918 Tetracyanoquinodimethane 1518-16-7 0.4 1.25 10 50

2919 Tetracycline hydrochloride 64-75-5 0.75 2.5 15 500

2920Tetradecafluorohexane; (Perfluoro-n-hexane;

Fluorinert FC72)355-42-0 2,500 7,500 60,000 350,000 Rat TClo, rat LC lo minimum.

2921 Tetradecane; (N-tetradecane) 629-59-4 0.125 0.4 2.5 10,000PAC-2/21, PAC-2/7, mouse sk TDlo, mouse iv LD

lo.

2922 Tetradecanoic acid; (Myristic acid) 544-63-8 0.35 1 7.5 35

2923 Tetradecyltrimethylammonium bromide 1119-97-7 15 50 350 500 Rat oral LD50.

2924 Tetraethyl lead 78-00-2 0.117 0.468 0.781 62.4


6/19/2009



PAC Rev 24B





2925Tetraethyl orthosilicate; (Ethyl silicate;

Tetraethoxysilane)78-10-4 213 213 850 2,550 ERPG-1, ERPG-1, ERPG-2, ERPG-3.

2926 Tetraethyl pyrophosphate; (TEPP) 107-49-3 0.05 0.15 1 5 PEL-TWA, LOC, IDLH.

2927 Tetraethylammonium chloride 56-34-8 0.25 0.75 6 500 Human iv TDlo, rat LD50.

2928 Tetraethylene glycol 112-60-7 125 350 500 500

2929 Tetraethylene glycol diacrylate 17831-71-9 1 3.5 25 350 WEEL-TWA, rabbit sk TDlo, rat oral LD50.

2930 Tetraethylenepentamine 112-57-2 5 15 350 500 WEEL-TWA, rat oral LD50.

2931 Tetraethyltin; (Tetraethylstannane) 597-64-8 0.198 0.396 7 49.5

2932Tetrafluoroethane, 1,1,1,2-; (HFC

134a)811-97-2 4,000 33,400 54,200 113,000 WEEL-TWA, AEGL-1, AEGL-2, AEGL-3

2933 Tetrafluoroethane, 1,1,2,2-; (HFC 134) 359-35-3 3.5 10 15 350 Fluoride concentration limits.

2934 Tetrafluoroethylene 116-14-3 7.5 899 2,250 13,500 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

2935 Tetrafluorohydrazine 10036-47-2 3.5 10 75 400

2936 Tetrahydro-2,5-dimethyl furan 1003-38-9 15 50 350 500

2937 Tetrahydrofuran 109-99-9 150 295 1,470 14,700 TLV-TWA, ERPG-1, ERPG-2, ERPG-3.

2938 Tetrahydrofuran-d8 1693-74-9 300 300 1,500 15,000 Used tetrahydrofuran (109-99-9) limits.

2939 Tetrahydronaphthalene, 1,2,3,4-; (Tetralin) 119-64-2 1.25 3.5 25 100 Human TClo, guinea pig LC50.


6/19/2009



PAC Rev 24B





2940 Tetrahydropyridine, 1,2,3,6- 694-05-3 10 30 50 250 PNOS default.

2941Tetramethoxypropane, 1,1,3,3-; (Malonaldehyde

bis(dimethyl acetal))102-52-3 7.5 25 150 500 Estimated rat oral LD50.

2942 Tetramethoxysilane; (Methyl silicate) 681-84-5 5.66 5.66 5.66 8.71 AEGL-2, AEGL-2, AEGL-2, AEGL-3.

2943 Tetramethyl ammonium, tetrahydroborate(1-) 16883-45-7 0.3 1 6 35 Rat oral LD50.

2944 Tetramethyl ethylene diamine 110-18-9 50 150 600 600

2945 Tetramethyl lead 75-74-1 0.0968 0.581 4 51.6

2946Tetramethyl-1,3-butanediamine, N,N,N',N'-;

(Tetramethyl butanediamine)97-84-7 2 6 40 200

2947Tetramethyl-3,5-heptanedione, 2,2,6,6-;

(Dipivaloylmethane)1118-71-4 10 30 50 250 PNOS default used.

2948 Tetramethyl-5-decyne-4,7-diol, 2,4,7,9- 126-86-3 10 30 50 250

2949 Tetramethylammonium chloride 75-57-0 0.2 0.6 4 20 Rat oral LD50.

2950 Tetramethylammonium hydroxide 75-59-2 0.06 0.15 1.25 6

2951 Tetramethylammonium hydroxide pentahydrate 10424-65-4 0.3 0.75 6 6 Rat skin TDlo, mouse sc LD lo.

2952 Tetramethylammonium silicate 53116-81-7 10 30 50 250 PNOS default used.

2953 Tetramethylbenzene, 1,2,3,5- 527-53-7 0.15 0.5 3.5 500 Rat skin TDlo, rat oral LD50.

2954 Tetramethylbenzene, 1,2,4,5- 95-93-2 30 100 500 500 Rat 24 hour TClo, rat LD50.


6/19/2009



PAC Rev 24B





2955 Tetramethylbenzidine, 3,3',5,5'- 54827-17-7 0.5 1.5 10 60 Mouse ip LD50

2956Tetramethylene sulfone; (Sulfolane;

Tetrahydrothiophene-1,1-dioxide)126-33-0 125 200 200 200 Monkey TClo, rat 8 hr LC lo minimum.

2957 Tetramethylsilane 75-76-3 15 50 75 350

2958 Tetranitromethane 509-14-8 4.17 4.17 4.17 13.6 AEGL-2, AEGL-2, AEGL-2, AEGL-3

2959 Tetraoxadodecane, 2,5,8,11- 112-49-2 6 20 150 750 Mouse oral TDlo preg.

2960Tetraoxatetracosan-1-ol, 3,6,9,12-; ((Laurel

alcohol tri(oxyethylene) ethanol; BRIJ 30)5274-68-0 10 30 50 250

2961Tetraphenylarsonium chloride;

(Tetraphenylarsenium chloride)507-28-8 2.79 8.38 14 25

2962Tetrapotassium ethylenediaminetetraacetate;

(EDTA tetrapotassium salt)5964-35-2 4 15 75 400 SAR

2963 Tetrapropoxysilane 682-01-9 7.5 25 150 500 Rat oral LD50 estimated from HHR = 2.

2964 Tetrapropylammonium hydroxide 4499-86-9 0.15 0.5 3.5 15

2965 Tetrapropylorthotitanate 3087-37-4 10 30 50 250 PNOS default.

2966 Tetrasodium pyrophosphate 7722-88-5 5 15 25 500 REL-TWA, TEEL-0*3, TEEL-0*5, rat oral LD50.

2967 Tetrazole, 1H- 288-94-8 10 30 50 150 TLV-TWA default, HHR-based rat oral LD50.

2968 Thallium 7440-28-0 0.1 0.3 2 15

2969 Thallium chloride; (Thallium(I) chloride) 7791-12-0 0.4 1.25 2 10


6/19/2009



PAC Rev 24B





2970 Thallium hydroxide 12026-06-1 0.108 0.325 0.542 16.2

2971 Thallium nitrate; (Thallium(I) nitrate) 10102-45-1 0.13 0.391 19.6 19.6

2972 Thallium nitrite 13826-63-6 0.123 0.368 0.613 18.4

2973 Thallium oxide 1314-12-1 0.104 0.312 0.52 15

2974Thallium sulfate; (Sulfuric acid, dithallium(1+)

salt)10031-59-1 0.107 0.32 2 16

2975Thallium(I) acetate; (Acetic acid, thallium(1+)

salt)563-68-8 0.129 0.387 2.5 19.3

2976 Thallium(I) carbonate (2:1) 6533-73-9 0.4 1.25 2 10

2977Thallium(I) sulfate; (Sulfuric acid, dithallium(1+)

salt)7446-18-6 0.123 0.37 0.617 1.5

PEL-TWA, TEEL-0 x 3, human oral TDlo, human

oral LD lo.

2978 Thallium(III) oxide 1314-32-5 0.4 1.25 2 20 PAC-2/5, PAC-2*3/5, LOC, rat oral LD50

2979 Thallium(III) perchlorate hexahydrate 15596-83-5 0.299 0.897 7.5 44.8

2980 Thallous malonate 2757-18-8 0.125 0.375 2 18.7

2981 Thenoyltrifluoroacetone 326-91-0 1.25 3.5 25 125

2982 Thioacetamide 62-55-5 10 30 50 125

2983 Thioacetic acid 507-09-5 0.02 0.06 0.4 30 Rat skin TG lo, mouse ip LD50.

2984 Thiobis(4-chloro-6-methyl)phenol, 2,2’- 4418-66-0 0.25 0.75 1.3 1.3 LOC, rat oral LD50.


6/19/2009



PAC Rev 24B





2985 Thiocarbazide; (Thiocarbohydrazide) 2231-57-4 20 60 100 100

2986 Thiocresol, p-; (p-Toluenethiol) 106-45-6 0.75 2.5 15 75 Mouse ip LD50.

2987Thiocyanic acid, compound with guanidine (1:1);

(Guanidene thiocyanate salt)593-84-0 1.25 3.5 25 125 Mouse ip LD50.

2988 Thiodiglycol 111-48-8 25 75 500 500

2989 Thiofanox; (Dacamox) 39196-18-4 8.5 8.5 8.5 30

2990 Thionazin; (Ethyl pyrazinyl phosphorothioate) 297-97-2 0.6 2 3.5 3.5

2991 Thionyl chloride 7719-09-7 0.3 0.97 11.7 68.1 ERPG-1/3, ERPG-1, AEGL-2, AEGL-3.

2992 Thiophosphoryl chloride 3982-91-0 1.25 4 25 60 Rat oral TDlo, rat 240 min LC50.

2993 Thiosemicarbazide 79-19-6 0.075 0.2 1.5 4

2994 Thiourea 62-56-6 10 10 25 125

2995Thiram; (Tetramethylthioperoxydicarbonic

diamide)137-26-8 5 5 5 100 PEL-TWA, TEEL-O, TEEL-0, IDLH.

2996 Thorium 7440-29-1 0.2 0.6 4 20 Human TClo.

2997 Thorium hydroxide 13825-36-0 0.75 0.75 2.5 75 SAR

2998 Thorium nitrite z-0079 0.05 0.125 0.75 75 SAR

2999 Thorium oxalate 2040-52-0 42.1 126 210 500 T-0 based on DRL for Th.


6/19/2009



PAC Rev 24B





3000 Thorium oxide; (Thorium dioxide) 1314-20-1 25 75 500 500 Human intra-arterial TDlo, rat it LD50 minimum.

3001 Thorium perchlorate 16045-17-3 31.4 94.3 157 500 T-0 based on DRL for Th.

3002 Thorium(IV) nitrate 13823-29-5 0.75 2 15 25 Rat sc TDlo, rat ip LD50.

3003 Thulium 7440-30-4 10 30 50 250 PNOS default used.

3004 Thulium chloride 13537-18-3 15 50 350 500 Mouse oral LD50.

3005 Thulium oxide 12036-44-1 11.4 34.3 60 300 PNOS default.

3006Thymol blue; (6,6-(3H-2,1-benzoxathiol-3-

ylidene)dithymol, S,S-dioxide)76-61-9 10 30 50 250 PNOS default used.

3007 Thyodene; (Amylodextrin) 9005-84-9 10 30 50 250

3008 Tin 7440-31-5 2 6 100 100PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH

inorganic compounds, as Sn.

3009 Tin fluoroborate 13814-97-6 4.93 14.8 25 246PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3010 Tin hydroxide 12026-24-3 2.57 7.72 12.9 129PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3011 Tin nitrate 41480-79-9 4.09 12.3 20.4 204PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3012 Tin nitrite 100737-27-7 3.55 10.7 17.8 178PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3013Tin(II) chloride dihydrate; (Stannous chloride

dihydrate)10025-69-1 3.8 11.4 20 190

PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3014 Tin(II) oxide 1332-29-2 2.54 7.62 12.7 60 TLV-TWA, TLV-TWA*3, TLV-TWA*5, PAC-2*5


6/19/2009



PAC Rev 24B





3015 Tin(II) sulfate; (Stannous sulfate) 7488-55-3 3.62 10.9 18.1 181PEL-TWA, TLV-TWA*3, TLV-TWA*5, IDLH


3016 Tin(IV) isopropoxide 1184-61-8 0.35 0.7 15 87.4PEL-TWA, TLV-STEL, PAC-3/5, IDLH organic

compounds, as Sn.

3017 Tin(IV) oxide; (Stannic oxide) 18282-10-5 2.54 7.62 12.7 500TLV-TWA, TLV-TWA*3, TLV-TWA*5, rat oral

LD50 minimum.

3018 Titanium 7440-32-6 10 30 50 50

3019 Titanium aluminide 39410-63-4 10 30 50 250

3020 Titanium boride 12045-63-5 10 30 50 250

3021 Titanium carbide 12070-08-5 12.5 37.5 62.6 300

3022 Titanium chloride 7705-07-9 0.5 1.5 10 50

3023 Titanium hydride 7704-98-5 1.5 5 35 150

3024 Titanium oxide; (Titanium dioxide) 13463-67-7 15 15 15 500

3025 Titanium tetrachloride 7550-45-0 0.5 5 7.75 44.2 WEEL-TWA, ERPG-1, AEGL-2, AEGL-3.

3026 Titanium(II) oxide 12137-20-1 10 30 50 250

3027 Titanium(III) fluoride 13470-08-1 4.6 12.5 75 460 Fluoride concentration limits.

3028 Titanium-based alloy; (Titanium compounds) z-0081 10 30 50 250

3029 Toluene 108-88-3 75 753 4,520 16,900 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.


6/19/2009



PAC Rev 24B





3030 Toluene diisocyanate (mixed isomers) 26471-62-5 1.5 5 12.5 12.5

3031 Toluene-2,4-diisocyanate; (TDI) 584-84-9 0.035 0.142 0.591 3.63 TLV-TWA, AEGL-1, AEGL-2, AEGL-3

3032Toluene-2,6-diamine; (2-Methyl-1,3-

benzenediamine)823-40-5 1.5 4 30 150

3033 Toluene-2,6-diisocyanate 91-08-7 0.035 0.142 0.591 3.63 TLV-TWA, AEGL-1, AEGL-2, AEGL-3

3034 Toluene-d8; (Deuterated toluene) 2037-26-5 200 750 2,000 10,000 Used Toluene (108-88-3) PACs.

3035 Toluenediamine, 2,4-; (2,4-Diaminotoluene) 95-80-7 0.005 7.5 60 250 WEEL-TWA, PAC-2/7, rat oral TDlo, rat oral LD50.

3036 Toluenesulfonamide, p-; (Pasam) 70-55-3 1 3 20 100 Mouse ip LD50.

3037 Toluenesulfonic acid, methyl ester, p- 80-48-8 0.75 2.5 15 150 Rat oral TDlo and LD50.

3038 Toluenesulfonyl chloride, p- 98-59-9 2.5 7.5 50 250 WEEL-C, rat oral TDlo.

3039Toluenesulphonic acid monohydrate, para-; (4-

Methylbenzenesulphonic acid monohydrate)6192-52-5 10 30 200 500

3040 Toluenethiol, m- 108-40-7 0.2 0.6 4 20

3041 Toluidine, m-; (3-Methylaniline) 108-44-1 7.5 35 200 200 TLV-TWA, rat oral TDlo, rat oral LD50.

3042 Toluidine, o- 95-53-4 20 20 20 200 Concentration limits, Human TClo.

3043 Toluidine, p-; (4-Methylbenzenamine) 106-49-0 2 15 125 150 TLV-TWA, rat oral TDlo, rat oral LD50.

3044 Toxaphene; (Chlorinated camphene) 8001-35-2 0.5 1 20 200 PEL-TWA, TLV-STEL, LOC, IDLH.


6/19/2009



PAC Rev 24B





3045 Trans-1,4-dichlorobutene; (2-Butylene dichloride) 110-57-6 0.2 0.6 4 40

3046Transformer oil; (Mineral oil, petroleum distillates,

hydrotreated (mild) light naphthenic)64742-53-6 5 15 100 500

3047Tri(2-ethylhexyl) phosphate; (Tris(2-

ethylhexyl)phosphate)78-42-2 12.5 12.5 12.5 12.5

3048 Triacetin; (Triacetyl glycerin) 102-76-1 12.5 35 250 500

3049 Triamiphos 1031-47-6 2 6 10 10

3050 Triaryl sulfonium chloride salts 109037-76-5 10 10 25 125

3051Triazine-1,3,5(2H,4H,6H)-triethanol, s-; (Onyxide

200)4719-04-4 3 10 60 350

3052 Triazofos; (Triazophos) 24017-47-8 0.5 1.5 2.8 125

3053 Tribenzylamine 620-40-6 10 30 50 250 PNOS default.

3054 Tributyl citrate 77-94-1 15 50 350 1,250 Mouse ip LD50 and TDlo.

3055 Tributyl phosphate 126-73-8 5 25 150 300 PEL-TWA, rat oral TDlo, IDLH.

3056 Tributyl(2,4-dichlorobenzyl)phosphonium chloride 115-78-6 0.75 2 15 75

3057Tributyl-1-butanaminium iodide, N,N,N-;

(Tetrabutylammonium iodide)311-28-4 7.5 25 150 500 Rat oral D50.

3058 Tributylphosphine 998-40-3 3 7.5 60 300 Rat oral LD50.

3059 Tributyltetradecylphosphonium chloride 81741-28-8 10 30 50 250 PNOS default used


6/19/2009



PAC Rev 24B





3060 Trichloramine; (Nitrogen chloride) 10025-85-1 0.6 1.5 12.5 100

3061Trichloro(dichlorophenyl) silane;

(Dichlorophenyltrichlorosilane)27137-85-5 2 6.88 83.7 378 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3062 Trichloro-2,2,2-trifluoroethane, 1,1,1- 354-58-5 250 500 500 500

3063 Trichloroacetaldehyde hydrate; (Chloral hydrate) 302-17-0 10 30 50 50

3064 Trichloroacetaldehyde; (Chloral) 75-87-6 2.5 7.5 50 250

3065 Trichloroacetic acid 76-03-9 6 6 15 150

3066 Trichloroacetyl chloride 76-02-8 0.2 0.6 4 50 Rat 240 min LC50.

3067 Trichlorobenzene, 1,2,3- 87-61-6 6 15 125 500

3068 Trichlorobenzene, 1,2,4- 120-82-1 35 35 35 300

3069Trichloroethane, 1,1,1-; (Methyl

chloroform)71-55-6 1,250 1,250 3,270 22,900 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

3070 Trichloroethane, 1,1,2- 79-00-5 50 50 75 500

3071 Trichloroethanol, 2,2,2- 115-20-8 12.5 35 250 250 Ratoral TDlo, rat oral LD50.

3072 Trichloroethylene 79-01-6 50 698 2,420 20,400 TLV-TWA, AEGL-1, AEGL-2, AEGL-3.

3073Trichloroethylsilane; (Ethyl

trichlorosilane)115-21-9 1.25 4.01 48.8 221 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3074Trichlorofluoromethane; (Fluorotrichloromethane,

Freon 11)75-69-4 5,000 5,000 7,500 10,000 PEL-TWA, TEEL-0, EEGL, IDLH.


6/19/2009



PAC Rev 24B





3075

Trichlorohydroxyethyl dimethylphosphonate;

((2,2,2-Trichloro-1-

hydroxyethyl)dimethylphosphonate; Trichlorphon)

52-68-6 1 3 5 500 TLV-TWA, human TClo, rat 240 min LC50.

3076 Trichloroisocyanuric acid 87-90-1 30 75 500 500 Human oral LD lo.

3077 Trichloronaphthalene 1321-65-9 5 15 25 50 PEL-TWA, TEEL-0*3, TEEL-0*5, IDLH.

3078Trichloronate; (Ethyl

trichlorophenylethylphosphonothioate)327-98-0 2 6 10 300

3079 Trichlorophenol, 2,3,6- 933-75-5 1.25 4 25 125

3080 Trichlorophenol, 2,4,5- 95-95-4 10 30 350 350

3081 Trichlorophenol, 2,4,6- 88-06-2 10 30 350 350

3082Trichlorophenoxy)propionic acid, 2-(2,4,5-;

(Silvex)93-72-1 10 30 200 250

3083 Trichlorophenoxyacetic acid, 2,4,5-; (2,4,5-T) 93-76-5 10 30 50 250

3084 Trichlorophenylsilane 98-13-5 1.5 5.19 63.1 285 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3085 Trichloropropane, 1,2,3- 96-18-4 60 60 60 600

3086 Trichlorosilane 10025-78-2 1 3.32 40.4 183 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3087 Trichlorotrifluoroethane; (Freon 113; CFC113) 76-13-1 7,500 10,000 10,000 15,000

3088 Tridecane 629-50-5 0.125 0.35 2.5 50 Rabbit skin TDlo, rat 480 min LC50 minimum.


6/19/2009



PAC Rev 24B





3089Tridodecylamine; (Alamine 304; N,N-didodecyl-1-

dodecanamine)102-87-4 7.5 25 150 500 Rat oral LD50 based on HHR.

3090 Triethanolamine; (Trihydroxytriethylamine) 102-71-6 5 5 20 500

3091 Triethoxysilane 998-30-1 0.35 3.36 26.9 67.2 WEEL-TWA, ERPG-1, ERPG-2, ERPG-3.

3092 Triethoxyvinylsilane 78-08-0 125 400 2,500 12,500 Rat 240 min LC lo.

3093 Triethyl phosphate; (TEP) 78-40-0 75 200 500 500 Rat TClo, rat LC lo.

3094 Triethyl phosphite 122-52-1 12.5 40 300 1,500

3095 Triethylaluminum 97-93-8 8.46 8.46 50 250Aluminum alkyls (as Al) TLV-TWA, rat 15 min

LC50.

3096 Triethylamine 121-44-8 4 12.5 12.5 750

3097 Triethylammonium bicarbonate buffer ph 8.5 15715-58-9 10 30 50 250 PNOS default used.

3098 Triethylbenzene (mixed isomers) 25340-18-5 40 125 750 4,000

3099 Triethylene glycol 112-27-6 300 500 500 500

3100 Triethylene glycol monomethyl ether 112-35-6 40 125 500 500

3101 Triethylenetetramine 112-24-3 6 50 350 1,000WEEL-TWA, pregnant rat oral TDlo, rat oral

LDF50.

3102Triethylethanaminium hydroxide, N,N,N-;

(Tetraethyl ammonium hydroxide)77-98-5 0.35 1 7.5 35 Mouse subcutaneous LD lo

3103 Triethyloxonium tetrafluoroborate 368-39-8 6.25 18.8 31.3 500 Fluoride concentration limits.


6/19/2009



PAC Rev 24B





3104 TrietHylphosphorothioate; (Tepto) 126-68-1 1.25 4 25 125 Rat 240 min LC50.

3105Trifluoro-1-(2-thienyl)-1,3-butanedione, 4,4,4-,

boron difluoride22502-27-8 0.75 2.5 15 75 Mouse iv LD50.

3106Trifluoro-4-nitro-m-cresol, alpha,alpha,alpha-; (4-

Nitro-3-(trifluoromethyl)phenol)88-30-2 0.6 1.5 12.5 60 Rat oral LD50.

3107Trifluoroacetaldehyde hydrate; (2,2,2-Trifluoro-

1,1-ethanediol)421-53-4 2.5 7.5 50 250 Mouse oral LD50.

3108 Trifluoroacetic acid anhydride 407-25-0 4.61 13.8 23 461 Concentration limits, as F

3109 Trifluoroacetic acid; (Trifluoroethanoic acid) 76-05-1 50 75 75 75

3110 Trifluoroacetyl chloride 354-32-5 6 15 250 1,250

3111 Trifluoroethanol, 2,2,2-; (Trifluoroethyl alcohol) 75-89-8 1.25 35 250 250 WEEL-TWA, rat TClo, rat LC50.

3112 Trifluoromethanesulfonic acid; (Triflic acid) 1493-13-6 0.6 1.5 12.5 60 Rat 240 min LC50 based on HR =3.

3113 Trifluoromethanesulfonic anhydride 358-23-6 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

3114 Trifluoromethyl iodide; (Iodotrifluoromethane) 2314-97-8 15,000 35,000 35,000 35,000 Rat 2 week TClo, rat 4 hour LC lo.

3115Trifluoromethyl)benzenamine, 3-( ; (m-

Aminobenzal fluoride)98-16-8 0.75 2.5 4.4 150

3116Trifluralin; (2,6-Dinitro-N,N-dipropyl-4-

(trifluoromethyl) benzenamine)1582-09-8 0.025 0.075 0.6 300

3117 Triisobutylaluminum 100-99-2 14.7 44.1 500 500

3118 Trimethoxy(3,3,3-fluoropropyl) silane 429-60-7 9.57 28.7 50 500 Fluoride concentration limits.


6/19/2009



PAC Rev 24B





3119 Trimethoxyboroxine 102-24-9 20 60 400 500

3120 Trimethoxysilane 2487-90-3 0.25 2.5 4.15 12.5 WEEL-TWA, ERPG-1, AEGL-2, AEGL-3.

3121 Trimethoxysilyl)-1-propanamine, 3-( 13822-56-5 10 30 50 250 PNOS default

3122Trimethoxysilyl-1-Propanethiol, 3-; (3-

Mercaptopropyltrimethoxysilane)4420-74-0 3 7.5 60 300 Rat oral LD50

3123Trimethoxysilylpropyl methacrylate, 3-; (Silane A-

174)2530-85-0 6 15 125 500 Rat TClo, rat oral LD50.

3124 Trimethoxysilylpropyl) ethylenediamine, N-(3- 1760-24-3 30 75 500 500 Rat oral LD50.

3125Trimethoxyvinylsilane; (Vinyltrimethoxysilane;

Silane, trimethoxyvinyl)2768-02-7 750 2,500 7,500 7,500 PAC-2/21, PAC-2/7, rat TClo, rat LC50.

3126 Trimethyl borate 121-43-7 25 75 500 2,500 Rat oral LD50

3127 Trimethyl N', 2-hydroxyethyl-propylenediamine 82136-26-3 10 30 50 250 Used PNOS default.

3128 Trimethyl phosphate; (TMP) 512-56-1 25 75 350 350

3129 Trimethyl phosphite 121-45-9 10 350 2,500 4,000

3130Trimethyl-1,3-pentanediol monoisobutyrate, 2,2,4-

; (Texanol)25265-77-4 25 75 500 500

3131 Trimethyl-1-pentene, 2,4,4-; (Diisobutylene) 107-39-1 350 1,000 1,500 7,500 WEEL-TWA

3132Trimethyl-2,5,8,11-tetraoxatetradecan-13-ol,

4,7,10-20324-34-9 10 30 50 250

3133 Trimethyl-2-hexene, 4,4,5- 55702-61-9 10 30 50 250


6/19/2009



PAC Rev 24B





3134

Trimethyl-2-oxepanone (mixed isomers);

(Hexanoic acid, 6-hydroxytrimethyl, epsilon-

lactone)

64047-30-9 30 75 500 500 Rat oral LD50

3135 Trimethylacetic acid; (Pivalic acid) 75-98-9 3.5 10 75 400 Rat oral LD50.

3136 Trimethylacetyl chloride; (Pivaloyl chloride) 3282-30-2 0.5 1.5 10 50 Rat 240 min LC50 assumed from HR=3

3137 Trimethylaluminum 75-24-1 5.34 16 26.7 125 TLV-TWA

3138 Trimethylamine 75-50-3 12.5 19.3 290 918 TLV-TWA, AEGL-1, AEGL-3, AEGL-3.

3139 Trimethylaniline, 2,4,6- 88-05-1 0.125 0.4 2.9 40

3140 Trimethylbenzene, 1,2,3- 526-73-8 125 688 1,770 7,500 TLV-TWA, AEGL-1, AEGL-2, rat oral LD lo.

3141Trimethylbenzene, 1,2,4-;

(Pseudocumene)95-63-6 125 688 1,770 7,500

TLV-TWA, AEGL-1, AEGL-2, rat 240 min

LC50.

3142Trimethylbicyclo(3.1.1)-2-hept-2-ene, 2,6,6-;

(alpha-Pinene)80-56-8 0.0002 0.0005 0.0035 0.015 Rat LClo

3143 Trimethylchlorosilane 75-77-4 2.5 7.99 142 577 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3144 Trimethyldecane, 2,2,8- 62238-01-1 350 350 1,500 7,500 NIOSH REL-TWA for alkanes.



3147 Trimethylene oxide; (Oxetane) 503-30-0 0.1 0.3 2 75 Rat sc TDlo and LD50.

3148 Trimethylgallium 1445-79-0 1.5 5 35 150 Rat oral LD50 based on HHR.


6/19/2009



PAC Rev 24B





3149 Trimethylhexane, 2,2,5- 3522-94-9 350 350 1,500 7,500 NIOSH REL-TWA for alkanes.

3150 Trimethyloctane 98060-52-7 350 350 1,500 6,000 NIOSH REL-TWA for alkanes.

3151 Trimethyloctane, 2,2,6- 62016-28-8 350 350 1,500 7,500 NIOSH REL-TWA for alkanes.




3155 Trimethylolpropane ethoxylate 50586-59-9 10 30 50 250 PNOS default.

3156 Trimethylolpropane phosphite 824-11-3 0.125 0.35 2.5 6

3157 Trimethylopropane methylated copolymer 71342-93-3 10 30 50 250 Used PNOS default.

3158 Trimethylphosphine 594-09-2 0.3 1 6 35 Rat 240 min LC50 based on HHR = 3.

3159 Trimethylpyridine, 2,4,6- 108-75-8 7.5 25 150 750

3160 Trimethylsilanol 1066-40-6 0.15 1.5 7.5 15 SAR

3161 Trimethylsilylmethyllithium 1822-00-0 1.5 5 35 150 Estimated rat oral LD50 based on HHR.

3162 Trimethyltin chloride; (Chlorotrimethylstannane) 1066-45-1 0.168 0.336 20 42

3163Trimethyltriheptylamine, 6,6',6''-;

(Triisooctylamine)2757-28-0 10 15 125 500


6/19/2009



PAC Rev 24B





3164 Tri-n-butylamine 102-82-9 0.15 0.5 3.5 60 Rat oral TDlo, rat 240 min LC lo.

3165 Trinitrobenzene, 1,3,5- 99-35-4 10 30 50 125

3166 Trinitrochlorobenzene; (Picryl chloride) 28260-61-9 10 30 50 250

3167 Trinitrophenylmethylnitramine, 2,4,6-; (Tetryl) 479-45-8 1.5 7.5 50 500

3168 Trinitrotoluene, 2,4,6- 118-96-7 1.5 7.5 60 500

3169Tri-n-octylphosphine oxide; (Trioctylphophine

oxide) 78-50-2 10 30 50 250

3170 Trioctylamine; (N,N-Dioctyl-1-octanamine) 1116-76-3 4 12.5 75 400

3171 Trioctylphosphine; (Tri-n-octylphosphine) 4731-53-7 0.5 1.5 10 50 Mouse 10 minute LC50 minimum.

3172 Tri-o-tolyl phosphate; (Triorthocresyl phosphate) 78-30-8 1.5 4 7.5 600

3173 Tripentaerythritol 78-24-0 10 30 50 250

3174 Triphenyl phosphate 115-86-6 3 9 500 500

3175 Triphenyl phosphite 101-02-0 7.5 25 150 200

3176 Triphenylborane 960-71-4 7.5 25 150 500 Rat oral LD50 based on HHR

3177 Triphenylethoxysilane 1516-80-9 10 30 50 250 PNOS default.

3178 Triphenylolmethane triglycidyl ether 66072-38-6 10 30 50 250 PNOS default.


6/19/2009



PAC Rev 24B





3179 Triphenylphosphine 603-35-0 1.5 5 40 500

3180 Triphenyltin chloride; (Chlorotriphenylstannane) 639-58-7 0.325 0.65 20 81.2

3181

Tripotassium (2-

hydroxyethyl)ethylenediaminetriacetate;

(Tripotassium HEDTA)

62029-50-9 5 15 125 600 SAR

3182 Tripotassium arsenate 13464-36-3 0.0342 0.103 0.171 17.1

3183 Tripropylamine 102-69-2 20 60 400 2,000 Rat 240 min LC50.

3184 Tripropylene glycol methyl ether 25498-49-1 12.5 40 250 500 Rat oral LD50.

3185

Tripropylene glycol monomethyl ether; (1-(2-(2-

Methoxy-1-methylethoxy)-1-methylethoxy)-2-

propanol)

20324-33-8 0.04 0.125 0.75 1,500

3186Tripropylene glycol; (((1-methyl-1,2-

ethanediyl)bis(oxy))bispropanol)24800-44-0 12.5 35 250 1,250 Rat oral LD50.

3187

Tris hydrochloride; (Trizma hydrochloride;

Tris(hydroxymethyl) aminomethane

hydrochloride)

1185-53-1 7.5 25 150 500 Rat oral LD50 based on MSDS HHR = 2.

3188Tris((hydroxymethyl)methylamino)propane-1-

sulphonic acid, 3-29915-38-6 10 30 50 250 PNOS default.

3189 Tris(2-aminoethyl)amine 4097-89-6 2 6 40 100 Rat oral TDlo, rat oral LD50.

3190Tris(2-chloroethyl) phosphate; (2-Chloroethanol

phosphate)115-96-8 7.5 20 150 500

3191Tris(2-chloroethyl)amine; (Nitrogen

mustard-3)555-77-1 0.001 0.003 0.022 0.37 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

3192 Tris(dimethylaminomethyl)phenol, 2,4,6- 90-72-2 5 15 100 500


6/19/2009



PAC Rev 24B





3193 Tris-hydroxymethylaminomethane; (THAM) 77-86-1 25 75 500 500

3194 Trisodium arsenate 13464-38-5 0.0277 0.0832 0.139 13.9

3195Trisodium arsenate, heptahydrate; (Arsenic(V)

acid, trisodium salt, heptahydrate (1:3:7))64070-83-3 0.0446 0.134 0.223 22.3

3196 Trisodium citrate 68-04-2 6 20 125 600

3197

Trisodium N-

hydroxyethylethylenediaminetriacetate;

(Trisodium N-(2-

hydroxyethyl)ethylenediaminetriacetate)

139-89-9 4 12.5 75 400

3198Triton X-100; (Poly(oxyethylene)-p-tert-

octylphenyl ether)9002-93-1 15 40 300 500

3199 Trypan blue 72-57-1 10 30 50 500

3200 Trypsin; (Parenzyme; Chymotrypsin inhibitor) 9002-07-7 0.025 0.075 0.6 30 Mouse intramuscular TDlo, rat iv LD40.

3201 Trypsinogen 9002-08-8 7.5 25 150 500 Rat oral LD50 based on HHR = 2.

3202 Tungsten 7440-33-7 5 10 10 500

3203 Tungsten boride 12007-09-9 5.29 10.6 26.5 125 Tungsten insoluble compound limits.

3204 Tungsten carbide 12070-12-1 5.33 10.7 10.7 10.7

3205 Tungsten hexafluoride 7783-82-6 1.62 4.86 75 405

3206 Tungsten trioxide; (Tungsten(VI) oxide) 1314-35-8 6.31 12.6 400 400


6/19/2009



PAC Rev 24B





3207 Tungsten(IV) chloride; (Tungsten tetrachloride) 13470-13-8 10 30 50 250 PNOS default used.

3208 Tungsten(IV) oxide 12036-22-5 5.87 11.7 11.7 11.7

3209 Tungstic acid 7783-03-1 6.8 13.6 13.6 13.6

3210 Tungstosilicic acid 11130-20-4 6.52 13 13 13 TLV-TWA, TLV-STEL, TLV-STEL, TLV-STEL.

3211 Turpentine 8006-64-2 100 100 100 4,000 TLV-TWA, TEEL-0, human TClo, IDLH.

3212 Undecane 1120-21-4 2 6 40 200 Rat oral LD50.

3213 Undecanone, 2-; (Methyl nonyl ketone) 112-12-9 1.25 4 30 2,000

3214 Uranine; (Fluorescein sodium) 518-47-8 12.5 40 250 500

3215 Uranium 7440-61-1 0.05 0.6 2 10 Concentration limits.

3216Uranium hexafluoride; (Uranium

fluoride)7783-81-5 0.0739 3.6 9.6 36 PEL-TWA, AEGL-1, AEGL-2, AEGL-3

3217 Uranium hydride; (Uranium(III) hydride) 13598-56-6 0.0506 0.608 2 10.1 Uranium compound concentration limits.

3218 Uranium oxide; (Triuranium octaoxide) 1344-59-8 0.059 0.707 10 50 PEL-TWA, TLV-STEL, ERPG-2, ERPG-3.

3219 Uranium telluride 12138-37-3 0.104 1.24 4 20.7 Uranium compound concentration limits.

3220 Uranium telluride A 12138-37-3a 0.0857 1.03 3.5 17.1 Uranium compound concentration limits.

3221 Uranium trioxide 1344-58-7 0.0601 0.5 0.5 3 PEL-TWA, PAC-2, ERPG-2, ERPG-3.


6/19/2009



PAC Rev 24B





3222 Uranium(IV) oxide; (Uranium dioxide) 1344-57-6 0.0567 0.681 10 30 PEL-TWA, TLV-STEL, ERPG-2, ERPG-3.

3223 Uranium: insoluble compounds z-0083 0.05 0.6 2 10 Uranium compound concentration limits.

3224 Uranium: soluble compounds z-0084 0.05 0.6 2 10 Uranium compound concentration limits.

3225 Uranyl acetate; (Uranium oxyacetate) 541-09-3 0.0891 1.07 3.5 17.8 Uranium compound concentration limits.

3226 Uranyl fluoride; (Uranium oxyfluoride) 13536-84-0 0.0647 0.776 2.5 12.9 Uranium compound concentration limits.

3227 Uranyl hydroxide 13470-18-3a 0.0639 0.766 2.5 12.8 Uranium compound concentration limits.

3228 Uranyl hydroxide (liquids) 13470-18-3b 0.0639 0.766 2.5 12.8 Uranium compound concentration limits.

3229Uranyl nitrate (solid); (Bis(nitrato-

O,O')dioxouranium)10102-06-4 0.0828 0.993 3 16.6 Uranium compound concentration limits.

3230 Uranyl nitrate (yellow salt) 36478-76-9 0.0828 0.993 0.993 16.6 Uranium compound concentration limits.

3231 Uranyl nitrate hexahydrate 13520-83-7 0.105 1.27 1.27 21.1 Uranium compound concentration limits.

3232 Uranyl nitrite (liquids) z-0087 0.076 0.913 3 15.2 Uranium compound concentration limits.

3233 Urea 57-13-6 10 10 15 500 WEEL-TWA, women implant TDlo, rat oral LD50.

3234 Urea peroxide; (Urea hydrogen peroxide) 124-43-6 1.5 5 35 150 Rat oral LD50 estimated from HHR = 3.

3235Urea, substituted; (Urea, N,N''-(4-methyl-1,3-

phenylene)bis[N',N'-dimethyl-)17526-94-2 1.5 5 35 150 Estimated rat oral LD50

3236Urethane; (Carbamic acid, ethyl ester; Ethyl

carbamate)51-79-6 500 500 500 500


6/19/2009



PAC Rev 24B





3237 Valeric acid 109-52-4 30 75 500 500 Rat oral preg. 10 day TDlo, mouse oral LD50

3238 Valinomycin 2001-95-8 0.5 1.5 2.5 2.5

3239 Vanadium 7440-62-2 0.05 0.15 0.5 35

3240 Vanadium pentoxide; (Vanadium(V) oxide) 1314-62-1 0.05 0.075 0.5 35

3241 Vanadium sulfate 16785-81-2 0.5 1.5 10 50

3242 Vanadium tetrachloride 7632-51-1 0.6 2 12.5 60

3243 Vanadium trioxide 1314-34-7 0.0412 0.124 50 50 V2.O5 TLV-TWA, rat TClo, mouse oral LD50.

3244 Vanadium(II) sulfate heptahydrate 36907-42-3 0.05 0.05 0.05 0.25

3245 Vanadium(III) sulfate 13701-70-7 0.107 0.107 0.107 0.5

3246 Vanadium, trichlorooxo 7727-18-6 0.6 1.5 12.5 60 Rat oral LD50.

3247Vanadyl sulfate pentahydrate; (Vanadium(IV)

sulfate oxide hydrate)12439-96-2 0.0696 3 20 200

3248 Vanadyl sulfate; (Oxysulfatovanadium) 27774-13-6 0.05 0.075 0.5 35

3249 Vanilin 121-33-5 5 15 125 500 Rat TClo, rat LD50.

3250 Vegetable oil 68956-68-3 15 30 50 500

3251 Veratraldehyde 120-14-9 7.5 25 150 500 Rat oral LD50.


6/19/2009



PAC Rev 24B





3252 Vermiculite, exfoliated 1318-00-9 10 30 50 250

3253Vinyl 2-chloroethylsulfide; (2-Chloroethylthio

ethene)81142-02-1 0.15 0.4 3 15 Mouse 10 min LC lo for allyl 2-chloroethylsulfide.

3254 Vinyl acetate 108-05-4 23.6 23.6 633 2,150 AEGL-1, AEGL-1, AEGL-2, AEGL-3.

3255Vinyl acetate-vinyl chloride copolymer; (Acetic

acid, vinyl ester, polymer with chloroethylene)9003-22-9 35 100 500 500

3256Vinyl acrylic resin; (Vinyl acetate, polymer with n-

butyl acrylate)25067-01-0 10 30 50 250

3257 Vinyl bromide 593-60-2 20 60 100 200

3258 Vinyl chloride 75-01-4 2.5 639 3,070 12,300 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

3259 Vinyl ethyl ether; (Ethoxy ethene) 109-92-2 50 150 1,000 5,000

3260 Vinyl fluoride 75-02-5 1.5 100 750 150,000 TLV-TWA, REL-C, rat 240 min LC50.

3261Vinyl terminated dimethylsiloxane-

diphenylsiloxane copolymer68951-96-2 75 250 500 500 Rat oral LD50 based on HHR.

3262 Vinyl trichlorosilane 75-94-5 1.25 3.96 48.2 218 AEGL-1/3, AEGL-1, AEGL-2, AEGL-3.

3263 Vinyl-2-pyrrolidinone, 1- 88-12-0 0.2 25 150 350 TLV-TWA, rat TClo, rat 240 min LC50

3264 Vinylbenzylchloride; (4-Vinylbenzyl chloride) 1592-20-7 1.5 5 35 150 Rat oral LD50 based on HHR = 3.

3265 Vinylcyclohexene, 4-; (Cyclohexenylethylene) 100-40-3 0.4 1.25 200 15,000 TLV-TWA, TEEL-0*3, Rat TClo, rat 240 min LC lo.

3266 Vinylformamide, N- 13162-05-5 5 15 100 500 Rat 249 min. LC50 minimum.


6/19/2009



PAC Rev 24B





3267 Vinylidene chloride; (1,1-dichloroethylene) 75-35-4 20 250 1,980 3,960 TLV-TWA, ERPG-2/7, ERPG-2, ERPG-3.

3268 Vinylidene fluoride; (1,1-Difluoroethene) 75-38-7 1,250 1,250 1,250 35,000

3269 Vinylmagnesium bromide 1826-67-1 1.5 5 35 150 Estimated rat oral LD50 based on HHR.

3270 Vinylpyrrolidone/vinyl acetate copolymer 25086-89-9 100 250 250 250 Rat oral TDlo, rat oral LD50 minimum.

3271

Virginia refrigeration oil 150 and 300; (Mineral oil,

petroleum distillates, hydrotreated (mild) heavy

naphthenic)

64742-52-5 15 40 300 500 Mouse skin 22 week TDlo, rat oral LD50 minimum.

3272 Warfarin 81-81-2 0.1 0.3 20 100 PEL-TWA, TEEL-0*3, LOC, IDLH.

3273 Warfarin sodium 129-06-6 1.5 5 9 9

3274 Xenon 7440-63-3 350,000 350,000 1,250,000 2,000,000 Simple asphyxiant

3275 Xylene, m- 108-38-3 400 600 750 4,000

3276 Xylene, o- 95-47-6 400 600 750 4,000

3277 Xylene, p- 106-42-3 400 600 750 4,000

3278 Xylenes 1330-20-7 400 564 3,990 10,800 PEL-TWA, AEGL-1, AEGL-2, AEGL-3.

3279 Xylenol orange tetrasodium salt 3618-43-7 10 30 50 250

3280 Xylidine 1300-73-8 25 25 25 250

3281 Xylidine, 2,6- 87-62-7 6 20 125 350


6/19/2009



PAC Rev 24B





3282 Xylidine, o-; (2,3-Xylidine) 87-59-2 2.5 50 50 250

3283 Xylylene dichloride 28347-13-9 0.4 1.25 2 75

3284 Yeast extract 8013-01-2 15 50 400 500

3285 Ytterbium fluoride 13760-80-0 10.1 10.1 10.1 10.1

3286 Ytterbium oxide 1314-37-0 10 30 50 250

3287 Yttrium 7440-65-5 1 3 5 500 PEL-TWA, TEEL-0*3, TEEL-0*5, IDLH.

3288 Yttrium chloride, hexahydrate 10025-94-2 3.41 10.2 500 500 PEL-TWA, TEEL-0*3, rat oral TDlo, IDLH.

3289 Yttrium oxide 11130-29-3 1.18 3.54 150 500 PEL-TWA, TEEL-0*3, rat TClo, IDLH.

3290 Yttrium trioxide 1314-36-9 1.27 3.81 40 500 PEL-TWA, TEEL-0*3, rat TClo, IDLH.

3291 Zeolites, CaA 68989-20-8 7.5 25 150 500 Estimated rat oral LD50 from HHR.

3292 Zeolites, KA 68989-21-9 10 30 50 250 Used PNOS default

3293 Zeolites, NaA 68989-22-0 6 15 125 500 PAC-2/21, PAC-2/7, rat TClo, PAC-2 * 5.

3294 Zeolites, NaX 68989-23-1 10 30 50 250 Used PNOS default

3295 Zinc 7440-66-6 10 30 50 200

3296 Zinc acetate 557-34-6 0.3 0.75 6 500


6/19/2009



PAC Rev 24B





3297 Zinc acetate dihydrate 5970-45-6 25 75 350 350

3298 Zinc bromide 7699-45-8 10 30 50 200

3299 Zinc carbonate 3486-35-9 5 15 100 500

3300 Zinc carbonate hydroxide 5263-02-5 10 30 50 250 PNOS default.

3301 Zinc chloride 7646-85-7 1 2 50 50 PEL-TWA, TLV-STEL, human TClo, IDLH.

3302 Zinc cyanide 557-21-1 22.6 22.6 22.6 113

3303 Zinc fluoride 7783-49-5 6.8 6.8 20 100

3304 Zinc hydroxide 20427-58-1 0.6 0.6 1.5 60 SAR

3305 Zinc nitrate 7779-88-6 10 10 10 10

3306 Zinc nitrate hexahydrate 10196-18-6 5 15 100 500

3307 Zinc nitrite 10102-02-0 0.035 0.075 0.6 60 SAR

3308 Zinc oxide 1314-13-2 2 10 15 500 TLV-TWA, TLV-STEL, REL-C, IDLH.

3309 Zinc perchlorate 13637-61-1 10 30 50 250 PNOS default.

3310Zinc phenolsulfonate; (Zinc p-

hydroxybenzenesulfonate)127-82-2 0.6 2 15 500

3311 Zinc phosphate (3:2) 7779-90-0 2 6 50 250


6/19/2009



PAC Rev 24B





3312 Zinc phosphide 1314-84-7 0.5 1.5 10.5 19 AEGL-2/21, AEGL-2/7, AEGL-2, AEGL-3.

3313 Zinc stearate 557-05-1 15 30 50 150

3314 Zinc sulfate 7733-02-0 0.15 0.5 3.5 500

3315 Zinc sulfate heptahydrate (1:1:7) 7446-20-0 100 200 200 200 Rat oral TDlo, human uk LD lo.

3316 Zirconium boride 12045-64-6 6.19 12.4 61.9 61.9 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3317 Zirconium carbide 12070-14-3 6.32 12.6 12.6 63.2 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3318 Zirconium chloride 10026-11-6 12.8 25.5 25.5 128 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3319 Zirconium chloride oxide octahydrate 13520-92-8 17.7 35.3 35.3 177 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3320 Zirconium compounds (as Zr) 7440-67-7 5 10 10 50 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3321 Zirconium fluoride 7783-64-4 9.17 18.3 18.3 91.7 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3322 Zirconium hydride 7704-99-6 5.11 10.2 51.1 51.1 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3323 Zirconium hydroxide 14475-63-9 8.73 17.5 17.5 87.3 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3324 Zirconium nitrate 13746-89-9 18.6 37.2 37.2 186 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3325 Zirconium nitride 25658-42-8 5.77 11.5 11.5 57.7 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3326 Zirconium nitrite z-0088 7.52 15 15 75.2 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.


6/19/2009



PAC Rev 24B





3327 Zirconium oxide 1314-23-4 6.75 13.5 13.5 67.5 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3328 Zirconium oxynitrate hydrate 14985-18-3 13.7 27.4 27.4 137 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3329 Zirconium phosphide 12037-80-8 8.4 16.8 16.8 84 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3330Zirconium potassium fluoride; (Potassium

fluorozirconate)16923-95-8 37.3 149 150 500 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3331 Zirconium silane z-0089 8.08 16.2 16.2 80.8 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3332Zirconium silicate; (Zirconium silicon oxide;

Zircon))10101-52-7 10.3 20.5 51.3 103 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3333 Zirconium sulfate tetrahydrate 7446-31-3 19.5 39 39 195 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3334 Zirconyl chloride; (Zirconium oxychloride) 7699-43-6 9.76 19.5 97.6 97.6 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3335 Zirconyl nitrate; (Bis(nitrato-O)oxozirconium) 13826-66-9 12.7 25.3 25.3 127 PEL-TWA, TLV-STEL, TLV-STEL, IDLH.

3336 Zonyl fsn fluorosurfactant 65545-80-4 60 150 500 500 Rat oral LD50.

3337 zzAcrylic latex z-0090 10 30 50 250

3338 zzAlumination 301 z-0091 10 30 50 250

3339 zzHydranal coulomat / AG z-0092 10 30 50 250

3340 zzHydrocarbon polymer z-0093 10 30 50 250

3341 zzHydrocount(R), LSC cocktail z-0094 10 30 50 250


6/19/2009



PAC Rev 24B





3342 zzIconol(R) z-0095 10 30 50 250

3343 zzMachine coolant 1 z-0096 10 30 50 250

3344 zzMonophase- S z-0097 10 30 50 250

3345 zzMornar z-0098 10 30 50 250

3346zzOpti-Fluor; (Alkyl benzene blend, 3%

tributylphophate)z-0099 7.5 25 37.5 250 MSDS data for mixture.

3347 zzPaint solvent z-0100 10 10 10 10

3348 zzPropanol (-2) aluminum derivative z-0101 2 6 10 50

3349 zzScintillation cocktail, Ultima Gold XR z-0102 0.15 0.5 3 15 MSDS data for mixture.

3350 zzSicapent z-0103 10 30 50 250

3351 zzSynthetic resins z-0104 10 30 50 250

3352 zzTotal sequestrant reagent #5 z-0105 35 40 100 500 MSDS data for mixture.

3353zzTrifluoroacetyl)-N,0,0,0-

tetrakis((TMS)norepinephrine, N-(z-0106 0.04 0.125 0.75 7.5

3354 zzWaste oil z-0107 10 30 50 250


table 2: protective action criteria (pac) rev 22b based on ... · limit values (tlvs), recommended...

Documents